Sentence,class,file
Chang Ho Song (e-mail: chsong@ syu.ac.kr) ©2014 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/85/1d/jpts-26-81.PMC3927048.pdf
Kyoung-Ok Min (e-mail: ptcountry@ hanmail.net) ©2014 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/29/ec/jpts-26-87.PMC3927049.pdf
Kak Hwangbo (e-mail: hbgak@ daegu.ac.kr) ©2014 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d3/28/jpts-26-93.PMC3927050.pdf
Boin Kim (e-mail: awareness0@ naver.com) ©2014 The Society of Physical Therapy Science This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/40/e2/jpts-26-97.PMC3927051.pdf
"In addition to in vitro and in vivo data, in silico predictions of certain physicochem- ical properties, including the partition coefﬁcient (Log P), compound type, dissociation constant (p Ka) and blood to plasma partition ratio ( B/P), were made using data from the following publicly available sources: ChemSpider, the freechemical database ( http://www.chemspider.com ; Royal Society of Chemistry, Cambridge, UK), ADMET Predic- tor TMversion 6 (Simulations Plus, Inc., Lancaster, CA, USA) and PubChem ( http://pubchem.ncbi.nlm.nih.gov ; National Institutes of Health, Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/74/c2/40262_2013_Article_117.PMC3927056.pdf
"It has to be noted that the CL int,Tfor Teff,awas generally unidentiﬁable with the available data for each substrate.Table 1 Drug-dependent parameter summary table for oseltamivir carboxylate, cidofovir and cefuroxime Parameter Oseltamivir carboxylate Cidofovir Cefuroxime Renal clearance by active secretion (%)62 39 55 Molecular weight (g/mol) 312.4a279.2a424.4a LogP -2.1b-1.5a-0.9a Compound type AmpholytebMonoprotic acidcMonoprotic acida Acid p Ka 3.6b6.9c3.15a Base p Ka 8.2bN/A N/A B/P 0.60b0.98c0.56c fu,p 0.97b0.90 (0.56 in severe RI)d0.67e Vss(L/kg) 0.44f0.49f0.20f Kpscalar 1.0 1.5 (optimized based on serum concentration–time IV proﬁle)g0.7 (optimized based on serum concentration–time IV proﬁle)g CLiv(L/h) 19.0h12.8d11.0e CLr(L/h) 19.0h11.4d11.0e Hepatic elimination (liver S9 intrinsic clearance)N/A 0.41 (retrograde analysis; sensitivity analysis to match with S9)N/A CLint,T(lL/min/106cells) by T up,b12.0 (optimized based on plasma concentration–time proﬁle)g3.33 (optimized based on serum concentration–time proﬁle)g9.62 (optimized based on serum concentration–time proﬁle)g CLint,T(lL/min/106cells) byTeff,a1([0.001 based on urine data)g20 ([0.2 based on urine data)g10 ([0.1 based on urine data)g fa 0.80hN/A N/A ka(1/h) 0.15 (optimized)gN/A N/A Lag time (h) 0.60 (optimized)gN/A N/A B/Pblood to plasma partition ratio, CLint,Tin vitro transporter-mediated intrinsic clearance, CLivin vivo clearance, CLrrenal clearance, fa fraction available from dosage form, fu,pfraction unbound in plasma, IVintravenous, kaﬁrst-order absorption rate constant, Kptissue-to-plasma partition coefﬁcient, LogP partition coefﬁcient, N/A not applicable, pKa dissociation constant, RIrenal impairment, Teff,aefﬂux transporter on apical membrane, Tup,buptake transporter on basolateral membrane, Vssvolume of distribution at steady state aFrom ChemSpider ( http://www.chemspider.com ; Royal Society of Chemistry, Cambridge, UK) bFrom Parrott et al.",Non-OADS,/arxiv_data1/oa_pdf/74/c2/40262_2013_Article_117.PMC3927056.pdf
"In addition, probenecid appears to be a much stronger inhibitor of basolateral uptake trans- porters (University of Washington Metabolism andTransporter database: http://www.druginteractioninfo.org ).",Non-OADS,/arxiv_data1/oa_pdf/74/c2/40262_2013_Article_117.PMC3927056.pdf
Cidofovir (US label); 2013. http://www.accessdata.fda.gov/ drugsatfda_docs/label/1999/020638s003lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/74/c2/40262_2013_Article_117.PMC3927056.pdf
Cidofovir (EMA summary for the public); 2013. http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/74/c2/40262_2013_Article_117.PMC3927056.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Ruptured venous aneurysm of cervicomedullary junction Ashish Aggarwal, Pravin Salunke, Sameer Futane, S. N. Mathuriya, Ajay Kumar1, K. K. Mukherjee,  B. D. Radotra2 Departments of Neurosurgery, 1Radiodiagnosis, 2Pathology, PGIMER, Chandigarh, India E‑mail: *Ashish Aggarwal ‑ aaggarwal_7@yahoo.com; Pravin Salunke ‑ drpravin_salunke@yahoo.co.uk; Sameer Futane ‑ sfutane@gmail.com;   SN Mathuriya ‑ snmaturiya@yahoomail.com; Ajay Kumar ‑ ajay2509@gmail.com; KK Mukherjee ‑ kk_mukherjee@hotmail.com;   BD Radotra ‑ bishanradotra@hotmail.com   *Corresponding author Received: 18 July 13  Accepted: 11 December 13  Published: 14 January 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.124977  Quick Response Code: Abstract Background:  Ruptured venous aneurysm is often seen with arterio‑venous  malformation (AVM) or developmental venous anomaly (DVA).",Non-OADS,/arxiv_data1/oa_pdf/db/3d/SNI-5-2.PMC3927081.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/2/124977 Copyright: © 2014 Aggarwal A.,Non-OADS,/arxiv_data1/oa_pdf/db/3d/SNI-5-2.PMC3927081.pdf
"Surgical Neurology International 2014, 5:2  http://www.surgicalneurologyint.com/content/5/1/2Computerized tomography angiography (CTA)   [Figure 1b ‑d] and digital substraction angiography (DSA)  [Figure 1e and f] revealed a saccular contrast filling pouch  in the left lateral aspect of CMJ.",Non-OADS,/arxiv_data1/oa_pdf/db/3d/SNI-5-2.PMC3927081.pdf
"Surgical Neurology International 2014, 5:2  http://www.surgicalneurologyint.com/content/5/1/2walled vascular structure with no arterial ostia.",Non-OADS,/arxiv_data1/oa_pdf/db/3d/SNI-5-2.PMC3927081.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comT echnical Note Convexity meningiomas enhanced by sodium fluorescein Carlos Eduardo da Silva, Vinicius Duval da Silva1, Jefferson Luis Braga da Silva2 Departments of Neurosurgery and Skull Base Surgery, Hospital Ernesto Dornelles, 1Pathology and Radiation, 2Service of Hand Surgery and Reconstructive  Microsurgery, Pontifical Catholic University of Rio Grande do Sul – PUCRS, Porto Alegre/RS, Brazil E‑mail: *Carlos Eduardo da Silva ‑ dasilvacebr@yahoo.com.br, Vinicius Duval da Silva ‑ vinids@pucrs.br, Jefferson Luis Braga da Silva ‑ jeffersonbraga@ig.com.br   *Corresponding author Received: 10 November 13  Accepted: 07 December 13  Published: 14 January 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.124978  Quick Response Code: INTRODUCTION The recognition of the meningiomas and surrounding  dural tail limits is one of the most challenging goals  during a meningioma resection.",Non-OADS,/arxiv_data1/oa_pdf/e3/4a/SNI-5-3.PMC3927087.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/3/124978 Copyright: © 2014 da Silva CE.,Non-OADS,/arxiv_data1/oa_pdf/e3/4a/SNI-5-3.PMC3927087.pdf
"Surgical Neurology International 2014, 5:3  http://www.surgicalneurologyint.com/content/5/1/3transoperative SF administration, showed strong evidence  of dural and tumoral dye enhancement [Figures 1a and 2].",Non-OADS,/arxiv_data1/oa_pdf/e3/4a/SNI-5-3.PMC3927087.pdf
"Surgical Neurology International 2014, 5:3  http://www.surgicalneurologyint.com/content/5/1/3risk of recurrence.",Non-OADS,/arxiv_data1/oa_pdf/e3/4a/SNI-5-3.PMC3927087.pdf
"Surgical Neurology International 2014, 5:3  http://www.surgicalneurologyint.com/content/5/1/3in convexity meningiomas, the goal should be tumor  resection plus excision of the dural tail and, if possible,  an additional dural margin of 2 cm, that is, a grade zero  removal.",Non-OADS,/arxiv_data1/oa_pdf/e3/4a/SNI-5-3.PMC3927087.pdf
"Surgical Neurology International 2014, 5:3  http://www.surgicalneurologyint.com/content/5/1/3considerable fluorescent tool for convexity meningiomas  surgery.",Non-OADS,/arxiv_data1/oa_pdf/e3/4a/SNI-5-3.PMC3927087.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Noninvasive diagnosis and management of spontaneous  intracranial hypotension in patients with marfan syndrome: Case  Report and Review of the Literature Luigi Bassani, Christopher S. Graffeo1, Navid Behrooz2, Vineet T yagi1, Taylor Wilson1,   Saul Penaranda1, David Zagzag3, Daniel B Rifkin4, Mary Helen Barcellos‑Hoff4,5, Girish Fatterpekar6,  Dimitris Placantonakis1 Department of Neurosurgery, University of Utah School of Medicine, 1Departments of Neurosurgery, 3Pathology, 4Cell Biology, 5Radiation Oncology, and  6Radiology, New York University School of Medicine, 2Department of Emergency Medicine, New York‑Presbyterian Hospital, New York, USA E‑mail:  Luigi Bassani ‑ Luigi.Bassani@gmail.com; Christopher S. Graffeo ‑ Graffeo@gmail.com; Navid Behrooz ‑ nab9080@nyp.org;   Vineet Tyagi ‑ Vineet.Tyagi@med.nyu.edu; Taylor Wilson ‑ Taylor.Wilson@nyumc.org; Saul Penaranda ‑ Spenaran@hunter.cuny.edu;   David Zagzag ‑ David.Zagzag@nyumc.org; Daniel B Rifkin ‑ Daniel.Rifkin@nyumc.org; Mary Helen Barcellos‑Hoff ‑ MHBarcellos‑Hoff@nyumc.org;   Girish Fatterpekar ‑ Girish.Fatterpekar@nyumc.org; *Dimitris Placantonakis ‑ Dimitris.Placantonakis@nyumc.org   *Corresponding author Received: 22 October 13  Accepted: 06 November 13  Published: 21 January 14 Abstract Background:  Spontaneous intracranial hypotension is an uncommon clinical entity.",Non-OADS,/arxiv_data1/oa_pdf/cd/ed/SNI-5-8.PMC3927088.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/8/125629 *Luigi Bassani and Christopher S. Graffeo contributed equally.Copyright: © 2014 Luigi B.,Non-OADS,/arxiv_data1/oa_pdf/cd/ed/SNI-5-8.PMC3927088.pdf
"Surgical Neurology International 2014, 5:8  http://www.surgicalneurologyint.com/content/5/1/8pain, cranial nerve palsies, tinnitus or decreased hearing,  blurry vision, or chronic headaches.",Non-OADS,/arxiv_data1/oa_pdf/cd/ed/SNI-5-8.PMC3927088.pdf
"Surgical Neurology International 2014, 5:8  http://www.surgicalneurologyint.com/content/5/1/8In spite of the different mechanisms each supports, all  of these studies link structurally weak connective tissue  to DE and dural structural abnormalities in general and,  consequently, elevated risk of SIH.",Non-OADS,/arxiv_data1/oa_pdf/cd/ed/SNI-5-8.PMC3927088.pdf
"Surgical Neurology International 2014, 5:8  http://www.surgicalneurologyint.com/content/5/1/8for a site of leak.",Non-OADS,/arxiv_data1/oa_pdf/cd/ed/SNI-5-8.PMC3927088.pdf
"Surgical Neurology International 2014, 5:8  http://www.surgicalneurologyint.com/content/5/1/8while MR myelography ultimately demonstrated CSF  extravasation in the thoracic spine.",Non-OADS,/arxiv_data1/oa_pdf/cd/ed/SNI-5-8.PMC3927088.pdf
"Surgical Neurology International 2014, 5:8  http://www.surgicalneurologyint.com/content/5/1/8Ahn’s and Oosterhof’s methodologies agreed on 13.",Non-OADS,/arxiv_data1/oa_pdf/cd/ed/SNI-5-8.PMC3927088.pdf
"Surgical Neurology International 2014, 5:8  http://www.surgicalneurologyint.com/content/5/1/8in spontaneous CSF leaks.",Non-OADS,/arxiv_data1/oa_pdf/cd/ed/SNI-5-8.PMC3927088.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Optic nerve glioma: A great mimicker Poonam Bhaker, Ruchita T yagi, Divyesh Mahajan1, Sandeep Mohindra2, Rakesh K. Vasishta Departments of Pathology, 1Radiodiagnosis, 2Neurosurgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India E‑mail:  Poonam Bhaker ‑ punam4_84@yahoo.co.in; Ruchita Tyagi ‑ ruchitatyagi@gmail.com; Divyesh Mahajan ‑ drdivyeshmahajan@yahoo.com;   Sandeep Mohindra ‑ sandeepmohindra@gmail.com; *Rakesh K. Vasishta ‑ r_vasishta@yahoo.com   *Corresponding author Received: 25 August 2013  Accepted: 19 December 2013  Published: 23 January 14 Abstract Background:  Arachnoid proliferation, although rare, is known to occur in  association with optic gliomas.",Non-OADS,/arxiv_data1/oa_pdf/eb/4d/SNI-5-9.PMC3927089.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/9/125777 Copyright: © 2014 Bhaker P .,Non-OADS,/arxiv_data1/oa_pdf/eb/4d/SNI-5-9.PMC3927089.pdf
"Surgical Neurology International 2014, 5:9  http://www.surgicalneurologyint.com/content/5/1/9CASE REPORT History and Examination A 27-year -old male presented with progressive, painless  loss of vision in right eye, associated with vomiting  and headache for one and a half months, without  accompanying loss of consciousness or fever.",Non-OADS,/arxiv_data1/oa_pdf/eb/4d/SNI-5-9.PMC3927089.pdf
"Surgical Neurology International 2014, 5:9  http://www.surgicalneurologyint.com/content/5/1/9proliferation of meningothelial cells.",Non-OADS,/arxiv_data1/oa_pdf/eb/4d/SNI-5-9.PMC3927089.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comT echnical Note Temporary clamping of bilateral external carotid arteries for  surgical excision of a complex dural arteriovenous fistula Shih‑Chieh Shen, Wen‑Hsieh Chen1, Se‑ Yi Chen2, Ming‑Hsi Sun2, Chiung‑Chyi Shen2,  Yuang‑Seng T suei2 Departments of Surgery, Tri‑Service General Hospital Songshan Branch, Taipei, 1Radiology, 2Neurosurgery, Taichung Veterans General Hospital, Taichung, Taiwan E‑mail: Shih‑Chieh Shen ‑ james701004@yahoo.com.tw; Wen‑Hsieh Chen ‑ whchen@vghtc.gov.tw; Se‑Yi Chen  ‑ s861085@gmail.com;   Ming‑Hsi Sun ‑ mgsun@vghtc.gov.tw; Chiung‑Chyi Shen ‑ shengeorge@yahoo.com; *Yuang‑Seng Tsuei ‑ astrocytoma2001@yahoo.com.tw   *Corresponding author: Received: 18 June 13   Accepted: 18 December 13  Published: 23 January 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.125780  Quick Response Code: Abstract Background: Some complex dural arteriovenous fistulas (DAVFs) are lesions that  typically have numerous arterial feeders.",Non-OADS,/arxiv_data1/oa_pdf/62/5f/SNI-5-10.PMC3927090.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/10/125780 Copyright: © 2014 Shen SC.,Non-OADS,/arxiv_data1/oa_pdf/62/5f/SNI-5-10.PMC3927090.pdf
"Surgical Neurology International 2014, 5:10  http://www.surgicalneurologyint.com/content/5/1/10CT angiography of the brain revealed no intracranial  hemorrhage but did show numerous engorged vessels in  bilateral cerebral hemisphere and superficial scalp.",Non-OADS,/arxiv_data1/oa_pdf/62/5f/SNI-5-10.PMC3927090.pdf
"Surgical Neurology International 2014, 5:10  http://www.surgicalneurologyint.com/content/5/1/10exposure is close to the involved sinus.",Non-OADS,/arxiv_data1/oa_pdf/62/5f/SNI-5-10.PMC3927090.pdf
"Surgical Neurology International 2014, 5:10  http://www.surgicalneurologyint.com/content/5/1/10A limitation of our report is that we just completely  obliterated all fistulas primarily on our first case, but  the second did not.",Non-OADS,/arxiv_data1/oa_pdf/62/5f/SNI-5-10.PMC3927090.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report C7 intralaminar screw placement, an alternative to lateral mass or  pedicle fixation for treatment of cervical spondylytic myelopathy ,  kyphotic deformity, and trauma: A  case report and technical note Michael T .",Non-OADS,/arxiv_data1/oa_pdf/b7/50/SNI-5-4.PMC3927091.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/4/125283 Copyright: © 2014 Koltz MT.,Non-OADS,/arxiv_data1/oa_pdf/b7/50/SNI-5-4.PMC3927091.pdf
"Surgical Neurology International 2014, 5:4  http://www.surgicalneurologyint.com/content/5/1/4therefore making it a favorable target to stabilize a  construct.",Non-OADS,/arxiv_data1/oa_pdf/b7/50/SNI-5-4.PMC3927091.pdf
"Surgical Neurology International 2014, 5:4  http://www.surgicalneurologyint.com/content/5/1/4reveals good screw placement with a good construct.",Non-OADS,/arxiv_data1/oa_pdf/b7/50/SNI-5-4.PMC3927091.pdf
"Surgical Neurology International 2014, 5:4  http://www.surgicalneurologyint.com/content/5/1/4fluoroscopy may not be needed in selected patients.",Non-OADS,/arxiv_data1/oa_pdf/b7/50/SNI-5-4.PMC3927091.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Efficacy of a new video‑based training model in spinal surgery Heiland D. H., Petridis A. K., Maslehaty H., Thissen J., Kinzel A., Scholz M., Schreiber L. Department of Neurosurgery, Klinikum Duisburg, Academic T eaching Hospital of  The University Duisburg‑Essen, Germany E‑mail:  Heiland D.H ‑ dieter.henrik.heiland@uniklinik‑freiburg.de; *Athanasios K. Petridis ‑ opticdisc@aol.com; Maslehaty H ‑ h.maslehaty@gmx.de;   Thissen J ‑ thissenj@sana.de; Kinzel A ‑ kinzela@sana.de; Scholz M ‑ martin.scholz‑kdu@sana.de; Schreiber L ‑ lutzschreiber1@aol.com   *Corresponding author Received: 02 September 2013   Accepted: 16 October 2013  Published: 14 January 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.124973  Quick Response Code: Abstract Background:  An important part of neurosurgical training is the improvement of  surgical skills.",Non-OADS,/arxiv_data1/oa_pdf/2b/ac/SNI-5-1.PMC3927092.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/1/124973 Copyright: © 2014 Heiland DH.,Non-OADS,/arxiv_data1/oa_pdf/2b/ac/SNI-5-1.PMC3927092.pdf
"Surgical Neurology International 2014, 5:1  http://www.surgicalneurologyint.com/content/5/1/1of surgery capabilities can be mapped by a learning  curve.",Non-OADS,/arxiv_data1/oa_pdf/2b/ac/SNI-5-1.PMC3927092.pdf
"Surgical Neurology International 2014, 5:1  http://www.surgicalneurologyint.com/content/5/1/1t‑test and regression analysis.",Non-OADS,/arxiv_data1/oa_pdf/2b/ac/SNI-5-1.PMC3927092.pdf
"Surgical Neurology International 2014, 5:1  http://www.surgicalneurologyint.com/content/5/1/1DISCUSSION Every learning process has a learning curve.",Non-OADS,/arxiv_data1/oa_pdf/2b/ac/SNI-5-1.PMC3927092.pdf
"Surgical Neurology International 2014, 5:1  http://www.surgicalneurologyint.com/content/5/1/1learning plateau.",Non-OADS,/arxiv_data1/oa_pdf/2b/ac/SNI-5-1.PMC3927092.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Abstract Background: Spinal dural arteriovenous fistula (SDAVF) is a rare spinal vascular  malformation with an annual incidence of 5-10 cases per million.",Non-OADS,/arxiv_data1/oa_pdf/bd/23/SNI-5-7.PMC3927093.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/7/125628 Copyright: © 2014 Gokhale S. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.Comparison of surgical and endovascular approach in  management of spinal dural arteriovenous fistulas: A  single  center experience of 27 patients Sankalp Gokhale, Shariq A. Khan1, David L. McDonagh2, Gavin Britz3 Division of Neurocritical Care, Departments of Neurology, 1Division of Neuro‑anesthesia, Anesthesiology, Duke University Hospital, Duke University School  of Medicine, 2Anesthesiology and Neurology, Chief, Division of Neuro‑anesthesiology, Duke University Medical Center, Durham, NC 27710, 3Department of  Neurosurgery, Methodist Hospital of Houston, University of T exas ‑Houston, 6560 Fannin St. Suite 944, Houston, TX 77030, USA E‑mail: *Sankalp Gokhale ‑ sankalpsgokhale@gmail.com; Shariq A. Khan ‑ shariq.khan@duke.edu; David L. McDonagh ‑ david.mcdonagh@duke.edu;  Gavin Britz ‑ gbritz@tmhs.org   *Corresponding author: Received: 28 July 13   Accepted: 21 November 13  Published: 21 January 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.125628  Quick Response Code:",Non-OADS,/arxiv_data1/oa_pdf/bd/23/SNI-5-7.PMC3927093.pdf
"Surgical Neurology International 2014, 5:7  http://www.surgicalneurologyint.com/content/5/1/7INTRODUCTION Vascular malformations of spinal cord are rare clinical  entities.",Non-OADS,/arxiv_data1/oa_pdf/bd/23/SNI-5-7.PMC3927093.pdf
"Surgical Neurology International 2014, 5:7  http://www.surgicalneurologyint.com/content/5/1/7Statistical analysis Mann–Whitney U test or Chi-square tests were used for  intergroup comparisons as appropriate.",Non-OADS,/arxiv_data1/oa_pdf/bd/23/SNI-5-7.PMC3927093.pdf
"Surgical Neurology International 2014, 5:7  http://www.surgicalneurologyint.com/content/5/1/7magnetic resonance angiography (MRA), which  was diagnostic of SDADF in four patients and was  suggestive in three patients.",Non-OADS,/arxiv_data1/oa_pdf/bd/23/SNI-5-7.PMC3927093.pdf
"Surgical Neurology International 2014, 5:7  http://www.surgicalneurologyint.com/content/5/1/7veins.",Non-OADS,/arxiv_data1/oa_pdf/bd/23/SNI-5-7.PMC3927093.pdf
"Surgical Neurology International 2014, 5:7  http://www.surgicalneurologyint.com/content/5/1/7CONCLUSIONS SDAVF is a rare acquired disorder of spinal cord.",Non-OADS,/arxiv_data1/oa_pdf/bd/23/SNI-5-7.PMC3927093.pdf
"Surgical Neurology International 2014, 5:7  http://www.surgicalneurologyint.com/content/5/1/7series preclude meaningful statistical comparison.",Non-OADS,/arxiv_data1/oa_pdf/bd/23/SNI-5-7.PMC3927093.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Subarachnoid hemorrhage due to nonbranching aneurysm of the  middle cerebral artery in a young adult with a history of Kawasaki  disease Atsushi Ishida, Seigo Matsuo, Shunji Kawamura1, Toshio Nishikawa2  Departments of Neurosurgery, Moriyama Memorial Hospital, T okyo, Japan, 1Pathology, T okyo Women’s Medical University Yachiyo Medical Center, Chiba, Japan 2Surgical Pathology, T okyo Women’s Medical University, T okyo, Japan E‑mail: *Atsushi Ishida ‑ v2danyon@gmail.com; Seigo Matsuo ‑ sergio5679@gmail.com; Shunji Kawamura ‑ shunji@tymc.twmu.ac.jp;   T oshio Nishikawa‑ nishikawat@twmu.ac.jp   *Corresponding author Received: 01 October 13  Accepted: 26 November 13  Published: 17 January 14  Abstract Background:  The incidence of subarachnoid hemorrhage (SAH) in young adults  is relatively rare.",Non-OADS,/arxiv_data1/oa_pdf/c7/2b/SNI-5-5.PMC3927094.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/5/125285 Copyright: © 2014 Ishida A.,Non-OADS,/arxiv_data1/oa_pdf/c7/2b/SNI-5-5.PMC3927094.pdf
"Surgical Neurology International 2014, 5:5  http://www.surgicalneurologyint.com/content/5/1/5and cervical lymphadenopathy.",Non-OADS,/arxiv_data1/oa_pdf/c7/2b/SNI-5-5.PMC3927094.pdf
"Surgical Neurology International 2014, 5:5  http://www.surgicalneurologyint.com/content/5/1/5complete absence of elastic lamina.",Non-OADS,/arxiv_data1/oa_pdf/c7/2b/SNI-5-5.PMC3927094.pdf
"Surgical Neurology International 2014, 5:5  http://www.surgicalneurologyint.com/content/5/1/5aneurysm at the bifurcation of major arteries.",Non-OADS,/arxiv_data1/oa_pdf/c7/2b/SNI-5-5.PMC3927094.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Gowers’ intrasyringeal hemorrhage associated with Chiari type I  malformation in Noonan syndrome Takafumi Mitsuhara, Satoshi Yamaguchi, Masaaki Takeda, Kaoru Kurisu Department of Neurosurgery, Graduate School of Biomedical Sciences, Hiroshima University, 1‑2‑3 Kasumi, Minami‑ku, Hiroshima 734‑8551, Japan E‑mail:  *Takafumi Mitsuhara ‑ mitsuhar@kuhp.kyoto‑u.ac.jp; Satoshi Yamaguchi ‑ satoya@hiroshima‑u.ac.jp; Masaaki Takeda ‑ tkdmsk@hiroshima‑u.ac.jp;  Kaoru Kurisu ‑ kuka422@hiroshima‑u.ac.jp   *Corresponding author Received: 18 September 13   Accepted: 06 November 13  Published: 20 January 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.125546  Quick Response Code: Abstract Background:  Idiopathic hemorrhage in a syrinx is a rare entity known as Gowers’  intrasyringeal hemorrhage.",Non-OADS,/arxiv_data1/oa_pdf/fc/af/SNI-5-6.PMC3927095.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/6/125546 Copyright: © 2014 Mitsuhara T.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/fc/af/SNI-5-6.PMC3927095.pdf
"Surgical Neurology International 2014, 5:6  http://www.surgicalneurologyint.com/content/5/1/6in childhood and had been diagnosed with Noonan  syndrome on the basis of molecular genetic analysis.",Non-OADS,/arxiv_data1/oa_pdf/fc/af/SNI-5-6.PMC3927095.pdf
"Surgical Neurology International 2014, 5:6  http://www.surgicalneurologyint.com/content/5/1/6hemorrhage.",Non-OADS,/arxiv_data1/oa_pdf/fc/af/SNI-5-6.PMC3927095.pdf
"Surgical Neurology International 2014, 5:6  http://www.surgicalneurologyint.com/content/5/1/6Commentary Idiopathic hemorrhage in a Syrinx (also known as Gowers’  intrasyringeal hemorrhage) is a rare event in the overall  clinical history of a Syringomyelia (SM) cavity.",Non-OADS,/arxiv_data1/oa_pdf/fc/af/SNI-5-6.PMC3927095.pdf
http://www.syntaxscore.com.,Non-OADS,/arxiv_data1/oa_pdf/99/29/PWKI-9-21731.PMC3927107.pdf
17. http://hipotermiaterapeutyczna.pl/.,Non-OADS,/arxiv_data1/oa_pdf/11/9d/PWKI-9-21735.PMC3927111.pdf
http://www.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/38/b0/40262_2013_Article_126.PMC3927118.pdf
http://www.invokanahcp.com/prescribing-information.,Non-OADS,/arxiv_data1/oa_pdf/38/b0/40262_2013_Article_126.PMC3927118.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/cd/95/ijbsv10p0181.PMC3927130.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/41/ijbsv10p0192.PMC3927131.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/62/66/ijbsv10p0200.PMC3927132.pdf
http://www.geneious.com.,Non-OADS,/arxiv_data1/oa_pdf/62/66/ijbsv10p0200.PMC3927132.pdf
"Tracer v1.4, Available from  http://beast.bio.ed.ac.uk/Tracer.",OADS,/arxiv_data1/oa_pdf/62/66/ijbsv10p0200.PMC3927132.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8f/89/ijbsv10p0212.PMC3927133.pdf
This is an open- access article dis tributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/13/9b/ijbsv10p0225.PMC3927134.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4114 | DOI: 10.1038/srep04114 5",Non-OADS,/arxiv_data1/oa_pdf/b2/fb/srep04114.PMC3927205.pdf
"The online bioinformatics software SIFT(http://sift.jcvi.org/) predicts a deleterious effect of this substitution.Taken together, these data indicate that the p.P88T substitution is acausative disease mutation rather than a simple polymorphism.Different expression pattern and high expression level of mutant protein .To dissect the molecular consequences of the mutation identified in this family, we generated the patients-associated Flag- tagged and GFP-tagged Cx50 mutants.",Non-OADS,/arxiv_data1/oa_pdf/0c/0e/srep04121.PMC3927206.pdf
"We further took advantage of a membrane-tagged expression of RFP, encoded by the pmTmG plasmid (original from Addgene http://www.addgene.org/17787/), and used it as control for labeling the plasma membrane, which confirms that the p.P88T Cx50 mutant protein has a distinct expression pattern of connexins (see Supple- mentary Fig.",Non-OADS,/arxiv_data1/oa_pdf/0c/0e/srep04121.PMC3927206.pdf
"Furthermore, we used the online bioinformaticssoftware SIFT (http://sift.jcvi.org/) to predict whether the amino acid substitution p.P88T in Cx50 could have a phenotypic effect.",OADS,/arxiv_data1/oa_pdf/0c/0e/srep04121.PMC3927206.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0c/0e/srep04121.PMC3927206.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4121 | DOI: 10.1038/srep04121 6",Non-OADS,/arxiv_data1/oa_pdf/0c/0e/srep04121.PMC3927206.pdf
"http://www.ncdc.noaa.gov/oa/climate/research/sst/oi- daily-information.php, (accessed 08.08.2013).",OADS,/arxiv_data1/oa_pdf/27/6b/srep04119.PMC3927207.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/srep04119.PMC3927207.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4119 | DOI: 10.1038/srep04119 5",Non-OADS,/arxiv_data1/oa_pdf/27/6b/srep04119.PMC3927207.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4118 | DOI: 10.1038/srep04118 5",Non-OADS,/arxiv_data1/oa_pdf/9a/f9/srep04118.PMC3927208.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4125 | DOI: 10.1038/srep04125 6",Non-OADS,/arxiv_data1/oa_pdf/91/b3/srep04125.PMC3927209.pdf
"For fine-mapping, we used the cer466314, cer459267 and cer453616 InDel polymorphisms (Table S1) from Monsanto (http://www.arabidopsis.org/ browse/Cereon).",Non-OADS,/arxiv_data1/oa_pdf/eb/67/srep04122.PMC3927210.pdf
The presence of the T-DNA insertion in rpl36aa was confirmed by PCR using the rpl36aa_F/R primers designed with the T-DNA PrimerDesign tool (http://signal.salk.edu/tdnaprimers.2.html) (Table S1).,OADS,/arxiv_data1/oa_pdf/eb/67/srep04122.PMC3927210.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/eb/67/srep04122.PMC3927210.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4122 | DOI: 10.1038/srep04122 7",Non-OADS,/arxiv_data1/oa_pdf/eb/67/srep04122.PMC3927210.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2d/e3/srep04123.PMC3927211.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4123 | DOI: 10.1038/srep04123 6",Non-OADS,/arxiv_data1/oa_pdf/2d/e3/srep04123.PMC3927211.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0d/d1/srep04124.PMC3927214.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4124 | DOI: 10.1038/srep04124 5",Non-OADS,/arxiv_data1/oa_pdf/0d/d1/srep04124.PMC3927214.pdf
"HYPERLINK “http://www.ncbi.nlm.nih.gov/pubmed/2104528”  \o nesthesiology.” Anesthesiology  1990;73:1290-2.How to cite this article: Gupta A, Usha U. Spinal anesthesia in children:  A review.",Non-OADS,/arxiv_data1/oa_pdf/7f/da/JOACP-30-10.PMC3927267.pdf
Available from: http://www.resus.org.uk/pages/reaction.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2f/ab/JOACP-30-104.PMC3927269.pdf
Available from: http://www.nysora.com/regional_anesthesia/neuraxial_techniques/3026-epidural-blockade.html.,Non-OADS,/arxiv_data1/oa_pdf/36/32/JOACP-30-112.PMC3927274.pdf
Available from: http://emedicine.medscape.com/article/336605-overview#a21.,Non-OADS,/arxiv_data1/oa_pdf/36/32/JOACP-30-112.PMC3927274.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d5/d2/JOACP-30-20.PMC3927286.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/ae/eb/JOACP-30-25.PMC3927287.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/JOACP-30-59.PMC3927294.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4126 | DOI: 10.1038/srep04126 7",Non-OADS,/arxiv_data1/oa_pdf/4a/58/srep04126.PMC3927305.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/22/d8/JOMFP-17-321.PMC3927327.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/22/d8/JOMFP-17-321.PMC3927327.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/84/d0/JOMFP-17-329.PMC3927330.pdf
Available  from URL http://www.freepatentsonline.com/6993175.html.,Non-OADS,/arxiv_data1/oa_pdf/c4/47/JOMFP-17-334.PMC3927331.pdf
Available from: http://www.osha.gov/comp-links.html  [Last accessed on 2009 Dec 16].,OADS,/arxiv_data1/oa_pdf/19/ba/JOMFP-17-363.PMC3927336.pdf
Available from: http://www.ipcc-nggip.iges.or.jp/public/gp/ english/8_QA-QC.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/c1/JOMFP-17-402.PMC3927343.pdf
Avaliable from: http://www.rcpath.org/ Resources/RCPath/Migrated%20Resources/Documents/G/ G012-RecsForDevpmtOfHisto-CytoEQASchemes.pdf.Table 2: Safety measures while handling hazardous  chemicals General principles Minimize all chemical exposures by taking precautions If possible substitute less toxic materials E.g.,Non-OADS,/arxiv_data1/oa_pdf/a6/c1/JOMFP-17-402.PMC3927343.pdf
Available from: http://www.medicinaoral.,Non-OADS,/arxiv_data1/oa_pdf/91/aa/JOMFP-17-447.PMC3927354.pdf
Available from: http://dx.doi.org/10.1016/j.ajoms.,OADS,/arxiv_data1/oa_pdf/83/82/JOMFP-17-463.PMC3927358.pdf
"Using 50 AML WGS cases, sciClone (http://github.com/ genome/sciclone) detected DNMT3A mutations in the founding clone for 100% (8 out of 8) of cases and NRAS mutations in the subclone for 75% (3 out of 4) of cases (Extended Data Fig.",OADS,/arxiv_data1/oa_pdf/4f/2f/41586_2013_Article_BFnature12634.PMC3927368.pdf
METHODS SUMMARY Mutation data were standardized for 12 cancer types and tracked on Synapse with documentation (http://dx.doi.org/10.7303/syn1729383.2).,OADS,/arxiv_data1/oa_pdf/4f/2f/41586_2013_Article_BFnature12634.PMC3927368.pdf
"Cross-cancer survival analysis was based on the Cox proportional hazards model, as implemented in the R package ‘survival’ (http://cran.r-project.org/web/ packages/survival/), and the sciClone algorithm (http://github.com/genome/sci- clone) generated mutation clusters using point mutations from copy number neutral segments.",OADS,/arxiv_data1/oa_pdf/4f/2f/41586_2013_Article_BFnature12634.PMC3927368.pdf
"To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-sa/3.0ARTICLE RESEARCH 17 OCTOBER 2013 | VOL 502 | NATURE | 339 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/4f/2f/41586_2013_Article_BFnature12634.PMC3927368.pdf
"We used the standard Cox proportional hazards model for individual cancer types as well as cross-cancer survival ana- lysis, as implemented in the R package ‘survival’ (http://cran.r-project.org/web/ packages/survival/).",Non-OADS,/arxiv_data1/oa_pdf/4f/2f/41586_2013_Article_BFnature12634.PMC3927368.pdf
SciClone (http://github.com/genome/sciclone) was used for generating muta- tion clusters using point mutations from copy number neutral segments.,OADS,/arxiv_data1/oa_pdf/4f/2f/41586_2013_Article_BFnature12634.PMC3927368.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/36/TOORTHJ-8-20.PMC3927375.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/8a/TOORTHJ-8-24.PMC3927377.pdf
"PLoS Genet 2013; 9:e1003207; PMID:23341784; http://dx.doi.org/10.1371/journal.p gen.10 03207.Keywords:  childhood obesity, hypo - thalamus, POMC, leptin, Prader-Willi  Syndrome, electrophysiology, neuropep - tide Y, mouse model Submitted: 02/27/13Accepted: 03/22/13Published Online: 04/10/13http://dx.doi.org/10.4161/rdis.24421 Citation: Colmers WF, Wevrick R. Leptin signaling  defects in a mouse model of Prader-Willi syn - drome: An orphan genetic obesity syndrome no more?",Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
JAMA 2013; 309:71-82; PMID:23280227; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
PLoS One 2011; 6:e27135;  PMID:22087252; http://dx.doi.org/10.1371/jour - nal.pone.0027135.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
PLoS One 2012; 7:e30153; PMID:22347368; http://dx.doi.org/10.1371/jour - nal.pone.0030153.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Nat Genet 2012; 44:526-31; PMID:22484627;  http://dx.doi.org/10.1038/ng.2247.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
"Nat Genet  2009; 41:25-34; PMID:19079261; http://dx.doi.org/10.1038/ng.287.That is, while POMC neurons are present  in near normal numbers in the ARC of the hypothalamus, they fail to depolarize in response to leptin, while normal hyperpo - larizing responses were detected in AgRP/NPY cells.",OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Hum Mol Genet 2000; 9:1813-9; PMID:10915770; http://dx.doi.org/10.1093/ hmg/9.12.1813.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Nature  2001; 411:480-4; PMID:11373681; http://dx.doi.org/10.1038/35078085.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
J Neurosci 2010; 30:1560-5; PMID:20107083; http://dx.doi.org/10.1523/ JNEUROSCI.4816-09.2010.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Neuron 2004; 42:983-91; PMID:15207242; http://dx.doi.org/10.1016/j.neuron.2004.06.004.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Endocrinology 2007; 148:72-80; PMID:17023536;  http://dx.doi.org/10.1210/en.2006-1119.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Curr Biol 2007; 17:1586- 94; PMID:17825558; http://dx.doi.org/10.1016/j.cub.2007.08.034.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Hum Mol Genet 1997; 6:1873-8; PMID:9302265; http://dx.doi.org/10.1093/ hmg/6.11.1873.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Nat Genet 1999; 23:199-202;  PMID:10508517; http://dx.doi.org/10.1038/13828.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Hum Mol Genet 2000; 9:3101- 10; PMID:11115855; http://dx.doi.org/10.1093/ hmg/9.20.3101.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Endocrinology 2011; 152:967- 78; PMID:21248145; http://dx.doi.org/10.1210/ en.2010-0709.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Am J Med Genet A 2012; 158A:966-8; PMID:22419655; http://dx.doi.org/10.1002/ ajmg.a.35249.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Hum Mol Genet 2010; 19:4895-905;  PMID:20876615; http://dx.doi.org/10.1093/hmg/ ddq424.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Prog Brain Res 2006; 153:57-73; PMID:16876568;  http://dx.doi.org/10.1016/S0079-6123(06)53003-1.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Genet Med 2012; 14:10- 26; PMID:22237428; http://dx.doi.org/10.1038/ gim.0b013e31822bead0.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Am J Med Genet A 2011;  155A:1040-9; PMID:21465655; http://dx.doi.org/10.1002/ajmg.a.33951.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
J Clin Invest 2011; 121:2080-6; PMID:21633175; http://dx.doi.org/10.1172/JCI46044.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Am J Clin Nutr 2009; 89:973S-9S; PMID:19190071;  http://dx.doi.org/10.3945/ajcn.2008.26788B.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
"Endocrinol Metab Clin  North Am 2008; 37:733-51, x; PMID:18775361;  http://dx.doi.org/10.1016/j.ecl.2008.07.003.",OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
PLoS One 2008; 3:e1709; PMID:18320030;  http://dx.doi.org/10.1371/journal.pone.0001709.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Nucleic Acids Res 2012; 40:6800-7; PMID:22495932; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Hum Mol Genet 2012; 21:4038-48; PMID:22694955; http://dx.doi.org/10.1093/hmg/ dds228.6.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Nat Genet 2010; 42:937- 48; PMID:20935630; http://dx.doi.org/10.1038/ ng.686.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Endocrinology 2008;  149:6043-52; PMID:18703626; http://dx.doi.org/10.1210/en.2008-0544.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
N Engl J Med 2007; 356:237- 47; PMID:17229951; http://dx.doi.org/10.1056/ NEJMoa063988.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Nature 1997; 387:903-8; PMID:9202122;  http://dx.doi.org/10.1038/43185.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Nature 2010; 463:666-70; PMID:19966786;  http://dx.doi.org/10.1038/nature08689.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Nat Neurosci  2004; 7:1187-9; PMID:15494731; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Obes Rev 2009; 10:593-609; PMID:19712437; http://dx.doi.org/10.1111/j.1467- 789X.2009.00597.x.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Nature 2006; 443:289- 95; PMID:16988703; http://dx.doi.org/10.1038/ nature05026.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Cell Metab  2012; 16:144-52; PMID:22883229; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
Am J Med  Genet B Neuropsychiatr Genet 2009; 150B:1085- 99; PMID:19199291; http://dx.doi.org/10.1002/ ajmg.b.30934.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
PLoS One  2009; 4:e4291; PMID:19172181; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/2c/rdis-1-e24421.PMC3927482.pdf
"Nat Struct Mol Biol 2013; 20:671-8; PMID:23644600; http://dx.doi.org/10.1038/nsmb.2571Keywords:  Complex genetics, multifac - torial, compound heterozygotes, DUX4,  D4Z4 contractions Submitted: 07/08/13Revised: 08/08/13Accepted: 08/13/13Published Online: 09/17/13 Citation: Stadler G, King OD, Robin JD, Shay JW,  Wright WE.",OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Rare Diseases 2013; 1:e26142; http://dx.doi.org/10.4161/rdis.26142*Correspondence to: Woodring E Wright;   Email: Woodring.Wright@utsouthwestern.eduFacioscapulohumeral muscular dystro - phy (FSHD) is a progressive myopa - thy with a relatively late age of onset  (usually in the late teens) compared with Duchenne and many other muscular dystrophies.,Non-OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Proc Natl Acad Sci U S A 2012; 109:16234-9; PMID:22988124; http://dx.doi.org/10.1073/ pnas.1209508109 20.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Hum Mol Genet 2013; PMID:23821646; http://dx.doi.org/10.1093/hmg/ddt314 21.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Dev Cell 2012; 22:38-51; PMID:22209328; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Hum Mol Genet 2006; 15:45-51;  PMID:16311252; http://dx.doi.org/10.1093/hmg/ ddi424 23.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Exp Neurol 2008; 214:87-96; PMID:18723017; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
PLoS Genet  2013; 9:e1003550; PMID:23785297; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
PLoS One 2008; 3:e3389; PMID:18852887; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Nat Genet 2012; 44:1370-4;  PMID:23143600; http://dx.doi.org/10.1038/ ng.2454 11.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Eur J Hum Genet 2012; 20:404-10; PMID:22108603; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Am J  Hum Genet 2012; 90:628-35; PMID:22482803;  http://dx.doi.org/10.1016/j.ajhg.2012.02.019 13.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Am J Hum Genet 2007; 81:884-94;  PMID:17924332; http://dx.doi.org/10.1086/521986 14.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
EMBO J 2008; 27:2766- 79; PMID:18833193; http://dx.doi.org/10.1038/ emboj.2008.201 15.,Non-OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Neuromuscul  Disord 2007; 17:611-23; PMID:17588759; http://dx.doi.org/10.1016/j.nmd.2007.04.002 16.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Ann Neurol 2011; 69:540-52;  PMID:21446026; http://dx.doi.org/10.1002/ ana.22275 17.,Non-OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Curr Opin Neurol 2012; 25:614-20; PMID:22892954;  http://dx.doi.org/10.1097/WCO.0b013e328357f22d 2.,Non-OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Am J Hum Genet 2004; 75:1124-30; PMID:15467981; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Science 2010; 329:1650-3; PMID:20724583; http://dx.doi.org/10.1126/science.1189044 4.,Non-OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Hum Mol Genet 2012; 21:4419-30;  PMID:22798623; http://dx.doi.org/10.1093/hmg/ dds284 7.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
PLoS Genet 2010; 6:e1001181; PMID:21060811; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Neuromuscul Disord 2009; 19:140- 2; PMID:19147353; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Neuromuscul Disord 2008; 18:881-5;  PMID:18684626; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Neuromuscul Disord 2002; 12:554-7;  PMID:12117479; http://dx.doi.org/10.1016/S0960- 8966(02)00014-729.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Neuromuscul Disord 2008; 18:579-82; PMID:18586493; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Neuromuscul Disord 1991; 1:275-8; PMID:1822806;  http://dx.doi.org/10.1016/0960-8966(91)90101-W 31.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
Neuromuscul Disord  2012; 22:534-40; PMID:22245016; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/b3/rdis-1-e26142.PMC3927483.pdf
"We hope that with the support of those involved in rare disease research we will be successful in providing a resource for the  community.Introducing Rare Diseases Patricia s zajner1 and t imur Yusufzai2 1Landes Bioscience; Boston, MA U sA; 2Harvard Medical s chool; Boston, MA U sA Correspondence to: Patricia Szajner and Timur Yusufzai; Email: patricia@landesbioscience.com and tyusufzai@lroc.harvard.edu Submitted: 04/16/13; Accepted: 04/16/13; Published Online: 04/19/13http://dx.doi.org/10.4161/rdis.24735Citation: Szajner P , Yusufzai T. Introducing Rare Diseases .",Non-OADS,/arxiv_data1/oa_pdf/5b/9d/rdis-1-e24735.PMC3927484.pdf
Available from: http://rarediseases.info.nih.gov 2.,Non-OADS,/arxiv_data1/oa_pdf/5b/9d/rdis-1-e24735.PMC3927484.pdf
"PLoS Genet 2013; 9:e1003435; PMID:23593030; http://dx.doi.org/10.1371/journal.pgen.1003435.Keywords:  Ataxia oculomotor apraxia  type 2 (AOA2), SETX gene, senataxin,  RNA processing, R-loops, DNA double strand breaks, neurodegeneration Submitted: 05/13/13Accepted: 05/31/13Published Online: 06/18/13 Citation: Lavin MF, Yeo AJ, Becherel OJ.",Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
"Rare Diseases 2013; 1:e25230; http://dx.doi.org/10.4161/rdis.25230*Correspondence to: Martin F. Lavin;  Email: martin.lavin@qimr.edu.auAtaxia oculomotor apraxia type 2  (AOA2) is a rare autosomal reces - sive disorder characterized by cerebellar atrophy, peripheral neuropathy, loss of Purkinje cells and elevated α -fetoprotein.",Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Nat Rev Genet 2008; 9:204-17; PMID:18227811;  http://dx.doi.org/10.1038/nrg2268 18.,Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Mol Cell 2011; 41:21-32;  PMID:21211720; http://dx.doi.org/10.1016/j.mol - cel.2010.12.007 20.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Cell 2012; 151:835- 46; PMID:23141540; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Mol Cell Biol 2013; 33:406- 17; PMID:23149945; http://dx.doi.org/10.1128/ MCB.01195-12 23.,Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Brain 2011; 134:1808-28; PMID:21576111; http://dx.doi.org/10.1093/brain/awr084 24.,Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
PLoS Genet 2013; 9:e1003435; PMID:23593030; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
DNA Repair (Amst) 2013; In  press; PMID:23731731; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Orphanet J Rare Dis 2006; 1:47;  PMID:17112370; http://dx.doi.org/10.1186/1750- 1172-1-47 2.,Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Lancet Neurol 2007; 6:245-57; PMID:17303531;  http://dx.doi.org/10.1016/S1474-4422(07)70054-6 4.,Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Neurology 2006; 66:1207-10; PMID:16636238; http://dx.doi.org/10.1212/01.,Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Nat Genet 2004; 36:225-7; PMID:14770181; http://dx.doi.org/10.1038/ng1303 7.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Neurobiol Dis 2006; 23:97-108; PMID:16644229;  http://dx.doi.org/10.1016/j.nbd.2006.02.007 8.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
J Cell Biol  2007; 177:969-79; PMID:17562789; http://dx.doi.org/10.1083/jcb.2007010429.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Am J Hum Genet 2004; 74:1128-35;  PMID:15106121; http://dx.doi.org/10.1086/421054 10.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Neurogenetics 2007; 8:45-9; PMID:17096168;  http://dx.doi.org/10.1007/s10048-006-0067-8 12.,Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Nucleic Acids Res  2004; 32:2441-52; PMID:15121901; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
DNA Repair (Amst) 2011; 10:199-209; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Hum Mol Genet  2009; 18:3384-96; PMID:19515850; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Mol Cell 2011;  42:794-805; PMID:21700224; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Nucleic Acids Res 2012; 40:e16; PMID:22121227; http://dx.doi.org/10.1093/nar/ gkr1075 32.,Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
FEBS J 2011; 278:3550-68; PMID:21777389;  http://dx.doi.org/10.1111/j.1742-4658.2011.08258.x 30.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Am J  Med Genet A 2007; 143A:1775-7; PMID:17593543;  http://dx.doi.org/10.1002/ajmg.a.31816 27.,Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
Cerebellum 2009; 8:448-53; PMID:19727998; http://dx.doi.org/10.1007/s12311- 009-0130-8 28.,Non-OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
FEBS J 2011; 278:3569-77; PMID:21810174; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/bb/rdis-1-e25230.PMC3927485.pdf
"Rare Diseases 2013; 1:e25378; http://dx.doi.org/10.4161/rdis.25378*Correspondence to: Puneet Opal;  Email: p-opal@northwestern.edu;  Robert D. Goldman;  Email: r-goldman@northwestern.eduGiant axonal neuropathy (GAN)1 is  a rare autosomal recessive neuro - logical disorder caused by mutations in  the GAN  gene that encodes gigaxonin,  a member of the BTB/Kelch family of E3 ligase adaptor proteins.",Non-OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
J Clin Invest 2013; 123:1964-75; PMID:23585478; http://dx.doi.org/10.1172/JCI66387,Non-OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Bioessays 2006; 28:1194-202; PMID:17120193;  http://dx.doi.org/10.1002/bies.20500 20.,Non-OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Nat Cell Biol 2003; 5:1001-7;  PMID:14528312; http://dx.doi.org/10.1038/ ncb1056 21.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
J Biol Chem  1997; 272:30135-40; PMID:9374493; http://dx.doi.org/10.1074/jbc.272.48.30135 24.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
J Hepatol 2000; 32:689-702;  PMID:10782920; http://dx.doi.org/10.1016/S0168-8278(00)80233-0 25.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Int J Dev Neurosci  2002; 20:259-68; PMID:12175861; http://dx.doi.org/10.1016/S0736-5748(02)00019-9 26.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
FASEB J 2011;  25:3896-905; PMID:21828286; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Cell Mol Life Sci 2004; 61:3057-75; PMID:15583867; http://dx.doi.org/10.1007/ s00018-004-4268-810.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Hum Mol Genet  2009; 18:1384-94; PMID:19168853; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
J Cell Biol 1985; 100:245-50; PMID:3880753; http://dx.doi.org/10.1083/ jcb.100.1.245 12.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
J  Neurochem 2008; 107:253-64; PMID:18680552;  http://dx.doi.org/10.1111/j.1471-4159.2008.05601.x 16.,Non-OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Mol Neurodegener 2011; 6:25; PMID:21486449; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Hum Gene Ther 2013; 24:209-19; PMID:23316953; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Nature 2003; 425:316-21; PMID:13679922; http://dx.doi.org/10.1038/nature01985References 1.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
J Clin Invest 2013;  123:1964-75; PMID:23585478; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Cell Mol Life Sci 2007; 64:601- 9; PMID:17256086; http://dx.doi.org/10.1007/ s00018-007-6396-4 3.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Arch Neurol 1974; 31:312-6; PMID:4153361; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
J Clin Invest  2009; 119:1763-71; PMID:19587451; http://dx.doi.org/10.1172/JCI38339 7.,Non-OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Acta Neuropathol 1977; 40:213-8; PMID:602684;  http://dx.doi.org/10.1007/BF00691956 8.,Non-OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Neuropediatrics 1994; 25:89-93; PMID:8072681;  http://dx.doi.org/10.1055/s-2008-1071592 9.,Non-OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
Hum Mol Genet 2003; 12:813-22; PMID:12668605; http://dx.doi.org/10.1093/ hmg/ddg092support to enable us to carry out this  research as well as NIH 1P01GM096971–01 to R.D.G.,OADS,/arxiv_data1/oa_pdf/88/42/rdis-1-e25378.PMC3927486.pdf
"Brain 2013; 136:957-70; PMID:23404338; http://dx.doi.org/10.1093/brain/aws367Keywords:  myotonic dystrophy type 1,  trinucleotide repeat expansion, RNA tox - icity, RNA splicing, central nervous sys - tem, transgenic mice, synaptic function,  synaptic protein, RAB3A, synapsin I Abbreviations:  CELF, CUGBP/Elav-like  factor; CUGBP, CUG RNA binding  protein; DM, myotonic dystrophy; DM1, myotonic dystrophy type 1; DMPK, DM protein kinase; MBNL, muscleblind-like; RAB, RAS oncogene family; UTR, untranslated region Submitted: 05/17/13Revised: 06/24/13Accepted: 06/25/13Published Online: 07/23/13 Citation: Hernández-Hernández O, Sicot G, Dinca  DM, Huguet A, Nicole A, Buée L, et al.",Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Rare Diseases 2013; 1:e25553; http://dx.doi.org/10.4161/rdis.25553*Correspondence to: Mário Gomes-Pereira;   Email: mario.pereira@inserm.frThe toxicity of expanded transcripts  in myotonic dystrophy type 1  (DM1) is mainly mediated by the disrup - tion of alternative splicing.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
PLoS Genet 2012; 8:e1003043; PMID:23209425;  http://dx.doi.org/10.1371/journal.pgen.1003043 22.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Mol Cell Neurosci  2012; In press; PMID:23247071; http://dx.doi.org/10.1016/j.mcn.2012.12.003.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Neuron 2012; 75:437-50; PMID:22884328; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
PLoS One  2012; 7:e33218; PMID:22427994; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
RNA 2002; 8:671-85;  PMID:12022233; http://dx.doi.org/10.1017/ S1355838202027036 27.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
J Neuropathol Exp Neurol  2011; 70:678-85; PMID:21760538; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
EMBO J 2006; 25:4271- 83; PMID:16946708; http://dx.doi.org/10.1038/ sj.emboj.7601296 30.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Annu Rev Neurosci 2004; 27:509-47; PMID:15217342;  http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Cell 1993; 75:661-70; PMID:7902212; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
EMBO J 2000; 19:4439-48; PMID:10970838; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Hum  Mol Genet 2006; 15:2087-97; PMID:16717059; http://dx.doi.org/10.1093/hmg/ddl132 14.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Mol Cell 2002; 10:45-53;  PMID:12150906; http://dx.doi.org/10.1016/S1097- 2765(02)00572-5 15.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Mol Cell  2002; 10:35-44; PMID:12150905; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Nat Med 2011; 17:720-5; PMID:21623381;  http://dx.doi.org/10.1038/nm.2374 17.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Hum Mol Genet 2004; 13:3079- 88; PMID:15496431; http://dx.doi.org/10.1093/ hmg/ddh327 19.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Hum  Mol Genet 2000; 9:1185-94; PMID:10767343; http://dx.doi.org/10.1093/hmg/9.8.1185 20.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Muscle Nerve 2007; 36:294-306; PMID:17486579; http://dx.doi.org/10.1002/mus.20800 3.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Brain 2011; 134:3530-46;  PMID:22131273; http://dx.doi.org/10.1093/brain/ awr299 4.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Neurol Sci 2010; 31:757- 63; PMID:20842397; http://dx.doi.org/10.1007/ s10072-010-0406-2 5.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Neurology 1996; 47:711-7; PMID:8797469; http://dx.doi.org/10.1212/WNL.47.3.711 6.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Hum Mol Genet 2001; 10:2143-55; PMID:11590131; http://dx.doi.org/10.1093/ hmg/10.19.2143 7.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Clin Genet 2007; 71:59-66; PMID:17204048; http://dx.doi.org/10.1111/j.1399-0004.2007.00732.x 8.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Cell 1992; 68:799-808; PMID:1310900; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Biochim Biophys Acta 2013; 1832:1390- 409; PMID:23500957; http://dx.doi.org/10.1016/j.bbadis.2013.03.002 10.,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Hum Mol Genet 2011; 20(R2):R116-23;  PMID:21821673; http://dx.doi.org/10.1093/hmg/ ddr343,OADS,/arxiv_data1/oa_pdf/c0/1a/rdis-1-e25553.PMC3927487.pdf
Rare Diseases 2013; 1:e26144; http://dx.doi.org/10.4161/rdis.26144Introduction Many rare genetic conditions with low reproductive fitness have  been difficult to genetically define using methods of linkage and association.,Non-OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Am J Hum Genet 2001; 69:1033-45;  PMID:11590545; http://dx.doi.org/10.1086/324267 24.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Blood 2012; 119:238-50; PMID:21908426; http://dx.doi.org/10.1182/blood- 2011-06-358853 25.,Non-OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Eur J Med Genet 2013; 56:7- 12; PMID:23123319; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Am J Hum Genet 2004; 74:770-6; PMID:15015131;  http://dx.doi.org/10.1086/383285 27.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
J Biol Chem 2004; 279:2800- 8; PMID:14594953; http://dx.doi.org/10.1074/jbc.M309981200 29.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
J Biol Chem 2004; 279:41263- 6; PMID:15292239; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Gene 2003; 312:165-71; PMID:12909352;  http://dx.doi.org/10.1016/S0378-1119(03)00613-9 13.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
J Cell Sci 2008; 121:11- 8; PMID:18096687; http://dx.doi.org/10.1242/ jcs.007112 14.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Proc Natl Acad Sci U S A 2010; 107:14645-50;  PMID:20679233; http://dx.doi.org/10.1073/ pnas.1004023107 15.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Mech Dev 1998; 78:33-6; PMID:9858676;  http://dx.doi.org/10.1016/S0925-4773(98)00136-1 16.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Mol Biol Cell 2004; 15:2568-79; PMID:15034141; http://dx.doi.org/10.1091/mbc.E03-11-0836 17.,Non-OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Mol Biol Cell 2006; 17:2138-49;  PMID:16481398; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Proc Natl Acad Sci U S A  1997; 94:12407-12; PMID:9356462; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
J Comp Neurol  2001; 433:62-74; PMID:11283949; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Mol Biol Cell 2007; 18:2305-12;  PMID:17429076; http://dx.doi.org/10.1091/mbc.E07-01-0073 21.,Non-OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Nat Genet 2000; 26:106-8; PMID:10973260; http://dx.doi.org/10.1038/79069 22.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Medicine (Baltimore)  2003; 82:203-15; PMID:12792306; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Nat Genet 2010; 42:1109-12;  PMID:21076407; http://dx.doi.org/10.1038/ng.712 4.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Annu Rev Genet 2011; 45:81- 104; PMID:21910631; http://dx.doi.org/10.1146/ annurev-genet-110410-132512 6.,Non-OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
"J Med Genet 2012; 49:179- 83; PMID:22368300; http://dx.doi.org/10.1136/ jmedgenet-2011-100542 7. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen  DA, de Vries P , Gilissen C, et al.",OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
N Engl J Med 2012; 367:1921-9; PMID:23033978;  http://dx.doi.org/10.1056/NEJMoa1206524 8.,Non-OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Nat Rev Mol Cell Biol  2009; 10:778-90; PMID:19851336; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Circ  Res 2003; 93:330-7; PMID:12893741; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Mol Biol  Cell 2004; 15:982-9; PMID:14699073; http://dx.doi.org/10.1091/mbc.E03-06-0359 11.,Non-OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
Circ Res  1991; 69:530-9; PMID:1860190; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/3f/rdis-1-e26144.PMC3927488.pdf
"Second, the mutant CUG repeats GSK3 β is a new therapeutic target for myotonic dystrophy type 1 Christina Wei1, Karlie Jones1, Nikolai A. Timchenko2, and Lubov Timchenko1,* 1Department of Molecular Physiology and Biophysics; Baylor College of Medicine; Houston, TX USA; 2Pathology and Immunology; Huffington Center on  Aging; Baylor College of Medicine; Houston, TX USA Keywords:  myotonic dystrophy  type 1, CUG repeats, CUGBP1, GSK3 β, lithium, TDZD-8 Abbreviations: DMI, myotonic dystrophy type 1; GSK3 β, glycogen- synthase kinase-3β ; DMPK, dystrophia  myotonica  protein kinase; TDZD-8,  4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione *Correspondence to: Timchenko Lubov;  email: lubovt@bcm.tmc.edu Submitted: 07/31/2013; Revised: 09/16/2013;   Accepted: 09/20/2013;  Published Online: 10/15/2013 http://dx.doi.org/10.4161/rdis.26555Citation: Wei C, Jones K, Timchenko NA, Timchenko  L. GSK3 β is a new therapeutic target for myotonic  dystrophy type 1.",Non-OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
J Clin Invest 2012; 122:4461-72; PMID:23160194 ; http://dx.doi.org/10.1172/ JCI64081,Non-OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Cell 1992;  68:799-808;  PMID:1310900 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Science   1992 ; 255:1256 -8; PMID :1546326 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Am J Hum Genet  1999 ; 64:360-4; PMID:9973273 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Science  2000 ; 289:1769 - 73; PMID:10976074 ; http://dx.doi.org/10.1126/ science.289.5485.1769 6.,Non-OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Hum Mol Genet 2001 ; 10:2717 -26; PMID:11726559 ;  http://dx.doi.org/10.1093/hmg/10.23.2717 7.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Annu Rev Neurosci  2006 ; 29:259-77; PMID:16776586 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Hum Mol Genet 1996 ; 5:115- 21; PMID:8789448 ; http://dx.doi.org/10.1093/ hmg/5.1.115 10.,Non-OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Nucleic Acids Res 1996 ;  24:4407 -14; PMID:8948631 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
EMBO J 2000 ; 19:4439 -48; PMID:10970838 ;  http://dx.doi.org/10.1093/emboj/19.17.4439 12.,Non-OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
J  Cell Biol  1995 ; 128:995-1002 ; PMID:7896884 ;  http://dx.doi.org/10.1083/jcb.128.6.995 13.,Non-OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Science  2003 ; 302:1978 - 80; PMID:14671308 ; http://dx.doi.org/10.1126/ science.1088583 14.,Non-OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
J Biol Chem 2001 ; 276:7820 - 6; PMID:11124939 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Nat Genet 2001 ; 29:40-7;  PMID :11528389 ; http://dx.doi.org/10.1038/ng704 16.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Mol Cell  2007 ; 28:68-78;  PMID:17936705 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
FASEB J   2010 ; 24:3706 -19; PMID:20479119 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
J Biol Chem 2005 ; 280:20549 -57; PMID:15788409 ;  http://dx.doi.org/10.1074/jbc.M409563200 19.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
J Biol Chem 2006 ; 281:32806 -19; PMID :16931514 ;  http://dx.doi.org/10.1074/jbc.M605701200 20.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
J Cell Biol  2006 ; 172:803-8; PMID:16520386 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Science  1998 ; 280:737- 41; PMID:9563950 ; http://dx.doi.org/10.1126/ science.280.5364.737 23.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
J Clin Invest  2012 ; 122:4461 -72; PMID:23160194 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
J Cell Sci 2004 ; 117:3769 -83;  PMID:15252116 ; http://dx.doi.org/10.1242/ jcs.01210 27.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Science  2009 ; 325:336- 9; PMID:19608921 ; http://dx.doi.org/10.1126/ science.1173110 28.,Non-OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
Nature   2012 ; 488:111-5; PMID:22859208 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
J Cell Sci 2003 ; 116:1175 - 86; PMID:12615961 ; http://dx.doi.org/10.1242/ jcs.00384,OADS,/arxiv_data1/oa_pdf/80/6f/rdis-1-e26555.PMC3927489.pdf
"10,11 The RAS/ ERK pathway regulates a broad spectrum From an orphan disease to a generalized molecular mechanism PTPN11  loss-of-function mutations in the pathogenesis of metachondromatosis Wentian  Yang1,* and Benjamin G  Neel2 1Department of Orthopaedics and COBRE Center for Stem Cell Biology; Brown University Alpert Medical School and Rhode Island Hospital;   Providence, RI USA; 2Princess Margaret Cancer Center; University Health Network and Department of Medical Biophysics; University of Toronto;   Toronto, ON Canada Keywords:  groove of Ranvier, IHH,  PTHrP, metachondromatosis, enchon - dromas, osteochondromas, protein-tyrosine phosphatases, PTPN11 *Correspondence to: Wentian Yang;  Email: wyang@lifespan.org Submitted: 08/26/2013; Accepted: 09/30/2013;   Published Online: 10/24/2013http://dx.doi.org/10.4161/rdis.26657Citation: Yang W, Neel BG.",Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Nature 2013; 499:491-5; PMID:23863940; http://dx.doi.org/10.1038/nature12396,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
PLoS Genet  2010; 6:e1000991;  PMID:20577567 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Orphanet J  Rare Dis 2008; 3:3; PMID:18271966 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
J Bone Joint Surg Am 2010 ; 92:1507-13 ;  PMID:20516327 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Adv Cancer Res 2010; 106:53- 89; PMID:20399956 ; http://dx.doi.org/10.1016/ S0065-230X(10)06002-1 12.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Nature 2013; 499:491-5; PMID:23863940 ;  http://dx.doi.org/10.1038/nature12396 16.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
EMBO J  1997; 16:2352-64;  PMID:9171349 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Dev Cell 2006; 10:317-27; PMID:16516835 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
J Med Genet  2002; 39:571-4;  PMID :12161596 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Nat Genet 2001; 29:465-8;  PMID:11704759 ; http://dx.doi.org/10.1038/ng772 20.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Proc Natl Acad Sci U S A 2009; 106 :15436-41;  PMID:19706403 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Hum Mutat  2004; 23:267-77;  PMID:14974085 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Front Med 2012; 6:275- 9; PMID:22869052 ; http://dx.doi.org/10.1007/ s11684-012-0216-4 24.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Proc Natl Acad Sci U S A  2010; 107:2054-9;  PMID:20080592 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Proc Natl Acad Sci U S A 2010; 107:1813-4; PMID:20133829 ; http://dx.doi.org/10.1073/ pnas.0914431107 28.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Ann N Y Acad Sci 2007;  1116:59-64;  PMID:18083921 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
"Hum Genet 2013; 132:603-17; PMID:23504071 ;  http://dx.doi.org/10.1007/s00439-013-1286-3 30. de Crombrugghe B, Lefebvre V, Nakashima K. Regulatory mechanisms in the pathways of car - tilage and bone formation.",OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Curr Opin Cell Biol 2001; 13:721-7;  PMID:11698188 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Genes Dev 2002; 16:1446-65;  PMID:12080084 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Trends Genet 2003; 19:458- 66; PMID:12902164 ; http://dx.doi.org/10.1016/ S0168-9525(03)00176-8 33.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
J Cell Biochem 2006; 97:33- 44; PMID :16215986 ; http://dx.doi.org/10.1002/ jcb.20652 34.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Nature 2003; 423:332-6;  PMID:12748651 ; http://dx.doi.org/10.1038/ nature01657 35.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Curr Top Dev Biol 2006; 76:1-48; PMID:17118262 ; http://dx.doi.org/10.1016/ S0070-2153(06)76001-X 36.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Genes Dev 2002; 16:859-69;  PMID:11937493 ; http://dx.doi.org/10.1101/ gad.965602 39.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Genes Dev 1999; 13:2072- 86; PMID:10465785 ; http://dx.doi.org/10.1101/ gad.13.16.2072 41.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Nat Genet 2002; 30:306-10;  PMID:11850620 ; http://dx.doi.org/10.1038/ng84442.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Lab Invest  2000; 80:1925-34;  PMID:11140704 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Bone 2006; 39:17-26;  PMID:16476576 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
J  Clin Invest 2001; 107:295-304; PMID:11160153 ;  http://dx.doi.org/10.1172/JCI11706 45.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Sci Signal 2012; 5:re6;  PMID:23074268 ; http://dx.doi.org/10.1126/ scisignal.2002906 46.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Cell  1996; 85:841-51;  PMID:8681379 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Int J Biochem Cell Biol 2012; 44:2144- 51; PMID:22981632 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Expert Opin Ther Targets 2012; 16:1227-38; PMID:22992192 ; http://dx.doi.org/10.1517/147282 22.2012.720975 49.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Am J Pathol  2006; 168:321-30;  PMID:16400033 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Expert Opin Ther Pat 2013;  23:345-61;  PMID:23294277 ; http://dx.doi.org/10.1 517/13543776.2013.75730451.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
J Postgrad Med  2013; 59:48-50;  PMID:23525058 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Bone 2009; 44:717-28;  PMID:19118660 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Arthritis Rheum 2004; 50:1522-32;  PMID :15146422 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Arthritis Rheum 2010; 62:2206-18;  PMID :20506158 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Arthritis Res Ther 2009; 11:R85;  PMID:19500336 ; http://dx.doi.org/10.1186/ar2719 57.,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Cell Stem Cell 2009; 4:324- 35; PMID:19341622 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Int Orthop 2006; 30:353- 6; PMID:16652202 ; http://dx.doi.org/10.1007/ s00264-006-0082-2 59.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
J Anat 2009;  215:355-63 ;  PMID:19563472 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
Drug  Discov Today 2009; 14:1166-73; PMID:19818412 ;  http://dx.doi.org/10.1016/j.drudis.2009.09.008,Non-OADS,/arxiv_data1/oa_pdf/2b/c9/rdis-1-e26657.PMC3927490.pdf
1 The majority of the  more than 460 currently identified LMNA   mutations cause diseases affecting skel - etal and cardiac muscle (see http://www.umd.be/LMNA/).,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
"Unlike mutations responsible for FPLD  and HGPS that are mostly restricted to specific nucleotides (C1824T for HGPS) or concentrated around a small region on the surface of the Ig-fold of lamin A/C (as in the case of FPLD), mutations that Novel insights into the disease etiology of laminopathies Chin Yee Ho1,2, Diana E. Jaalouk1,2,3, and Jan Lammerding1,2,* 1Weill Institute for Cell and Molecular Biology/Department of Biomedical Engineering; Cornell University; Ithaca, NY; USA; 2Department of Medicine;  Brigham and Women’s Hospital; Boston, MA; USA; 3Department of Biology; American University of Beirut; Beirut, Lebanon Keywords:  lamin, MKL1, MAL,  MRTF-A, dilated cardiomyopathy, nuclear actin, mechanotransduction Abbreviations: CMD, congenital  muscular dystrophy; DCM, dilated cardiomyopathy; EDMD, Emery-Dreifuss muscular dystrophy; FPLD, familial partial lipodystrophy; HGPS, Hutchison-Gilford progeria syndrome; MKL1, megakaryoblastic leukemia 1; MRTF-A, myocardin-related transcription factor-1; MAL, megakaryocytic acute leukemia protein; NLS, nuclear localization signal; SRF, serum response factor *Correspondence to: Jan Lammerding;   Email: jan.lammerding@cornell.edu Submitted: 08/01/2013; Revised: 10/14/2013;   Accepted: 10/30/2013;  Published Online: 12/02/2013 http://dx.doi.org/10.4161/rdis.27002Citation: Ho CY, Jaalouk DE, Lammerding J.",Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Nature 2013; 497:507-11; PMID:23644458; http://dx.doi.org/10.1038/nature12105,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Cell 2013; 152:1365- 75; PMID:23498943 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Nat Genet 1994; 8:323-7; PMID:7894480 ; http://dx.doi.org/10.1038/ ng1294-323 3.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Muscle Nerve 2004; 30:444-50; PMID:15372542 ; http://dx.doi.org/10.1002/ mus.20122 5.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Hum Mol Genet  2013; 22:2335-49;  PMID:23427149 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
J Cell Biol 2005; 170:781-91; PMID :16115958 ;  http://dx.doi.org/10.1083/jcb.200502148 8.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
J Mol Cell Cardiol 2010; 48:1290-7; PMID:19913544 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Hum Mol Genet 2005; 14:2167-80;  PMID:15972724 ; http://dx.doi.org/10.1093/hmg/ ddi221 11.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Nature  2013; 497:507-11;  PMID:23644458 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Circ Res 2007;  100:633-44;  PMID:17363709 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Nat Rev Mol Cell Biol 2010; 11:353- 65; PMID:20414257 ; http://dx.doi.org/10.1038/ nrm289014.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
J Cardiovasc  Transl Res 2012; 5:794-804; PMID:22898751 ;  http://dx.doi.org/10.1007/s12265-012-9397-0 15.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Mol Cell Biol 2006; 26:5809- 26; PMID:16847333 ; http://dx.doi.org/10.1128/ MCB.00024-06 16.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Mol Cell Biol  2010; 30:4134-48;  PMID:20606005 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Biochem Biophys Res Commun  2011; 414:373-8;  PMID:21964294 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
EMBO J 2010; 29:3448-58; PMID:20818336 ; http://dx.doi.org/10.1038/ emboj.2010.216 19.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
J Biol Chem 1997; 272:18222- 31; PMID:9218459 ; http://dx.doi.org/10.1074/ jbc.272.29.18222 20.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Am J Cardiol 1997; 80(11A):15L- 25L; PMID:9412539 ; http://dx.doi.org/10.1016/ S0002-9149(97)00845-X 22.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Curr Opin Cardiol 1999; 14:225-9; PMID:10358794 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Biophys J 2008; 95:5462- 75; PMID:18790843 ; http://dx.doi.org/10.1529/ biophysj.108.139428 27.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Exp Cell Res 2007; 313:3432-45; PMID:17714703 ;  http://dx.doi.org/10.1016/j.yexcr.2007.07.00828.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Exp Cell Res 2007;  313:2144-56;  PMID:17493612 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Eur J Hum Genet 2013; 21:1105- 11; PMID:23463027 ; http://dx.doi.org/10.1038/ ejhg.2013.16 30.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Ann Neurol 2008; 64:177-86; PMID:18551513 ;  http://dx.doi.org/10.1002/ana.21417 31.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Neuromuscul Disord 2002; 12:958- 63; PMID:12467752 ; http://dx.doi.org/10.1016/ S0960-8966(02)00178-5 32.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Hum Mol Genet  2013; 22:3152-64;  PMID:23575224 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Cell Stem Cell 2011; 8:31-45; PMID:21185252 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
J Biol Chem 2011; 286:44116-25; PMID:22049076 ;  http://dx.doi.org/10.1074/jbc.M111.276931 36.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Science 2013; 340:864-7; PMID:23558171 ;  http://dx.doi.org/10.1126/science.1235038 39. de Lanerolle P. Nuclear actin and myosins at a glance.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
J Cell Sci 2012; 125:4945-9; PMID:23277533 ;  http://dx.doi.org/10.1242/jcs.099754 40.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Mol Biol Cell 2013; 24:982-94;  PMID:23447706 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
J Clin Invest  2007; 117:1282-93;  PMID:17446932 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Biochim  Biophys Acta 2009; 1792:75-81; PMID:19022376 ;  http://dx.doi.org/10.1016/j.bbadis.2008.10.012 43.,OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Hum Mol Genet 2007; 16:1884-95;  PMID:17567779 ; http://dx.doi.org/10.1093/hmg/ ddm13744.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Circulation  2011; 123:53-61;  PMID:21173351 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Clin Cancer Res  2012; 18:555-67;  PMID:22048237 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Cardiovasc Res 2012; 93:311- 9; PMID:22068161 ; http://dx.doi.org/10.1093/cvr/ cvr301 48.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Mol Cell Biol 2008; 28:6302- 13; PMID:18694962 ; http://dx.doi.org/10.1128/ MCB.00427-08 49.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
Curr Opin Cardiol  2013; 28:297-304;  PMID:23455585 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/d0/rdis-1-e27002.PMC3927491.pdf
"Rare Diseases 2013; 1:e27209 http://dx.doi.org/10.4161/rdis.27209*Correspondence to: Fatima Bosch;   Email: fatima.bosch@uab.es Addendum to: Haurigot V, Marcó S, Ribera A, Garcia M, Ruzo A, Villacampa P , Ayuso E, Añor S, Andaluz A, Pineda M, et al.",Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
J Clin Invest 2013; 123:3254-71; PMID:23863627; http://dx.doi.org/10.1172/JCI66778,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
J Inherit Metab Dis 2008; 31:240-52;  PMID:18392742 ; http://dx.doi.org/10.1007/ s10545-008-0838-5 2.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Pediatrics 2007;  120:e1255-61;  PMID:17938166 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Ann Neurol 2010; 68:876-87; PMID:21061399 ; http://dx.doi.org/10.1002/ ana.22092 4.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Neurosurg Focus  2008; 24:E12;  PMID:18341388 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Hum Gene Ther Methods 2012; 23:324- 35; PMID:23131032 ; http://dx.doi.org/10.1089/ hgtb.2012.120 6.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
J Clin Invest 2013; 128:3254-71; PMID:23863627 ;  http://dx.doi.org/10.1172/JCI66778 7.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Hum Gene Ther 2009; 20:350-60;  PMID:19272011 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Hum Mol Genet 2010; 19:147-58;  PMID:19837699 ; http://dx.doi.org/10.1093/hmg/ ddp475 9.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Nat Biotechnol 2009; 27:59-65; PMID:19098898 ;  http://dx.doi.org/10.1038/nbt.1515 10.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Mol Ther 2009; 17:1187-96; PMID:19367261 ;  http://dx.doi.org/10.1038/mt.2009.71 11.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Nat Rev Genet 2011; 12:341-55;  PMID:21499295 ; http://dx.doi.org/10.1038/ nrg2988 12.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Adenovirus- associated virus vector-mediated gene transfer in  hemophilia B. N Engl J Med 2011; 365:2357-65;  PMID:22149959 ; http://dx.doi.org/10.1056/ NEJMoa1108046 13.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Blood  2012; 119:3038-41;  PMID:22271447 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
J Neurosurg Pediatr  2010; 6:115-22;  PMID:20672930 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Ann Neurol 2006; 60:204- 13; PMID:16718701 ; http://dx.doi.org/10.1002/ ana.20870 16.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Sci Transl Med  2012; 4:ra163; PMID:23253610 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Hum Gene Ther  2008; 19:463-74;  PMID:18473686 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Neurology 2009; 73:1662-9; PMID:19828868 ;  http://dx.doi.org/10.1212/WNL.0b013e3181c29356 19.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Lancet 2007; 369:2097-105; PMID:17586305 ;  http://dx.doi.org/10.1016/S0140-6736(07)60982-9 20.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Lancet Neurol 2010; 9:1164-72; PMID:20970382 ;  http://dx.doi.org/10.1016/S1474-4422(10)70254-4 21.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Cereb Cortex  2012; 22:1-12;  PMID:21613470 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
N Engl J Med  2008; 358:2240-8;  PMID:18441370 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Lancet 2009; 374:1597- 605; PMID:19854499 ; http://dx.doi.org/10.1016/ S0140-6736(09)61836-5 26.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Trends Immunol 2007; 28:12-8;  PMID:17129764 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Pharmacotherapy 2009; 29:832-45; PMID:19558257 ; http://dx.doi.org/10.1592/ phco.29.7.83230.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Nat Med 2006; 12:342- 7; PMID:16474400 ; http://dx.doi.org/10.1038/ nm1358 32.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Hum Gene Ther 2010; 21:704- 12; PMID:20095819 ; http://dx.doi.org/10.1089/ hum.2009.182 34.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Clin Vaccine Immunol 2011; 18:1586-8; PMID:21775517 ; http://dx.doi.org/10.1128/ CVI.05107-11 35.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Gene Ther 2012; 19:288-94; PMID:21697954 ;  http://dx.doi.org/10.1038/gt.2011.9036.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Hum Gene Ther 2012; 23:1237- 4; PMID:22909060 ; http://dx.doi.org/10.1089/ hum.2012.029 37.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Mol Ther  2011; 19:1025-33;  PMID:21386820 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Mol Ther 2012; 20:254-66; PMID:22008915 ; http://dx.doi.org/10.1038/ mt.2011.220 39.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Brain Res 2006; 1104:1-17;  PMID:16828069 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
Behav Brain Res  2005; 158:191-9;  PMID:15698885 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
J Clin Invest 2006; 116:3070-82;  PMID:17080200 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/f5/rdis-1-e27209.PMC3927492.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ group.bmj.com  on February 18, 2014 - Published by jnnp.bmj.com Downloaded from",Non-OADS,/arxiv_data1/oa_pdf/da/79/jnnp-2012-302402.PMC3927562.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/bf/awt356.PMC3927700.pdf
"Available from: http://CRAN.R-project.org/package=survival (16 January 2014, date last accessed).778 |Brain 2014: 137; 770–778 H. Westerlind et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/bf/awt356.PMC3927700.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/4b/awt371.PMC3927703.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004070).,Non-OADS,/arxiv_data1/oa_pdf/2e/34/bmjopen-2013-004070.PMC3927707.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004113).,Non-OADS,/arxiv_data1/oa_pdf/99/5c/bmjopen-2013-004113.PMC3927708.pdf
"Terminology For the purpose of de ﬁning multimorbidity, we will use the list of ch ronic conditions 20com- piled by the Family Medicine Research Centre(FMRC), University of Sydney, available online at http://sydney.edu.au/medicine/fmrc/ classiﬁcations/De ﬁningChronicConditions.pdf.",Non-OADS,/arxiv_data1/oa_pdf/99/5c/bmjopen-2013-004113.PMC3927708.pdf
http://www.woncaeurope.org/sites/default/files/documents/Definition%203rd%20ed%202011%20with%20revised%20wonca%20tree.pdf.,Non-OADS,/arxiv_data1/oa_pdf/99/5c/bmjopen-2013-004113.PMC3927708.pdf
http://pns.dgs.pt/files/2010/05/Doen%C3%A7as-cr%C3%B3nicas_EU_ Maio_2010-2.pdf Published 2010.,OADS,/arxiv_data1/oa_pdf/99/5c/bmjopen-2013-004113.PMC3927708.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004488).,Non-OADS,/arxiv_data1/oa_pdf/ea/19/bmjopen-2013-004488.PMC3927709.pdf
2008. http://www.improvement.nhs.uk/lung/?TabId=98 3.,Non-OADS,/arxiv_data1/oa_pdf/ea/19/bmjopen-2013-004488.PMC3927709.pdf
2013. http://www.lj.se/ microsystemfestival 4.,Non-OADS,/arxiv_data1/oa_pdf/ea/19/bmjopen-2013-004488.PMC3927709.pdf
http://www.innovations.ahrq.gov/content.aspx?id=2407 8.,OADS,/arxiv_data1/oa_pdf/ea/19/bmjopen-2013-004488.PMC3927709.pdf
2013. http://www.cihi.ca/CIHI-ext-portal/pdf/internet/CCRS_QI_RISK_ADJ_METH_2013_EN15.,OADS,/arxiv_data1/oa_pdf/ea/19/bmjopen-2013-004488.PMC3927709.pdf
2013. http://www.cihi.ca/CIHI-ext-portal/internet/en/document/types+of+care/hospital+care/continuing+care/ccrs_metadata 16.,Non-OADS,/arxiv_data1/oa_pdf/ea/19/bmjopen-2013-004488.PMC3927709.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004015).,Non-OADS,/arxiv_data1/oa_pdf/e5/56/bmjopen-2013-004015.PMC3927710.pdf
http://www.cdc.gov/ visionhealth/basic_information/eye_disorders.htm [2013 (cited 2013Jul 20).,Non-OADS,/arxiv_data1/oa_pdf/e5/56/bmjopen-2013-004015.PMC3927710.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004076).,Non-OADS,/arxiv_data1/oa_pdf/91/c3/bmjopen-2013-004076.PMC3927711.pdf
http://www.worldwidebreastcancer.com/learn/ breast-cancer-statistics-worldwide/ (accessed 19 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/91/c3/bmjopen-2013-004076.PMC3927711.pdf
BMC Public Health 2010;10:157. http://www.biomedcentral.com/content/pdf/ 1471-2458-10-157 (accessed 8 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/91/c3/bmjopen-2013-004076.PMC3927711.pdf
"HCPRDU evaluation tool for mixed methods studies 2002, http://usir.salford.ac.uk/13070/ (accessed 8 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/91/c3/bmjopen-2013-004076.PMC3927711.pdf
BMC Med Res Methodol 2008;8:45. http://www.biomedcentral.com/content/pdf/1471 –2288 –8– 45 (accessed 8 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/91/c3/bmjopen-2013-004076.PMC3927711.pdf
BMC Womens Health 2008;8:4. http://www.biomedcentral.com/1472-6874/8/4 (accessed 8Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/91/c3/bmjopen-2013-004076.PMC3927711.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003736).,Non-OADS,/arxiv_data1/oa_pdf/e2/b1/bmjopen-2013-003736.PMC3927712.pdf
"Lyon, France: IARC Press, 2008. http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/wcr_2008.pdf 2.",Non-OADS,/arxiv_data1/oa_pdf/e2/b1/bmjopen-2013-003736.PMC3927712.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004120).,Non-OADS,/arxiv_data1/oa_pdf/26/25/bmjopen-2013-004120.PMC3927713.pdf
"We also identi ﬁed three relevant ongoing trials, one investigating minocycline (http://clinicaltrials.gov/ct2/ show/study/NCT01468844), one investigating a com- bination of bevacizumab and triamcinolone (http://clinicaltrials.gov/show/NCT00566761) and one investi- gating ranibizumab (http://clinicaltrials.gov/show/ NCT01123564).",Non-OADS,/arxiv_data1/oa_pdf/26/25/bmjopen-2013-004120.PMC3927713.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/26/25/bmjopen-2013-004120.PMC3927713.pdf
http://www.rcophth.ac.uk/core/core_picker/download.asp?id=728&filetitle=Interim+Guidelines+for +Management+of+Retinal+Vein+Occlusion+2010 [2010 [cited 7 Sep 2013].,Non-OADS,/arxiv_data1/oa_pdf/26/25/bmjopen-2013-004120.PMC3927713.pdf
doi:10.1136/bmjopen-2013- 004053 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004053).,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/bmjopen-2013-004053.PMC3927714.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/bmjopen-2013-004053.PMC3927714.pdf
2012. http://www.oecd.org/employment/database 2.,OADS,/arxiv_data1/oa_pdf/0e/4a/bmjopen-2013-004053.PMC3927714.pdf
Data Sources for the Appraisal of Regeneration Impacts: TAG Unit 3.5.13. http://www.dft.gov.uk/webtag/documents/expert/pdf/unit3.5.13.pdf (accessed 18 Nov2013).,OADS,/arxiv_data1/oa_pdf/0e/4a/bmjopen-2013-004053.PMC3927714.pdf
2013. http://www.tco.se/Documents/Additionalcomments.pdf 60.,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/bmjopen-2013-004053.PMC3927714.pdf
2012. http://www.renalreg.com/Reports/2012.html 2.,OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2011. http://www.kidneycare.nhs.uk/our_work_programmes/commissioning/dialysis_capacity_survey/# 3.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
"NHS Kidney Care, 2013. http://www.kidneycare.nhs.uk/our_work_programmes/improving_choice_for_kidney_patients/home_therapies/ 5.",Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
"King’s Fund , 2012. http://www.kingsfund.org.uk/publications/payment-results-0 12.",Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2012. http://www.monitor-nhsft.gov.uk/home/news-events-publications/our-publications/browse-category/guidance-health-care-providers-and-co-15 13.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2013. http://www.nottingham.ac.uk/business/documents/news-documents/evaluation-of-the-commissioning-for-quality-and-innovation-framework —final-report —feb-2013.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2013. http://www.organdonation.nhs.uk/statistics/centre-specific_reports/kidney_centre-specific_reports.asp 17.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
http://www.usrds.org/atlas.aspx 18.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2002. http://publications.nice.org.uk/guidance-on-home- compared-with-hospital-haemodialysis-for-patients-with-end-stage-renal-failure-ta48 30.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
"Department of Health, 2004. https://www.gov.",Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2011. http://www.kidneycare.nhs.uk/ resources_old/faqs/ 32.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2012. http://www.england.nhs.uk/wp-content/uploads/ 2012/12/everyonecounts-planning.pdf 34.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2011. http://www.renal.org/Clinical/ GuidelinesSection/VascularAccess.aspx#downloads 35.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2011. http://www.hqip.org.uk/assets/ NCAPOP-Library/National-Kidney-Care-Audit-Vascular-Access- Report-2010.pdf 36.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2012. http://www.hqip.org.uk/assets/ NCAPOP-Library/VAReport2011Interactive03082011-FINAL.pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2011. http://gp.dh.gov.uk/2011/03/28/updated-payment-by-results-pbr-arrangements-for-2011-12/ 39.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2012. https://www.gov.uk/government/publications/confirmation-of-payment-by-results-pbr-arrangements-for-2012-13 40.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2010. http://www.institute.nhs.uk/world_class_ commissioning/pct_portal/cquin.html 41.,Non-OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2011. http://www.renalreg.com/Reports/ 2011.html 42.,OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
2010. http://www.renalreg.com/Reports/ 2010.html 43.,OADS,/arxiv_data1/oa_pdf/19/59/bmjopen-2013-004249.PMC3927715.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004324).,Non-OADS,/arxiv_data1/oa_pdf/94/82/bmjopen-2013-004324.PMC3927716.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2014, 25: 22701 - http://dx.doi.org/10.3402/mehd.v25.22701 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/48/a3/MEHD-25-22701.PMC3927743.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 22701 - http://dx.doi.org/10.3402/mehd.v25.22701",Non-OADS,/arxiv_data1/oa_pdf/48/a3/MEHD-25-22701.PMC3927743.pdf
"¥A coryneform strain with identification signature that discourages suggesting a particular species.Corynebacteria in semen: species and biofilm Citation: Microbial Ecology in Health & Disease 2014, 25: 22701 - http://dx.doi.org/10.3402/mehd.v25.22701 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/48/a3/MEHD-25-22701.PMC3927743.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 22701 - http://dx.doi.org/10.3402/mehd.v25.22701",Non-OADS,/arxiv_data1/oa_pdf/48/a3/MEHD-25-22701.PMC3927743.pdf
"nov., a new species associatedCorynebacteria in semen: species and biofilm Citation: Microbial Ecology in Health & Disease 2014, 25: 22701 - http://dx.doi.org/10.3402/mehd.v25.22701 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/48/a3/MEHD-25-22701.PMC3927743.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 22701 - http://dx.doi.org/10.3402/mehd.v25.22701",Non-OADS,/arxiv_data1/oa_pdf/48/a3/MEHD-25-22701.PMC3927743.pdf
"Veritas® collagen matrix safety studies, Synovis  Surgical Innovations, White paper 88004D 04/05, 2001,  http://www.synovissurgical.com/pdfs/88004D_Oray_paper.",Non-OADS,/arxiv_data1/oa_pdf/0b/48/10.1177_2041731413505305.PMC3927753.pdf
"White  paper MMCR 6 of Davol Inc , http://www.davol.com/default/ assets/File/Product_Files/XenMatrix_Clin_SurgMono_ Final.pdf (2009, accessed on 15 October 15 2012).",OADS,/arxiv_data1/oa_pdf/0b/48/10.1177_2041731413505305.PMC3927753.pdf
Available athttp://www.irdes.fr/EspaceAnglais/Publications/Working Papers/DT52SocioEconomicDeterminantsFrailty.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9c/1b/aft136.PMC3927771.pdf
Available at http://epc2010.princeton.edu/ papers/100401 .,Non-OADS,/arxiv_data1/oa_pdf/9c/1b/aft136.PMC3927771.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/1b/aft136.PMC3927771.pdf
"Availableathttp://app.fhi.se/PXwebF HI/Dialog/varval.asp?ma= Totalkonsumtion&ti=Total+alkoholkonsumtion+efter+ dryck+och+%E5r.+Antal+liter+omr%E4knat+till+100% 25+alkohol++per+inv%E5nare+15-w+%E5r.+Riket&path=../Database/Folkhalsodata/m12Alkohol/bKonsumtion/&lang=2 (3 June 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/9c/1b/aft136.PMC3927771.pdf
"Available at http://www.rcpsych.ac.uk/ ﬁles/pdfversion/ CR165.pdf (16 January 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/9c/1b/aft136.PMC3927771.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/5c/aft155.PMC3927772.pdf
2000: http://www.jointcommission.,Non-OADS,/arxiv_data1/oa_pdf/8d/5c/aft155.PMC3927772.pdf
"BMC Health Serv Res 2012; 12: 84. http://www.biomedcentral.com/1472 –6963/12/84 (31 March 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/8d/5c/aft155.PMC3927772.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/63/aft207.PMC3927775.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/b1/63/aft207.PMC3927775.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004123).,Non-OADS,/arxiv_data1/oa_pdf/fe/3e/bmjopen-2013-004123.PMC3927796.pdf
Vroome E. Prevalence of sickness absence and ‘presenteeism ’: http://eurofound.europa.eu/ewco/2006/07/NL0607019I.htm(accessed 17 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/fe/3e/bmjopen-2013-004123.PMC3927796.pdf
2013. http://www.ssb.no/en/forside;jsessionid=7DD320ACBC7AE638FDAFC68DA7DD52FF.kpld-as-prod03 21.,Non-OADS,/arxiv_data1/oa_pdf/fe/3e/bmjopen-2013-004123.PMC3927796.pdf
2013. http://www.scb.se/ default____2154.aspx 22.,Non-OADS,/arxiv_data1/oa_pdf/fe/3e/bmjopen-2013-004123.PMC3927796.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004369).,Non-OADS,/arxiv_data1/oa_pdf/e0/d4/bmjopen-2013-004369.PMC3927798.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e0/d4/bmjopen-2013-004369.PMC3927798.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004180).,Non-OADS,/arxiv_data1/oa_pdf/87/58/bmjopen-2013-004180.PMC3927799.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/87/58/bmjopen-2013-004180.PMC3927799.pdf
2008. http://www.abep.org (accessed 5 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/87/58/bmjopen-2013-004180.PMC3927799.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004104).,Non-OADS,/arxiv_data1/oa_pdf/da/cf/bmjopen-2013-004104.PMC3927800.pdf
"Case 2: The East African consortia reciprocal monitoring model The East Africa Consortium for Clinical Research (http://www.eaccr.org) is a partnership of 35 institutionsinﬁve countries (Tanzania, Uganda, Kenya, Sudan and Ethiopia).",Non-OADS,/arxiv_data1/oa_pdf/da/cf/bmjopen-2013-004104.PMC3927800.pdf
"All the data collection tools, templates and data will then be made available on http://globalresearchmethods.tghn.org when this paper is published.",OADS,/arxiv_data1/oa_pdf/da/cf/bmjopen-2013-004104.PMC3927800.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.Guideline for Good Clinical Practice E6(R1).,Non-OADS,/arxiv_data1/oa_pdf/da/cf/bmjopen-2013-004104.PMC3927800.pdf
1996. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/ E6_R1/Step4/E6_R1__Guideline.pdfInternational (accessed 21 Sep 2011).,Non-OADS,/arxiv_data1/oa_pdf/da/cf/bmjopen-2013-004104.PMC3927800.pdf
2012. http://www.fda.gov/ ScienceResearch/SpecialTopics/RunningClinicalTrials/ucm155713.htm—FDARegulations 3.,Non-OADS,/arxiv_data1/oa_pdf/da/cf/bmjopen-2013-004104.PMC3927800.pdf
2012. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000316.jsp&mid=WC0b01ac05800a4902 4.,Non-OADS,/arxiv_data1/oa_pdf/da/cf/bmjopen-2013-004104.PMC3927800.pdf
"Guidance for industry oversight of clinical investigations — a risk-based approach to monitoring (draft guidance) .N e wH a m p s h i r e : Food and Drug Administration, 2011 http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/ProposedRegulationsandDraftGuidances/default.htm (accessed 7 Oct 2011).",Non-OADS,/arxiv_data1/oa_pdf/da/cf/bmjopen-2013-004104.PMC3927800.pdf
2012. http://www.dtmi.duke.edu/news-publications/upcoming-events/symposium-on-the-sensible-guidelines-for-the-conduct-of-clinical-trials-may-24-25 15.,Non-OADS,/arxiv_data1/oa_pdf/da/cf/bmjopen-2013-004104.PMC3927800.pdf
2010. http://www.trialstransformation.org/projects/ effective-and-efficient-monitoring/Workstream3 (accessed 4 Oct 2011).,OADS,/arxiv_data1/oa_pdf/da/cf/bmjopen-2013-004104.PMC3927800.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004365).,Non-OADS,/arxiv_data1/oa_pdf/57/22/bmjopen-2013-004365.PMC3927801.pdf
"Oslo, 2012. http://www.whocc.no/atc_ddd_index/ (accessed 17 Mar 2012).",Non-OADS,/arxiv_data1/oa_pdf/57/22/bmjopen-2013-004365.PMC3927801.pdf
"Eurostat Statistics in focus, 2011. http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-SF-11 –066/EN/KS-SF-11-066-EN.PDF (accessed 13 Nov 2012).",Non-OADS,/arxiv_data1/oa_pdf/57/22/bmjopen-2013-004365.PMC3927801.pdf
http://www.abs.gov.au/ausstats/ abs@.nsf/Latestproducts/8146.0Main.Features12010-11?opendocument&tabname=Summary&prodno=8146.,Non-OADS,/arxiv_data1/oa_pdf/57/22/bmjopen-2013-004365.PMC3927801.pdf
2011. http://www.statcan.gc.ca/daily-quotidien/111012/dq111012a-eng.htm (accessed 13 Nov 2012).,OADS,/arxiv_data1/oa_pdf/57/22/bmjopen-2013-004365.PMC3927801.pdf
"Information & Communications: Internet Publishing andBroadcasting and Internet Usage, 2010. http://www.census.gov/compendia/statab/cats/information_communications/internet_publishing_and_broadcasting_and_internet_usage.html (accessed 13 Nov 2012).",OADS,/arxiv_data1/oa_pdf/57/22/bmjopen-2013-004365.PMC3927801.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004020).,Non-OADS,/arxiv_data1/oa_pdf/32/ee/bmjopen-2013-004020.PMC3927812.pdf
2012. http://www.statcompiler.com 9.,Non-OADS,/arxiv_data1/oa_pdf/32/ee/bmjopen-2013-004020.PMC3927812.pdf
http://www.who.int/quantifying_ ehimpacts/national/countryprofile/ethiopia.pdf (accessed 3 Dec2013).,Non-OADS,/arxiv_data1/oa_pdf/32/ee/bmjopen-2013-004020.PMC3927812.pdf
2011. http://resources.ghtechproject.net.,Non-OADS,/arxiv_data1/oa_pdf/32/ee/bmjopen-2013-004020.PMC3927812.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003960).,Non-OADS,/arxiv_data1/oa_pdf/64/d9/bmjopen-2013-003960.PMC3927813.pdf
Get with the Guidelines Stroke participationwas determined from the American Heart Association website (http://www.heart.org).,Non-OADS,/arxiv_data1/oa_pdf/64/d9/bmjopen-2013-003960.PMC3927813.pdf
2012. http://www.jointcommission.org/about_us/about_the_joint_commission_main.aspx 17.,Non-OADS,/arxiv_data1/oa_pdf/64/d9/bmjopen-2013-003960.PMC3927813.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003312).,Non-OADS,/arxiv_data1/oa_pdf/b2/cd/bmjopen-2013-003312.PMC3927814.pdf
"ISS, International Smoking Statistics32; ILI, influenza-like illness; NIPH, Norwegian Institute of Public Health, Oslo, Norway; NIVEL, The Netherlands Institute for Health Services Rese arch, Utrecht, The Netherlands (www.nivel.nl); OECD, Organisation for Economic Co-operation and Development (www.oecd.org); STIVORO, Stichting Volk sgezondheid en Roken, Den Haag, The Netherlands (http://www.stivoro.nl).",Non-OADS,/arxiv_data1/oa_pdf/b2/cd/bmjopen-2013-003312.PMC3927814.pdf
Data retrieved from Statistics Norway (http://www.ssb.no).,OADS,/arxiv_data1/oa_pdf/b2/cd/bmjopen-2013-003312.PMC3927814.pdf
"57The proportion of chil- dren born in Norway with low birth weight (<2500 g) was,however, relatively stable in the period 1975 –2008 (5.2 – 6.4%) (http://www.norgeshelsa.no).",OADS,/arxiv_data1/oa_pdf/b2/cd/bmjopen-2013-003312.PMC3927814.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004605).,Non-OADS,/arxiv_data1/oa_pdf/55/c0/bmjopen-2013-004605.PMC3927815.pdf
http://www.wtf.org/wtf_eng/main/ main_eng.html (accessed 29 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/55/c0/bmjopen-2013-004605.PMC3927815.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004167).,Non-OADS,/arxiv_data1/oa_pdf/be/2b/bmjopen-2013-004167.PMC3927816.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/89/6a/ncomms3963.PMC3927877.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Stathopulos, P. B. et al.",Non-OADS,/arxiv_data1/oa_pdf/89/6a/ncomms3963.PMC3927877.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3963 12 NATURE COMMUNICATIONS | 4:2963 | DOI: 10.1038/ncomms3963 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/89/6a/ncomms3963.PMC3927877.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/42/d5/bmjopen-2013-004242.PMC3927923.pdf
http://www.un.org/ womenwatch/confer/beijing/reports/plateng.htm (accessed 14 Oct2012).,Non-OADS,/arxiv_data1/oa_pdf/42/d5/bmjopen-2013-004242.PMC3927923.pdf
http://www.shura.gov.sa/wps/wcm/connect/ShuraEn/internet/Councils+Resolutions/Second+Term/Fourth+Year/(accessed 14 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/42/d5/bmjopen-2013-004242.PMC3927923.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004378).,Non-OADS,/arxiv_data1/oa_pdf/e7/be/bmjopen-2013-004378.PMC3927928.pdf
http://dx.doi.org/10.1080/02673843.2012.733313 4.,Non-OADS,/arxiv_data1/oa_pdf/e7/be/bmjopen-2013-004378.PMC3927928.pdf
http://www.crdp.org/CRDP 23.,Non-OADS,/arxiv_data1/oa_pdf/e7/be/bmjopen-2013-004378.PMC3927928.pdf
2013. http://www.who.int/mediacentre/factsheets/fs311/en/index.html 2. WHO.,Non-OADS,/arxiv_data1/oa_pdf/60/8c/bmjopen-2013-003926.PMC3927930.pdf
doi:http://dx.doi.org/10.2196/jmir.2665 38.,Non-OADS,/arxiv_data1/oa_pdf/60/8c/bmjopen-2013-003926.PMC3927930.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003875).,Non-OADS,/arxiv_data1/oa_pdf/a2/a8/bmjopen-2013-003875.PMC3927931.pdf
http://www.bfarm.de/EN/Home/home_node.html(accessed 30 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/a2/a8/bmjopen-2013-003875.PMC3927931.pdf
"London: General Medical Council, 2009.http://www.gmc-uk.orh/guidance/ethical-guidance/confidentiality.asp (accessed 20 Jul 2012).",Non-OADS,/arxiv_data1/oa_pdf/a2/a8/bmjopen-2013-003875.PMC3927931.pdf
"London: General Medical Council, 2009. http://www.gmc-uk.orh/guidance/ethical-guidance/confidentiality.asp (accessed 20 Jul 2012).",Non-OADS,/arxiv_data1/oa_pdf/a2/a8/bmjopen-2013-003875.PMC3927931.pdf
http://www.oed.com/view/Entry/135518?redirectedFrom=ownership(accessed 6 Jun 2012).,Non-OADS,/arxiv_data1/oa_pdf/a2/a8/bmjopen-2013-003875.PMC3927931.pdf
http://www.qresearch.org (accessed 17 Sep 2009).,Non-OADS,/arxiv_data1/oa_pdf/a2/a8/bmjopen-2013-003875.PMC3927931.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003846).,Non-OADS,/arxiv_data1/oa_pdf/82/60/bmjopen-2013-003846.PMC3927932.pdf
2012. http://lungecancer.dk/ 00007/00058/ 17.,Non-OADS,/arxiv_data1/oa_pdf/82/60/bmjopen-2013-003846.PMC3927932.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003757).,Non-OADS,/arxiv_data1/oa_pdf/02/3a/bmjopen-2013-003757.PMC3927933.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003481).,Non-OADS,/arxiv_data1/oa_pdf/67/5c/bmjopen-2013-003481.PMC3927934.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003827).,Non-OADS,/arxiv_data1/oa_pdf/cd/bd/bmjopen-2013-003827.PMC3927936.pdf
Guideline 101: British Guideline on the Management ofAsthma 2011. http://www.sign.ac.uk/guidelines/fulltext/101/index.html(accessed 04 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/cd/bd/bmjopen-2013-003827.PMC3927936.pdf
http://www.asthma.org.uk/about-asthma/my-child-has- asthma/asthma-your-child/ (accessed 28 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/cd/bd/bmjopen-2013-003827.PMC3927936.pdf
http://books.nap.edu/ openbook.php?record_id=9610&page=6 9.,Non-OADS,/arxiv_data1/oa_pdf/cd/bd/bmjopen-2013-003827.PMC3927936.pdf
http://www.sign.ac.uk/ guidelines/fulltext/50/annexb.html (accessed 31 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/cd/bd/bmjopen-2013-003827.PMC3927936.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.Vol.",Non-OADS,/arxiv_data1/oa_pdf/52/56/kwt298.PMC3927974.pdf
"RelevantStata code (StataCorp LP, College Station, Texas) is availablefrom the University of Cambridge ( http://www.phpc.cam.ac.",OADS,/arxiv_data1/oa_pdf/52/56/kwt298.PMC3927974.pdf
"Various sources have supported recruit-ment, follow-up, and laboratory measurements in the cohortscontributing to the Emerging Risk Factors Collaboration.Investigators in several of these studies have contributed toa list of relevant funding sources ( http://ceu.phpc.cam.ac.",Non-OADS,/arxiv_data1/oa_pdf/52/56/kwt298.PMC3927974.pdf
"APPENDIX Emerging Risk Factors Collaboration investigators/ contributors —Air Force/Texas Coronary Atherosclerosis Prevention Study: Robert W. Tipping; Atherosclerosis Riskin Communities Study: Aaron R. Folsom, David J. Couper,Christie M. Ballantyne, Josef Coresh; British RegionalHeart Study: S. Goya Wannamethee, Richard W. Morris;Bruneck Study: Stefan Kiechl, Johann Willeit, Peter Willeit,Georg Schett; British Women ’s Heart and Health Study: Shah Ebrahim, Debbie A. Lawlor; Caerphilly ProspectiveStudy: John W. Yarnell, John Gallacher; CardiovascularHealth Study: Mary Cushman, Bruce M. Psaty, Russ Tracy(see http://www.chs-nhlbi.org for acknowledgements); Co- penhagen City Heart Study: Anne Tybjærg-Hansen, RuthFrikke-Schmidt, Marianne Benn, Børge G. Nordestgaard;Edinburgh Artery Study: Jackie F. Price, Amanda J. Lee,Stela McLachlan; European Prospective Investigation of Cancer –NorfolkStudy:Kay-TeeKhaw,NicholasJ.Wareham; Epidemiologische Studie zu Chancen der Verhütung,Früherkennung und Therapie chronischer Erkrankungen inder älteren Bevölkerung: Hermann Brenner, Ben Schöttker,Heiko Müller, Dietrich Rothenbacher; First Myocardial In-farction in Northern Sweden: Jan-Håkan Jansson, PatrikWennberg; Finrisk Cohort 1992, Finrisk Cohort 1997:Veikko Salomaa, Kennet Harald, Pekka Jousilahti,Erkki Vartiainen; Fletche r Challenge Blood Study: Mark Woodward; Framingham Offspring Study: Ralph B.D’Agostino, Sr., Philip A. Wolf, Ramachandran S. Vasan, Emelia J. Benjamin; Research Centre for Prevention andHealth: Else-Marie Bladbjerg, Torben Jørgensen, LarsMøller, Jørgen Jespersen; Hisayama Study: Yutaka Kiyohara,Hisatomi Arima, Yasufumi Doi, Toshiharu Ninomiya; HoornStudy: Jacqueline M. Dekker, Giel Nijpels, Coen D. A.Stehouwer; Kuopio Ischaemic Heart Disease Study: JussiKauhanen, Jukka T. Salonen; L ower Extremity Arterial Disease Event Reduction Trial: Tom W. Meade, JackieA.",Non-OADS,/arxiv_data1/oa_pdf/52/56/kwt298.PMC3927974.pdf
"Cooper; Multi-Ethnic Study of Atherosclerosis: MaryCushman, Aaron R. Folsom, Bruce M. Psaty, Steven Shea(see http://www.mesa-nhlbi.org for acknowledgements); MONICA/KORA Augsburg Surveys S1, S2, and S3: AngelaDöring, Wolfgang Koenig, Christa Meisinger; Multiple RiskFactor Intervention Trial 1: Lewis H. Kuller, Greg Grandits;Third National Health and Nutrition Examination Survey:Richard F. Gillum, Michael Mussolino; Nurses ’Health Study: Eric B. Rimm, Sue E. Hankinson, JoAnn E. Manson,Jennifer K. Pai; Nova Scotia Health Survey: Susan Kirkland,Jonathan A. Shaffer, Daichi Shimbo; Prevention of Renal andVascular End Stage Disease Study: Stephan J. L. Bakker,Ron T. Gansevoort, Hans L. Hillege; Prospective Epidemio-logical Study of Myocardial Infarction: Philippe Amouyel,Dominique Arveiler, Alun Evans, Jean Ferrières; ProspectiveStudy of Pravastatin in the Elderly at Risk: Naveed Sattar,Rudi G. Westendorp, Brendan M. Buckley; Quebec Cardio-vascular Study: Bernard Cantin, Benoît Lamarche, Jean- Pierre Després, Gilles R. Dagenais; Rancho Bernardo Study: Elizabeth Barrett-Connor, Deborah L. Wingard, RicheleBettencourt; Reykjavik Study: Vilmundur Gudnason, ThorAspelund, Gunnar Sigurdsson, Bolli Thorsson; RotterdamStudy: Maryam Kavousi, Jacqueline C. Witteman, AlbertHofman, Oscar H. Franco; Strong Heart Study: BarbaraV.",Non-OADS,/arxiv_data1/oa_pdf/52/56/kwt298.PMC3927974.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.Vol.",Non-OADS,/arxiv_data1/oa_pdf/54/73/kwt302.PMC3927976.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted reuse, distribution, and reproduction in anymedium, provided the original work is properly cited.Vol.",Non-OADS,/arxiv_data1/oa_pdf/2e/6a/kwt303.PMC3927977.pdf
Statistical analyses were conducted using an online χ 2 calculator (http://www.graphpad.com).,OADS,/arxiv_data1/oa_pdf/ab/c7/bmjopen-2013-004320.PMC3927994.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/c7/bmjopen-2013-004320.PMC3927994.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004273).,Non-OADS,/arxiv_data1/oa_pdf/e8/9d/bmjopen-2013-004273.PMC3927996.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003843).,Non-OADS,/arxiv_data1/oa_pdf/2a/66/bmjopen-2013-003843.PMC3927997.pdf
2013. http://www.who.int/mental_health/ management/depression/definition/en/print.html 2.,Non-OADS,/arxiv_data1/oa_pdf/2a/66/bmjopen-2013-003843.PMC3927997.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004257).,Non-OADS,/arxiv_data1/oa_pdf/75/e8/bmjopen-2013-004257.PMC3927998.pdf
http://www.ine.es/jaxi/menu.do?,Non-OADS,/arxiv_data1/oa_pdf/75/e8/bmjopen-2013-004257.PMC3927998.pdf
"Copenhagen, Denmark Europe, 2007. http://www.euro.who.int/__data/assets/pdf_file/0010/74746/E90711.pdf (accessed 23 May 2013).",Non-OADS,/arxiv_data1/oa_pdf/75/e8/bmjopen-2013-004257.PMC3927998.pdf
http://www.aemps.gob.es/medicamentosUsoHumano/observatorio/informes.htm (accessed 23 Aug 2012).,Non-OADS,/arxiv_data1/oa_pdf/75/e8/bmjopen-2013-004257.PMC3927998.pdf
http://www.msssi.gob.es/estadEstudios/ estadisticas/sisInfSanSNS/home.htm (accessed 23 Aug. 2012).,Non-OADS,/arxiv_data1/oa_pdf/75/e8/bmjopen-2013-004257.PMC3927998.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/bd/cvt333.PMC3928001.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/d5/cvt338.PMC3928002.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/64/cvt339.PMC3928003.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/cc/ott-7-235.PMC3928058.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 235–244OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  235Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S4133 6Treating malignant glioma in Chinese patients:  update on temozolomide Liang Chang1 Jun Su1 Xiuzhi Jia2,3 Huan Ren2,3 1Department of Neurosurgery,   The T umor Hospital of Harbin  Medical University, 2Department  of immunology, Harbin Medical  University, 3Key Lab infection and  immunity, Heilongjiang Province,   Harbin, People’s Republic of China Correspondence: Huan Ren   Key Lab infection and immunity,  Heilongjiang Province, Harbin 150086,  People’s Republic of China   Tel +86 451 86674566   Fax +86 451 86697322   email  renhuan@ems.hrbmu.edu.cnAbstract:  Malignant glioma, ie, anaplastic astrocytoma and glioblastoma, is the most common  type of primary malignant brain tumor in the People’ s Republic of China, and is particularly  aggressive.",Non-OADS,/arxiv_data1/oa_pdf/67/cc/ott-7-235.PMC3928058.pdf
Available from: http://www.tasly.com /.,Non-OADS,/arxiv_data1/oa_pdf/67/cc/ott-7-235.PMC3928058.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/67/cc/ott-7-235.PMC3928058.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/cc/ott-7-235.PMC3928058.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/7b/ndt-10-297.PMC3928059.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 297–310Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  297Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S3870 6Frontotemporal lobar degeneration:   current perspectives Lina Riedl1 ian R Mackenzie2 Hans Förstl1 Alexander Kurz1 Janine Diehl-Schmid1 1Center for Cognitive Disorders,   Department of Psychiatry and  Psychotherapy, Klinikum rechts der  isar, T echnische Universität München,   Munich, Germany; 2Department of  Pathology and Laboratory Medicine,   University of British Columbia,   vancouver, Canada Correspondence: Lina Riedl   Department of Psychiatry and  Psychotherapy, Klinikum rechts der isar,   Technische Universität München,  ismaninger Str 22, 81675 Munich,  Germany   Tel +49 89 4140 4275   Fax +49 89 4140 4923   email lina.riedl@mri.tum.d eAbstract:  The term frontotemporal lobar degeneration (FTLD) refers to a group of  progressive  brain diseases, which preferentially involve the frontal and temporal lobes.",Non-OADS,/arxiv_data1/oa_pdf/d9/7b/ndt-10-297.PMC3928059.pdf
Available from: http://www4.parinc.com/Products/Product.aspx?,Non-OADS,/arxiv_data1/oa_pdf/d9/7b/ndt-10-297.PMC3928059.pdf
Available from: http://clinicaltrials.gov/ show/NCT0162637 8.,Non-OADS,/arxiv_data1/oa_pdf/d9/7b/ndt-10-297.PMC3928059.pdf
Available  from: http://clinicaltrials.gov/show/NCT0135036 2.,Non-OADS,/arxiv_data1/oa_pdf/d9/7b/ndt-10-297.PMC3928059.pdf
Available  from: http://clinicaltrials.gov/show/NCT0104939 9.,Non-OADS,/arxiv_data1/oa_pdf/d9/7b/ndt-10-297.PMC3928059.pdf
Available  from: http://clinicaltrials.gov/show/NCT0118788 8.,Non-OADS,/arxiv_data1/oa_pdf/d9/7b/ndt-10-297.PMC3928059.pdf
Available from: http://clinicaltrials.gov/show/NCT0111072 0.,Non-OADS,/arxiv_data1/oa_pdf/d9/7b/ndt-10-297.PMC3928059.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d9/7b/ndt-10-297.PMC3928059.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/7b/ndt-10-297.PMC3928059.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/5a/imcrj-7-023.PMC3928060.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2014:7 23–25International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  23Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S5436 1Conventional mesh repair of a giant   iatrogenic bilateral diaphragmatic hernia   with an enterothorax philipp Lingohr1 thomas Galetin2 Boris Vestweber2 Hanno Matthaei1 Jörg C Kalff1 Karl-Heinz Vestweber2 1Department of surgery, University of  Bonn, Bonn, Germany; 2Department  of surgery, Klinikum Leverkusen,   Leverkusen, Germany Correspondence: philipp Lingohr   Department of surgery, University   of Bonn, sigmund-Freud-strasse 25,   53127 Bonn, Germany   tel +49 228 287 15215   Fax +49 228 287 19585   email p hilipp.lingohr@ukb.uni-bonn.d ePurpose:  Diaphragmatic hernias (DHs) are divided into congenital and acquired hernias,  most of which are congenital.",Non-OADS,/arxiv_data1/oa_pdf/4a/5a/imcrj-7-023.PMC3928060.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/4a/5a/imcrj-7-023.PMC3928060.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/5a/imcrj-7-023.PMC3928060.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/84/ott-7-223.PMC3928061.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 223–234OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  223Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S5352 4Mechanism of action and clinical activity of  tasquinimod in castrate-resistant prostate cancer Neha Gupta Omar Al Ustwani Li Shen Roberto Pili Department of Medicine, Roswell  Park Cancer institute, Buffalo,    NY, USA Correspondence: Roberto Pili   Genitourinary Program, Roswell   Park Cancer institute, elm and Carlton   Streets, Buffalo, NY 14263, USA   Tel +1 716 845 3851   Fax +1 716 845 8232   email roberto.pili@roswellpark.or gAbstract:  Castrate-resistant prostate cancer (CRPC) is a disease where survival is poor and  treatment is challenging.",Non-OADS,/arxiv_data1/oa_pdf/eb/84/ott-7-223.PMC3928061.pdf
Available from: http://cancerres.aacrjournals.org/cgi/content/ short/72/8_MeetingAbstracts/1551.,Non-OADS,/arxiv_data1/oa_pdf/eb/84/ott-7-223.PMC3928061.pdf
Available from: http://cancerres.aacrjournals.org/cgi/ content/meeting_abstract/73/8_MeetingAbstracts/4746.,Non-OADS,/arxiv_data1/oa_pdf/eb/84/ott-7-223.PMC3928061.pdf
Available from: http://clinicaltrials.gov/show/NCT0173254 9.,Non-OADS,/arxiv_data1/oa_pdf/eb/84/ott-7-223.PMC3928061.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/eb/84/ott-7-223.PMC3928061.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/84/ott-7-223.PMC3928061.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/dhps-6-015.PMC3928062.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug, Healthcare and Patient Safety 2014:6 15–20Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  15Original reSearcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DHPS.S5966 5Use of Streptococcus salivarius  K12 in the  prevention of streptococcal and viral  pharyngotonsillitis in children Francesco Di Pierro1 Maria colombo2 alberto Zanvit3 Paolo risso4 amilcare S rottoli5 1Scientific Department, Velleja  research, Milan, 2Pediatric  Department, University of Parma,   Parma, 3Stomatology institute,   Milan, 4laboratory of epidemiology  and Social Psychiatry, Mario  negri institute, Milan, 5Pediatric  Department, Uboldo Hospital,   cernusco sul naviglio, italy correspondence: Francesco Di Pierro   Scientific Department, Velleja Research,  23 Viale lunigiana, Milan 20125, italy   Tel +39 349 552 7663   Fax +39 0523 511 894   email f.dipierro@vellejaresearch.co mBackground:  Streptococcus salivarius  K12 is an oral probiotic strain releasing two lantibiotics  (salivaricin A2 and salivaricin B) that antagonize the growth of S. pyogenes , the most important  bacterial cause of pharyngeal infections in humans also affected by episodes of acute otitis media.",Non-OADS,/arxiv_data1/oa_pdf/a9/e8/dhps-6-015.PMC3928062.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/a9/e8/dhps-6-015.PMC3928062.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/dhps-6-015.PMC3928062.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/6b/jmdh-7-119.PMC3928063.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 119–122Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  119Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S5478 6is there an increased risk of hip fracture   in multiple sclerosis?,Non-OADS,/arxiv_data1/oa_pdf/b2/6b/jmdh-7-119.PMC3928063.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/b2/6b/jmdh-7-119.PMC3928063.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b2/6b/jmdh-7-119.PMC3928063.pdf
"Available from:  http://nof.org/files/nof/public/content/resource/913/files/580.pd f.  Accessed January 8, 2014.",OADS,/arxiv_data1/oa_pdf/b2/6b/jmdh-7-119.PMC3928063.pdf
"Hum Vaccin  immu nother 2013; 9:1991- 2001; PM id:23 777748; http://dx.doi.org/10.4161/ hv.25249 Role of zinc in the pathogenesis of enteroaggregative Escherichia coli enteroaggregative Es cherichia coli ( ea eC) i s  a major pathogen worldwide, associated with  diarrheal disease in both children and adults, suggesting the need for new preventive and therapeutic treatments.",Non-OADS,/arxiv_data1/oa_pdf/b6/4f/gmic-4-423.PMC3928154.pdf
Virulence 2013; 4:624-33; PM id:23 958904; http://dx.doi.org/10.4161/ viru.26120,Non-OADS,/arxiv_data1/oa_pdf/b6/4f/gmic-4-423.PMC3928154.pdf
Virulence  2013; 4:592-6; PM id:24 060961; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/4f/gmic-4-423.PMC3928154.pdf
"Correspondence to: Richard M Peek; Email: richard.peek@vanderbilt.edu http://dx.doi.org/10.4161/gmic.27169Special issue Helicobacter pylori richard M Peek division of Gastroenterology, Hepatology, and nutr ition; depa rtment of Medicine; Vanderbilt- ingr am can cer cent er and can cer Biology; nas hville, tn uSa",Non-OADS,/arxiv_data1/oa_pdf/48/e7/gmic-4-425.PMC3928155.pdf
"Continuing the theme of non-coding RNAs in development, Lopez-Ramirez and Nicoli (p. 90) review the interplay between epigenetics and miRNAs during embryonic and adult neurogenesis, while  Correspondence to: Frank J Slack; Email: frank.slack@yale.edu Submitted: 12/18/2013; Accepted: 12/18/2013; Published Online: 12/19/2013http://dx.doi.org/10.4161/epi.27579In this issue of Epigenetics Special focus on non-coding RNAs in epigenetic regulation Frank J s lack department of Molecular, Cellular and d evelopmental Biology; Yale University; New Haven, C t UsA",Non-OADS,/arxiv_data1/oa_pdf/56/22/epi-9-1.PMC3928171.pdf
"9 TDRD1  *Correspondence to: Manel Esteller; Email: mesteller@idibell.cat Submitted: 10/21/2013; Revised: 11/15/2013; Accepted: 11/18/2013; Published Online: 11/18/2013http://dx.doi.org/10.4161/epi.27237Epigenetic loss of the PIWI/piRNA machinery   in human testicular tumorigenesis Humberto J f erreira1,2, Holger Heyn1, Xavier Garcia del Muro3, August Vidal4, Sara Larriba5, Clara Muñoz6, Alberto Villanueva6,  and Manel e steller1,7, 8* 1Cancer e pigenetics and Biology p rogram ( peBC); Bellvitge Biomedical r esearch i nstitute ( iDiBeLL); Barcelona, Spain; 2programme in e xperimental Biology and Biomedicine;  Centre for Neurosciences and Cell Biology; University of Coimbra; Coimbra, p ortugal; 3Medical o ncology Department; Catalan i nstitute of o ncology; Bellvitge Biomedical  research i nstitute ( iDiBeLL); Barcelona, Spain; 4pathology Department; University Hospital Bellvitge; Bellvitge Biomedical r esearch i nstitute ( iDiBeL); Barcelona, Spain;   5Human Molecular Genetics Group; Bellvitge Biomedical r esearch i nstitute ( iDiBeLL); Barcelona, Spain; 6translational r esearch Laboratory; Catalan i nstitute of o ncology;  Bellvitge Biomedical r esearch i nstitute ( iDiBeLL); Barcelona, Spain; 7Department of p hysiological Sciences ii ; School of Medicine; University of Barcelona; Barcelona, Spain;  8institucio Catalana de r ecerca i e studis Avançats ( iCreA); Barcelona, Spain Keywords:  DNA methylation, non-coding RNA, piRNAs, PIWI proteins, testicular cancer, epigenetics Although most cancer research has focused in m rNA, non-coding r NAs are also an essential player in tumorigenesis.",Non-OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Nat Rev Genet 2011; 12:861-74; PMID:22094949 ;  http://dx.doi.org/10.1038/nrg3074 2.,OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Genes Dev  2012 ; 26:2361 -73; PMID:23124062 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Nat Rev Genet 2013 ; 14:447- 59; PMID:23732335 ; http://dx.doi.org/10.1038/ nrg3462 4.,OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Dev Cell  2002 ; 2:819-30;  PMID:12062093 ; http://dx.doi.org/10.1016/ S1534-5807(02) 00165-X 5.,OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Development  2004 ; 131:839-49; PMID:14736746 ;  http://dx.doi.org/10.1242/dev.00973 6.,OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
PLoS One  2012 ; 7:e44479 ;  PMID:23071498 ; http://dx.doi.org/10.1371/ journal.pone.0044479 7.,Non-OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
PLoS One  2012 ; 7:e47892 ;  PMID:23112866 ; http://dx.doi.org/10.1371/ journal.pone.00478928.,Non-OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Stem Cells  2012 ; 30:2603 - 11; PMID:22996918 ; http://dx.doi.org/10.1002/ stem.1237 9.,Non-OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
J Biol Chem 2009 ;  284:6507 -19; PMID :19114715 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Genes Dev 2010 ; 24:636-46;  PMID:20360382 ; http://dx.doi.org/10.1101/ gad.1899210 11.,OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
N Engl J Med  2008 ; 358:1148 -59; PMID:18337604 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Epigenetics  2011 ; 6:692- 702; PMID:21593595 ; http://dx.doi.org/10.4161/ epi.6.6.1619615.,Non-OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Cell 2007 ; 128:1089 -103;  PMID:17346786 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Mol Cell   2008 ; 31:785-99; PMID:18922463 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Nat Rev Urol 2009 ; 6:550- 6; PMID:19724246 ; http://dx.doi.org/10.1038/ nrurol.2009.179 19.,Non-OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
PLoS One  2009 ; 4:e5591 ;  PMID:19440348 ; http://dx.doi.org/10.1371/ journal.pone.0005591 20.,Non-OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
Br J Cancer 2006 ; 95:475- 84; PMID:16880791 ; http://dx.doi.org/10.1038/ sj.bjc.6603284,Non-OADS,/arxiv_data1/oa_pdf/d7/65/epi-9-113.PMC3928173.pdf
"*Correspondence to: Gunnar H Heine; Email: Gunnar.Heine@uks.eu Submitted: 09/19/2013; Revised: 10/16/2013; Accepted: 10/23/2013; Published Online: 11/01/2013http://dx.doi.org/10.4161/epi.26931Massive analysis of cDNA ends (MACE) and miRNA  expression profiling identifies proatherogenic  pathways in chronic kidney disease  adam M Zawada1, Kyrill s Rogacev1, sören Müller2,3, Björn Rotter2, Peter Winter2, Danilo Fliser1, and Gunnar h hein e1 1Department of Internal Medicine IV; saa rland University Medical cen ter; hom burg, Germany; 2GenXPro Gmb h; Fr ankfurt am Main, Germany;   3Molecular Bio sci ences; Biocenter; Johann Wolfgang Goethe University; Frankfurt am Main, Germany Keywords:  miRNA, epigenetics, kidney disease, hemodialysis, atherosclerosis, cardiovascular disease, MACE,   next-generation sequencing epigenetic dysregulation contributes to the high cardiovascular disease burden in chronic kidney disease ( cKD )  patients.",Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Interaction network analysesNext we generated interaction networks of gene products  of differentially expressed genes in HD patients by using the String 9.0 software (http://string-db.org/; Fig.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
"The Genetic Association Database (accessible from the National Institutes of Health; http://geneticassociationdb.nih.gov) linked 22 out of these 80 genes to cardiovascular disease (e.g., KLF6 , DUSP6 , VIM , CXCL5 ,  KLF4 ), and 34 genes to infection/immune disease (e.g., ZFP36 ,  SOCS3 , FOS, JUND , ZAP70 ) (Table  S 6A and B ).",OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Mapping of reads to the human genome (hg19) was performed with novoalign (http://novocraft.com/).,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
The mapping coordinates of each read were overlapped with the refseq annotation track from the UCSC table browser (http://genome.ucsc.edu/cgi-bin/hgTables?command=start) to quantify mature mRNA expression.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
"48 GO-enrichment analysis was performed using the  GO-enrichment toolkit from http://genxpro.ath.cx, which is based on the Fisher’s exact test among transcripts that are differentially expressed at a P value of 0.05.",OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Quantification of miRNA expressionSmall RNA-Seq libraries were analyzed with omiRas (detailed  workflow is presented at http://tools.genxpro.net/omiras).,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Kidney Int 2011; 80:572-86; PMID:21750584 ; http://dx.doi.org/10.1038/ ki.2011.223 2.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Kidney Int  2011 ; 79:23-32;  PMID:20881938 ; http://dx.doi.org/10.1038/ ki.2010.335 3.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Nephrol Dial Transplant  2008 ; 23:1493 -6;  PMID:18308770 ; http://dx.doi.org/10.1093/ndt/ gfn056 4.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Nephrol Dial Transplant  2013 ; 28:1663 -71;  PMID:23512108 ; http://dx.doi.org/10.1093/ndt/ gft042 5.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Circ Cardiovasc Genet 2012 ; 5: 611-20;  PMID:23074332 ; http://dx.doi.org/10.1161/ CIRCGENETICS.112.963207 6.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
J  Clin Invest 2012 ; 122:4190 -202; PMID:23041630 ;  http://dx.doi.org/10.1172/JCI61716 9.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Nature  2011 ; 469:336- 42; PMID:21248840 ; http://dx.doi.org/10.1038/ nature09783 10.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Arterioscler Thromb Vasc Biol  2013 ; 33:449-54; PMID:23324496 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Circ Res  2012 ; 110:483-95; PMID:22302755 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Circ Res  2010 ; 107:677-84; PMID:20595655 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Biochem Biophys Res Commun  2010 ; 394:792- 7; PMID:20230787 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
"Clin Sci (Lond) 2010 ; 119:335-43; PMID:20528768 ;  http://dx.doi.org/10.1042/CS20100043 15.  va n Empel  VP, De Windt  LJ, da Costa Martins  PA.",OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Curr Hypertens Rep 2012 ;  14:498-509; PMID:22996205 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
"Circulation  2012 ; 126(Suppl 1 ):S81- 90; PMID:22965997 ; http://dx.doi.org/10.1161/ CIRCULATIONAHA.111.084186 17. va n Rooij  E, Purcell  AL, Levin  AA.",Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Circ Res 2012 ; 110:496- 507; PMID:22302756 ; http://dx.doi.org/10.1161/ CIRCRESAHA.111.247916 18.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Circulation  2013 ; 127:1609 - 19; PMID:23513069 ; http://dx.doi.org/10.1161/ CIRCULATIONAHA.112.000736 19.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Arterioscler Thromb Vasc Biol 2013 ; 33:1973 - 7; PMID:23702658 ; http://dx.doi.org/10.1161/ ATVBAHA.113.301732 20.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
N Engl J Med  2013 ; 368:1685 -94; PMID:23534542 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Stat Med 1990 ;  9:811-8; PMID:2218183 ; http://dx.doi.org/10.1002/ sim.4780090710 22.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Circ Res  2013 ; 112:1073 -84; PMID:23538277 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Arterioscler Thromb Vasc Biol 2013 ; 33:178- 85; PMID:23325474 ; http://dx.doi.org/10.1161/ ATVBAHA.112.300144 24.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
BMC Genomics  2009 ; 10:531; PMID:19917133 ;  http://dx.doi.org/10.1186/1471-2164-10-53125.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
N Engl J Med 1999 ; 340:115-26; PMID:9887164 ;  http://dx.doi.org/10.1056/NEJM199901143400207 27.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Blood  2013 ; 121:984-95; PMID:23144169 ;  http://dx.doi.org/10.1182/blood-2011-08-374793 28.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Arterioscler Thromb Vasc Biol  2013 ; 33:206-14; PMID:23325478 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Circulation  2012 ; 125:2892 -903;  PMID:22580331 ; http://dx.doi.org/10.1161/ CIRCULATIONAHA.111.087817 30.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Nat Immunol   2010 ; 11:141-7; PMID:19946272 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Proc Natl Acad Sci U S A  2006 ; 103:12481 -6; PMID:16885212 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Atherosclerosis  2011 ; 219:211-7;  PMID:21820659 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Thromb Haemost  2012 ; 107:619- 25; PMID:22370758 ; http://dx.doi.org/10.1160/ TH11-09-0607 36.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
J Am Coll Cardiol  2012 ; 60:290-9; PMID:22813605 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
PLoS One  2012 ; 7:e35877 ;  PMID:22558252 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Kidney Int  2008 ; 73:622- 9; PMID:18160960 ; http://dx.doi.org/10.1038/ sj.ki.5002744 39.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Nat Rev Nephrol   2012 ; 8: 362-9; PMID:22410492 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
J Am Coll Cardiol 2012 ; 60:1512 - 20; PMID:22999728 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Immunobiology   2012 ; 217:1273 -84; PMID:22898391 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Blood  2011 ; 118:e50-61; PMID:21803849 ;  http://dx.doi.org/10.1182/blood-2011-01-326827 44.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Nephrol Dial  Transplant  2011 ; 26:3794 -802; PMID:21891774 ;  http://dx.doi.org/10.1093/ndt/gfr485 45.,Non-OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Clin J  Am Soc Nephrol 2011 ; 6:1540 -6; PMID:21700819 ;  http://dx.doi.org/10.2215/CJN.0043011146.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Methods  2008 ; 44:3- 12; PMID:18158127 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Genome Biol  2010 ; 11:R106 ;  PMID:20979621 ; http://dx.doi.org/10.1186/ gb-2010-11-10-r106 49.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Bioinformatics  2013 ; 29:2651 - 2; PMID:23946503 ; http://dx.doi.org/10.1093/ bioinformatics/btt457 50.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Bioinformatics  2009 ; 25:1754 -60; PMID:19451168 ;  http://dx.doi.org/10.1093/bioinformatics/btp324 51.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
Bioinformatics   2010 ; 26:136-8; PMID:19855105 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/43/epi-9-161.PMC3928179.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:1-5 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.1 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 1 −Department of Thoracic and Cardi ovascular Surgery, Samsung Medi cal Center, Sungkyunkwan University School of Medicine Received: June 28, 2013, Revised: August 9, 2013, Accepted: Aug ust 10, 2013 Corresponding author: Dong Seop Jeong, Department of Thoracic an d Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 1 35-710, Korea (Tel) 82-2-3410-1278 (Fax) 82-2-3410-0089 (E-mail) cabg@korea.c om  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/a8/4a/kjtcs-47-1.PMC3928256.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:13-19 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.13 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 13 −Department of Thoracic and Cardiovascular Surgery, Chonnam Nati onal University Hwasun Hospital,  Chonnam National University Me dical  School Received: July 1, 2013, Revised: August 31, 2013, Accepted: Sep tember 17, 2013 Corresponding author: Kook Joo Na, Department of Thoracic and Ca rdiovascular Surgery, Chonnam National University Hwasun Hospit al,  Chonnam National University Medical School, 322 Seoyang-ro, Hwa sun 519-763, Korea (Tel) 82-61-379-7664 (Fax) 82-61-379-7665 (E-mail) kjna1125@han mail.net  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/59/c8/kjtcs-47-13.PMC3928257.pdf
Available from: http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/59/c8/kjtcs-47-13.PMC3928257.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:20-25 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.20 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 20 −1Department of Thoracic and Cardiovascular Surgery, Chonbuk Nati onal University Medical School, 2Research Institute of Clinical Medicine of  Chonbuk National Univer sity-Biomedical Research Institute of Ch onbuk National University Hospital †This paper was presented at the 44th Fall Meeting of the Korean  Society for Thoracic and Cardiovascular Surgery Symposium in a utumn  2012.",Non-OADS,/arxiv_data1/oa_pdf/ec/73/kjtcs-47-20.PMC3928258.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:26-31 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.26 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 26 −1Department of Thoracic and Cardiovascular Surgery, Konyang Univ ersity Hospital, Konyang Univ ersity College of Medicine, 2Department of  Thoracic and Cardiovascular Surgery, Pusan National University Hospital, Pusan National Univ ersity School of Medicine, 3Department of  Anesthesiology and Pain Medicine, Konyang University Hospital, Konyang University College of Medicine Received: August 7, 2013, Revised: September 17, 2013, Accepted : September 23, 2013 Corresponding author: Young Jin Kim, Department of Thoracic and Cardiovascular Surgery, Konyang University Hospital, Konyang Un iversity  College of Medicine, 158 Gwanjeodong-ro, Seo-gu, Daejeon 302-71 8, Korea (Tel) 82-42-600-9150 (Fax) 82-42-600-9090 (E-mail) kyjcs@kyuh.a c.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/b2/cd/kjtcs-47-26.PMC3928259.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:32-34 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.32 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 32 −Departments of 1Thoracic and Cardiovascular Surgery and 2Anesthesiology and Pain Medicine, Kyungpook National University  School of  Medicine Received: July 1, 2013, Revised: O ctober 8, 2013, Accepted: Oct ober 10, 2013 Corresponding author: Youngok Lee, Department of Thoracic and Ca rdiovascular Surgery, Kyungpook National University Hospital, K yungpook  National University School of Medicine, 130 Dongdeok-ro, Jung-g u, Daegu 700-721, Korea (Tel) 82-53-420-5665 (Fax) 82-53-426-4765 (E-mail) yolee1210@kn u.ac.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/32/b4/kjtcs-47-32.PMC3928260.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:35-38 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.35 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 35 −Departments of 1Thoracic and Cardiovascular Surgery and 2Pathology, Konkuk University Medical Center, Konkuk University School of  Medicine Received: June 5, 2013, Revised: August 22, 2013, Accepted: Aug ust 23, 2013 Corresponding author: Je Kyoun Shin, Department of Thoracic and Cardiovascular Surgery, Konkuk University Medical Center, Konku k  University School of Medicine, 120 Neungdong-ro, Gwangjin-gu, S eoul 143-729, Korea (Tel) 82-2-2030-7591 (Fax) 82-2-2030-7749 (E-mail) 20080186@kuh .ac.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/c1/aa/kjtcs-47-35.PMC3928261.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:39-42 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.39 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 39 −Department of Thoracic and Cardi ovascular Surgery, Inje Univers ity Ilsan Paik Hospital, Inje University College of Medicine Received: April 15, 2013, Revised: September 12, 2013, Accepted : September 17, 2013 Corresponding author: Woo-Ik Chang, Department of Thoracic and C ardiovascular Surgery, Inje University Ilsan Paik Hospital, Inj e University  College of Medicine, 170 Juhwa-ro , Ilsanseo-gu, Goyang 411-706,  K o r e a (Tel) 82-31-910-7365 (Fax) 82-31-910-7614 (E-mail) CWI87@paik.a c.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/9f/04/kjtcs-47-39.PMC3928262.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:43-46 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.43 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 43 −1Department of Thoracic and Cardiovascular Surgery, Korea Univer sity Anam Hospital, 2Department of Thoracic and Cardiovascular Surgery,  Kangwon National University Hospital, 3Department of Cardiovascular Surgery, Sejong Heart Institute, S ejong General Hospital Received: June 24, 2013, Revised: September 4, 2013, Accepted: September 17, 2013 Corresponding author: Kilsoo Yie, Department of Cardiovascular S urgery, Sejong Heart Institute, Sejong General Hospital, 28 Hoh yeon-ro  489beon-gil, Sosa-gu, Bucheon 422-711, Korea (Tel) 82-32-340-1439 (Fax) 82-32-340-1236 (E-mail) kilsooyie@gm ail.com   C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/6e/a7/kjtcs-47-43.PMC3928263.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:47-50 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.47 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 47 −Department of Thoracic and Cardi ovascular Surgery, Asan Medical  Center, University of Ulsan College of Medicine Received: July 15, 2013, Revised: August 21, 2013, Accepted: Au gust 23, 2013 Corresponding author: Dong Kwan Kim, Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsa n College  of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Ko rea (Tel) 82-2-3010-3580 (Fax) 82-2-3010-6966 (E-mail) dkkim@amc.se oul.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/03/ec/kjtcs-47-47.PMC3928264.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:51-54 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.51 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 51 −1Department of Thoracic and Cardiovascular Surgery, Seoul St. Ma ry’s Hospital, The Catholic University of Korea College of Medi cine,  2Department of Thoracic and Cardiovascular Surgery, Bucheon St. M a r y ’ s  H o s p i t a l ,  T h e  C a t h o l i c  U n i v e r s i t y  o f  K o r e a  C o l l e g e  o f  M e dicine,  3Department of Pathology, Seoul St. Mary’s Hospital, The Catholi c University of Korea College of Medicine Received: July 30, 2013, Revised : September 26, 2013, Accepted:  October 1, 2013 Corresponding author: Jae Kil Park, Department of Thoracic and C ardiovascular Surgery, Seoul St. Mary’s Hospital, The Catholic University of  Korea College of Medicine, 222 B anpo-daero, Seocho-gu, Seoul 13 7-701, Korea (Tel) 82-2-2258-2858 (Fax) 82-2-594-8644 (E-mail) Jaekpark@cath olic.ac.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/16/6e/kjtcs-47-51.PMC3928265.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:55-58 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.55 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 55 −1Department of Thoracic and Cardiovascular Surgery, Chonnam Nati onal University Hwasun Hospital, Chonnam National University Me dical  School, 2Department of Pathology, Chonnam National University Hospital, Chonnam National Univer sity Medical School Received: September 2, 2013, Revised: September 11, 2013, Accep ted: September 17, 2013 Corresponding author: Sang Yun S ong, Lung and Esophageal Cancer Clinic, Department of Thoracic and Cardiovascular Surgery, Chon nam  National University Hwasun Hospital, 322 Seoyang-ro, Hwasun 519 -763, Korea (Tel) 82-61-379-7663 (Fax) 82-61-379-7665 (E-mail) sysong@jnu.a c.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/d9/24/kjtcs-47-55.PMC3928266.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:59-62 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.59 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 59 −Department of Thoracic and Cardi ovascular Surgery, Kosin Univer sity Gospel Hospital, Kosin University College of Medicine Received: August 7, 2013, Revised: September 21, 2013, Accepted : September 23, 2013 Corresponding author: Sung Dal Park, Department of Thoracic and Cardiovascular Surgery, Kosin University Gospel Hospital, Kosin  University  College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan 602-702, Ko rea (Tel) 82-51-990-6466 (Fax) 82-51-990-3066 (E-mail) psdal6048@gm ail.com  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/18/13/kjtcs-47-59.PMC3928267.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:6-12 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.6 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 6 −1Department of Thoracic and Cardiovascular Surgery, Asan Medical  Center, University of Ulsan College of Medicine, 2Department of Thoracic  and Cardiovascular Surgery, Univ ersity of Ulsan College of Medi cine, 3Department of Radiology, Asan Medical Center, University of Uls an  College of Medicine Received: September 2, 2013, Revised: October 8, 2013, Accepted : October 10, 2013 Corresponding author: Joon Bum Kim, Department of Thoracic and C ardiovascular Surgery, Asan Medical Center, University of Ulsan  C o l l e g e   of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Ko rea (Tel) 82-2-3010-5416 (Fax) 82-2-3010-6966 (E-mail) jbkim1975@am c.seoul.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/3b/03/kjtcs-47-6.PMC3928268.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:63-65 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.63 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 63 −1Department of Thoracic and Cardiovascular Surgery, Chonnam Nati onal University Hwasun Hospital, Chonnam National University Me dical  School, 2Department of Pathology, Chonnam National University Hospital, Chonnam National Univer sity Medical School Received: July 23, 2013, Revised: August 31, 2013, Accepted: Se ptember 3, 2013 Corresponding author: Kook Joo Na, Department of Thoracic and Ca rdiovascular Surgery, Chonnam National University Hwasun Hospit al,  Chonnam National University Medical School, 322 Seoyang-ro, Hwa sun 519-763, Korea (Tel) 82-61-379-7664 (Fax) 82-61-379-7665 (E-mail) kjna1125@han mail.net  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/65/01/kjtcs-47-63.PMC3928269.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:66-70 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.66 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 66 −Departments of 1Thoracic and Cardiovascular Surgery and 2Anesthesiology and Pain Medicine, Kyungpook National University  School of  Medicine Received: June 19, 2013, Revised: September 16, 2013, Accepted:  October 24, 2013 Corresponding author: Seong Wook Hong, Department of Anesthesiol ogy and Pain Medicine, Kyungpook National University School of  Medicine, 680 Gukchaebosang-ro, Jung-gu, Daegu 700-842, Korea (Tel) 82-53-200-5872 (Fax) 82-53-426-2760 (E-mail) hsuaa@naver.",Non-OADS,/arxiv_data1/oa_pdf/07/34/kjtcs-47-66.PMC3928270.pdf
"Korean J Thorac Cardiovasc Surg 2014;47:71-74 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.71 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 71 −Department of Thoracic and Cardiovascular Surgery, SMG-SNU Bora mae Medical Center Received: June 19, 2013, Revised: September 21, 2013, Accepted:  September 23, 2013 Corresponding author: Jae-Sung Choi, Department of Thoracic and Cardiovascular Surgery, SMG-SNU Boramae Medical Center, 20 Bora mae-ro  5-gil, Dongjak-gu, Seoul 156-707, Korea (Tel) 82-2-870-2293 (Fax) 82-2-870-3866 (E-mail) truejsreal@han mail.net  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/ef/4d/kjtcs-47-71.PMC3928271.pdf
Korean J Thorac Cardiovasc Surg 2014;47:75 □ Corrigendum  □ http://dx.doi.or g/10.5090/k jtcs.2014.47.1.75 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) Fig.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/kjtcs-47-75.PMC3928272.pdf
"Corrigendum: Moderate and Deep Hypothermia Produces  Hyporesposiveness to Phenylephrine in Isolated Rat Aorta Jun Woo Cho, M.D.1, Chul Ho Lee, M.D.1, Jae Seok Jang, M.D.1,  Oh Choon Kwon, M.D.1, Woon Seok Roh, M.D.2, Jung Eun Kim, M.D.2 http://dx.doi.org/10.5090/kjtcs.2013.46.6.402.",Non-OADS,/arxiv_data1/oa_pdf/0f/ad/kjtcs-47-75.PMC3928272.pdf
"Department of Neurosurgery, Yeungnam University Medical Center, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 705-717, Korea  Tel : +82-53-620-3790,  Fax : +82-53-620-3770,  E-mail : jyjns@yu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 1-4, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.1 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/8d/c4/jkns-55-1.PMC3928341.pdf
"Key Words :  Cylindrical cage · ACDF · Subsidence · Fusion.Clinical Article • Received : March 18, 2013  • Revised : June 17, 2013  • Accepted : December 16, 2013 • Address for reprints : Sang Don Kim, M.D., Ph.D.  Department of Neurosurgery, College of Medicine, The Catholic University of Korea, Bucheon St. Mary’s Hospital, 327 Sosa-ro, Wonmi-gu, Bucheon 420-717, Korea   Tel : +82-32-340-7033,  Fax : +82-32-340-7391,  E-mail : kimsd@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 12-17, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.12 Copyright © 2014 The Korean Neurosurgical Society  Print  ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/7c/b6/jkns-55-12.PMC3928342.pdf
"Department of Neurosurgery, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 705-717, Korea   Tel : +82-53-620-3790,  Fax : +82-53-620-3770,  E-mail : olkim@med.yu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 18-25, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.18 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/cf/9d/jkns-55-18.PMC3928343.pdf
"Key Words :  Brain injuries · Intracranial pressure monitoring · Decompressive craniectomy · Mortality.Clinical Article • Received : June 14, 2013  • Revised : October 2, 2013  • Accepted : December 16, 2013 • Address for reprints : Byung-chul Son, M.D., Ph.D.  Department of Neurosurgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel : +82-2-2258-6122,  Fax : +82-2-594-4248,  E-mail : sbc@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 26-31, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.26 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/17/17/jkns-55-26.PMC3928344.pdf
"Department of Neurosurgery, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel : +82-2-2258-6125,  Fax : +82-2-594-4248,  E-mail : nsshin@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 32-35, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.32 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/f1/46/jkns-55-32.PMC3928345.pdf
"Department of Neurosurgery, Eulji University Hospital, 95 Dunsanseo-ro, Seo-gu, Daejeon 302-799, Korea  Tel : +82-42-611-3442,  Fax : +82-42-611-3444,  E-mail : heeyah20@eulji.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 36-39, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.36 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/ad/06/jkns-55-36.PMC3928346.pdf
"Department of  Neurological Sciences-Neurosurgery, Sapienza University of Rome, Via Degli Ausoni 9, 00161 Rome, Italy  Tel : +390649979105,  Fax : +390649979113,  E-mail : padonnarumma@hotmail.it • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 40-42, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.40 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/bc/a2/jkns-55-40.PMC3928347.pdf
"Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China  Tel : +86055162922237,  Fax : +86055162922049,  E-mail : chw001@163.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 43-47, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.43 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/4d/79/jkns-55-43.PMC3928348.pdf
"Department of Neurosurgery, Şevket Yılmaz Training and Research Hospital, Mimar Sinan Ward, Emniyet Avenue, Bursa 16300, Turkey  Tel : +90-224-2955000,  Fax : +90-224-295 54 97,  E-mail : mehmetali.ekici@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 48-50, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.48 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/af/09/jkns-55-48.PMC3928349.pdf
"Key Words :  High-grade glioma · Concurrent radiochemotherapy · Pseudoprogression · Pseudoresponse.Clinical Article • Received : March 19, 2013  • Revised : May 24, 2013  • Accepted : December 16, 2013 • Address for reprints : In Ah Kim, M.D., Ph.D.  Department of Radiation Oncology, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, Korea  Tel : +82-31-787-7651,  Fax : +82-31-787-4019,  E-mail : inah228@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 5-11, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.5 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/bb/95/jkns-55-5.PMC3928350.pdf
"Hadjigeorgiou, M.D., Ph.D.  Department of Neurosurgery, Red Cross Hospital, Athanasaki 1 & Erithrou Stavrou, Athens 11526, Greece  Tel : +30-2132068742,  Fax : +30-2132068587,  E-mail : georgehadji@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 51-53, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.51 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/51/a1/jkns-55-51.PMC3928351.pdf
Avail - able at : http://guidance.nice.org.uk/CG56velopment of the haematoma.,Non-OADS,/arxiv_data1/oa_pdf/51/a1/jkns-55-51.PMC3928351.pdf
"Department of Neurosurgery, Sri Sathya Sai Institute of Higher Medical Sciences, EPIP area, Whitefield, Bangalore 560 066, India  Tel : +918028413576,  Fax : +91-080-8411503,  E-mail : ravi.dadlani@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 54-56, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.54 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/49/10/jkns-55-54.PMC3928352.pdf
"Department of Urology, University of Ulsan College of Medicine, Ulsan University Hospital, 877 Bangeojinsunhwando-ro, Dong-gu, Ulsan 682-714, Korea  Tel : +82-52-250-7190,  Fax : +82-52-250-7198,  E-mail : scpark@amc.seoul.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 57-60, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.57 Copyright © 2014 The Korean Neurosurgical Society  Print  ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Fig.",Non-OADS,/arxiv_data1/oa_pdf/78/c4/jkns-55-57.PMC3928353.pdf
"Key Words :  Neurosarcoidosis · Neurosyphilis · Sarcoidosis · Cavernous sinus.Case Report • Received : January 24, 2013  • Revised : July 14, 2013  • Accepted : December 16, 2013 • Address for reprints : Won Ho Cho, M.D., Ph.D.  Department of Neurosurgery, Pusan National University Hospital, Pusan National University School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 602-739, Korea  Tel : +82-51-240-7257,  Fax : +82-51-244-0282,  E-mail : mdcwh@naver.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 61-63, 2014http://dx.doi.org/10.3340/jkns.2014.55.1.61 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/57/5c/jkns-55-61.PMC3928354.pdf
"Department 	of	Neurosurgery, 	Soonchunhyang 	University 	Bucheon 	Hospital, 	Soonchunhyang 	University 	School 	of	Medicine, 	170	Jomaru-ro, 	Wonmi-gu, 	Bucheon 	420-767, 	 	 Korea 	 	Tel	:	+82-32-621-5289, 		Fax	:	+82-32-621-5017, 		E-mail 	:	bumtkim@gmail.com •	This	is	an	Open 	Access 	article 	distributed 	under 	the	terms 	of	the	Creative 	Commons 	Attribution 	Non-Commercial 	License 	(http://creativecommons.org/licenses/by-nc/3.0) 			 	 which 	permits 	unrestricted 	non-commercial 	use,	distribution, 	and	reproduction 	in	any	medium, 	provided 	the	original 	work 	is	properly 	cited.J Korean Neurosurg Soc 55  : 64-65, 	2014http://dx.doi.org/10.3340/jkns.2014.55.1.64 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Fig.",Non-OADS,/arxiv_data1/oa_pdf/88/a6/jkns-55-64.PMC3928355.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/f7/tcrm-10-095.PMC3928396.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 95–105Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  95open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S4016 0REVIEW Epidemiology and risk factors for invasive  candidiasis Nur Yapar Department of Infectious Diseases  and Clinical Microbiology, Faculty  of Medicine, Dokuz Eylül University,   I˙zmir, T urkey Correspondence: Nur Yapar   Department of Infectious Diseases and  Clinical Microbiology, Faculty of Medicine,  Dokuz Eylül University, Mithatpasa Street,   35340 Inciralti I˙zmir, Turkey   Email nur.yapar@deu.edu.t r;  nuryapar@gmail.co mAbstract:  The number of immunosuppressive patients has increased significantly in recent years.",Non-OADS,/arxiv_data1/oa_pdf/e8/f7/tcrm-10-095.PMC3928396.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/e8/f7/tcrm-10-095.PMC3928396.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/f7/tcrm-10-095.PMC3928396.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2a/14/ppa-8-211.PMC3928397.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 211–218Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  211OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5538 2Proportion and risk indicators of nonadherence   to antihypertensive therapy: a meta-analysis Mark lemstra M Wasem Alsabbagh Academic Family Medicine, college of  Medicine, University of saskatchewan,   saskatoon, sK, canada correspondence: Mark lemstra   Academic Family Medicine,   college of Medicine, University of   saskatchewan, 110 science Place,   saskatoon, sK s7n 5c9, canada   Tel +1 306 966 2108   Fax +1 306 966 6377   email mark.lemstra@usask.c aPurpose:  The World Health Organization (WHO) concluded that poor adherence to treatment  is the most important cause of uncontrolled high blood pressure, with approximately 75% of  patients not achieving optimum blood pressure control.",Non-OADS,/arxiv_data1/oa_pdf/2a/14/ppa-8-211.PMC3928397.pdf
Available  from: http://www.census.gov/compendia/statab/2012/ table s/12s0711.,OADS,/arxiv_data1/oa_pdf/2a/14/ppa-8-211.PMC3928397.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/2a/14/ppa-8-211.PMC3928397.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/14/ppa-8-211.PMC3928397.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/0c/tcrm-10-087.PMC3928401.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 87–94Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  87Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5367 5Active axial spondyloarthritis: potential   role of certolizumab pegol Sriya Ranatunga Anne v Miller Department of internal Medicine,   Southern illinois University School of  Medicine, Springfield, iL, USA Correspondence: Sriya Ranatunga   Department of internal Medicine,  Southern illinois University School   of Medicine, Springfield, IL, USA   Tel +1 217 545 0184   Fax +1 217 545 0540   email: sranatunga@siumed.ed uAbstract:  The axial spondyloarthropathies are a group of chronic inflammatory diseases  that predominantly affect the axial joints.",Non-OADS,/arxiv_data1/oa_pdf/4a/0c/tcrm-10-087.PMC3928401.pdf
Available from; http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/4a/0c/tcrm-10-087.PMC3928401.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/4a/0c/tcrm-10-087.PMC3928401.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/0c/tcrm-10-087.PMC3928401.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/3d/ppa-8-191.PMC3928402.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 191–198Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  191Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S4906 0ensuring patient adherence to clean   intermittent self-catheterization Jai H Seth Collette Haslam Jalesh N Panicker Department of Uro-Neurology,   University College London institute  of Neurology and the National  Hospital for Neurology and  Neurosurgery, London, UK Correspondence: Jai H Seth   Department of Uro-Neurology,  University College of London, institute of  Neurology and the National Hospital for  Neurology and Neurosurgery, London  wC1N 3BG, UK   email seth.jai@gmail.co mAbstract:  Patient performance of clean intermittent self-catheterization is a crucial component  of the management of incomplete bladder emptying, which can arise from a variety of  conditions.",Non-OADS,/arxiv_data1/oa_pdf/65/3d/ppa-8-191.PMC3928402.pdf
Or use: http://dvpr.es/1gwAut x,Non-OADS,/arxiv_data1/oa_pdf/65/3d/ppa-8-191.PMC3928402.pdf
Available  from http://guidance.nice.org.uk/cg9 7.,Non-OADS,/arxiv_data1/oa_pdf/65/3d/ppa-8-191.PMC3928402.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/65/3d/ppa-8-191.PMC3928402.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/3d/ppa-8-191.PMC3928402.pdf
Available from: https://www.gov.uk/government/uploads/system/ uploads/attachment_data/file/198114/National_Service_Framework_ for_Long_Term_Conditions.pdf.,OADS,/arxiv_data1/oa_pdf/65/3d/ppa-8-191.PMC3928402.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/75/prbm-7-047.PMC3928403.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPsychology Research and Behavior Management 2014:7 47–52Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  47ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PRBM.S5574 3calligraphy and meditation for stress reduction:  an experimental comparison henry sR Kao1 lin Zhu2 an an chao3 hao Yi chen4 ivy cY liu5 Manlin Zhang6 1Department of social Work and  social administration, University of  hong Kong, hong Kong; 2Department  of Psychology, Renmin University  of china, Beijing, 3international  society of calligraphy Therapy, hong  Kong; 4Department of Business  administration, n ational chengchi  University, Taipei, Taiwan, 5Department  of Psychology, Fu Jen catholic  University, Taipei, Taiwan; 6Department  of Psychology, sun Yat-sen University,  guangzhou, People’s Republic of china correspondence: henry sR Kao   Department of Psychology, Fu Jen  catholic University, ZhongZheng Rd,  Xinzhuang District, new Taipei, Taiwan   email henry.srkao@gmail.co m;  Kaohenry@hotmail.co mBackground:  Chinese calligraphic handwriting (CCH) has demonstrated a new role in health  and therapy.",Non-OADS,/arxiv_data1/oa_pdf/83/75/prbm-7-047.PMC3928403.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/83/75/prbm-7-047.PMC3928403.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/83/75/prbm-7-047.PMC3928403.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6d/f3/ijn-9-963.PMC3928453.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 963–973International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  963OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5343 2In vitro transfection of bone marrow-derived  dendritic cells with T aTp-liposomes Juan sebastián Pappalardo1–3 cecilia a langellotti2 sebastián Di giacomo1 Valeria Olivera1 Valeria Quattrocchi2 Patricia I Zamorano1,2 William c hartner3 Tatyana s levchenko3 Vladimir P T orchilin3 1Virology Institute, center for research  in Veterinary and agronomic sciences,  National Institute for agricultural  T echnology (INT a), hurlingham, B a,  argentina; 2National council for  scientific and T echnical research  (cONIceT), autonomous city of  Buenos aires, argentina; 3center  for Pharmaceutical Biotechnology  and Nanomedicine, Northeastern  University, Boston, M a, Usa correspondence: Vladimir P Torchilin   center for Pharmaceutical Biotechnology   and Nanomedicine, Bouvé college   of health sciences, 140 The Fenway/ room 215, Northeastern University,   360 huntington avenue, Boston,   Ma 02115, Usa   Tel +1 617 373 5596   Fax +1 617 373 7509   email v.torchilin@neu.ed uAbstract:  Dendritic cells (DC) are antigen-presenting cells uniquely capable of priming naïve  T cells and cross-presenting antigens, and they determine the type of immune response elicited  against an antigen.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/ijn-9-963.PMC3928453.pdf
ImageJ freeware image  processing developed at the National Institutes of Health was  used for image analysis ( http://rsbweb.nih.go v/ij/).,OADS,/arxiv_data1/oa_pdf/6d/f3/ijn-9-963.PMC3928453.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/ijn-9-963.PMC3928453.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/f3/ijn-9-963.PMC3928453.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/28/ceor-6-083.PMC3928454.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2014:6 83–92ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  83ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S5526 5antibiotic expected effectiveness and cost under  real life microbiology: evaluation of ertapenem  and ceftriaxone in the treatment of community- acquired pneumonia for elderly patients in spain santiago grau1 Virginia lozano2 amparo Valladares3 Rafael Cavanillas4 Yang Xie5 gonzalo nocea3 1hospital del Mar, Barcelona, spain;   2Pharmacoeconomics and Outcomes  Research iberia, Madrid, spain;   3Outcomes Research Merck sharp and  Dohme ltd, Madrid, spain; 4Medical  affairs, Merck sharp and Dohme  ltd, Madrid, spain; 5global health  Outcomes, Merck sharp and Dohme  ltd, Whitehouse station, nJ, Usa Correspondence: santiago grau   hospital el Mar, Passeig Marítim 25-29,  08003 Barcelona, spain   Tel +34 93 248 3000   Fax +34 93 248 3254   Email sgrau@parcdesalutmar.ca tBackground:  Clinical efficacy of antibiotics may be affected by changes in the susceptibility  of microorganisms to antimicrobial agents.",Non-OADS,/arxiv_data1/oa_pdf/8c/28/ceor-6-083.PMC3928454.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/8c/28/ceor-6-083.PMC3928454.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/28/ceor-6-083.PMC3928454.pdf
Available from: http://pestadistico.msc.es./ PEMSC25 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/28/ceor-6-083.PMC3928454.pdf
"Available from: http://www.msps.es/profesionales/farmacia/pdf/ margenesFactoresConversion.pd f. Accessed October 30, 2013.",Non-OADS,/arxiv_data1/oa_pdf/8c/28/ceor-6-083.PMC3928454.pdf
"Available from: http://www.msps.es/pro - fesionales/farmacia/notasInfor.ht m. Accessed October 30, 2013.",Non-OADS,/arxiv_data1/oa_pdf/8c/28/ceor-6-083.PMC3928454.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0f/f9/ijn-9-899.PMC3928455.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 899–912International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  899RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5417 1Nanoparticles in relation to peptide   and protein aggregation Masihuz Zaman ejaz Ahmad Atiyatul Qadeer Gulam Rabbani Rizwan Hasan Khan Interdisciplinary Biotechnology   Unit, Aligarh Muslim University,   Aligarh, India Correspondence: Rizwan Hasan Khan   Interdisciplinary Biotechnology Unit,  Aligarh Muslim University,   Aligarh-202002, Uttar Pradesh, India   Tel +91 571 272 0388   Fax +91 571 272 1776   email rizwanhkhan@hotmail.co mAbstract:  Over the past two decades, there has been considerable research interest in the use of  nanoparticles in the study of protein and peptide aggregation, and of amyloid-related diseases.",Non-OADS,/arxiv_data1/oa_pdf/0f/f9/ijn-9-899.PMC3928455.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0f/f9/ijn-9-899.PMC3928455.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/f9/ijn-9-899.PMC3928455.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/80/cia-9-293.PMC3928456.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 293–300Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  293OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5375 4serum total cholesterol concentration and   10-year mortality in an 85-year-old population Yutaka Takata1 T oshihiro Ansai2 Inho soh2 shuji Awano2 Ikuo nakamichi1 sumio Akifusa3 Kenichi goto1 Akihiro Y oshida2 hiroki Fujii1 ritsuko Fujisawa1 Kazuo sonoki3 1Division of general Internal  Medicine, 2Division of Community  Oral health Development,   3Department of Oral health and  environment, school of Oral health  science, Kyushu Dental College,   Kitakyushu, Japan Correspondence: Yutaka Takata   Division of general Internal   Medicine, Kyushu Dental College,   Manazuru 2-6-1, Kokurakita-ku,   Kitakyushu City 803-8580, Japan   Tel +81 93 582 1131 (ext 2011)   Fax +81 93 582 0592   email yutaka@kyu-dent.ac.j pAbstract:  Little is known about the association between total cholesterol (TC) and all-cause  mortality in the elderly (especially the very elderly).",Non-OADS,/arxiv_data1/oa_pdf/44/80/cia-9-293.PMC3928456.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/44/80/cia-9-293.PMC3928456.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/80/cia-9-293.PMC3928456.pdf
Available from: http://apps.who.int/clas - sifications/icd10/browse/2010/en.,OADS,/arxiv_data1/oa_pdf/44/80/cia-9-293.PMC3928456.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/e3/dddt-8-227.PMC3928457.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 227–237Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  227Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5495 6characterization of renal biomarkers   for use in clinical trials: biomarker   evaluation in healthy volunteers David a Brott1 scott h adler1 ramin arani2 susan c lovick3 Mark Pinches4 stephen T Furlong1 1Translational Patient safety and  enabling sciences, astraZeneca  Pharmaceuticals, 2astraZeneca  Pharmaceuticals, Wilmington, D e,   Usa; 3astraZeneca Pharmaceuticals,   4global safety assessment,   astraZeneca Pharmaceuticals,   Macclesfield, cheshire, UK correspondence: stephen T Furlong   astraZeneca Pharmaceuticals,   1800 concord Pike, D3c-421,   Wilmington, De 19850, Usa   Tel +1 302 886 8588   email stephen.furlong@astrazeneca.co mBackground:  Several preclinical urinary biomarkers have been qualified and accepted by  the health authorities (US Food and Drug Administration, European Medicines Agency, and  Pharmaceuticals and Medical Devices Agency) for detecting drug-induced kidney injury dur - ing preclinical toxicologic testing.",Non-OADS,/arxiv_data1/oa_pdf/1c/e3/dddt-8-227.PMC3928457.pdf
Available  from: http://www.salimetrics.com/documents/spit-tips/ publications/ Inter%20and%20Intra%2 0Assay%20Coefficients%20of%20 Variability.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/e3/dddt-8-227.PMC3928457.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1c/e3/dddt-8-227.PMC3928457.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/e3/dddt-8-227.PMC3928457.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/67/ijn-9-913.PMC3928458.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 913–920International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  913ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5689 4Self-microemulsifying drug-delivery system  for improved oral bioavailability of 20(S)- 25-methoxyl-dammarane-3 β, 12β, 20-triol:  preparation and evaluation Shuang Cai1,* Cai-Hong Shi2,* Xiangrong Zhang2 Xiaojiao Tang2 Hao Suo2 Li Yang2 Yuqing Zhao2 1Department of Pharmacy, The First  Affiliated Hospital of China Medical  University, 2Shenyang Pharmaceutical  University, Shenyang, People’s  Republic of China *These authors contributed equally   to this work Correspondence: Shuang Cai; Yuqing  Zhao   Department of Pharmacy, The First   Affiliated Hospital of China Medical   University, Shenyang 110001,   People’s Republic of China   Tel +86 24 8328 2490   Fax +86 24 8328 2490   Email caishuang1972@126.co m;  zyq4885@126.co mAbstract:  The objective of this study was to develop a self-microemulsifying drug delivery  system (SMEDDS) to enhance the oral bioavailability of the poorly water-soluble compound  20(S)-25-methoxydammarane-3 β;12β;20-triol (25-OCH3-PPD).",Non-OADS,/arxiv_data1/oa_pdf/6c/67/ijn-9-913.PMC3928458.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6c/67/ijn-9-913.PMC3928458.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/67/ijn-9-913.PMC3928458.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/fe/ijn-9-951.PMC3928459.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 951–962International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  951OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5657 9The use of nanoencapsulation to decrease human  skin irritation caused by capsaicinoids renata V contri1 luiza a Frank2 Moacir Kaiser1 adriana r Pohlmann1,3 silvia s guterres1,2 1Programa de Pós-graduação em  ciências Farmacêuticas, 2Faculdade  de Farmácia, 3Instituto de Química,   Universidade Federal do rio grande  do sul, Porto alegre, rio grande do  sul, Brazil correspondence: silvia s guterres   Faculdade de Farmácia, Universidade  Federal do rio grande do sul,   av Ipiranga, 2752/405 ceP 90610-000,   Porto alegre, rio grande do sul, Brazil   Tel +55 51 3308 5500   Fax +55 51 3308 5247   email silvia.guterres@ufrgs.b rAbstract:  Capsaicin, a topical analgesic used in the treatment of chronic pain, has irritant  properties that frequently interrupt its use.",Non-OADS,/arxiv_data1/oa_pdf/6a/fe/ijn-9-951.PMC3928459.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/6a/fe/ijn-9-951.PMC3928459.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6a/fe/ijn-9-951.PMC3928459.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/fe/ijn-9-951.PMC3928459.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijwh-6-207.PMC3928460.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 207–219International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  207OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5198 8cultural protection against traumatic stress:   traditional support of children exposed   to the ritual of female genital cutting Jon-Håkon schultz Inger-lise lien norwegian centre for Violence   and Traumatic stress studies,    Oslo, norway correspondence: Jon-Håkon schultz   norwegian centre for Violence and   Traumatic stress studies, PO Box 181,   nydalen, Oslo 0409, norway   Tel +47 9348 3440   email j.h.schultz@nkvts.unirand.n oAbstract:  This study explores the factors addressed in folk psychology in The Gambia for  protecting the girl-child from the potential traumatic stress of female genital cutting (FGC).",Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijwh-6-207.PMC3928460.pdf
Available from:  http://www.who.int/mediacentre/factsheets/fs241/en /.,Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijwh-6-207.PMC3928460.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/ NBK56494 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijwh-6-207.PMC3928460.pdf
"Available from: http://www.iom.edu/ Reports/2001/Crossing-the-Quality-Chasm-A-New-Health-System-for- the-21st-Century.asp x. Accessed December 22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijwh-6-207.PMC3928460.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijwh-6-207.PMC3928460.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/b2/ijwh-6-207.PMC3928460.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/4e/ijn-9-891.PMC3928461.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 891–898International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  891OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5411 3Virgin olive oil blended polyurethane   micro/nanofibers ornamented with copper   oxide nanocrystals for biomedical applications T ouseef amna1 M shamshi hassan2 Jieun Yang1 Myung-seob Khil2 Ki-Duk song3 Jae-Don Oh3 Inho hwang1 1Department of animal sciences  and Biotechnology, 2Department  of Organic Materials and Fiber  engineering, chonbuk National  University, Jeonju, south Korea ;   3genomic Informatics center,   hankyong National University,   anseong, south Korea correspondence: Inho hwang;   Touseef amna   Department of animal sciences and  Biotechnology, chonbuk National  University Jeonju, Jeollabuk-do 561-756,   south Korea   Tel +82 63 270 2351   Fax +82 63 270 4249   email  inho.hwang@jbnu.ac.k r;  touseefamna@gmail.co mAbstract:  Recently, substantial interest has been generated in using electrospun biomimetic  nanofibers of hybrids, particularly organic/inorganic, to engineer different tissues.",Non-OADS,/arxiv_data1/oa_pdf/6f/4e/ijn-9-891.PMC3928461.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6f/4e/ijn-9-891.PMC3928461.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/4e/ijn-9-891.PMC3928461.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/f8/ott-7-211.PMC3928462.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 211–221OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  211Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5608 4Midazolam induces apoptosis in Ma-10 mouse  leydig tumor cells through caspase activation   and the involvement of MaPK signaling pathway edmund cheung so1,2 Yu-Xuan lin3 chi hao Tseng1 Bo-syong Pan3 Ka-shun cheng2 Kar-lok Wong2 lyh-Jyh hao4 Yang-Kao Wang5 Bu-Miin huang3 1Department of anesthesia, Tainan  Municipal an nan hospital, china  Medical University, Tainan, Taiwan;   2Department of anesthesia, china  Medical University, Taichung, Taiwan;   3Department of cell Biology and  anatomy, national cheng Kung  University, Tainan, Taiwan; 4Department  of internal Medicine, Division of  endocrinology and Metabolism,   Kaohsiung Veteran general hospital  Tainan Branch Tainan, Taiwan; 5graduate  institute of Biomedical Materials and  Tissue engineering, Taipei Medical  University, Taipei, Taiwan correspondence: Yang-Kao Wang   graduate institute of Biomedical  Materials and Tissue engineering, Taipei  Medical University, Taipei, Taiwan   Tel +886 2 2736 1661 ext 5200   Fax +886 2 2736 2295   email humwang@tmu.edu.t w    Bu-Miin huang   Department of cell Biology and  anatomy, college of Medicine, national  cheng Kung University, 1 University  road, Tainan, Taiwan   Tel +886 6 235 3535 ext 5337   Fax +886 6 209 3007   email bumiin@mail.ncku.edu.t wPurpose:  The present study aims to investigate how midazolam, a sedative drug for clinical  use with cytotoxicity on neuronal and peripheral tissues, induced apoptosis in MA-10 mouse  Leydig tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/5f/f8/ott-7-211.PMC3928462.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5f/f8/ott-7-211.PMC3928462.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/f8/ott-7-211.PMC3928462.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/81/1a/ijn-9-921.PMC3928463.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 921–935International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  921OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5331 0GE11-modified liposomes for non-small   cell lung cancer targeting: preparation,   ex vitro and in vivo evaluation liang cheng1,* Fa-Zhen huang1,2,* li-Fang cheng1 Ya-Qin Zhu1 Qing hu1 ling li1 lin Wei1 Da-Wei chen1 1Department of Pharmaceutics,   college of Pharmaceutical science,   soochow University, suzhou, Jiangsu  Province, 2Department of Pharmacy,   central hospital of Zaozhuang  Minging group, Zaozhuang, shandong  Province, People’s republic of china *These authors contributed equally   to this work correspondence: Da-Wei chen   college of Pharmaceutical science,   soochow University, 199 ren’ai road,   suzhou 215123, People’s republic of china   Tel +86 512 6588 4729   Fax +86 24 2398 6250   email chendawei@syphu.edu.c nAbstract:  Non-small cell lung cancer (NSCLC) is a serious threat to human health, and  40%–80% of NSCLCs express high levels of epidermal growth factor receptor (EGFR).",Non-OADS,/arxiv_data1/oa_pdf/81/1a/ijn-9-921.PMC3928463.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/81/1a/ijn-9-921.PMC3928463.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/1a/ijn-9-921.PMC3928463.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/5b/ijn-9-937.PMC3928464.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 937–950International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  937OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5589 2Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/96/5b/ijn-9-937.PMC3928464.pdf
"Or use: http://dvpr.es/1fPTT7 FFabrication of nanoadjuvant with poly- ε- caprolactone (Pcl) for developing a single-shot  vaccine providing prolonged immunity chandravilas Keshvan  Prashant1 Madhusudan Bhat1 sandeep Kumar srivastava1 ankit saxena2 Manoj Kumar3 amar singh2 Mohammed samim4 Farhan Jalees ahmad5 amit Kumar Dinda1 1Department of Pathology, 2Department  of Transplant Immunology and  Immunogenetics, all India Institute of  Medical sciences, 3centre for Biomedical  engineering, Indian Institute of T echnology,   4Department of chemistry, Faculty of  sciences, 5Department of Pharmaceutics,   Faculty of Pharmacy, Jamia hamdard, New  Delhi, India correspondence: amit Kumar Dinda   Department of Pathology –1084,   all India Institute of Medical sciences,  aurobindo Marg, ansari Nagar,   New Delhi 110029, India   Tel +91 11 2659 3412   Fax +91 11 2658 8663   email amit_dinda@yahoo.co mPurpose:  The aim of the study was to load a model antigen, tetanus toxoid (TT), in poly- ε- caprolactone nanoparticles (PCL NPs) of two size ranges, ie, mean 61.2 nm (small) and 467.6 nm  (large), and study its effect on macrophage polarization as well as antigen presentation in human  monocyte-derived macrophages in vitro, along with humoral and cell-mediated immune (CMI)  response generated in Swiss albino mice following immunization with the TT -loaded NPs.",Non-OADS,/arxiv_data1/oa_pdf/96/5b/ijn-9-937.PMC3928464.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/96/5b/ijn-9-937.PMC3928464.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/5b/ijn-9-937.PMC3928464.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/1d/ott-7-253.PMC3928465.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 253–261OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  253Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S4509 6Role of erlotinib in the targeted treatment   of non-small-cell lung cancer in Chinese patients wei Li Fei Zhou Caicun Zhou Shanghai Pulmonary Hospital, Cancer  institute, T ongji University School of  Medicine, Shanghai, People’s Republic  of China Correspondence: Caicun Zhou   Shanghai Pulmonary Hospital,   Cancer institute, Tongji University   School of Medicine, 1239 Siping Road,   Shanghai 200433, People’s Republic   of China   Tel +86 21 6511 5006 ext 3050   email caicunzhoudr@163.co mAbstract:  Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have  been demonstrated to improve responses and clinical outcomes significantly in patients with  advanced non-small-cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/80/1d/ott-7-253.PMC3928465.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/80/1d/ott-7-253.PMC3928465.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/1d/ott-7-253.PMC3928465.pdf
Available from: http://clinicaltrials.gov/ct2/ show/NCT01410214?term=NCT01410214&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/80/1d/ott-7-253.PMC3928465.pdf
Available from: http://clinicaltrials.gov/ct2/ show/NCT01407822?term=NCT01407822&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/80/1d/ott-7-253.PMC3928465.pdf
Avail - able from: http://clinicaltrials.gov/ct2/show/NCT01217619?term=   NCT01217619&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/80/1d/ott-7-253.PMC3928465.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01544179?term=   NCT01544179&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/80/1d/ott-7-253.PMC3928465.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/9b/ijwh-6-201.PMC3928466.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 201–205International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  201OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5632 4Acceptability of artificial donor insemination   among infertile couples in enugu,   southeastern nigeria emmanuel O Ugwu1 godwin U Odoh1 samuel n Obi1 Frank O ezugwu2 1Department of Obstetrics and  gynaecology, University of nigeria  T eaching Hospital, Ituku/Ozalla, enugu,   nigeria; 2Department of Obstetrics  and gynaecology, enugu state  University T eaching Hospital, Parklane,   enugu, nigeria correspondence: emmanuel O Ugwu   Department of Obstetrics and   gynaecology, University of nigeria   Teaching Hospital, Ituku/Ozalla,   enugu, nigeria   Tel +23 480 3779 0402   email vajel@yahoo.co mBackground:  Male factor infertility presents one of the greatest challenges with respect to  infertility treatment in Africa.",Non-OADS,/arxiv_data1/oa_pdf/e0/9b/ijwh-6-201.PMC3928466.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/e0/9b/ijwh-6-201.PMC3928466.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/9b/ijwh-6-201.PMC3928466.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/2e/ott-7-245.PMC3928467.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 245–251OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  245Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S4693 3Targeted treatment of head and neck squamous- cell carcinoma: potential of lapatinib Mitul D Gandhi Mark Agulnik Division of Hematology and Oncology,   Robert H Lurie Comprehensive  Cancer Center, Feinberg School of  Medicine, Northwestern University,   Chicago, iL, USA Correspondence: Mark Agulnik   Division of Hematology and Oncology,  Robert H Lurie Comprehensive Cancer  Center, Northwestern University,  Feinberg School of Medicine,   676 N Saint Clair Street Suite 850,  Chicago, iL 60611, USA   Tel +1 312 695 6180   Fax +1 312 695 6189   email mark.agulnik@nmff.or gAbstract:  Squamous-cell cancer of the head and neck is a heterogeneous malignancy with  treatment predicated on a multimodality therapy involving surgery, chemotherapy, and  radiation.",Non-OADS,/arxiv_data1/oa_pdf/c3/2e/ott-7-245.PMC3928467.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c3/2e/ott-7-245.PMC3928467.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/2e/ott-7-245.PMC3928467.pdf
Available from: http://clinicaltrials.gov/show /NCT01711658.,Non-OADS,/arxiv_data1/oa_pdf/c3/2e/ott-7-245.PMC3928467.pdf
Available from: http://clinicaltrials.gov/show /NCT01612351.,Non-OADS,/arxiv_data1/oa_pdf/c3/2e/ott-7-245.PMC3928467.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/84/dmso-7-055.PMC3928478.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 55–64Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  55 REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S4826 0Akt/PKB activation and insulin signaling: a novel  insulin signaling pathway in the treatment   of type 2 diabetes Richard WA Mackenzie Bradley T Elliott Department of Human and Health  Sciences, Facility of Science and  T echnology, University of Westminster,   London, UK Correspondence: Richard WA Mackenzie   Department of Human and Health  Sciences, Facility of Science and  Technology, University of Westminster,  115 New Cavendish St,   London W1W 6UW, UK   Tel +44 020 7911 5000 ext 3811   Email r.mackenzie@westminster.ac.u kAbstract:  Type 2 diabetes is a metabolic disease categorized primarily by reduced insulin  sensitivity, β-cell dysfunction, and elevated hepatic glucose production.",Non-OADS,/arxiv_data1/oa_pdf/ad/84/dmso-7-055.PMC3928478.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/ad/84/dmso-7-055.PMC3928478.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/84/dmso-7-055.PMC3928478.pdf
"15 The major drawbacks are that the studies Open Access Received: December 30, 2013    Accepted:  December 30, 2013 Correspondence: Il Ju Choi Center for Gastric Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea Tel: +82-31-920-2282, Fax: +82-31-920-1520, E-mail: cij1224@ncc.re.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Interobserver Agreement in Using Magnifying Narrow Band   Imaging System Il Ju Choi Center for Gastric Cancer, National Cancer Center, Goyang, Korea See “Observer Variability in Gastric Neoplasm Assessment Using the Vessel Plus Surface Classification for Magnifying En- doscopy with Narrow Band Imaging” by Chan Hui Y oo, Moo In Park, Seun Ja Park, et al., on page 74-78Clin Endosc  2014 ;47:1-2COMMENTARY Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.1",Non-OADS,/arxiv_data1/oa_pdf/a5/64/ce-47-1.PMC3928479.pdf
"Key Words :  Esophagus; Polyps; Asphyxia; SnoringOpen Access Received: February 19, 2013    Revised: March 10, 2013 Accepted:  March 20, 2013 Correspondence: Byoung Wook BangDivision of Gastroenterology, Department of Internal Medicine, Inha Univer - sity Hospital, Inha University School of Medicine, 27 Inhang-ro, Jung-gu, Incheon 400-711, KoreaTel: +82-32-890-2548, Fax: +82-32-890-2549, E-mail: bangbu@inha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.101 INTRODUCTION Fibrovascular polyps (FVPs) of the esophagus are rare, be- nign intraluminal tumor-like lesions arising from the sub - mucosal layer of the cervical esophagus.1 These masses are  composed of loose or dense fibrous tissue, vascular structures,  and adipose tissue covered by normal squamous epithelium.2  FVPs are the most common intraluminal, nonepithelial neo-plasms of the esophagus, accounting for 0.5% to 1% of all be-nign esophageal tumors.",Non-OADS,/arxiv_data1/oa_pdf/bd/e9/ce-47-101.PMC3928480.pdf
"Key Words :  Fundoplication; Deglutition disorders; Gastroesophageal reflux; Pneumatic dilatationOpen Access Received:  March 7, 2013    Revised:  May 8, 2013 Accepted:  June 9, 2013 Correspondence:  Hyojin Park Division of Gastroenterology, Department of Internal Medicine, Gangnam  Severance Hospital, Y onsei University College of Medicine, 211 Eonju-ro,  Gangnam-gu, Seoul 135-720, Korea Tel: +82-2-2019-3318, Fax: +82-2-3463-3882, E-mail:  HJPARK21@yuhs.ac cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.104",Non-OADS,/arxiv_data1/oa_pdf/58/3c/ce-47-104.PMC3928481.pdf
"Key Words :  Balloon-assisted enteroscopy; Overtube; Metal stent; Small bowel obstruction; Double-balloon enteroscopyOpen Access Received:  March 29, 2013    Revised:  May 17, 2013 Accepted:  June 1, 2013 Correspondence:  Klaus M Önkemüller Division of Gastroenterology and Hepatology, Basil Hirschowitz Endoscopic  Center of Excellence, University of Alabama at Birmingham, Endoscopy Unit,  JT 664, 619 19th St S, Birmingham, AL 35249, USA Tel: +1-205-934-6110, Fax: +1-205-934-1537, E-mail:  klaus1@uab.edu cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.108",Non-OADS,/arxiv_data1/oa_pdf/b2/86/ce-47-108.PMC3928482.pdf
"Key Words :  Appendicolith; Stump appendicitis; Endoscopic removalOpen Access Received: February 5, 2013    Revised: June 9, 2013 Accepted:  July 18, 2013 Correspondence: Sang Wook ParkDepartment of Internal Medicine, Kwangju Christian Hospital, 37 Y angnim- ro, Nam-gu, Gwangju 503-715, Korea Tel: +82-62-650-5023, Fax: +82-62-650-5277, E-mail: kch20113@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.112 INTRODUCTION Appendicitis is one of the most common causes of acute  abdomen, and its diagnosis is relatively easy because most  cases are identified on the basis of typical symptoms and physical examination.",Non-OADS,/arxiv_data1/oa_pdf/c5/c0/ce-47-112.PMC3928483.pdf
"Key Words :  Extramedullary plasmacytoma; Pancreas; Endosonography; Biopsy, fine-needleOpen Access Received: April 16, 2013    Revised: June 26, 2013 Accepted:  July 20, 2013 Correspondence: Sang Y oun HwangGastrointestinal Cancer Center, Department of Internal Medicine, Dongnam  Institute of Radiological & Medical Sciences, 40 Jwadong-gil, Jangan-eup, Gi- jang-gun, Busan 619-953, KoreaTel: +82-51-720-5114, Fax: +82-51-720-5992  E-mail: mongmani@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.115",Non-OADS,/arxiv_data1/oa_pdf/77/a0/ce-47-115.PMC3928484.pdf
"Eventually, granu-BRIEF REPORT White Esophageal Mucosa and Black Gastric Mucosa: Upper   Gastrointestinal Injury Due to Hydrochloric Acid Ingestion Woong Cheul Lee, Tae Hee Lee and Jun-Hyung Cho Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine,  Seoul, KoreaOpen Access Received: December 31, 2012    Revised: April 28, 2013 Accepted:  September 13, 2013 Correspondence: Tae Hee LeeInstitute for Digestive Research, Digestive Disease Center, Soonchunhyang  University Hospital, Soonchunhyang University College of Medicine, 59 Dae- sagwan-ro, Y ongsan-gu, Seoul 140-743, KoreaTel: +82-2-709-9691, Fax: +82-2-709-9696, E-mail: iman0825@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.119",Non-OADS,/arxiv_data1/oa_pdf/73/3b/ce-47-119.PMC3928485.pdf
"Key Words :  Barrett esophagus; Prevalence; Risk factorsOpen Access Received: December 1, 2013    Revised: December 16, 2013 Accepted:  January 2, 2014 Correspondence: Seong Woo JeonDepartment of Internal Medicine, Kyungpook National University Hospital,  Kyungpook National University School of Medicine, 130 Dongdeok-ro, Jung- gu, Daegu 700-721, KoreaTel: +82-53-200-3517, Fax: +82-53-200-2027, E-mail: swjeon@knu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.15",Non-OADS,/arxiv_data1/oa_pdf/3a/4b/ce-47-15.PMC3928486.pdf
"Key Words :  Barrett esophagus; Stomach neoplasms; Endoscopy; Confocal laser endomicroscopy; Molecular imagingOpen Access Received:  December 4, 2013    Accepted:  December 10, 2013 Correspondence:  Hwoon-Y ong Jung Department of Gastroenterology, Asan Medical Center, University of Ulsan  College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3197, Fax: +82-2-476-0824, E-mail:  hyjung@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.23FOCUSED REVIEW SERIES:  Endoscopic and Molecular Imaging of Premalignant GI Lesions, Part II",Non-OADS,/arxiv_data1/oa_pdf/b0/7a/ce-47-23.PMC3928487.pdf
"11 con-Open Access Received: December 23, 2013    Accepted:  December 27, 2013 Correspondence: Ki Baik Hahm Digestive Disease Center, CHA Bundang Medical Center, CHA University, 59 Y atap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5218, Fax: +82-31-780-5219, E-mail: hahmkb@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Rectal Retroflexion during Colonoscopy: A Bridge over Troubled  Water Kwang An Kwon1 and Ki Baik Hahm2 1Department of Gastroenterology, Gachon University Gil Medical Center, Gachon University of Medicine and Science, Incheon, 2Digestive Disease  Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea See “Diagnostic Yield and Therapeutic Impact of Rectal Retroflexion: A Prospective, Single-Blind Study Conducted in Three  Centers” by Félix Téllez-Ávila, Josué Barahona-Garrido, Sandra García-Osogobio, et al., on page 79-83Clin Endosc  2014 ;47:3-4COMMENTARY Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.3",Non-OADS,/arxiv_data1/oa_pdf/04/c7/ce-47-3.PMC3928488.pdf
"Key Words :  Barrett esophagus; Endoscopic mucosal resection; Pathology; Dysplasia; Biological markersOpen Access Received: December 10, 2013    Accepted:  December 14, 2013 Correspondence: Catherine J. Streutker Division of Pathology, Department of Laboratory Medicine, The Li Ka Shing Knowledge Institute, St. Michael’s Hospital, the University of Toronto Faculty  of Medicine, 30 Bond ST, Toronto, ON M5B 1W8, Canada Tel: +1-416-360-4000, Fax: +1-416-864-5648, E-mail: streutkerc@smh.ca cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.31 INTRODUCTION Although uncommon 50 years ago in North America, Bar - rett esophagus (BE) and BE-associated dysplasia and malig- nancy have rapidly increased in incidence, such that patholo - gists in North America encounter screening biopsies for BE routinely, and glandular dysplasia/malignancies much more frequently than squamous lesions.",Non-OADS,/arxiv_data1/oa_pdf/32/59/ce-47-31.PMC3928489.pdf
"Key Words :  Barrett esophagus; Endoscopy; Mass screening; EpidemiologyOpen AccessPrint ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.40 Received: December 15, 2013    Revised: December 23, 2013 Accepted:  December 25, 2013 Correspondence: Gabor KandelDivision of Gastroenterology, The Centre for Therapeutic Endoscopy and En- doscopic Oncology, St. Michael’s Hospital, Level 16 Cardinal Carter Building,  30 Bond St, Toronto, ON M5B 1W8, CanadaTel: +1-416-864-3093, Fax: +1-416-864-5994, E-mail: kandelg@smh.ca cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.FOCUSED REVIEW SERIES:  Endoscopic and Molecular Imaging of Premalignant GI Lesions, Part II",Non-OADS,/arxiv_data1/oa_pdf/4f/53/ce-47-40.PMC3928490.pdf
"Key Words :  Barrett esophagus; Esophageal adenocarcinoma; Advanced imagingOpen Access Received: December 22, 2013    Revised: December 30, 2013 Accepted:  December 30, 2013 Correspondence: Norman MarconDivision of Gastroenterology, Department of Medicine, The Center for Ad- vanced Therapeutic Endoscopy and Endoscopic Oncology, St. Michael’s Hos- pital, University of Toronto Faculty of Medicine, 30 Bond St, Toronto, ON M5B 1W8, Canada Tel: +1-416-864-3092, Fax: +1-416-864-5993 E-mail: norman.marcon@utoronto.ca cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.47FOCUSED REVIEW SERIES:  Endoscopic and Molecular Imaging of Premalignant GI Lesions, Part II",Non-OADS,/arxiv_data1/oa_pdf/8d/26/ce-47-47.PMC3928491.pdf
"There are few well-designed animal studies investigating Open Access Received: December 23, 2013    Accepted:  December 26, 2013 Correspondence: Ji Kon Ryu Division of Gastroenterology, Department of Internal Medicine and Liver Re-search Institute, Seoul National University College of Medicine, 101 Daehak- ro, Jongno-gu, Seoul 110-744, Korea Tel: +82-2-2072-1962, Fax: +82-2-762-9662, E-mail: jkryu@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Metal Stenting in Benign Biliary Strictures Ji Kon Ryu Division of Gastroenterology, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul,  Korea See “Histological Changes in the Bile Duct after Long-Term Placement of a Fully Covered Self-Expandable Metal Stent with - in a Common Bile Duct: A Canine Study” by Sang Soo Lee, Tae Jun Song, Mee Joo, et al., on page 84-93Clin Endosc  2014 ;47:5-6COMMENTARY Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.5",Non-OADS,/arxiv_data1/oa_pdf/32/e9/ce-47-5.PMC3928492.pdf
"Key Words :  Barrett esophagus; Therapeutics; Dysplasia; Endoscopy; Endoscopic treatmentOpen Access Received: December 23, 2013    Revised: December 27, 2013 Accepted:  December 28, 2013 Correspondence: Norman MarconDivision of Gastroenterology, Department of Medicine, The Center of Ad- vanced Therapeutic Endoscopy and Endoscopic Oncology, St. Michael’s Hospi - tal, University of Toronto Faculty of Medicine, 30 Bond St, Toronto, ON M5B  1W8, Canada Tel: +1-416-864-3092, Fax: +1-416-864-5993 E-mail: norman.marcon@utoronto.ca cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.55FOCUSED REVIEW SERIES:  Endoscopic and Molecular Imaging of Premalignant GI Lesions, Part II",Non-OADS,/arxiv_data1/oa_pdf/31/cc/ce-47-55.PMC3928493.pdf
"Key Words :  Colorectal neoplasms; Obstruction; Self-expanding metallic stentsOpen Access Received:  April 29, 2013    Revised:  July 18, 2013 Accepted:  July 18, 2013 Correspondence:  Chang Heon Yang Department of Internal Medicine, Dongguk University Gyeongju Hospital,  Dongguk University College of Medicine, 87 Dongdae-ro, Gyeongju 780-350,  Korea Tel: +82-54-770-8206, Fax: +82-54-770-8378 E-mail:  chhyang@dongguk.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.65",Non-OADS,/arxiv_data1/oa_pdf/d5/57/ce-47-65.PMC3928494.pdf
"cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.7FOCUSED REVIEW SERIES:  Endoscopic and Molecular Imaging of Premalignant GI Lesions, Part II",Non-OADS,/arxiv_data1/oa_pdf/5a/bf/ce-47-7.PMC3928495.pdf
"Key Words :  Endoscopy; Neoplasms; StomachOpen Access Received:  April 17, 2013    Revised:  June 30, 2013 Accepted:  August 14, 2013 Correspondence:  Moo In Park Department of Internal Medicine, Kosin University College of Medicine, 262  Gamcheon-ro, Seo-gu, Busan 602-702, Korea Tel: +82-51-990-5205, Fax: +82-51-990-5055 E-mail:  mipark@kosinmed.or.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.74 See commentary on page 1-2",Non-OADS,/arxiv_data1/oa_pdf/af/d0/ce-47-74.PMC3928496.pdf
"Key Words :  Colonoscopy; Retroflexion; Rectum; Colorectal polypsOpen Access Received: May 14, 2013    Revised: July 21, 2013 Accepted:  August 12, 2013 Correspondence: Félix Téllez-ÁvilaEndoscopy Department, Instituto Nacional de Ciencias Médicas y Nutrición  Salvador Zubirán, Vasco de Quiroga 15, Tlalpan, CP 14000, Mexico City,  MexicoTel: +52-55-5487-0900, Fax: +52-55-5487-0900 E-mail: felixtelleza@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.79 INTRODUCTION Colonoscopy is a diagnostic and therapeutic method wide - ly used worldwide.",Non-OADS,/arxiv_data1/oa_pdf/9d/ae/ce-47-79.PMC3928497.pdf
"cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.84 See commentary on page 5-6",Non-OADS,/arxiv_data1/oa_pdf/de/c3/ce-47-84.PMC3928498.pdf
"Key Words :  Propofol; Midazolam; Cholangiopancreatography, endoscopic retrograde; Conscious sedationOpen Access Received: December 22, 2012    Revised: February 17, 2013 Accepted:  February 17, 2013 Correspondence: Myung-Hwan KimDivision of Gastroenterology, Department of Internal Medicine, Asan Medi- cal Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 138-736, KoreaTel: +82-2-3010-3183, Fax: +82-2-476-0824, E-mail: mhkim@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.1.94 INTRODUCTION Endoscopic retrograde cholangiopancreatography (ERCP)  is a very highly advanced upper endoscopic procedure, and  is very useful for the diagnosis and treatment of pancreatobi-liary disorders.",Non-OADS,/arxiv_data1/oa_pdf/cb/67/ce-47-94.PMC3928499.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/73/btt716.PMC3928524.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/dd/btt720.PMC3928527.pdf
TED lecture available at https://www.ted.com/ta lks/anthony_atala_growing_organs_engineering_ tissue.html 4.,Non-OADS,/arxiv_data1/oa_pdf/1f/f1/467_2013_Article_2579.PMC3928531.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a4/d0/srep04132.PMC3928575.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4132 | DOI: 10.1038/srep04132 7",Non-OADS,/arxiv_data1/oa_pdf/a4/d0/srep04132.PMC3928575.pdf
"Finally, the fact that 72 over- and 54 under-expressed genes encoded uncharacterised proteins suggests that these proteins mayplay yet unknown roles in radial defence and metabolic alterations.Interestingly, 48 highly expressed genes were components of 14operons (containing at least 3 genes each) whose expression, accord-ing to ProdoNet (http://www.prodonet.tu-bs.de/query.php), is con-trolled by the transcriptional regulatory genes anr,PA4493 and PA5344 , none of which were found to be differentially expressed in our experimental conditions.",Non-OADS,/arxiv_data1/oa_pdf/79/d4/srep04134.PMC3928576.pdf
"This findingis of special significance because these genes regulate operons con-sisting of 20, 41 and 16 genes (http://www.prodonet.tu-bs.de/query.php), thus indicating a rapid and concerted regulatory deactivationas a direct consequence of TiO 2photocatalysis.",Non-OADS,/arxiv_data1/oa_pdf/79/d4/srep04134.PMC3928576.pdf
"Linear optimisations were performed utilising the CPLEX (IBM, Armonk, NY, USA) and Gurobi (http://www.gurobi.com/) linear programming solvers.",OADS,/arxiv_data1/oa_pdf/79/d4/srep04134.PMC3928576.pdf
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://www.proteomexchange.org) via the PRIDE partner repository 59with the dataset identifier PXD000732.,OADS,/arxiv_data1/oa_pdf/79/d4/srep04134.PMC3928576.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/79/d4/srep04134.PMC3928576.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4134 | DOI: 10.1038/srep04134 9",Non-OADS,/arxiv_data1/oa_pdf/79/d4/srep04134.PMC3928576.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/50/28/srep04129.PMC3928615.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4129 | DOI: 10.1038/srep04129 6",Non-OADS,/arxiv_data1/oa_pdf/50/28/srep04129.PMC3928615.pdf
"2009; [Cited 2011 Nov 8] available from: http://www.fda.gov/dow nloads/Drugs/Guidances/UCM193282.pdf [4] Fairbank JC, Couper J, Davies JB, O'Brien JP.",OADS,/arxiv_data1/oa_pdf/22/e9/TOORTHJ-8-11.PMC3928668.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/e9/TOORTHJ-8-11.PMC3928668.pdf
"Available from: http://www.nature.com/ news/bid-to-cure-hiv-ramps-up-1.1326 8, accessed on June  1,  2013.",Non-OADS,/arxiv_data1/oa_pdf/41/d0/IJMR-138-663.PMC3928698.pdf
"Available from: http://www.nature.com/ nature/journal/v487/n7407/full/487293a.htm l, accessed on    July 1, 2012.",Non-OADS,/arxiv_data1/oa_pdf/41/d0/IJMR-138-663.PMC3928698.pdf
Available from:  http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/59/1f/IJMR-138-700.PMC3928700.pdf
Available from: 28. http://www.hla.alleles.org .,Non-OADS,/arxiv_data1/oa_pdf/19/02/IJMR-138-749.PMC3928705.pdf
"Available from: 29. http://www.bmdw.org .Go 30. urraud P A, Gilson L, Girard M, Peschanski M. The role  of human leukocyte antigen matching in the development  of multiethnic “haplobank” of induced pluripotent stem cell  lines.",OADS,/arxiv_data1/oa_pdf/19/02/IJMR-138-749.PMC3928705.pdf
Available from: 32. http://www.efiweb.org .,Non-OADS,/arxiv_data1/oa_pdf/19/02/IJMR-138-749.PMC3928705.pdf
Available from: http://www.ehow.com/about_4707268_disadvantages- of-chemotherapy.html.,Non-OADS,/arxiv_data1/oa_pdf/9b/aa/IJPhS-75-707.PMC3928735.pdf
Available from: http://pi.lilly.,Non-OADS,/arxiv_data1/oa_pdf/9b/aa/IJPhS-75-707.PMC3928735.pdf
Dessertation available at http://www.diva-portal.org/smash/get/ diva2:164877/FULLTEXT01.pdf [last accessed on 24 October 2013].,Non-OADS,/arxiv_data1/oa_pdf/60/67/IJPhS-75-736.PMC3928741.pdf
Avalilable from: http://bvsms.saude.gov.br/bvs/publicacoes/projeto_ sb2004.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/a9/jaos-20-01-0038.PMC3928770.pdf
"Available from: <http://www.forp.usp.br/restauradora/gmc/gmc.html#gmc>.6- Delbem ACB, Sassaki KT, Vieira Ae, Rodrigues e, Bergamaschi M, Stock SR, et al.",Non-OADS,/arxiv_data1/oa_pdf/2f/a8/jaos-20-01-0094.PMC3928779.pdf
Available from: http://www.newbornscreening-bloodspot.org.uk [Last accessed on 2013 Jun 28].,Non-OADS,/arxiv_data1/oa_pdf/b3/dd/ABR-3-23.PMC3928837.pdf
"Gastric tissue samples  from 23 patients with gastric cancer who had  undergone gastrectomy at Cancer Institute, Iran  National Tumor Bank (http://www.irantumorbank.",Non-OADS,/arxiv_data1/oa_pdf/52/cc/ABR-3-16.PMC3928838.pdf
http://dx.doi.org/10.1016/j.ydbio.2013.11.014 nCorresponding authors.,OADS,/arxiv_data1/oa_pdf/76/18/main.PMC3928994.pdf
Making research count for patients: a new day.http://cancerprogressreport.org/2012/Documents/2012_Report.,Non-OADS,/arxiv_data1/oa_pdf/97/39/40259_2013_Article_58.PMC3929033.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2014, 3: 23244 - http://dx.doi.org/10.3402/jev.v3.23244 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/87/49/JEV-3-23244.PMC3929070.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23244 - http://dx.doi.org/10.3402/jev.v3.23244",OADS,/arxiv_data1/oa_pdf/87/49/JEV-3-23244.PMC3929070.pdf
"No significant difference in exosome levelsbetween tet-treated and tet-free cells was measured at24 hr, signifying that the number of exosomes released is independent of the tet-system.Exosome therapy and pancreatic cancer Citation: Journal of Extracellular Vesicles 2014, 3: 23244 - http://dx.doi.org/10.3402/jev.v3.23244 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/87/49/JEV-3-23244.PMC3929070.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23244 - http://dx.doi.org/10.3402/jev.v3.23244",OADS,/arxiv_data1/oa_pdf/87/49/JEV-3-23244.PMC3929070.pdf
"Data are the mean 9SD of 2 independent experiments.Exosome therapy and pancreatic cancer Citation: Journal of Extracellular Vesicles 2014, 3: 23244 - http://dx.doi.org/10.3402/jev.v3.23244 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/87/49/JEV-3-23244.PMC3929070.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23244 - http://dx.doi.org/10.3402/jev.v3.23244",OADS,/arxiv_data1/oa_pdf/87/49/JEV-3-23244.PMC3929070.pdf
"2008;195:221 /C18.Exosome therapy and pancreatic cancer Citation: Journal of Extracellular Vesicles 2014, 3: 23244 - http://dx.doi.org/10.3402/jev.v3.23244 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/87/49/JEV-3-23244.PMC3929070.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23244 - http://dx.doi.org/10.3402/jev.v3.23244",OADS,/arxiv_data1/oa_pdf/87/49/JEV-3-23244.PMC3929070.pdf
"2000;407:810 /C16.Exosome therapy and pancreatic cancer Citation: Journal of Extracellular Vesicles 2014, 3: 23244 - http://dx.doi.org/10.3402/jev.v3.23244 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/87/49/JEV-3-23244.PMC3929070.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/c5/cia-9-267.PMC3929165.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 267–274Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  267open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5868 2OrIg InAl reseArCh Prognostic value of severity indicators of nursing- home-acquired pneumonia versus community- acquired pneumonia in elderly patients Motoi Ugajin Kenichi Yamaki natsuko hirasawa Takanori Kobayashi Takeo Yagi Department of respiratory Medicine,   Ichinomiya-n ishi hospital, Ichinomiya  City, Japan Correspondence: Motoi Ugajin   Department of respiratory Medicine,  Ichinomiya-nishi hospital, 1 hira,   Kaimei, Ichinomiya City 494-0001, Japan   Tel +81 586 48 0077   Fax +81 586 48 0038   email ugarin2001@yahoo.co.j pBackground:  The credibility of prognostic indicators in nursing-home-acquired pneumonia  (NHAP) is not clear.",Non-OADS,/arxiv_data1/oa_pdf/25/c5/cia-9-267.PMC3929165.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/25/c5/cia-9-267.PMC3929165.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/c5/cia-9-267.PMC3929165.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/21/59/bctt-5-087.PMC3929248.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpBreast Cancer: Targets and Therapy 2013:5 87–101Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  87Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S5137 8enhanced radiation response in radioresistant  MCF-7 cells by targeting peroxiredoxin ii anthony Joseph gomez  Diaz1 Daniel Tamae2 Yun Yen3 JianJian li4 Tieli Wang1 1Department of Chemistry and  Biochemistry, California state  University at Dominguez hills,   Carson, C a, 2Center of excellence  in environmental T oxicology,   Department of Pharmacology,   University of Pennsylvania,   Philadelphia, P a, 3Department of  Clinical and Molecular Pharmacology,   Beckman research institute of City  of hope national Medical Center,   Duarte, C a, 4Department of radiation  Oncology, University of California  Davis, sacramento, C a, Usa Correspondence: Tieli Wang   Department of Chemistry and  Biochemistry, California state   University at Dominguez hills,   Carson, Ca 90747, Usa   T el +1 310 243 3388   Fax +1 310 243 2593   email twang@csudh.ed uAbstract:  In our previous study, we identified that a protein target, peroxiredoxin II (PrxII), is  overexpressed in radioresistant MCF +FIR3 breast-cancer cells and found that its expression and  function is associated with breast-cancer radiation sensitivity or resistance.",Non-OADS,/arxiv_data1/oa_pdf/21/59/bctt-5-087.PMC3929248.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/21/59/bctt-5-087.PMC3929248.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/19/e1/bctt-5-103.PMC3929249.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBreast Cancer: Targets and Therapy 2013:5 103–109Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  103Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S5075 0The incidence rate of female breast cancer  in saudi arabia: an observational descriptive  epidemiological analysis of data from saudi  Cancer registry 2001–2008 ibrahim g alghamdi1 issam i hussain1 Mohamed s alghamdi2 Mohamed a el-sheemy1,3 1University of lincoln, Brayford Pool,   lincoln, United Kingdom; 2Ministry of  health, general Directorate of health  affairs al-Baha, Kingdom of saudi  arabia; 3lincoln hospital, research  and Development, United lincolnshire  hospitals, national health service  Trust, lincoln, United Kingdom Correspondence: ibrahim g alghamdi   University of lincoln, school of life   sciences, Brayford Pool, lincoln,   ln6 7Ts, United Kingdom   Tel +44 11 6276 1913   email bio-stat@hotmail.co mBackground:  This study presents descriptive epidemiological data related to breast cancer cases  diagnosed from 2001 to 2008 among Saudi women, including the frequency and percentage of  cases, the crude incidence rate (CIR), and the age-standardized incidence rate (ASIR), adjusted  by the region and year of diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/19/e1/bctt-5-103.PMC3929249.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/19/e1/bctt-5-103.PMC3929249.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs297/en /.,Non-OADS,/arxiv_data1/oa_pdf/19/e1/bctt-5-103.PMC3929249.pdf
"A vailable  from: http://globocan.iarc.fr/factsheets/cancers/all.as p. Accessed  May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/19/e1/bctt-5-103.PMC3929249.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/d6/53/bctt-5-079.PMC3929250.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpBreast Cancer: Targets and Therapy 2013:5 79–85Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  79Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S3558 1Benefits of multidisciplinary teamwork   in the management of breast cancer Cath Taylor1 Amanda Shewbridge2 Jenny Harris1 James S Green3,4 1Florence Nightingale School of  Nursing and Midwifery, King’s College  London, London UK; 2Breast Cancer  Services, Guy’s and St Thomas’  NHS Foundation Trust, London, UK;   3Department of Urology, Barts Health  NHS Trust, London, UK; 4Department  of Health and Social Care, London  South Bank University, London, UK Correspondence: Cath Taylor   Florence Nightingale School of Nursing   and Midwifery, Room 3.21, James Clerk   Maxwell Building, King’s College London,   London SE1 8WA, UK   Tel +44 207 848 3508   Fax +44 207 836 3764   email cath.taylor@kcl.ac.u kAbstract:  The widespread introduction of multidisciplinary team (MDT)-work for breast  cancer management has in part evolved due to the increasing complexity of diagnostic and  treatment decision-making.",Non-OADS,/arxiv_data1/oa_pdf/d6/53/bctt-5-079.PMC3929250.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/d6/53/bctt-5-079.PMC3929250.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/09/bctt-6-001.PMC3929252.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBreast Cancer: Targets and Therapy 2014:6 1–13Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S3763 8Multidrug-resistant breast cancer: current  perspectives Heather L Martin1 Laura Smith2 Darren C T omlinson1 1BioScreening T echnology Group,   Leeds institutes of Molecular  Medicine, University of Leeds, Leeds,   UK; 2Leeds institute of Cancer   and Pathology, University of Leeds,   Leeds, UK Correspondence: Darren C Tomlinson   BioScreening Technology Group,  Leeds institutes of Molecular Medicine,  wellcome Trust Brenner Building,  St James’s University Hospital, Beckett  Street, Leeds LS9 7TF, UK   Tel +44 113 343 9077   email d.c.tomlinson@leeds.ac.u kAbstract:  Breast cancer is the most common cancer in women worldwide, and resistance to the  current therapeutics, often concurrently, is an increasing clinical challenge.",Non-OADS,/arxiv_data1/oa_pdf/54/09/bctt-6-001.PMC3929252.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/54/09/bctt-6-001.PMC3929252.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/17/opth-8-401.PMC3929265.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 401–403Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  401Case RepOR topen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5608 3Emphysema following vitrectomy with fluid–gas  exchange: description of a rare complication eduardo F Damasceno1 Nadyr Damasceno2 soraya Horowitz2 Marcio Mortera Rodrigues3 1Universidade Federal Fluminense,   Niterói, Brazil; 2Hospital Naval  Marcílio Dias, Rio de Janeiro, Brazil;   3Universidade Federal do Rio de  Janeiro, Rio de Janeiro, Brazil Correspondence: eduardo F Damasceno  Universidade Federal Fluminense   school of Medicine, Marques do paraná  303, Niteroi, Brazil   tel +552125687728   Fax +552125690304   email e_damasceno@yahoo.co mPurpose:  To report a case of subcutaneous emphysema involving the orbit, mediastinum, and  face after pars plana vitrectomy with fluid–gas exchange.",Non-OADS,/arxiv_data1/oa_pdf/b9/17/opth-8-401.PMC3929265.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b9/17/opth-8-401.PMC3929265.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/17/opth-8-401.PMC3929265.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/53/61/bctt-6-015.PMC3929326.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpBreast Cancer: Targets and Therapy 2014:6 15–27Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  15Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S4376 4emerging role of cell polarity proteins in breast   cancer progression and metastasis Sudipa June Chatterjee Luke McCaffrey Rosalind and Morris Goodman  Cancer Centre, Department   of Oncology, McGill University,    Montreal, QC, Canada Correspondence: Luke McCaffrey   Rosalind and Morris Goodman Cancer   Centre, Department of Oncology,   McGill University, 1160 Pine Avenue   west, Montreal, QC, Canada, H3A 1A3   Tel +1 514 398 8987   Fax +1 514 398 6769   email luke.mccaffrey@mcgill.c aAbstract:  Breast cancer is a heterogeneous group of diseases that frequently exhibits loss of  growth control, and disrupted tissue organization and differentiation.",Non-OADS,/arxiv_data1/oa_pdf/53/61/bctt-6-015.PMC3929326.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/53/61/bctt-6-015.PMC3929326.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/9e/bctt-5-073.PMC3929327.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpBreast Cancer: Targets and Therapy 2013:5 73–78Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  73Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S4717 2effects of CYP2D6  and UGT2B7  polymorphisms  on pharmacokinetics of tamoxifen in Thai breast  cancer patients n areepium1 D Panomvana1 P rungwanonchai1 s sathaporn2 n Voravud3 1Department of Pharmacy  Practice, Faculty of Pharmaceutical  sciences, Chulalongkorn University,   Bangkok, 2Department of surgery,   Phramongkutklao hospital, Bangkok,   3Department of Medicine, Faculty of  Medicine, Chulalongkorn University,   Bangkok, Thailand Correspondence: Duangchit Panomvana   Department of Pharmacy Practice,  Faculty of Pharmaceutical sciences,  Chulalongkorn University,   Bangkok 10330, Thailand   Tel +66 2218 8405   Fax +66 2218 8403   email duangchit.p@chula.ac.t hPurpose:  The objective of this study was to evaluate the impact of CYP2D6  and UGT2B7   polymorphisms on tamoxifen (TAM) pharmacokinetics in Thai breast cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/09/9e/bctt-5-073.PMC3929327.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/09/9e/bctt-5-073.PMC3929327.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/96/bctt-5-111.PMC3929331.pdf
Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpBreast Cancer: Targets and Therapy 2013:5 111–119Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  111PERSPECTIVESopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S4439 9Breast cancer causes and treatment:   where are we going wrong?,Non-OADS,/arxiv_data1/oa_pdf/83/96/bctt-5-111.PMC3929331.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/83/96/bctt-5-111.PMC3929331.pdf
"Available from:  http://www.telegraph.co.uk/health/10069585/15000-people-die-every- year-because-of-cancer-treatments-Lord-Saatchi-says.htm l. Accessed  October 30, 2013.71.",Non-OADS,/arxiv_data1/oa_pdf/83/96/bctt-5-111.PMC3929331.pdf
Available from: http://www.nytimes.com/2009/12/13/magazine/13Fob- wwln-t.html?_ r=0.,Non-OADS,/arxiv_data1/oa_pdf/83/96/bctt-5-111.PMC3929331.pdf
Available from: http://health.nytimes.com/health/ guides/test/mammography/news-and-features.html?pag e=3.,Non-OADS,/arxiv_data1/oa_pdf/83/96/bctt-5-111.PMC3929331.pdf
"Available from: http://en.wikipedia.org/wiki/ Scienc e. October 2, 2013.",Non-OADS,/arxiv_data1/oa_pdf/83/96/bctt-5-111.PMC3929331.pdf
"Available from: http://en.wikipedia.org/wiki/Paracelsu s.  Accessed October 2, 2013.",Non-OADS,/arxiv_data1/oa_pdf/83/96/bctt-5-111.PMC3929331.pdf
Available from: http://www.similima.,Non-OADS,/arxiv_data1/oa_pdf/83/96/bctt-5-111.PMC3929331.pdf
"OncoImmunology 2013; 2:e27220; http://dx.doi.org/10.4161/onci.27220An immunotherapeutic intervention   against tumor progression Targeting a driver of the epithelial-to-mesenchymal transition Claudia Palena*, r omaine I Fernando, and Duane h h amilton Laboratory of Tumor Immunology and Biology; Center for Cancer r esearch; National Cancer Institute; National Institutes of h ealth; Bethesda, MD usa Keywords:  anticancer vaccines, brachyury, EMT, metastasis, therapeutic resistance Targeting the epithelial-to-mesenchymal transition ( eMT) is emerging as a novel intervention against tumor pro - gression and metastatic dissemination, as well as the resistance to chemo- and radiotherapy displayed by multiple  carcinomas.",Non-OADS,/arxiv_data1/oa_pdf/49/bf/onci-3-e27220.PMC3929358.pdf
Nat Rev Cancer 2002; 2:442- 54; PMID:12189386 ; http://dx.doi.org/10.1038/ nrc822 3.,Non-OADS,/arxiv_data1/oa_pdf/49/bf/onci-3-e27220.PMC3929358.pdf
Proc Natl Acad Sci U S A  2009; 106:13820-5;  PMID:19666588 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/49/bf/onci-3-e27220.PMC3929358.pdf
J Clin Invest 2010; 120:533-44;  PMID:20071775 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/bf/onci-3-e27220.PMC3929358.pdf
Cancer Res 2011; 71:5296-306;  PMID:21653678 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0156 6.,Non-OADS,/arxiv_data1/oa_pdf/49/bf/onci-3-e27220.PMC3929358.pdf
Cell Death Dis  2013; 4:e682;  PMID:23788039 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/bf/onci-3-e27220.PMC3929358.pdf
Mol Cancer Ther  2013 ; 12:1805-15;  PMID:23783250 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/bf/onci-3-e27220.PMC3929358.pdf
"OncoImmunology 2013; 2:e27256; http://dx.doi.org/10.4161/onci.27256Immunotherapeutic implications of the  immunophenotype of pediatric brain tumors andrea M Griesinger1,2,*, andrew M Donson1,2, and Nicholas K Foreman1,2 1Department of Pediatrics; a nschutz Medical Campus; u niversity of Colorado at Denver; aurora, CO usa ; 2Children’s h ospital Colorado; aurora, CO usa Keywords:  flow cytometry, immune cell characterization, immunotherapy, pediatric brain tumor The cytofluorometric analysis of dissociated tumor samples identified distinct immunophenotypes among the most  common variants of pediatric brain tumor.",Non-OADS,/arxiv_data1/oa_pdf/0f/fe/onci-3-e27256.PMC3929359.pdf
J Immunol 2013; 191:4880-8; PMID:24078694 ;  http://dx.doi.org/10.4049/jimmunol.1301966 2.,Non-OADS,/arxiv_data1/oa_pdf/0f/fe/onci-3-e27256.PMC3929359.pdf
N  Engl J Med 2010; 363:1324-34; PMID:20879881 ;  http://dx.doi.org/10.1056/NEJMoa0911123 3.,Non-OADS,/arxiv_data1/oa_pdf/0f/fe/onci-3-e27256.PMC3929359.pdf
Nat Med 2000; 6:443-6;  PMID:10742152 ; http://dx.doi.org/10.1038/74704 4.,Non-OADS,/arxiv_data1/oa_pdf/0f/fe/onci-3-e27256.PMC3929359.pdf
J Immunol 2009; 183:7428- 40; PMID:19917695 ; http://dx.doi.org/10.4049/ jimmunol.09028115.,Non-OADS,/arxiv_data1/oa_pdf/0f/fe/onci-3-e27256.PMC3929359.pdf
Neuropediatrics 2008; 39:151-6;  PMID:18991194 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/fe/onci-3-e27256.PMC3929359.pdf
N Engl J Med 2013; 369:134-44;  PMID:23724846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/fe/onci-3-e27256.PMC3929359.pdf
N Engl J Med 2010; 363:711-23;  PMID:20525992 ; http://dx.doi.org/10.1056/ NEJMoa1003466,OADS,/arxiv_data1/oa_pdf/0f/fe/onci-3-e27256.PMC3929359.pdf
"OncoImmunology 2013; 2:e27218; http://dx.doi.org/10.4161/onci.27218Immunovirotherapy for the treatment   of glioblastoma Tooba a Cheema1, 2, Peter e Fecci1, Jianfang Ning1, and s amuel D r abkin1,* 1Brain Tumor r esearch Center; Department of Neurosurgery; Massachusetts General h ospital and h arvard Medical s chool; Boston, M a usa ;   2Momenta Pharmaceuticals; Cambridge, M a usa Keywords:  cancer stem cells, glioma, herpes simplex virus, interleukin-12, oncolytic virus, Treg Abbreviations: GBM, glioblastoma; GSC, glioblastoma stem cell; oHSV, oncolytic herpes simplex virus; Treg, regulatory T cell.",Non-OADS,/arxiv_data1/oa_pdf/02/8c/onci-3-e27218.PMC3929360.pdf
CA Cancer J Clin 2010; 60:166-93; PMID:20445000 ;  http://dx.doi.org/10.3322/caac.20069 2.,OADS,/arxiv_data1/oa_pdf/02/8c/onci-3-e27218.PMC3929360.pdf
"Neurosurgery   2012 ; 71:201-22, discussion 222-3 ; PMID:22353795 ;  http://dx.doi.org/10.1227/NEU.0b013e31824f840d3.",Non-OADS,/arxiv_data1/oa_pdf/02/8c/onci-3-e27218.PMC3929360.pdf
Cancer Res 2006 ; 66:3294 -302;  PMID:16540683 ; http://dx.doi.org/10.1158/0008- 5472.CAN-05-37734.,Non-OADS,/arxiv_data1/oa_pdf/02/8c/onci-3-e27218.PMC3929360.pdf
Proc Natl Acad Sci U S A 2013 ; 110:12006 -11;  PMID:23754388 ; http://dx.doi.org/10.1073/ pnas.1307935110,OADS,/arxiv_data1/oa_pdf/02/8c/onci-3-e27218.PMC3929360.pdf
Oncoimmunology  2013 ; 2:e24612 ; PMID:23894720 ;  http://dx.doi.org/10.4161/onci.24612 6.,Non-OADS,/arxiv_data1/oa_pdf/02/8c/onci-3-e27218.PMC3929360.pdf
Adv Exp Med Biol 2012 ;  746:178-86; PMID:22639168 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/8c/onci-3-e27218.PMC3929360.pdf
Cancer Res 2009 ; 69:3472 -81; PMID:19351838 ;  http://dx.doi.org/10.1158/0008-5472.CAN-08-38868.,Non-OADS,/arxiv_data1/oa_pdf/02/8c/onci-3-e27218.PMC3929360.pdf
Clin Cancer Res   2007 ; 13:4677 -85; PMID:17699845 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/8c/onci-3-e27218.PMC3929360.pdf
"In the  *Correspondence to: Jürgen Krauss; Email: juergen.krauss@nct-heidelberg.de Submitted: 09/18/2013; Revised: 11/15/2013; Accepted: 11/17/2013http://dx.doi.org/10.4161/mabs.27236Generation of “LYmph Node Derived Antibody  Libraries” (LYNDAL) for selecting fully human  antibody fragments with therapeutic potential philipp Diebolder1, Armin Keller1, Stephanie Haase1, Anne Schlegelmilch1, Jonathan D Kiefer1, tamana Karimi1, tobias Weber1,  Gerhard Moldenhauer2, Roland Kehm3, Anna M e is-Hübinger4, Dirk Jäger1, philippe A Federspil5, Christel Herold-Mende6,7,  Gerhard Dyckhoff5, Roland e Kontermann8, Michaela A e Arndt9, and Jürgen Krauss1,* 1Department of Medical o ncology; National Center for t umor Diseases; Heidelberg University Hospital; Heidelberg, Germany; 2Department of t ranslational Immunology;  National Center for t umor Diseases and German Cancer Research Center; Heidelberg, Germany; 3Department of Biotechnology; University of Heidelberg; Heidelberg,  Germany; 4Institute of Virology; University of Bonn Medical Center; Bonn, Germany; 5Department of o torhinolaryngology, Head and Neck Surgery; University of Heidelberg,  Germany; 6Division of e xperimental Neurosurgery; Department of Neurosurgery, University of Heidelberg; Heidelberg, Germany; 7Molecular Cell Biology Group; e Nt  Department; University of Heidelberg; Heidelberg, Germany; 8Institute of Cell Biology and Immunology; University of Stuttgart; Stuttgart, Germany; 9Immunotherapy  program; National Center for t umor Diseases and German Cancer Research Center; Heidelberg, Germany Keywords:  fully human antibodies, combinatorial libraries, phage display, lymph nodes, herpes simplex virus, neutralizing  antibodies, scFv, immune libraries Abbreviations:  CDR, complementarity-determining region; FR, framework region; gB, glycoprotein B of herpes simplex virus;  HSV, herpes simplex virus; IgG, immunoglobulin G; LYNDAL, LYmph Node Derived Antibody Libraries; PRNT, plaque  reduction neutralization test; scFv, single-chain variable fragment; VH, variable region of the heavy chain; VL, variable region of  the light chain the development of efficient strategies for generating fully human monoclonal antibodies with unique functional  properties that are exploitable for tailored therapeutic interventions remains a major challenge in the antibody  technology field.",Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Forward primer design was based on all functional variable gene sequences as represented in VBASE (http://www2.mrc-lmb.cam.ac.uk/vbase/).,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
"Sequences from at least five intact, randomly chosen scFvs per sublibrary were determined and analyzed by sequence alignment software DNAPLOT (http://www2.mrc-lmb.cam.ac.uk/vbase/dnaplot2.php) to identify the closest germline V, (D), and J segment genes as deposited in VBASE.",OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Complementarity-determining regions (CDRs) were additionally analyzed by using the Fab Analysis tool (http://www.vbase2.org/vbscAb.php) by aligning the scFv sequences to the VBASE2 database.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Supplemental Materials  Supplemental materials may be found here: http://www.landesbioscience.com/journals/mabs/article/27236/ Figure  9.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nat Rev Drug Discov 2010; 9:767- 74; PMID:20811384 ; http://dx.doi.org/10.1038/ nrd3229 2.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
MAbs  2013 ; 5:513-7; PMID:23727858 ;  http://dx.doi.org/10.4161/mabs.24990 3.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
F1000 Biol  Rep 2011 ; 3:17; PMID:21876728 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nat Med  2010 ; 16:123- 8; PMID:20023635 ; http://dx.doi.org/10.1038/ nm.20717.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nat Med   2004 ; 10:871-5; PMID :15247913 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Science  2003 ; 301:1374 -7;  PMID:12920303 ; http://dx.doi.org/10.1126/ science.1086907 10.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J Immunol Methods  1999 ; 231:11-23; PMID:10648924 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nat Biotechnol  2005 ; 23:1117-25;  PMID:16151405 ; http://dx.doi.org/10.1038/nbt113512.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J Immunol Methods 2004 ;  290:29-49; PMID :15261570 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nature   1990 ; 348:552-4; PMID:2247164 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Methods Mol Biol  2012 ;  901:11-32; PMID:22723092 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nat Biotechnol   2005 ; 23:1105 -16; PMID:16151404 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J  Biol Chem  1999 ; 274:18218 -30; PMID:10373423 ;  http://dx.doi.org/10.1074/jbc.274.26.18218,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Protein Eng Des Sel  2009 ; 22:159-68; PMID:18974080 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J Mol Biol  1991 ;  222:581-97; PMID:1748994 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nat Biotechnol   1996 ; 14:309-14; PMID:9630891 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Proc Natl Acad Sci U S A 1995 ; 92:6537 - 41; PMID:7604028 ; http://dx.doi.org/10.1073/ pnas.92.14.6537 22.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Endocrinology   2001 ; 142:4740 -50; PMID:11606439 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J Virol 2002 ; 76:251- 8; PMID:11739690 ; http://dx.doi.org/10.1128/ JVI.76.1.251-258.2002 24.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
FASEB  J 2011 ; 25:4211 -21; PMID:21859892 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Proc Natl Acad Sci U S A 2008 ; 105:5986 -91;  PMID:18413603 ; http://dx.doi.org/10.1073/ pnas.0801367105 26.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Virology  2004 ; 318:598-607;  PMID:14972527 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Eur  J Immunol  2005 ; 35:2131 -45; PMID:15971273 ;  http://dx.doi.org/10.1002/eji.20052613428.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Proc Natl Acad Sci U S A 1999 ; 96:6953 - 8; PMID:10359820 ; http://dx.doi.org/10.1073/ pnas.96.12.6953 29.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
PLoS One  2011 ; 6:e15921 ;  PMID:21264246 ; http://dx.doi.org/10.1371/ journal.pone.0015921 32.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J Mol Biol  2000 ; 296:57- 86; PMID:10656818 ; http://dx.doi.org/10.1006/ jmbi.1999.3444 34.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J Mol Biol  2008 ; 376:1182 - 200; PMID:18191144 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Proteomics  2005 ; 5:2340 - 50; PMID:15880779 ; http://dx.doi.org/10.1002/ pmic.200401273 37.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
MAbs  2013 ;  5:5; PMID :23571156 ; http://dx.doi.org/10.4161/ mabs.24218 38.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nat Biotechnol  2005 ; 23:344-8;  PMID:15723048 ; http://dx.doi.org/10.1038/ nbt1067 41.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J Biol Chem 1998 ; 273:21769 - 76; PMID:9705314 ; http://dx.doi.org/10.1074/ jbc.273.34.21769 42.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nat Biotechnol  2000 ; 18:852-6;  PMID:10932154 ; http://dx.doi.org/10.1038/78458 43.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Immunity  1996 ; 5:639- 52; PMID:8986722 ; http://dx.doi.org/10.1016/ S1074-7613(00)80277-0 44.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nat Rev Microbiol  2011 ; 9:369-81; PMID:21478902 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Eur J Clin Microbiol Infect Dis 2005 ; 24:131- 5; PMID :15692814 ; http://dx.doi.org/10.1007/ s10096-005-1286-x 47.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Proc Natl Acad Sci U S A  2013 ; 110:6760 -5; PMID:23569258 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
PLoS One  2011 ; 6:e24078 ;  PMID:21931643 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nature  2009 ; 458:636- 40; PMID:19287373 ; http://dx.doi.org/10.1038/ nature07930,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Science  2011 ; 333:1633 - 7; PMID:21764753 ; http://dx.doi.org/10.1126/ science.1207227 53.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Immunotechnology  1997 ; 3:195- 203; PMID:9358272 ; http://dx.doi.org/10.1016/ S1380-2933(97)00013-4 55.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Immunol Rev  2012 ; 247:52-63; PMID:22500831 ;  http://dx.doi.org/10.1111/j.1600-065X.2012.01124.x 56.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Annu Rev Immunol 2012 ; 30:429-57;  PMID:22224772 ; http://dx.doi.org/10.1146/ annurev-immunol-020711-075032 57.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Annu Rev Immunol 2005 ; 23:487-513;  PMID :15771579 ; http://dx.doi.org/10.1146/ annurev.immunol.23.021704.115732 58.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Eur J Immunol  2009 ; 39:2065 -75; PMID:19637202 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J Exp Med 2007 ; 204:2655 -65;  PMID:17938234 ; http://dx.doi.org/10.1084/ jem.20071006 60.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Proc Natl Acad Sci U  S A 1993 ; 90:4141 -5; PMID:7683424 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J Immunol  2011 ; 187:4229 -35; PMID:21930965 ;  http://dx.doi.org/10.4049/jimmunol.1000928 62.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nucleic Acids Res 1991 ; 19:4133 - 7; PMID:1908075 ; http://dx.doi.org/10.1093/ nar/19.15.4133 63.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nucleic Acids Res  2001 ; 29:205-6; PMID:11125092 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nucleic Acids Res  2005 ; 33:D671 -4; PMID:15608286 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nucleic Acids Res 2005 ; 33:D256 -61;  PMID :15608191 ; http://dx.doi.org/10.1093/nar/ gki01066.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J Virol 2007 ; 81:3827 -41; PMID:17267495 ;  http://dx.doi.org/10.1128/JVI.02710-06 68.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nucleic Acids Res  2008 ; 36:W465-9 ; PMID:18424797 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Nucleic Acids Res 2008 ; 36:W503-8 ;  PMID:18503082 ; http://dx.doi.org/10.1093/nar/ gkn316 70.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
Immunotechnology  1997 ; 3:137-44;  PMID:9237098 ; http://dx.doi.org/10.1016/ S1380-2933(97)00010-9 71.,Non-OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
J Biol Chem 2007 ;  282:12650 -60; PMID:17347147 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/34/mabs-6-130.PMC3929437.pdf
"11,20 *Correspondence to: Csaba Kiss; Email: csaba.kiss@lanl.gov Submitted: 11/01/2013; Revised: 11/04/2013; Accepted: 11/06/2013http://dx.doi.org/10.4161/mabs.27105The antibody mining toolbox An open source tool for the rapid  analysis of antibody repertoires Sara D’Angelo1, Jacob Glanville2, Fortunato Ferrara1, Leslie Naranjo3, Cheryl D Gleasner3, Xiaohong Shen3,  Andrew r M Bradbury3, and Csaba Kiss3,* 1New Mexico Consortium; Los Alamos, NM, USA; 2Stanford Immunology; Stanford University; Stanford, CA USA; 3B Division; Los Alamos National Laboratory;   Los Alamos, NM USA Keywords:  HCDR3, antibody library, deep sequencing, regular expression, AbMining ToolBox Abbreviations:  CDR, complementarity determining regions; VH, heavy chain variable domain; VL, light chain variable domain,  scFv, single chain fragment variable; RegEx, regular expression; Ab, antibody; aa, amino acid In vitro selection has been an essential tool in the development of recombinant antibodies against various antigen  targets.",Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
We provide the  necessary HCDR3 primer sequences and easy-to-use open source informatics tools to make deep sequencing routinely available for anti - body selection analysis (http://sourceforge.net/projects/abmining/).,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
"This software package is freely available at http://sourceforge.net/projects/abmining/ with instructions for the installation of the necessary packages for Windows, Mac and Linux operating systems.",Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
The AbMining ToolBox developed for this article is freely  available at Sourceforge (http://sourceforge.net/projects/abmining/).,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
J Mol Biol 1991;  222:581-97;  PMID:1748994 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Proc Natl Acad Sci U S A 1997; 94:4937-42; PMID:9144168 ; http://dx.doi.org/10.1073/ pnas.94.10.4937 4.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nat Biotechnol 2011; 29:245- 54; PMID:21390033 ; http://dx.doi.org/10.1038/ nbt.1791 5.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nat Methods  2011; 8:551-8;  PMID:21572409 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Protein Eng Des Sel 2010; 23:279- 88; PMID:20164216 ; http://dx.doi.org/10.1093/ protein/gzq003 7.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
J Mol Biol  1996; 255:28-43;  PMID:8568873 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Protein Sci 2004; 13:1882- 91; PMID :15169956 ; http://dx.doi.org/10.1110/ ps.03540504 11.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
J Immunol  2012; 189:3221-30;  PMID:22865917 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nature 1983; 302:575-81;  PMID:6300689 ;  http://dx.doi.org/10.1038/302575a0 15.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nat Immunol 2003; 4:829- 33; PMID:12942083 ; http://dx.doi.org/10.1038/ ni0903-829 17.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Annu Rev Immunol 1992; 10:359-83;  PMID:1590991 ; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Proc Natl Acad Sci U S A  1996; 93:13979-84;  PMID:8943046 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nature 1995;  376:732;  PMID :7651532 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Anal Chem 2011; 83:4327- 41; PMID:21612267 ; http://dx.doi.org/10.1021/ ac2010857 22.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
J Appl Genet  2011; 52:413-35;  PMID:21698376 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nat Rev Genet 2010; 11:31-46;  PMID:19997069 ; http://dx.doi.org/10.1038/ nrg2626 24.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nucleic Acids Res 2010; 38:e193;  PMID:20846958 ; http://dx.doi.org/10.1093/nar/ gkq789 25.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nucleic Acids Res 2010; 38:e110;  PMID:20144949 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Anal  Biochem 2012; 421:622-31; PMID:22178910 ;  http://dx.doi.org/10.1016/j.ab.2011.11.005 29.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
"Nat Methods 2011; 8:478-80; PMID:21516116 ; http://dx.doi.org/10.1038/ nmeth.1597one round of sorting using flow cytometry (FACSAria, BD).",OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nat Biotechnol  2010; 28:965-9;  PMID:20802495 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
PLoS One 2011; 6:e22365;  PMID:21829618 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Science 2009; 324:807- 10; PMID:19423829 ; http://dx.doi.org/10.1126/ science.1170020 33.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Molecules 2011; 16:790-817;  PMID:21248664 ; http://dx.doi.org/10.3390/ molecules1601079034.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
PLoS One 2012; 7:e49535;  PMID:23166701 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nat Biotechnol 2012; 30:434-9; PMID:22522955 ; http://dx.doi.org/10.1038/ nbt.2198 36.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nat Biotechnol 2000; 18:75-80; PMID:10625396 ;  http://dx.doi.org/10.1038/71958 37.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
J Mol Biol 2003; 334:733-49;  PMID:14636599 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
Nat Rev Genet 2012; 13:667-72; PMID:22898652 ; http://dx.doi.org/10.1038/ nrg3305 40.,OADS,/arxiv_data1/oa_pdf/cc/5c/mabs-6-160.PMC3929439.pdf
"13 Antibody-fluorophore  conjugates (AFCs) using the same linkers and conjugation chem - istries as ADCs, but with a non-toxic cargo, are valuable molecu - lar tools for mechanistic studies and PK evaluation as recently illustrated in several reports (e.g., Alexa488 14 and Alexa350,15  *Correspondence to: Elsa Wganer; Email: elsa.wagner@pierre-fabre.com ; Alain Beck; Email: alain.beck@pierre-fabre.com Submitted: 09/21/13; Revised: 10/09/13; Accepted: 10/10/13 http://dx.doi.org/10.4161/mabs.26773Antibody-drug conjugate model fast  characterization by LC-MS following IdeS  proteolytic digestion elsa Wagner- rousset1,*, Marie-Claire Janin-Bussat1, olivier Colas1, Melissa e xcoffier1, Daniel a youb1, Jean-François Haeuw1,   Ian r ilatt2,  Michel Perez2, Nathalie Corvaïa1, and a lain Beck1,* 1IrPF; Centre d’Immunologie Pierre Fabre; St Julien-en-Genevois, France; 2IrPF; Centre de r echerche Pierre Fabre; Castres, France Keywords:  ADC, antibody-drug conjugates, AFC, antibody-fluorophore conjugates, DAR, multimers, IdeS, N-linked  glycosylation, mass spectrometry Here we report the design and production of an antibody-fluorophore conjugate ( aFC) as a non-toxic model of an  antibody-drug conjugate ( aDC).",Non-OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Nat Rev Immunol 2010; 10:345-52; PMID:20414207 ; http://dx.doi.org/10.1038/ nri2747 2.,Non-OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
MAbs 2011; 3:331- 7; PMID:21691144 ; http://dx.doi.org/10.4161/ mabs.3.4.16612 3.,Non-OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
MAbs  2012; 4:637-47;  PMID:22909934 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Nat Rev Drug Discov 2013; 12:329-32; PMID:23629491 ; http://dx.doi.org/10.1038/ nrd4009 5.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Curr Opin Chem Biol 2013; 17:406- 11; PMID:23570980 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Curr Pharm  Biotechnol 2008; 9:482-501;  PMID:19075687 ;  http://dx.doi.org/10.2174/138920108786786411 9.,Non-OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Nat Biotechnol 2008; 26:925-32; PMID:18641636 ;  http://dx.doi.org/10.1038/nbt.1480 10.,Non-OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Nat Biotechnol 2012; 30:184-9; PMID:22267010 ;  http://dx.doi.org/10.1038/nbt.210811.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Bioconjug Chem 2013; 24:1256-63;  PMID:23808985 ; http://dx.doi.org/10.1021/ bc400217g 12.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
MAbs 2011; 3:161-72; PMID:21441786 ; http://dx.doi.org/10.4161/ mabs.3.2.14960 14.,Non-OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Nat Biotechnol 2012; 30:184-9; PMID:22267010 ;  http://dx.doi.org/10.1038/nbt.2108 15.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Chem Biol 2013; 20:161-7; PMID:23438745 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
MAbs  2012; 4:362-72;  PMID:22531451 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Proc Natl Acad Sci U S A 2012; 109:16101- 6; PMID:22988081 ; http://dx.doi.org/10.1073/ pnas.1211023109 18.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Cancer Chemother Pharmacol 2012; 70:439-49; PMID:22821053 ; http://dx.doi.org/10.1007/ s00280-012-1925-819.,Non-OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Bioconjug Chem 2005; 16:1282-90; PMID:16173809 ; http://dx.doi.org/10.1021/ bc050201y 20.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Anal Chem 2012; 84:2843-9; PMID:22384990 ; http://dx.doi.org/10.1021/ ac203346c 22.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Anal Chem 2013;  85:1699-704;  PMID:23289544 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
MAbs  2013; 5:915-22;  PMID :23995615 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
"org/10.4161/mabs.26282 24. von Pawel-Rammingen U, Johansson BP, Björck L.  IdeS, a novel streptococcal cysteine proteinase with  unique specificity for immunoglobulin G. EMBO J  2002 ; 21:1607-15;  PMID:11927545 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Biochemistry 2004; 43:15540-9;  PMID :15581366 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Anal Biochem 2011; 415:212-4; PMID :21596014 ;  http://dx.doi.org/10.1016/j.ab.2011.04.030 28.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Anal Chem 2013 ; 85:715-36 ;  PMID:23134362 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
TrAC Trends in Analytical Chemistry 2013; 48:81- 95; http://dx.doi.org/10.1016/j.trac.2013.02.014 30.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
MAbs 2013; 5:641-5; PMID:23839239 ; http://dx.doi.org/10.4161/ mabs.2530233.,OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Breast Cancer Res Treat 2011; 128:347- 56; PMID:20730488 ; http://dx.doi.org/10.1007/ s10549-010-1090-x 34.,Non-OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
Anal Chem 2010; 82:5219-26; PMID:20491447 ;  http://dx.doi.org/10.1021/ac100575n,Non-OADS,/arxiv_data1/oa_pdf/17/e7/mabs-6-173.PMC3929440.pdf
"klinguer.hamour@pierre-fabre.com; Pavel Strop; Email: pavel.strop@pfizer.com; Dhaval K Shah; Email: dshah4@buffalo.edu; Laurent Ducry; Email: laurent.ducry@lonza.com; April Xu; Email: april.Xu@pfizer.com; Alain Beck; Email: alain.beck@pierre-fabre.comSubmitted: 12/04/2013; Accepted: 12/04/2013http://dx.doi.org/10.4161/mabs.27437World Antibody-Drug Conjugate Summit,   October 15–16, 2013, San Francisco, CA Christine Klinguer-Hamour1, Pavel Strop2, Dhaval K Shah3, Laurent Ducry4, April Xu5, and Alain Beck1 1Centre d’Immunologie Pierre Fabre; Saint Julien en Genevois, France; 2rinat-Pfizer; South San Francisco, CA USA; 3Department of Pharmaceutical Sciences; The State  University of New y ork at Buffalo; Buffalo, N y USA; 4Lonza; Visp, Switzerland; 5Pfizer; Pearl r iver, N y USA Abbreviations:  ADC, antibody-drug conjugate; CRPC, castration-resistant prostate cancer; CMC, chemistry, manufacturing and  control; CTC, circulating tumor cell; CD, cluster of differentiation; CMO, contract manufacturing organization; DOE, design  of experiment; DAR, drug-to-antibody ratio; EGFR, epidermal growth factor receptor; FDA, Food and Drug Administration;  HER, human epidermal growth factor receptor; IHC, immuno-histo-chemistry; MBC, metastatic breast cancer, M&S, modeling  and simulation; mAb, monoclonal antibody; ORR, objective response rate; PD, pharmacodynamics; PK, pharmacokinetics; PFS,  progression-free survival; PSA, prostate-specific antigen; PBD, pyrrolobenzodiazepine; QRT-PCR, quantitative reverse transcriptase  polymerase chain reaction; TFF, tangential flow filtration; TD, toxicodynamic The World Antibody-Drug Conjugate (WADC) Summits  organized by Hanson Wade are currently the largest meetings  fully dedicated to ADCs.",Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Nat Rev Immunol 2010; 10:345-52;  PMID:20414207 ; http://dx.doi.org/10.1038/ nri2747 2.,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
MAbs  2011 ; 3:331- 7; PMID:21691144 ; http://dx.doi.org/10.4161/ mabs.3.4.16612 4.,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
MAbs   2012 ; 4:637-47; PMID:22909934 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Chem Biol  2013 ; 20:161- 7; PMID:23438745 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Angew Chem Int Ed Engl  2010 ; 49:9995 -7; PMID:21110357 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
J Clin Oncol  2005 ; 23:4591 -601; PMID:15837970 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
J Pharmacokinet  Pharmacodyn  2012 ; 39:643-59; PMID :23151991 ;  http://dx.doi.org/10.1007/s10928-012-9276-y 10.,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
J Pharmacokinet Pharmacodyn  2012 ; 39:67- 86; PMID:22143261 ; http://dx.doi.org/10.1007/ s10928-011-9232-2,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Clin Pharmacol Ther  2012 ; 92:520-7; PMID:22968044 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Cancer Chemother  Pharmacol  2012 ; 70:591-601; PMID:22886072 ;  http://dx.doi.org/10.1007/s00280-012-1934-7 13.,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
J Pharmacokinet Pharmacodyn   2013 ; 40:557-71; PMID:23933716 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Bioanalysis  2013 ; 5:989-92; PMID:23641690 ;  http://dx.doi.org/10.4155/bio.13.7815.,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Cancer Res 2009 ;  69:2358 -64; PMID:19258515 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Nat Biotechnol  2008 ; 26:925-32; PMID:18641636 ;  http://dx.doi.org/10.1038/nbt.1480 17.,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
J Clin Oncol 2003 ; 21:211- 22; PMID:12525512 ; http://dx.doi.org/10.1200/ JCO.2003.05.137 18.,Non-OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Proc Natl Acad Sci U S A 2009 ; 106:3000 - 5; PMID:19202059 ; http://dx.doi.org/10.1073/ pnas.0807820106 21.,OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Curr Opin Chem Biol  2010 ; 14:790-6; PMID:21030291 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Angew Chem  Int Ed Engl 2012 ; 51:4161 -5; PMID:22407566 ;  http://dx.doi.org/10.1002/anie.201108130 23.,OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Nat Protoc   2012 ; 7:1052 -67; PMID:22576105 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
Bioconjug Chem  2013 ; 24:846-51; PMID:23731037 ;  http://dx.doi.org/10.1021/bc400042a,OADS,/arxiv_data1/oa_pdf/0a/10/mabs-6-18.PMC3929441.pdf
"27  These in vitro evolution strategies imitate natural B cell affinity maturation in lymphoid organs, but they usually require small recombinant antibody fragments in order to obtain functional expression in E. coli  and display on phage, yeast 22 or ribosomes.41  *Correspondence to: Thomas Schirrmann; Email: th.schirrmann@tu-bs.de Submitted: 09/30/2013; Revised: 11/13/2013; Accepted: 11/15/2013http://dx.doi.org/10.4161/mabs.27227The influence of antibody fragment format   on phage display based affinity maturation of IgG Miriam Steinwand1, Patrick Droste1, André Frenzel1, Michael Hust1, Stefan Dübel1 and Thomas Schirrmann1,* 1Technische Universität Braunschweig; Institut für Biochemie, Biotechnologie, und Bioinformatik; Braunschweig, Germany;  Keywords:  phage display, antibody engineering, scFv fragment, scFab fragment, affinity maturation, therapeutic antibody,  mutagenesis, CD30, Hodgkin lymphoma, antibody library Today, most approved therapeutic antibodies are provided as immunoglobulin G (IgG), whereas small recombinant  antibody formats are required for in vitro antibody generation and engineering during drug development.",Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Proc Natl Acad Sci U S A 1995; 92:1254-6;  PMID:7877964 ; http://dx.doi.org/10.1073/ pnas.92.5.1254 2.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Immunity  1998 ;  8:751-9; PMID:9655489 ; http://dx.doi.org/10.1016/ S1074-7613(00)80580-4 3.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Infect Dis  1999 ; 180:35-40; PMID:10353858 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Nat  Biotechnol  2002 ; 20:597-601; PMID:12042864 ;  http://dx.doi.org/10.1038/nbt0602-597 5.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
AAPS J 2008 ; 10:425- 30; PMID:18686041 ; http://dx.doi.org/10.1208/ s12248-008-9045-4 6.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Mol Biol  2007 ; 368:652-65; PMID:17362988 ;  http://dx.doi.org/10.1016/j.jmb.2007.02.024 7.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Protein Eng Des Sel  2004 ; 17:847-60;  PMID:15708864 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Protein Eng Des Sel  2009 ; 22:175-88; PMID:19022801 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Nature   1990 ; 348:552-4; PMID:2247164 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Nature  1991 ; 352:624-8; PMID:1907718 ;  http://dx.doi.org/10.1038/352624a014.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Nucleic Acids Res 1991 ; 19:4133 - 7; PMID:1908075 ; http://dx.doi.org/10.1093/ nar/19.15.4133 15.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Genome Biol  2007 ; 8:R254 ;  PMID:18047641 ; http://dx.doi.org/10.1186/ gb-2007-8-11-r254 16.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Trends Biotechnol  2010 ; 28:333- 9; PMID:20538360 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Biotechnol  2011 ;  152:159-70; PMID:20883731 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Immunol Rev  1992 ; 130:109-24; PMID:1286867 ;  http://dx.doi.org/10.1111/j.1600-065X.1992.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
PLoS One  2011 ; 6:e15921 ;  PMID:21264246 ; http://dx.doi.org/10.1371/ journal.pone.0015921 20.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Proc Natl Acad Sci U S A  1998 ; 95:14130 -5; PMID:9826665 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Biotechnol   2009 ; 144:253-8; PMID:19818816 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Bioconjug Chem  2007 ;  18:947-55; PMID:17352456 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Methods Mol Biol  2009 ;  504:351-83; PMID:19159106 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Protein Eng  1998 ; 11:825- 32; PMID:9796833 ; http://dx.doi.org/10.1093/ protein/11.9.825 25.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Immunotechnology  1996 ; 2:127-43; PMID:9373321 ;  http://dx.doi.org/10.1016/1380-2933(96)00044-9 29.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Mol Biol  1996 ;  260:359- 68; PMID:8757799 ; http://dx.doi.org/10.1006/ jmbi.1996.0406 30.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Methods Mol Biol  2012 ;  805:139-61; PMID:22094805 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Mol Biol   1995 ; 254:392-403; PMID:7490758 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Gene  1993 ;  137:109-18; PMID:7506686 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Proc Natl Acad Sci U S  A 2001 ; 98:75-80; PMID:11134506 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Mol Biol   1996 ; 255:28-43; PMID:8568873 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Biochem  2008 ; 143:593-601;  PMID:18216066 ;  http://dx.doi.org/10.1093/jb/ mvn009 39.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Anal Chem  2010 ; 82:1027 -38; PMID:20047279 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Biotechnology (N Y) 1992 ; 10:779- 83; PMID:1368267 ; http://dx.doi.org/10.1038/ nbt0792-779 41.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Nucleic Acids Res 1997 ; 25:5132 - 4; PMID:9396828 ; http://dx.doi.org/10.1093/ nar/25.24.5132,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
BMC Biotechnol   2007 ; 7:14; PMID:17346344 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
MAbs  2010 ; 2:73- 6; PMID:20081378 ; http://dx.doi.org/10.4161/ mabs.2.1.10784 45.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
BMC Biotechnol   2013 ; 13:52; PMID:23802841 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Immunol Methods  1995 ; 184:177-86; PMID:7658022 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Nat Biotechnol   1999 ; 17:276-81; PMID:10096296 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Mol  Med (Berl) 2007 ; 85:1113 -23; PMID:17554518 ;  http://dx.doi.org/10.1007/s00109-007-0208-z 49.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Antibodies  2012 ; 1:19-38; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Blood  2008 ; 111:3830 - 7; PMID:18230757 ; http://dx.doi.org/10.1182/ blood-2007-04-082768 51.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Immunol Methods  2004 ; 289:65-80; PMID :15251413 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
MAbs  2012 ; 4:341- 8; PMID:22531438 ; http://dx.doi.org/10.4161/ mabs.19981 54.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Microb Cell  Fact 2007 ; 6:38; PMID:18042285 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
N Biotechnol   2009 ; 26:314-21; PMID:19631299 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
BMC Biotechnol  2008 ; 8:66; PMID:18764933 ;  http://dx.doi.org/10.1186/1472-6750-8-66 59.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Antimicrob Agents Chemother  2007 ; 51:2758 - 64; PMID:17517846 ; http://dx.doi.org/10.1128/ A AC.01528-06 61.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
PLoS One  2009 ; 4:e6625 ;  PMID:19675673 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Immunol  Methods  2000 ; 242:101-14; PMID:10986393 ;  http://dx.doi.org/10.1016/S0022-1759(00)00243-X63.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Proc Natl Acad Sci U S A 2002 ; 99:11346 - 50; PMID:12177434 ; http://dx.doi.org/10.1073/ pnas.172229899 64.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Biomed Biotechnol  2012 ;  2012 :597647 ; PMID:23226940 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Nat Biotechnol  1997 ; 15:768-71;  PMID:9255792 ; http://dx.doi.org/10.1038/ nbt0897-768 66.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Nucleic Acids Res 2002 ;  30:E9; PMID:11788735 ; http://dx.doi.org/10.1093/ nar/30.2.e9 67.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
Nat Biotechnol  2001 ; 19:75-8;  PMID:11135557 ; http://dx.doi.org/10.1038/83567 70.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
N Biotechnol  2009 ; 25:424-8;  PMID:19552889 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
J Immunol Methods 2007 ; 318:113- 24; PMID:17161420 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/5b/18/mabs-6-204.PMC3929444.pdf
"Currently, there are  *Correspondence to: Jamshid Tanha; E-mail: jamshid.tanha@nrc-cnrc.gc.ca Submitted: 09/11/2013; Revised: 10/15/2013; Accepted: 10/16/2013http://dx.doi.org/10.4161/mabs.26844Antibody light chain variable domains   and their biophysically improved versions   for human immunotherapy Dae y oung Kim1, rebecca To1, Hiba Kandalaft1, Wen Ding1, Henk van Faassen1, yan Luo1,†, Joseph D Schrag2,   Nadereh St- amant3,‡, Mary Hefford3, Tomoko Hirama1,§, John F Kelly1, roger MacKenzie1,4, and Jamshid Tanha1,4,5,* 1Human Health Therapeutics; National r esearch Council Canada; o ttawa, o N Canada; 2Human Health Therapeutics; National r esearch Council Canada; Montréal, QC Canada;  3Centre for Vaccine e valuation; Biologics and Genetic Therapies Directorate; Health Canada; o ttawa, o N Canada; 4School of e nvironmental Sciences; o ntario a gricultural  College; University of Guelph; Guelph, o N Canada; 5Department of Biochemistry, Microbiology, and Immunology; University of o ttawa; o ttawa, o N Canada Current affiliation: †Caprotec Bioanalytics GmbH; Berlin, Germany; ‡Canadian Nuclear Safety Commission;  ottawa, o N Canada; §5-2301 Kotesashicho 1-chome; Tokorozawa, Japan Keywords:  VL, single-domain antibody, disulfide linkage, thermal stability, protease resistance Abbreviations:  CDR, complementarity-determining region; CID, collision induced dissociation; DDA, data dependent analysis;  ETD, electron transfer dissociation; Fab, fragment antigen-binding; FR, framework region; HBS-EP buffer, 10 mM HEPES, pH  7.4, 150 mM NaCl, 3 mM EDTA and 0.005% P20 surfactant; GI, gastrointestinal; KD, equilibrium dissociation constant; MALS,  multiangle light scattering; Mapp, apparent molecular mass; Mfor, formula molecular mass; MMALS, molecular mass determined  by MALS; MS, mass spectrometry; RU, resonance unit; sdAb, single-domain antibody; SEC, size-exclusion chromatography;  scFv, single chain Fv fragment of an antibody; SPR, surface plasmon resonance; Tm, melting temperature; TRE, thermal refolding  efficiency; VH, antibody heavy chain variable domain; VHH, camelid heavy chain antibody variable domain; VL, antibody light  chain variable domain; VNAR, shark IgNAR (Ig New Antigen Receptor) variable domain We set out to gain deeper insight into the potential of antibody light chain variable domains (VLs) as immunothera - peutics.",Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
"The first  two complementarity-determining regions (CDR1 and CDR2) and a part of the CDR3 up to residue 95 are encoded by V L  segment genes; the rest of the CDR3 and the entire framework region (FR) 4 are encoded by J L gene segments.35 Human VLs  are classified as either κ or λ  subtypes, with seven Vκ gene seg - ment subgroups (Vκ1–7) within the κ  class and 11 Vλ gene seg - ment subgroups (Vλ1–11) within the λ class (http://www.imgt.",Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
See V B aSe (http://vbase.mrc-cpe.cam.ac.uk/index.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Protein homology structures were obtained using the Geno3D automatic modeling tool (http://pbil.ibcp.fr/htm/index.php).,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Theoretical numbers of pro - tease cleavage sites were determined by a protease digestion prediction webware (http://web.expasy.org/peptide_cutter).,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
The figures were drawn with PyM oL (http://www.pymol.org) and  manipulated using a dobe Photoshop CS2 software.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Nat Biotechnol 2013; 31:8;  PMID:23302914 ; http://dx.doi.org/10.1038/ nbt0113-8 2.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Nat Biotechnol  2009; 27:331-7;  PMID:19352366 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Nat Biotechnol  2005; 23:1126-36;  PMID:16151406 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Trends Biotechnol 2003; 21:484-90;  PMID:14573361 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Virol  2013; 87:1137-49;  PMID :23152508 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
PLoS One 2012; 7:e29941;  PMID:22238680 ; http://dx.doi.org/10.1371/jour - nal.pone.0029941 9.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Exp Cell Res 2012; 318:1112-24; PMID:22440788 ;  http://dx.doi.org/10.1016/j.yexcr.2012.03.00410.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
PLoS One 2011; 6:e28309; PMID:22164266 ; http://dx.doi.org/10.1371/jour - nal.pone.0028309 11.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
PLoS One 2011; 6:e26754; PMID:22046343 ;  http://dx.doi.org/10.1371/journal.pone.0026754 12.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Anal Biochem  2011; 415:158-67;  PMID :21569755 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
PLoS One  2011; 6:e26299;  PMID:22022593 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
FASEB J 2010; 24:3479- 89; PMID:20410443 ; http://dx.doi.org/10.1096/ fj.09-148213 16.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Protein Eng Des Sel 2009; 22:273-80;  PMID:19196718 ; http://dx.doi.org/10.1093/protein/ gzp00217.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Mol Immunol 2009; 46:1718-26; PMID:19269688 ;  http://dx.doi.org/10.1016/j.molimm.2009.02.007 18.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Biochem J 2009; 424:263-72;  PMID:19732033 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Mol Biol 2007; 373:941-53; PMID:17888451 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Biol Chem 2006; 281:10706-14; PMID:16481314 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Proc Natl Acad Sci U S A 2004; 101:17616-21;  PMID:15598740 ; http://dx.doi.org/10.1073/ pnas.0408134101,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Cancer Res 2004; 64:2853-7;  PMID:15087403 ; http://dx.doi.org/10.1158/0008- 5472.CAN-03-3935 25.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Proteins  2004; 55:187-97;  PMID:14997552 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Eur J Biochem 2003; 270:3543-54; PMID:12919318 ;  http://dx.doi.org/10.1046/j.1432-1033.2003.03737.x 28.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Mol Biol 2003; 331:1109-20; PMID:12927545 ;  http://dx.doi.org/10.1016/S0022-2836(03)00836-2 29.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Immunotechnology 1996; 2:169-79;  PMID:9373310 ;  http://dx.doi.org/10.1016/S1380-2933(96)00045-0 30.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Cancer  Metastasis Rev 2005; 24:501-19; PMID:16408159 ;  http://dx.doi.org/10.1007/s10555-005-6193-1 31.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Protein Eng Des  Sel 2012; 25:313-8; PMID:22490957 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Mol Biol 2003; 325:531-53;  PMID:12498801 ; http://dx.doi.org/10.1016/ S0022-2836(02)01237-8 34.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Exp Clin Immunogenet 2001; 18:242-54;  PMID:11872955 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Exp Clin Immunogenet  2001; 18:161-74;  PMID :11549845 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Mol Biol 2000; 296:57-86;  PMID:10656818 ; http://dx.doi.org/10.1006/ jmbi.1999.3444 39.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
"Viau M, Longo NS, Lipsky PE, Björck L, Zouali M. Specific in vivo deletion of B-cell subpopu - lations expressing human immunoglobulins by the B-cell superantigen protein L. Infect Immun  2004 ; 72:3515-23 ;  PMID :15155659 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Immunol Methods 1994;  177:151-63 ;  PMID:7822821 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
"J Mol Biol 1994; 242:309-20;  PMID:7932691 ; http://dx.doi.org/10.1016/ S0022-2836(84)71582-8 43.Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller  C. Sequences of Proteins of Immunological Interest,  5th ed., National Institutes of Health Publication  91-3242, National Institutes of Health, Bethesda,  MD 1991.",OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Mol Biol 1982; 160:325-42; PMID:7175935 ;  http://dx.doi.org/10.1016/0022-2836(82)90179-6 45.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Annu Rev Biochem 1979; 48:961-97;  PMID:89832 ; http://dx.doi.org/10.1146/ annurev.bi.48.070179.004525 46.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
PLoS One  2011; 6:e28218;  PMID:22140551 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Mol Biol 2008; 377:478-88; PMID:18262543 ;  http://dx.doi.org/10.1016/j.jmb.2008.01.022 51.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Biochemistry 2008; 47:11041-54;  PMID:18816062 ;  http://dx.doi.org/10.1021/bi8005797 52.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J  Biol Chem 2007; 282:36489-95; PMID:17932041 ;  http://dx.doi.org/10.1074/jbc.M70707820053.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Nat Biotechnol 2004; 22:1161-5; PMID :15300256 ; http://dx.doi.org/10.1038/ nbt1000 54.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Methods Mol Biol  2010; 634:309-30;  PMID:20676993 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Protein Eng Des Sel 2009; 22:59-66; PMID:19033278 ; http://dx.doi.org/10.1093/ protein/gzn071 56.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Anal Chem 2009; 81:112-22; PMID:19117448 ;  http://dx.doi.org/10.1021/ac801560k 57.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Mol Biol 2011; 414:337- 55; PMID:21968397 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Mol Cancer Ther  2005; 4:1801-9;  PMID:16276002 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Mol Biol  2004; 342:901-12;  PMID :15342245 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Mol Biol 2001; 310:591-601; PMID:11439026 ;  http://dx.doi.org/10.1006/jmbi.2001.4703 62.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Mol Biol 2005; 347:107- 20; PMID:15733921 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Biol Chem  2004; 279:9370-8;  PMID:14668335 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Structure  2001; 9:679-87;  PMID :11587642 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Proc Natl Acad Sci U S A 1980; 77:1144-8; PMID:6767243 ; http://dx.doi.org/10.1073/ pnas.77.2.1144 68.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Protein Eng Des Sel 2012; 25:39-46;  PMID:22143875 ; http://dx.doi.org/10.1093/ protein/gzr057 70.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Protein  Eng Des Sel 2006; 19:503-9; PMID:16971398 ;  http://dx.doi.org/10.1093/protein/gzl03771.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Biochemistry  2004; 43:2445-57;  PMID:14992582 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Mol Biol  2008; 376:926-31;  PMID:18199455 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Protein  Eng 1998; 11:349-59; PMID:9681867 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Protein Eng 1993; 6:637-42;  PMID:8234234 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Protein  Eng Des Sel 2007; 20:413-6; PMID:17720749 ;  http://dx.doi.org/10.1093/protein/gzm037 76.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Protein Eng Des Sel 2013; 26:151- 64; PMID:23173178 ; http://dx.doi.org/10.1093/ protein/gzs09077.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
J Biol Chem 1999; 274:18218-30; PMID:10373423 ;  http://dx.doi.org/10.1074/jbc.274.26.18218 78.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Immunotechnology 1998; 3:271-8;  PMID:9530560 ;  http://dx.doi.org/10.1016/S1380-2933(97)10004-5 79.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
Bioinformatics 2003; 19:1852- 3; PMID:14512360 ; http://dx.doi.org/10.1093/ bioinformatics/btg231 81.,OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
PLoS One 2012; 7:e30149;  PMID:22253912 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/68/7e/mabs-6-219.PMC3929445.pdf
"12-15  Orthosteric INSR autoantibodies isolated from humans have been studied in rats, and have been shown to be weak agonists  *Correspondence to: John A Corbin; Email: corbinjohn@gmail.com Submitted: 08/05/2013; Revised: 10/17/2013; Accepted: 10/18/2013http://dx.doi.org/10.4161/mabs.26871Inhibition of insulin receptor function by a human,  allosteric monoclonal antibody A potential new approach for the treatment  of hyperinsulinemic hypoglycemia John A Corbin1,*, Vinay Bhaskar1, Ira D Goldfine2, Hassan Issafras1, Daniel H Bedinger1, Angela Lau1, Kristen Michelson1,   Lisa M Gross1, Betty A Maddux2, Hua F Kuan1, Catarina Tran1, Llewelyn Lao1, Masahisa Handa1, Susan r Watson1,   Ajay J Narasimha1, Shirley Zhu1, raphael Levy1, Lynn Webster1, Sujeewa D Wijesuriya1, Naichi Liu1, Xiaorong Wu1,   David Chemla-Vogel1, Steve r Lee1, Steve Wong1, Diane Wilcock1, Paul r ubin1, and Mark L White1 1Preclinical r esearch; XOMA Corporation; Berkeley, CA USA; 2Department of Medicine; University of California; San Francisco, CA USA Keywords:  hypoglycemia, negative allosteric modulation, monoclonal antibody, insulin receptor, insulin, antagonist Novel therapies are needed for the treatment of hypoglycemia resulting from both endogenous and exogenous  hyperinsulinema.",Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Nat Rev Mol Cell Biol 2006; 7:85-96; PMID :16493415 ; http://dx.doi.org/10.1038/ nrm1837 2.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Biol Pharm Bull  2007; 30:1610-6;  PMID:17827708 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Annu Rev Biochem 1986; 55:1059-89;  PMID:3527041 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Sci Transl Med 2011; 3:13ps47;  PMID:22174312 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
J Clin Endocrinol Metab  2009; 94:709-28;  PMID :19088155 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
N Engl J Med 2011; 365:2002- 12; PMID:22111719 ; http://dx.doi.org/10.1056/ NEJMsa1103053 8.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
N Engl J Med 1995; 332:1144-52;  PMID:7700289 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Medicine (Baltimore) 2009; 88:141- 53; PMID:19440117 ; http://dx.doi.org/10.1097/ MD.0b013e3181a5b42e 13.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Diabetologia 1978;  14:311-7;  PMID:648762 ; http://dx.doi.org/10.1007/ BF0122302214.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Diabetes 1984; 33:301-4;   PMID:6365664 ; http://dx.doi.org/10.2337/ diab.33.3.301 15.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Medicine (Baltimore)  2002; 81:87-100;  PMID:11889410 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
J Clin Invest  1983; 72:1072-80;  PMID:6350362 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Br J Pharmacol 2011;  162:947-60;  PMID:21039416 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Nat Struct Mol Biol 2011; 18:437-42;  PMID:21378967 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Annu Rev Pharmacol Toxicol 2007; 47:1-51; PMID:17009927 ; http://dx.doi.org/10.1146/ annurev.pharmtox.47.120505.105159 20.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Cell Mol Life Sci 2009; 66:2721-32; PMID:19554259 ; http://dx.doi.org/10.1007/ s00018-009-0065-8 21.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Ann N Y Acad Sci 2009; 1160:45-53; PMID :19416158 ;  http://dx.doi.org/10.1111/j.1749-6632.2009.03837.x 22.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Trends  Biochem Sci 2008; 33:376-84; PMID:18640841 ;  http://dx.doi.org/10.1016/j.tibs.2008.06.003 23.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
J Biol Chem 2007;  282:35179-86;  PMID:17925406 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Diabetes 2012; 61:1263- 71; PMID:22403294 ; http://dx.doi.org/10.2337/ db11-1578 25.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Diabetes Obes Metab  2013 ; 15:272-5;  PMID:23039274 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Diabetes 2012; 61:984-5;  PMID:22517652 ; http://dx.doi.org/10.2337/ db12-0192 27.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Pharmacol Rev  2002; 54:323-74;  PMID:12037145 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
J Clin Invest 1980; 66:1124-34;  PMID:7000825 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Diabetes 1985; 34:205- 11; PMID:3882486 ; http://dx.doi.org/10.2337/ diab.34.3.205 30.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Endocr Rev 2009; 30:586- 623; PMID:19752219 ; http://dx.doi.org/10.1210/ er.2008-0047 33.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Front Endocrinol (Lausanne) 2012; 3:21;  PMID:22649410 ; http://dx.doi.org/10.3389/ fendo.2012.00021 34.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
J Biol Chem 2010; 285:20607-14;  PMID:20410301 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
World J Diabetes 2010; 1:68-75;  PMID :21537430 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
World J Surg 2005; 29:789-93;  PMID:15880279 ; http://dx.doi.org/10.1007/ s00268-005-7743-y 38.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Semin Fetal  Neonatal Med 2005; 10:369-76; PMID:15916932 ;  http://dx.doi.org/10.1016/j.siny.2005.03.001 40.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Early Hum Dev 2010; 86:287- 94; PMID:20550977 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Clin Chem  2008; 54:256-63;  PMID :18156285 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
J Clin Endocrinol Metab 2005; 90:789-94; PMID :15562009 ; http://dx.doi.org/10.1210/ jc.2004-1604 43.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Blood  2003; 102:2156-64;  PMID:12791668 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Mol Endocrinol  1989; 3:1263-9;  PMID:2779582 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Anal Biochem 2006; 358:281- 8; PMID:16962556 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Anal Biochem 2011; 411:139-51;  PMID:21168382 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Methods Mol Biol  2009; 503:65-88;  PMID:19151937 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
Biochem Biophys Res Commun  1989; 165:212-8;  PMID:2556135 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/04/mabs-6-262.PMC3929448.pdf
"Following internalization, the ADC must Review of Antibody-Drug Conjugates,   Methods in Molecular Biology series A book edited by Laurent Ducry Alain Beck Centre d’Immunologie Pierre Fabre; St Julien-en-Genevois, France Keywords:  antibody-drug conjugate,  cytotoxic drug, drug-to-antibody  ratio, hydrophobic interaction chro - matography, linker, mass spectrom - etry, site-directed conjugation Correspondence to: Alain Beck; Email:  alain.beck@pierre-fabre.com Submitted: 10/29/2013; Accepted: 10/29/2013http://dx.doi.org/10.4161/mabs.27005",Non-OADS,/arxiv_data1/oa_pdf/87/54/mabs-6-30.PMC3929452.pdf
"7  These compounds target cancer cells but also other dividing cells in the body, and patients receiving treatment experience severe side *Correspondence to: Jagath R Junutula; Email: jagath@gene.com Submitted: 09/20/2013; Revised: 10/30/2013; Accepted: 10/31/2013http://dx.doi.org/10.4161/mabs.27022Site-specific antibody drug conjugates   for cancer therapy Siler Panowski, Sunil Bhakta, Helga r aab, Paul Polakis and Jagath r  Junutula* Genentech, Inc; South San Francisco, CA USA Keywords:  site-specific conjugation, antibody drug conjugate, THIOMAB, internalization, tumor antigen, linker, cytotoxic drug Antibody therapeutics have revolutionized the treatment of  cancer over the past two decades.",Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Semin Cancer  Biol 2012; 22:3-13; PMID:22245472 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Nat Biotechnol 2005; 23:1073-8; PMID :16151394 ;  http://dx.doi.org/10.1038/nbt0905-1073 3.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Cancer Sci 2009;  100:1566-72;  PMID:19538497 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Curr Opin Pharmacol 2005; 5:543-9;  PMID:16087399 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Curr Opin Chem Biol 2009; 13:235-44; PMID:19414278 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Nat  Biotechnol 2005; 23:1137-46; PMID:16151407 ;  http://dx.doi.org/10.1038/nbt1141 7.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Cancer Res 2008; 68:8643-53; PMID:18974103 ;  http://dx.doi.org/10.1158/0008-5472.CAN-07-6611 8.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Curr Opin Oncol 2001; 13:522-7;  PMID:11673694 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Nat Biotechnol 2012; 30:631- 7; PMID:22781692 ; http://dx.doi.org/10.1038/ nbt.2289 18.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Cancer Res 2008; 68:9280-90; PMID:19010901 ; http://dx.doi.org/10.1158/0008- 5472.CAN-08-1776 19.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
MAbs 2013; 5:13-21; PMID:23221464 ;  http://dx.doi.org/10.4161/mabs.22854 20.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Annu Rev Med 2013; 64:15- 29; PMID:23043493 ; http://dx.doi.org/10.1146/ annurev-med-050311-201823 21.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Cancer Res 2006; 66:3214-21;  PMID:16540673 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Curr Cancer Drug Targets 2009; 9:982- 1004;  PMID:20025606 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Acc Chem Res 2008; 41:98- 107; PMID:17705444 ; http://dx.doi.org/10.1021/ ar700108g,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
J Pharmacol Exp Ther 2009; 330:932- 8; PMID:19498104 ; http://dx.doi.org/10.1124/ jpet.109.155549 25.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Leukemia 2010; 24:1566- 73; PMID:20596033 ; http://dx.doi.org/10.1038/ leu.2010.141 26.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Cancer J 2008; 14:154-69; PMID:18536555 ; http://dx.doi.org/10.1097/ PPO.0b013e318172d704 27.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Bioconjug Chem 2010; 21:5-13; PMID:19769391 ;  http://dx.doi.org/10.1021/bc9002019 28.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Cancer Res  2009; 69:2358-64;  PMID:19258515 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
J Natl Cancer Inst 2012; 104:622-34;  PMID:22457476 ; http://dx.doi.org/10.1093/jnci/ djs140 31.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Nat Biotechnol 2003; 21:778-84;  PMID:12778055 ; http://dx.doi.org/10.1038/nbt832 32.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Blood  2009; 113:4352-61;  PMID:19147785 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
J Am Chem Soc  1972; 94:1354-6;  PMID:5062169 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Science 1975; 189:1002- 5; PMID :1241159 ; http://dx.doi.org/10.1126/ science.1241159 35.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Proc Natl Acad Sci U  S A 1995; 92:3642-9; PMID:7731958 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Bioanalysis 2013; 5:1025-40; PMID:23641694 ;  http://dx.doi.org/10.4155/bio.13.72 42.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Nat Biotechnol 2008; 26:925-32; PMID:18641636 ;  http://dx.doi.org/10.1038/nbt.1480 44.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Protein Eng Des Sel 2006; 19:299- 307; PMID:16644914 ; http://dx.doi.org/10.1093/ protein/gzl013 45.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
J Virol 2003; 77:4546-57; PMID:12663761 ;  http://dx.doi.org/10.1128/JVI.77.8.4546-4557.2003 47.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
J Immunol Methods  2008; 332:41-52;  PMID:18230399 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Bioconjug Chem 2011;  22:1994-2004;  PMID :21913715 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Nat Biotechnol 2012; 30:184-9; PMID:22267010 ;  http://dx.doi.org/10.1038/nbt.210851.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Science 2003; 300:1439-43; PMID:12775843 ;  http://dx.doi.org/10.1126/science.1083516 52.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Cell Mol Life Sci 2006; 63:73-81; PMID:16416259 ;  http://dx.doi.org/10.1007/s00018-005-5402-y 53.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Biochemistry 2009;  48:12047-57;  PMID:19894757 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Nat Methods 2007; 4:239- 44; PMID:17322890 ; http://dx.doi.org/10.1038/ nmeth1016 55.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Proc Natl Acad Sci U S A 2003; 100:56-61;  PMID:12518054 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Proc Natl Acad Sci U S A 2012; 109:16101- 6; PMID:22988081 ; http://dx.doi.org/10.1073/ pnas.1211023109 57.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
J Mol Biol 2010; 395:361-74; PMID:19852970 ;  http://dx.doi.org/10.1016/j.jmb.2009.10.030 58.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Proc Natl Acad Sci U S A 2002; 99:19-24; PMID:11752401 ; http://dx.doi.org/10.1073/ pnas.012583299 59.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Trends Biochem Sci 2005; 30:53-62; PMID:15653326 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
J Biol Chem 2002; 277:20833-9;  PMID:11916963 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Bioconjug Chem  2009; 20:1228-36;  PMID:19425533 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Appl Microbiol  Biotechnol 2004; 64:447-54; PMID:14740191 ;  http://dx.doi.org/10.1007/s00253-003-1539-5 64.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Angew Chem Int Ed Engl  2010; 49:9995-7;  PMID:21110357 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Chem Biol 2013; 20:161- 7; PMID:23438745 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Org  Biomol Chem 2009; 7:3361-71; PMID:19675886 ;  http://dx.doi.org/10.1039/b908687k 67.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Nat Protoc  2012; 7:1052-67;  PMID:22576105 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Nucl Med Biol 2010; 37:289-97; PMID:20346868 ;  http://dx.doi.org/10.1016/j.nucmedbio.2009.11.010 71.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Adv Drug Deliv Rev 2007; 59:141-52; PMID:17434235 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Int J Antimicrob Agents 2009; 33:14- 20; PMID:18778918 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Hybridoma  1991; 10:347-56;  PMID:1916847 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Mol Immunol  1991; 28:1027-37;  PMID:1922108 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
Immunobiology  2009; 214:800-10;  PMID:19625102 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/77/kmab-06-01-10927022.PMC3929453.pdf
"For brentuximab vedotin, the thiols  *Corresponding author: Bin Liu; Email: liub@anesthesia.ucsf.edu Submitted: 09/03/2013; Revised: 09/24/2013; Accepted: 09/26/2013http://dx.doi.org/10.4161/mabs.26632Methods for site-specific drug conjugation   to antibodies Christopher r  Behrens and Bin Liu* Department of Anesthesia; UCSF Helen Diller Family Comprehensive Cancer Center; University of California at San Francisco; San Francisco, CA USA Keywords:  site-specific, antibody drug conjugate, ADC, targeted cancer therapy,  therapeutic index, THIOMAB, transglutaminase, unnatural amino acids Abbreviations : ADC, antibody drug conjugate; VC, valine citrulline; TDC, THIOMAB drug conjugate;  MMAE, monomethylauristatin E; MMAD, monomethyl dolastatin 10; LC-MS, liquid chromatography- mass spectrometry; ESI-MS, electrospray ionization mass spectrometry; AUC, area under the curve Antibody drug conjugates (ADCs) are an emerging class  of targeted therapeutics with the potential to improve  therapeutic index over traditional chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Nat Rev Cancer 2005; 5:65- 72;  PMID:15630416 ; http://dx.doi.org/10.1038/ nrc1529 .,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Nat Rev Cancer 2006; 6:583- 92;  PMID:16862189 ; http://dx.doi.org/10.1038/ nrc1893 .,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Nat  Biotechnol 2005; 23:1137-46;  PMID:16151407 ;  http://dx.doi.org/10.1038/nbt1141 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Proc Natl Acad Sci USA 1988; 85:1189- 93;  PMID:3422487 ; http://dx.doi.org/10.1073/ pnas.85.4.1189 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Methods Mol Biol 2013;  1045:71-100;  PMID:23913142 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
MAbs 2013; 5:5-12;  PMID:23255090 ;  http://dx.doi.org/10.4161/mabs.22909 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Annu Rev Med 2013; 64:15- 29;  PMID:23043493 ; http://dx.doi.org/10.1146/ annurev-med-050311-201823 .12.,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Acc Chem Res 2008;  41:98-107;  PMID:17705444 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Methods Mol Biol 2013; 1045:41-9;  PMID:23913140 ;  http://dx.doi.org/10.1007/978-1-62703-541-5_3 .,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Methods Mol Biol 2013; 1045:29-40;  PMID:23913139 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Nat Prod Rep  2013; 30:625-39;  PMID:23525375 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Cancer J 2008; 14:154-69;   PMID:18536555 ; http://dx.doi.org/10.1097/ PPO.0b013e318172d704 .,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Bioconjug Chem 2010; 21:5-13;  PMID:19769391 ;  http://dx.doi.org/10.1021/bc9002019 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Chem Biol  2010; 17:213-27;  PMID:20338513 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Nat Biotechnol 2012; 30:631- 7;  PMID:22781692 ; http://dx.doi.org/10.1038/ nbt.2289 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
MAbs 2012; 4:458-65;  PMID:22684302 ;  http://dx.doi.org/10.4161/mabs.20230 .,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Bioconjug Chem 2002; 13:855-69;   PMID:12121142 ; http://dx.doi.org/10.1021/ bc025536j .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Nat Biotechnol 2003; 21:778- 84;  PMID:12778055 ; http://dx.doi.org/10.1038/ nbt832 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Bioconjug Chem 2005; 16:1282- 90;  PMID:16173809 ; http://dx.doi.org/10.1021/ bc050201y .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Cancer Chemother Pharmacol  2007; 60:423-35;  PMID :17541593 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Clin Cancer Res  2006; 12:2591-6;  PMID:16638870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Mol Cancer Ther  2013; 12:1255-65;  PMID:23598530 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Mol  Cancer Ther 2013; 12:968-78;  PMID:23427296 ;  http://dx.doi.org/10.1158/1535-7163.MCT-12-1170 .32.,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Cancer Res  2008; 68:9280-90;  PMID:19010901 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Protein Sci 2005; 14:2436-46;   PMID:16081651 ; http://dx.doi.org/10.1110/ ps.051478705 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Nat  Biotechnol 2008; 26:925-32;  PMID:18641636 ;  http://dx.doi.org/10.1038/nbt.1480 .,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Cancer Res 2004; 64:4629-36;  PMID :15231675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Clin Cancer Res 2009; 15:4028-37;   PMID:19509164 ; http://dx.doi.org/10.1158/1078- 0432.CCR-08-2867 .,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Clin Cancer Res 2011; 17:6448-58;   PMID:22003072 ; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0485 .,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Clin Cancer Res 2004;  10:7063-70;  PMID:15501986 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Bioconjug Chem 2008; 19:759-65;  PMID:18314937 ; http://dx.doi.org/10.1021/ bc7004329 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Chem Asian  J 2009; 4:630-40;  PMID:19235822 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Clin Cancer Res 2010;  16:4769-78;  PMID:20805300 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Nat Biotechnol 2012; 30:184-9;  PMID:22267010 ;  http://dx.doi.org/10.1038/nbt.2108 .44.,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Blood 2013; 122:1455- 63;  PMID:23770776 ; http://dx.doi.org/10.1182/ blood-2013-03-491506 .,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Chem Biol 2013; 20:161- 7;  PMID:23438745 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Nat  Rev Mol Cell Biol 2003; 4:140-56;  PMID:12563291 ;  http://dx.doi.org/10.1038/nrm1014 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Angew Chem Int Ed Engl  2010; 49:9995-7;  PMID:21110357 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
J Agric Food Chem 2000;  48:6230-3;  PMID:11141280 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Curr  Opin Chem Biol 2013; 17:412-9;  PMID:23664497 ;  http://dx.doi.org/10.1016/j.cbpa.2013.04.017 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Angew Chem Int Ed Engl 2009; 48:6974-98;   PMID:19714693 ; http://dx.doi.org/10.1002/ anie.200900942 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Biochemistry 2009; 48:6571- 84;  PMID:19485420 ; http://dx.doi.org/10.1021/ bi9007726 .,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Science 2001; 292:498-500;  PMID:11313494 ;  http://dx.doi.org/10.1126/science.1060077 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Angew Chem Int Ed Engl 2004; 44:34- 66;  PMID:15599909 ; http://dx.doi.org/10.1002/ anie.200460627 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Prog Phys Org Chem 1964; 2:63-128; http://dx.doi.org/10.1002/9780470171813.ch2 56.,Non-OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Angew Chem Int Ed Engl 2008; 47:7523- 6;  PMID:18712739 ; http://dx.doi.org/10.1002/ anie.200802651 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
Bioconjug Chem 2006; 17:114- 24;  PMID:16417259 ; http://dx.doi.org/10.1021/ bc0502917 .,OADS,/arxiv_data1/oa_pdf/cd/58/mabs-6-46.PMC3929454.pdf
2013. http://dx.doi.org/10.1787/9789264 191655-en .,Non-OADS,/arxiv_data1/oa_pdf/7e/d8/40271_2013_Article_36.PMC3929769.pdf
2006. http://www.deakin.edu.au/research/acqol/instruments/ wellbeing_index.htm .,OADS,/arxiv_data1/oa_pdf/7e/d8/40271_2013_Article_36.PMC3929769.pdf
2011 http://www.ons.,Non-OADS,/arxiv_data1/oa_pdf/7e/d8/40271_2013_Article_36.PMC3929769.pdf
2012. http://www.buseco.monash.edu.au/ centres/che/che-publications.html .,Non-OADS,/arxiv_data1/oa_pdf/7e/d8/40271_2013_Article_36.PMC3929769.pdf
http://www.buseco.monash.edu.au/centres/che/pubs/researchpaper76.,Non-OADS,/arxiv_data1/oa_pdf/7e/d8/40271_2013_Article_36.PMC3929769.pdf
Kluwer Academic; 2002.http://ssrn.com/abstract=1077322 .96 J. Richardson et al.,Non-OADS,/arxiv_data1/oa_pdf/7e/d8/40271_2013_Article_36.PMC3929769.pdf
transplantbuddies.org ) and its companion social network site TransplantFriends ( http://www.transplantfriends.com ).,Non-OADS,/arxiv_data1/oa_pdf/e1/0f/40271_2013_Article_33.PMC3929770.pdf
"However, sites that permit only social sharing (e.g., text stories, photographs, and hyperlinks) stand in contrast to newer online commu- nities that integrate data sharing and analysis of quantita-tive information about the patients’ treatment and health (e.g., diagnoses, treatments, dosages, symptoms, and out- comes), such as 23andMe ( http://www.23andme.com ) and PatientsLikeMe ( http://www.patientslikeme.com ).",Non-OADS,/arxiv_data1/oa_pdf/e1/0f/40271_2013_Article_33.PMC3929770.pdf
"tudiabetes.org ) beneﬁt from a Spanish-language version (EsTuDiabetes; http://www.estudiabetes.org ), important issues such as adverse event reporting, safe and accurate communication between members, community moderation, and management of symptom terminology raise logisticalbarriers to multi-lingual sites.",Non-OADS,/arxiv_data1/oa_pdf/e1/0f/40271_2013_Article_33.PMC3929770.pdf
1.305].American Epilepsy Society; 2010. http://www.aesnet.org/ﬁles/ dmﬁle/Volume11Supplement1Abstracts2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e1/0f/40271_2013_Article_33.PMC3929770.pdf
"Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011. http://diabetes.niddk.nih.",Non-OADS,/arxiv_data1/oa_pdf/4c/57/40271_2013_Article_38.PMC3929775.pdf
"Agence de la sante ´et des services sociaux de Montre ´al 2007, Available http://publications.santemontreal.qc.ca/uploads/tx_asssmpublications/978-2-89494-620-6.pdf [last accessed 16 January 2012].Home Environment and Blood Lead Levels of Children Levallois et al 190 Journal of Exposure Science and Environmental Epidemiology (2014), 185 – 191 &2014 Nature America, Inc.",Non-OADS,/arxiv_data1/oa_pdf/10/cf/jes2012129a.PMC3929778.pdf
"Ofﬁce of Lead-Based Paint Abatement and Poisoning Prevention 1995, Available http://portal.hud.",Non-OADS,/arxiv_data1/oa_pdf/10/cf/jes2012129a.PMC3929778.pdf
"7: April 2 2008, Available: http://www12.statcan.ca/census-recensement/2006/rt-td/eth-eng.cfm [accessed 20 September 2011].",OADS,/arxiv_data1/oa_pdf/10/cf/jes2012129a.PMC3929778.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Exposure Science and Environmental Epidemiology website (http:// www.nature.com/jes)Home Environment and Blood Lead Levels of Children Levallois et al 191 &2014 Nature America, Inc. Journal of Exposure Science and Environmental Epidemiology (2014), 185 – 191",Non-OADS,/arxiv_data1/oa_pdf/10/cf/jes2012129a.PMC3929778.pdf
Calculations are done by hand according to the equations and a random part has been checked by running the calculations in ConsExpo 5.0 beta http://www.ConsExpo.com.,OADS,/arxiv_data1/oa_pdf/a5/d1/jes201333a.PMC3929779.pdf
http://www.mst.dk/Publikationer/Publications/2009/10/978-87-92548-81-8.htm.,Non-OADS,/arxiv_data1/oa_pdf/a5/d1/jes201333a.PMC3929779.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Exposure Science and Environmental Epidemiology website (http:// www.nature.com/jes)Deterministic versus probabilistic approach Gosens et al 214 Journal of Exposure Science and Environmental Epidemiology (2014), 208 – 214 &2014 Nature America, Inc.",Non-OADS,/arxiv_data1/oa_pdf/a5/d1/jes201333a.PMC3929779.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunicationsCompeting ﬁnancial interests: The authors declare that a patent (application number GB1311107.5) is pending on Pro-5FU and its method of activation for medical use.,Non-OADS,/arxiv_data1/oa_pdf/31/61/ncomms4277.PMC3929780.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Weiss, J. T. et al.",Non-OADS,/arxiv_data1/oa_pdf/31/61/ncomms4277.PMC3929780.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4277 ARTICLE NATURE COMMUNICATIONS | 5:3277 | DOI: 10.1038/ncomms4277 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/31/61/ncomms4277.PMC3929780.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/ad/68/ncomms4297.PMC3929781.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Liu, B.-Y.",Non-OADS,/arxiv_data1/oa_pdf/ad/68/ncomms4297.PMC3929781.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4297 6 NATURE COMMUNICATIONS | 5:3297 | DOI: 10.1038/ncomms4297 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/ad/68/ncomms4297.PMC3929781.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/6d/0a/ncomms4291.PMC3929782.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Mattiroli, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/6d/0a/ncomms4291.PMC3929782.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4291 10 NATURE COMMUNICATIONS | 5:3291 | DOI: 10.1038/ncomms4291 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/6d/0a/ncomms4291.PMC3929782.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/nature communications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/1a/30/ncomms4261.PMC3929783.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Han, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/1a/30/ncomms4261.PMC3929783.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4261 ARTICLE NATURE COMMUNICATIONS | 5:3261 | DOI: 10.1038/ncomms4261 | www.nature.com/naturecommunications 13 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/1a/30/ncomms4261.PMC3929783.pdf
Supplementary Information accompanies this paper at http://www.nature.com/nature communications.,Non-OADS,/arxiv_data1/oa_pdf/1e/60/ncomms4273.PMC3929784.pdf
Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions.,Non-OADS,/arxiv_data1/oa_pdf/1e/60/ncomms4273.PMC3929784.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4273 14 NATURE COMMUNICATIONS | 5:3273 | DOI: 10.1038/ncomms4273 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/1e/60/ncomms4273.PMC3929784.pdf
"H.L.L.designed all of the experiments, supervised and funded the study and contributed to thedata analysis and to the manuscript writing.Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.",Non-OADS,/arxiv_data1/oa_pdf/2a/dd/ncomms4303.PMC3929801.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Jiang, D.-S. et al.",Non-OADS,/arxiv_data1/oa_pdf/2a/dd/ncomms4303.PMC3929801.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4303 14 NATURE COMMUNICATIONS | 5:3303 | DOI: 10.1038/ncomms4303 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/2a/dd/ncomms4303.PMC3929801.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/bb/d7/ncomms4331.PMC3929802.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ishii, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/bb/d7/ncomms4331.PMC3929802.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4331 6 NATURE COMMUNICATIONS | 5:3331 | DOI: 10.1038/ncomms4331 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/bb/d7/ncomms4331.PMC3929802.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/15/ca/ncomms4280.PMC3929805.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Grissonnanche, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/15/ca/ncomms4280.PMC3929805.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4280 8 NATURE COMMUNICATIONS | 5:3280 | DOI: 10.1038/ncomms4280 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/15/ca/ncomms4280.PMC3929805.pdf
"One day post-training, the three groups 3Corresponding author E-mail dayane@ninds.nih.govArticle is online at http://www.learnmem.org/cgi/doi/10.1101 /lm.032417.113.This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the ﬁrst 12 months after the full-issue publication date (see http: //learnmem.",Non-OADS,/arxiv_data1/oa_pdf/59/f0/DayanLM032417.PMC3929848.pdf
9Corresponding authors E-mail erk5@columbia.eduE-mail yyh3@columbia.eduArticle is online at http://www.learnmem.org/cgi/doi/10.,Non-OADS,/arxiv_data1/oa_pdf/7d/f6/HuangLM032292.PMC3929850.pdf
"Similar re- sults have been reported with humans in a nonfear based task.As one example, in a series of experiments Rovee-Collier and col- leagues have shown that retention in human infants trained on an operant procedure (e.g., the mobile conjugate reinforcement task,where the infant learns to kick one leg to produce movement in an overhanging mobile, or the train task, where the infant learns to press a manipulandum to cause an electric train to move) increas- es monotonically with age over the ﬁrst years of life (for review, 1Corresponding author E-mail ssli@psy.unsw.edu.auArticle is online at http://www.learnmem.org/cgi/doi/10.",Non-OADS,/arxiv_data1/oa_pdf/04/08/LiLM031096.PMC3929851.pdf
"Indeed, one approach to negative occasionsetting maintains that on reinforced trials an excitatory relation- ship is formed between the tone and the US, but on nonrein- forced trials an inhibitory association between the tone and US 2Corresponding author E-mail david.j.bucci@dartmouth.eduArticle is online at http://www.learnmem.org/cgi/doi/10.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/MeyerLM033787.PMC3929852.pdf
"2013).Moreover, the reversal of the cellular changes mediating short- term or long-term memory as a result of inactivity or other forms of convergent activity results in the reversal of synaptic change to 1Corresponding author E-mail sms2@columbia.eduArticle is online at http://www.learnmem.org/cgi/doi/10.1101 /lm.027326.112.#2014 Schacher and Hu This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the ﬁrst 12 months after the full-issue publicationdate (see http: //learnmem.cshlp.org /site/misc /terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/57/36/SchacherLM027326.PMC3929853.pdf
3Corresponding author E-mail jrmoyer@uwm.eduArticle is online at http://www.learnmem.org/cgi/doi/10.,Non-OADS,/arxiv_data1/oa_pdf/11/71/SehgalLM032730.PMC3929854.pdf
RevMan 5.2 software http://ims.cochrane.org/revman/ download (accessed 01 March 2013).,OADS,/arxiv_data1/oa_pdf/43/f3/bjc2013750a.PMC3929865.pdf
Available at https://www.wp.dh.gov.uk/ publications/files/2012/12/9284-TSO-2900701-PROMS.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/f3/bjc2013750a.PMC3929865.pdf
Available at http://globocan.iarc.fr/factsheet.asp(accessed 10 September 2013).,Non-OADS,/arxiv_data1/oa_pdf/43/f3/bjc2013750a.PMC3929865.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER The role of CD44s in mesenchymal traits in HCC 966 www.bjcancer.com | DOI:10.1038/bjc.2013.759,Non-OADS,/arxiv_data1/oa_pdf/71/ed/bjc2013759a.PMC3929866.pdf
Power calculations were carried out using Quanto v1.2.4 (http://hydra.usc.edu/gxe/).,OADS,/arxiv_data1/oa_pdf/6b/6d/bjc2013769a.PMC3929867.pdf
"Nevertheless, we checked the chromosomal locations of th e 76 established risk-associated loci (http://www.natu re.com/icogs/primer/shared-susceptibility- loci-for-breast-prostate-and-o varian-cancers/) and found that none were located within 10 kb of any of the 39 genes considered, with the exception of the FGFR2 locus.",Non-OADS,/arxiv_data1/oa_pdf/6b/6d/bjc2013769a.PMC3929867.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER FGF receptor genes and breast cancer susceptibility 1100 www.bjcancer.com | DOI:10.1038/bjc.2013.769,Non-OADS,/arxiv_data1/oa_pdf/6b/6d/bjc2013769a.PMC3929867.pdf
"This study was funded by Sun Yat-Sen University Clinical Research 5010 Program, and was registered in Chinese Clinical Trial Registry (http://www.chictr.org/ cn/, No: ChiCTR-TRC-10001003).",Non-OADS,/arxiv_data1/oa_pdf/93/16/bjc2013777a.PMC3929868.pdf
"For partially incomplete questionnaires, imputation of the mean was used for scales containing at least 50% of the scores (http://groups.eortc.be/qol/).",Non-OADS,/arxiv_data1/oa_pdf/0b/f4/bjc2013779a.PMC3929869.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Prognostic miRNAs in operable NSCLC 1000 www.bjcancer.com | DOI:10.1038/bjc.2013.786,Non-OADS,/arxiv_data1/oa_pdf/e5/d6/bjc2013786a.PMC3929871.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)HBx mutants regulate HIF-1 ain HCC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.787 1073,Non-OADS,/arxiv_data1/oa_pdf/41/03/bjc2013787a.PMC3929872.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Loss of Smad4 induces resistance to 5-fluorouracil BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.789 957,Non-OADS,/arxiv_data1/oa_pdf/9a/c1/bjc2013789a.PMC3929873.pdf
"Exon flanking intronic primers were designed using Primer3 (http://frodo.wi.mit.edu/), DNA fragments amplified by PCR and PCR products weresequenced on the ABI 3730 Genetic Analyser (Applied Biosystems, San Francisco, CA, USA) using BDT V3.1.",OADS,/arxiv_data1/oa_pdf/29/8c/bjc2013792a.PMC3929874.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CDH1 mutations in women with LCIS BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.792 1057,Non-OADS,/arxiv_data1/oa_pdf/29/8c/bjc2013792a.PMC3929874.pdf
R package version 1.34.0 http://www.bioconductor.org.,Non-OADS,/arxiv_data1/oa_pdf/99/09/bjc2013795a.PMC3929876.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Circulating miRNAs in ovarian cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.795 983,Non-OADS,/arxiv_data1/oa_pdf/99/09/bjc2013795a.PMC3929876.pdf
"(b) General Practitioner: local doctor providing whole person health care to individuals and families in the community, (http://www.racgp.org.au/becomingagp/what-is-a-gp/ what-is-general-practice/).",Non-OADS,/arxiv_data1/oa_pdf/6c/06/bjc2013800a.PMC3929879.pdf
"Socio-economic status was classified using the Socio-Economic Indexes for Areas, 2006 (SEIFA 2011 had not been released at the time of writing), from the Australian Bureau of Statistics (http://www.abs.gov.au/AUSSTATS/abs@.nsf/ allprimarymainfeatures/356A4186CCDDC4D1CA257B3B001AC2 2C?opendocument).",OADS,/arxiv_data1/oa_pdf/6c/06/bjc2013800a.PMC3929879.pdf
"http://cancerforum.org.au/Issues/ 2009/November/Forum/General_practitionerbased_models_of_post treatment_follow_up.htm (last accessed August 9, 2013).",Non-OADS,/arxiv_data1/oa_pdf/6c/06/bjc2013800a.PMC3929879.pdf
"Surry Hills, NSW: Cancer Australia http://canceraustralia.gov.au/affected-cancer/cancer-types/breast-cancer/life-after-breast-cancer/shared-care (last accessed August 9, 2013).",Non-OADS,/arxiv_data1/oa_pdf/6c/06/bjc2013800a.PMC3929879.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Australian breast cancer survivors’ preferences for follow-up: a DCE BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.800 867,Non-OADS,/arxiv_data1/oa_pdf/6c/06/bjc2013800a.PMC3929879.pdf
Available at http://globocan.iarc.fr/ (2009) Fluorescence In Situ Hybridization (FISH) Application Guide .,OADS,/arxiv_data1/oa_pdf/23/d2/bjc2013802a.PMC3929881.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)FGFR2 amplification in gastric cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.802 975,Non-OADS,/arxiv_data1/oa_pdf/23/d2/bjc2013802a.PMC3929881.pdf
"GNA11 mutations occur in 33.2% of uveal melanomas and in 6.5% of blue nevi but are absent from other nevi ( n¼105) and extraocular melanomas ( n¼273) (Van Raamsdonk et al , 2010; see Supplementary Table 2 for mutation frequencies ofGNAQ ,GNA11 ,BAP1 ,SF3B1 and EIF1AX as obtained from the Catologue of somatic mutations in Cancer (COSMIC) data- base; http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/).",Non-OADS,/arxiv_data1/oa_pdf/3b/29/bjc2013804a.PMC3929883.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)TERT promoter mutation in uveal melanoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.804 1065,Non-OADS,/arxiv_data1/oa_pdf/3b/29/bjc2013804a.PMC3929883.pdf
"DISCLAIMER The trial is registered at http://www.clinicaltrials.gov, number NCT00783822.",Non-OADS,/arxiv_data1/oa_pdf/79/0e/bjc2013805a.PMC3929884.pdf
National Institute for Health and Clinical Excellence (2013) Familial breast cancer: full guideline DRAFT (January http://www.nice.org.uk/guidance/index.jsp?action=folder&o=62324.,Non-OADS,/arxiv_data1/oa_pdf/79/0e/bjc2013805a.PMC3929884.pdf
Statistics Netherlands (2011) http://www.cbs.nl/nl-NL/menu/methoden/ classificaties/overzicht/soi/2006/default.htm.,Non-OADS,/arxiv_data1/oa_pdf/79/0e/bjc2013805a.PMC3929884.pdf
Available at http://www.oncoline.nl/index.php?pagina=/richtlijn/item/pagina.php&richtlijn_id=608(Accessed on 7 February 2013).,Non-OADS,/arxiv_data1/oa_pdf/79/0e/bjc2013805a.PMC3929884.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Rapid genetics in breast cancer surgical treatment BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.805 1087,Non-OADS,/arxiv_data1/oa_pdf/79/0e/bjc2013805a.PMC3929884.pdf
Available at http://labeling.pfizer.com/ShowLabeling.aspx?id=759 (accessed 23 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/f7/45/bjc2013806a.PMC3929885.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)18FLT-PET imaging in patients treated with axitinib BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.806 881,Non-OADS,/arxiv_data1/oa_pdf/f7/45/bjc2013806a.PMC3929885.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER JMJD2B and DNA damage in colorectal cancer 1026 www.bjcancer.com | DOI:10.1038/bjc.2013.808,Non-OADS,/arxiv_data1/oa_pdf/af/fd/bjc2013808a.PMC3929886.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)NHE1 participates in CD44-mediated metastasis BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.809 927,Non-OADS,/arxiv_data1/oa_pdf/63/56/bjc2013809a.PMC3929887.pdf
Immunofluorescent staining of LC3-II protein was carried out according to the protocol available at the official web site of Cell Signaling Technology (http://www.cellsignal.com/support/ protocols/IF_methanol.html).,OADS,/arxiv_data1/oa_pdf/b0/6c/bjc2013810a.PMC3929888.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER TKIs and OATP1B1 inhibition 898 www.bjcancer.com | DOI:10.1038/bjc.2013.811,Non-OADS,/arxiv_data1/oa_pdf/01/19/bjc2013811a.PMC3929889.pdf
Available at: http://www.hscic.gov.uk/lung (accessed 7thAugust 2013).,Non-OADS,/arxiv_data1/oa_pdf/69/23/bjc2013812a.PMC3929890.pdf
Available at: http://www.chemodataset.nhs.uk/home.National institute for health and clinical excellence (2011) The diagnosis and treatment of lung cancer (update) NICE guideline.,Non-OADS,/arxiv_data1/oa_pdf/69/23/bjc2013812a.PMC3929890.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Treatment decisions and survival in small-cell lung cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.812 915,Non-OADS,/arxiv_data1/oa_pdf/69/23/bjc2013812a.PMC3929890.pdf
Available at:http://www.cquins.nhs.uk/download.php?d=/resources/reports/NCAT_NCPR_National_Report_2011-12.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/1c/bjc2013814a.PMC3929891.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Hypoxia enhances crosstalk between Nur77 and b-catenin BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.816 945,Non-OADS,/arxiv_data1/oa_pdf/c9/a6/bjc2013816a.PMC3929893.pdf
"NC3Rs (2013) Humane end points: National Centre for the Replacement, Refinement and Reduction of Animals in Research.http://www.nc3rs.org.uk/category.asp?catID=21 (accessed:08/12/2013).",Non-OADS,/arxiv_data1/oa_pdf/c4/43/bjc2013818a.PMC3929895.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Circulating miR-378 identifies colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.819 1007,Non-OADS,/arxiv_data1/oa_pdf/33/09/bjc2013819a.PMC3929896.pdf
Retrieved on 17 December 2013 from http://www.cancer.gov/cancertopics/factsheet/Risk/obesity.,Non-OADS,/arxiv_data1/oa_pdf/9b/01/bjc201412a.PMC3929897.pdf
"Although some reports describe a role http://dx.doi.org/10.1016/j.molmet.2013.10.004Abbreviations : CNS, central nervous system; Irs2, insulin receptor substrate 2; Irs4, insulin receptor substrate 4; LepRb, leptin receptor; ERK, extracellular s ignal-regulated kinase; Socs3, suppressor of cytokine signaling-3; Stat3, signal transducer and activator of transcription 3; POMC, proopiomelanocortin; PI3K, phosphatidylinositol 3-kinase; ARC, a rcuate nucleus of the hypothalamus★This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which p ermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/5e/2a/main.PMC3929908.pdf
Morphometric analysis of gonadal white adipose tissue from 400 cells from 4 different animals pergenotype was performed with NIH ImageJ software ( http://rsb.info.nih.,OADS,/arxiv_data1/oa_pdf/5e/2a/main.PMC3929908.pdf
SUPPORTING INFORMATION Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.molmet.2013.10.004 .,OADS,/arxiv_data1/oa_pdf/5e/2a/main.PMC3929908.pdf
"http://dx.doi.org/10.1016/j.molmet.2013.10.003Abbreviations : AcCoA, acetyl-coenzyme A; arm-GAL4, armadillo-GAL4; ASL, argininosuccinate lyase; BCAA, branch chain amino acid; CAFE, capillary feeder; da-GA L4, daughterless-Gal4; EASE, Expression Analysis Systematic Explorer (DAVID analysis); FAME, fatty acid methyl ester; Fdr, false discovery rate; GC/MS, gas chromatography/mass spectrom etry; HFD, high-fat Diet; MeOH, methanol; PCR, polymerase chain reaction; RT -PCR, reverse-transcriptase PCR; TBDMS, tert-butyldimethylsilyl; TCA, tricarboxylic acid; TG, triglyceride; TMS, trimethyl silyl; VDRC, Vienna Drosophila RNAi Center; w1118, white-1118%This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits n on-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c8/8f/main.PMC3929909.pdf
The microarray analysis data from this publication have been submitted to the Gene Expression Ominibusdatabase at http://www.ncbi.nlm.nih.gov/ geo and assigned the access number GSE46358.,OADS,/arxiv_data1/oa_pdf/c8/8f/main.PMC3929909.pdf
SUPPORTING INFORMATION Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.molmet.2013.10.003 .,OADS,/arxiv_data1/oa_pdf/c8/8f/main.PMC3929909.pdf
"Journal of Visualized Experiments 31:1425, http://dx.doi.org/10.3791/1425.",Non-OADS,/arxiv_data1/oa_pdf/c8/8f/main.PMC3929909.pdf
"Global inactivation of different clock genes leads to altered glucose metabolism: Clock mutant mice display hyperglycemia, obesity and metabolic syndrome [9];Per1 /Per2 double knockout mice and Cry1 /Cr2 double knockout mice exhibit glucose http://dx.doi.org/10.1016/j.molmet.2013.10.005Abbreviations : BSA, bovine serum albumin; 2-DG, 2-Deoxyglucose; GSEA, Gene Set Enrichment Analysis; imKO, inducible muscle-speciﬁc Bmal1 knockout; HK2, hexokinase 2; KHB, Krebs–Henseleit buffer; mKO, muscle-speciﬁc Bmal1 knockout; PDH, pyruvate dehydrogenase; PDK, PDH kinase; PDP , PDH phosphatase; SCN, suprachiasmatic nucleus; ZT, Zeitgeber time%This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits n on-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/2e/f7/main.PMC3929910.pdf
Over-representation analysis was performed using Gene Set Enrichment Analysis software (GSEA; http://www.broadinstitute.org/ gsea/index.jsp )[27] and gene sets from the KEGG database.,OADS,/arxiv_data1/oa_pdf/2e/f7/main.PMC3929910.pdf
"CircadiOmics All transcriptome and metabolome data are accessible through theCircadiOmics Website ( http://circadiomics.igb.uci.edu ), allowing users to search and view genes of interest and detected metabolites in Ctrl and Bmal1 mKO skeletal muscles, as well as their interactions and statistics.Importantly, gene expression and metabolite levels were derived fromcontralateral hindlimb muscles from the same animals, allowing for a more direct correlation of these metabolite –gene interactions.",OADS,/arxiv_data1/oa_pdf/2e/f7/main.PMC3929910.pdf
"Comparative analysis of genomic sequences For the identi ﬁcation of potential binding sites for clock genes, the genomic sequences for 6 eutherian species (about 400 bp upstream and 400 bp downstream of the relevant binding motif) were analyzed usingthe mVISTA tool ( http://genome.lbl.gov/vista ) and aligned with LAGAN.",OADS,/arxiv_data1/oa_pdf/2e/f7/main.PMC3929910.pdf
"Based on the JTK_CYCLE algorithm, and in agreement with circadian gene expression pro ﬁles obtained from high-resolution DNA microarray experiments ( http://bioinf.itmat.upenn.edu/circa/mouse ),Tbc1d1 tran- scripts display a circadian rhythm in skeletal muscles with a peak during the active phase, and their oscillation is blunted in both slow and fast mKO muscles ( Figure 3 L).",Non-OADS,/arxiv_data1/oa_pdf/2e/f7/main.PMC3929910.pdf
SUPPORTING INFORMATION Supplementary data associated with this article can be found in the online version athttp://dx.doi.org/10.1016/j.molmet.2013.10.005 .,OADS,/arxiv_data1/oa_pdf/2e/f7/main.PMC3929910.pdf
"Thus, the direct actions of insulin on the liver during a hyperinsulinemic clamp will in many settings mask the moresubtle effects that are exerted via the CNS on the liver and it is therefore often not a good protocol to study the role of the CNS in controlling http://dx.doi.org/10.1016/j.molmet.2013.10.008%This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which p ermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/25/79/main.PMC3929911.pdf
"Molecular Metabolism 3, http://dx.doi.org/ 10.1016/j.molmet.2013.10.002.",OADS,/arxiv_data1/oa_pdf/25/79/main.PMC3929911.pdf
"http://dx.doi.org/10.1016/j.molmet.2013.11.001%This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which p ermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c5/b6/main.PMC3929912.pdf
"Molecular Metabolism 3 , http://dx.doi.org/10.1016/j.molmet.2013.10.005.",OADS,/arxiv_data1/oa_pdf/c5/b6/main.PMC3929912.pdf
"The abundant expression of GHSRs in several distinct central nervous system (CNS) sites [25,26] and the induction of c-fos within several of these sites by ghrelin administration [7,27,28] suggests that the orexigenic and http://dx.doi.org/10.1016/j.molmet.2013.10.001Abbreviations : GHSR, growth hormone secretagogue receptor, ghrelin receptor; GOAT , ghrelin O-acyltransferase; CNS, central nervous system; Phox2b, paired-li ke homeobox 2b; AgRP , Agouti-related peptide; NPY , neuropeptide Y; GABA, gamma-aminobutyric acid; VGAT , vesicular GABA transporter; POMC, pro-opiomelanocortin; ARC, arcuate nucleus; BAC, ba cterial artiﬁcial chromosome; VTA, ventral tegmental area; DG, dentate gyrus; NAc, nucleus accumbens; DVC, dorsal vagal complex; G6p, glucose-6 phosphatase; Pepck, phosphoenolpyruvate carboxykinase; Hnf 4, hepatocyte nuclear factor 4; Foxo1, Forkhead box protein O1; Pcx, pyruvate carboxylase; GHRH, Growth-hormone-releasing hormone%This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits n on-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c5/99/main.PMC3929914.pdf
SUPPLEMENTARY MATERIAL Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.molmet.2013.10.001 .,OADS,/arxiv_data1/oa_pdf/c5/99/main.PMC3929914.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b7/15/srep04141.PMC3929915.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4141 | DOI: 10.1038/srep04141 7",Non-OADS,/arxiv_data1/oa_pdf/b7/15/srep04141.PMC3929915.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/99/88/srep04143.PMC3929916.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4143 | DOI: 10.1038/srep04143 5",Non-OADS,/arxiv_data1/oa_pdf/99/88/srep04143.PMC3929916.pdf
"The resulting http://dx.doi.org/10.1016/j.molmet.2013.10.007%This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which p ermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/93/a5/main.PMC3929919.pdf
"Foods commonly eaten in the United States, 1 –264 〈http://www.ars.usda.gov/ SP2UserFiles/Place/12355000/pdf/Portion.pdf 〉.",Non-OADS,/arxiv_data1/oa_pdf/93/a5/main.PMC3929919.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7a/5e/srep04146.PMC3930092.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4146 | DOI: 10.1038/srep04146 11",Non-OADS,/arxiv_data1/oa_pdf/7a/5e/srep04146.PMC3930092.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4139 | DOI: 10.1038/srep04139 7",Non-OADS,/arxiv_data1/oa_pdf/87/4b/srep04139.PMC3930093.pdf
wrote and reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/srep04104.PMC3930094.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4104 | DOI: 10.1038/srep04104 8",Non-OADS,/arxiv_data1/oa_pdf/bf/79/srep04104.PMC3930094.pdf
http://dx.doi.org/10.1016/j.nicl.2014.01.004 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/b5/ac/main.PMC3930097.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/9c/main.PMC3930100.pdf
Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl http://dx.doi.org/10.1016/j.nicl.2014.01.0092213-1582 © 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/9c/main.PMC3930100.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/9c/main.PMC3930100.pdf
"OSA and control subjects with body weight more than 125 kg (scanner limitation), or with MRI incompatible metallic implants were excluded, as described at the MRI safety website ( http://www.mrisafety.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/a4/9c/main.PMC3930100.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/a6/main.PMC3930112.pdf
Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl http://dx.doi.org/10.1016/j.nicl.2014.01.012 2213-1582/ © 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/79/a6/main.PMC3930112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/a6/main.PMC3930112.pdf
http://dx.doi.org/10.1016/j.nicl.2014.01.008 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/cc/ac/main.PMC3930113.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/19/main.PMC3930118.pdf
Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl http://dx.doi.org/10.1016/j.nicl.2014.01.010 2213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/17/19/main.PMC3930118.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/19/main.PMC3930118.pdf
"311http://www.who.int/mediacentre/factsheets/fs311/en/(2011, accessed 17 August 2011) 41.",Non-OADS,/arxiv_data1/oa_pdf/7b/6d/10.1177_2048004013514737.PMC3930156.pdf
"London: NCGC, 2011, http://www.nice.org.uk/nicemedia/live/13561/56007/56007.pdf 8.",Non-OADS,/arxiv_data1/oa_pdf/a0/68/10.1177_2048004014522440.PMC3930157.pdf
", 2011) and trans- membrane segments were predicted using TMHMM 2.0 (http://www.cbs.dtu.d k/services/TMHMM/).",OADS,/arxiv_data1/oa_pdf/80/70/ismej2013174a.PMC3930316.pdf
"Phylogenetic analysis of 16S rRNA, LSU-SSU rRNA and predicted proteins For 16S rRNA phylogeny, representatives of MCG and Marine benthic group B, Marine group I wereselected from ARB-silva (http://www.arb-silva.de/)as reference sequences.",OADS,/arxiv_data1/oa_pdf/80/70/ismej2013174a.PMC3930316.pdf
"For the phylogenetic tree of protein, the best protein model was deter- mined with ProteinModelSelection.pl (http://sco.h-its.org/exelixis/software.html).",OADS,/arxiv_data1/oa_pdf/80/70/ismej2013174a.PMC3930316.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Genetic and functional properties of uncultivated MCG archaea J Meng et al 659 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/80/70/ismej2013174a.PMC3930316.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Positive epistasis between coexisting plasmids A San Millan et al 612 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/61/d2/ismej2013182a.PMC3930321.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/0c/dddt-8-209.PMC3930477.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 209–217Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  209Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5406 4sinonasal inhalation of tobramycin vibrating  aerosol in cystic fibrosis patients with upper  airway Pseudomonas aeruginosa  colonization:  results of a randomized, double-blind,   placebo-controlled pilot study Jochen g Mainz1 Katja schädlich1 claudia schien1 ruth Michl1 Petra schelhorn-n eise2 assen Koitschev3 christiane Koitschev4 Peter M Keller5 Joachim riethmüller6 Baerbel Wiedemann7 James F Beck1 1cystic Fibrosis centre, Department  of Pediatrics, Jena University hospital,   Jena, germany; 2Otorhinolaryngology  Department, Jena University hospital,   Jena, germany; 3Otorhinolaryngology  Department, Klinikum stuttgart,   germany; 4Otorhinolaryngology  Department, University hospital,   Tübingen, germany; 5Microbiology,   Jena University hospital, Jena, germany;  6University hospital, Pediatric  cF-centre, Tübingen, germany;   7T echnical University, Biometrics,   Dresden, germany correspondence: Jochen g Mainz   cystic Fibrosis centre, Department   of Pediatrics, University of Jena,   Kochstrasse 2, D 07740 Jena,   germany   Tel +49 3641 938 425   Fax +49 3641 938 314   email jochen.mainz@med.uni-jena.d eRationale:  In cystic fibrosis (CF), the paranasal sinuses are sites of first and persistent  colonization  by pathogens such as Pseudomonas aeruginosa .",Non-OADS,/arxiv_data1/oa_pdf/b6/0c/dddt-8-209.PMC3930477.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b6/0c/dddt-8-209.PMC3930477.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/0c/dddt-8-209.PMC3930477.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/54/ijn-9-867.PMC3930478.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 867–876International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  867OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4605 5Development and characterization   of biocompatible isotropic and anisotropic   oil-in-water colloidal dispersions as a new   delivery system for methyl dihydrojasmonate   antitumor drug gisela Bevilacqua rolfsen  Ferreira da silva1 Maria Virginia scarpa1 gustavo rossanezi1 eryvaldo socrates Tabosa  do egito2 anselmo gomes de  Oliveira1 1Departamento de Fármacos e   Medicamentos, Universidade   estadual Paulista (UN esP),    araraquara, sP , Brazil; 2laboratório   de sistemas Dispersos, Universidade   Federal do rio grande do Norte   (UFrN) Natal, rN, Brazil correspondence: anselmo gomes de  Oliveira   Departamento de Fármacos e   Medicamentos, Faculdade de ciências   Farmacêuticas, Universidade estadual   Paulista (UNesP), rodovia araraquara-Jaú   Km 01, araraquara, sP 14801-902, Brazil   Tel +55 16 3301 6974   Fax +55 16 3301 6960   email oliveiag@fcfar.unesp.b rAbstract:  Microemulsions (MEs) are colloidal systems that can be used for drug-delivery and  drug-targeting purposes.",Non-OADS,/arxiv_data1/oa_pdf/bc/54/ijn-9-867.PMC3930478.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bc/54/ijn-9-867.PMC3930478.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/54/ijn-9-867.PMC3930478.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/77/jmdh-7-111.PMC3930479.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 111–117Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  111Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S3861 6Overview of guidelines for the prevention and  treatment of venous leg ulcers: a US perspective e Foy white-Chu1 T eresa A Conner-Kerr2 1Oregon Health and Science  University, Portland vA Medical  Center, Portland, OR, 2winston- Salem State University, Department  of Physical Therapy, winston Salem,   NC, USA Correspondence: e Foy white-Chu   Oregon Health and Science University,   Portland vA Medical Center, P3-Med,   PO Box 1034, Portland, OR 97207, USA   Tel +1 503 220 8262 ext 57772   Fax +1 503 721 7807   email whitechu@ohsu.ed uAbstract:  Comprehensive care of chronic venous insufficiency and associated ulcers requires  a multipronged and interprofessional approach to care.",Non-OADS,/arxiv_data1/oa_pdf/01/77/jmdh-7-111.PMC3930479.pdf
"Available from: http://www.aacn.nche.edu/ education-resources/ipecreport.pd f. Accessed November 28, 2013.",Non-OADS,/arxiv_data1/oa_pdf/01/77/jmdh-7-111.PMC3930479.pdf
"Available from: http://aawconline.org/wp-content/ uploads/2012/03/AAWC-Venous-Ulcer-Guideline-Update +Algorithm- v28.pd f. Accessed November 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/01/77/jmdh-7-111.PMC3930479.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/01/77/jmdh-7-111.PMC3930479.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/01/77/jmdh-7-111.PMC3930479.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/ba/btt-8-027.PMC3930480.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2014:8 27–38Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  27Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S5519 6Therapeutic vaccines and cancer: focus   on DPX-0907 Mohan Karkada1,2 Neil L Berinstein3 Marc Mansour1 1immuno vaccine inc, 2Department  of Microbiology/ immunology,  Dalhousie University, Halifax, NS,  Canada; 3Ontario institute for Cancer  Research, Toronto, ON, Canada Correspondence: Mohan Karkada   immunov accine inc, 1344 Summer   Street, Halifax, NS B3H 0A8, Canada   T el +1 902 421 5735   Fax +1 902 4212733   email mkarkada@imvaccine.co mAbstract:  In an attempt to significantly enhance immunogenicity of peptide cancer vaccines,  we developed a novel non-emulsion depot-forming vaccine platform called DepoVax™ (DPX).",Non-OADS,/arxiv_data1/oa_pdf/10/ba/btt-8-027.PMC3930480.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/10/ba/btt-8-027.PMC3930480.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/10/ba/btt-8-027.PMC3930480.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/89/ceor-6-075.PMC3930481.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2014:6 75–81ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  75ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S5295 0Duloxetine treatment adherence across mental  health and chronic pain conditions stephen l able1 Zhanglin Cui2 Wei shen2 1global health Outcomes, Eli lilly  and Company, indianapolis, in, Usa;   2global statistical sciences, Eli lilly  and Company, indianapolis, in, Usa Correspondence: stephen l able   Eli lilly and Company, 1 lilly   Corporate Center, indianapolis,   in 46285-0001, Usa   Tel +1 317 276 3612   Fax +1 317 277 7444   Email able_stephen _l@lilly.comPurpose:  This study applied a uniform methodology for measuring and comparing duloxetine  adherence in the treatment of multiple chronic medical conditions.",Non-OADS,/arxiv_data1/oa_pdf/44/89/ceor-6-075.PMC3930481.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/44/89/ceor-6-075.PMC3930481.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/89/ceor-6-075.PMC3930481.pdf
"Available from: http://pi.lilly.com/us/cymbalta-pi.pd f. Accessed  July 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/44/89/ceor-6-075.PMC3930481.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bd/28/btt-8-059.PMC3930482.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2014:8 59–65Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  59Hypo THesisopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/ 10.2147/BTT .S5405 6Does the cis/trans  configuration of peptide bonds  in bioactive tripeptides play a role in ACe-1  enzyme inhibition?,Non-OADS,/arxiv_data1/oa_pdf/bd/28/btt-8-059.PMC3930482.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/btt-8-059.PMC3930482.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/bd/28/btt-8-059.PMC3930482.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4b/4a/ceor-6-063.PMC3930483.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2014:6 63–74ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  63ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S5415 8Management of sacroiliac joint disruption   and degenerative sacroiliitis with nonoperative  care is medical resource-intensive and costly   in a United states commercial payer population stacey J ackerman1 David W Polly Jr2 Tyler Knight3 Tim holt4 John Cummings5 1Covance Market access services  inc, san Diego, C a, Usa; 2University  of Minnesota, Orthopaedic surgery,   Minneapolis, M n, Usa; 3Covance  Market access services inc,   gaithersburg, MD, Usa; 4Montgomery  spine Center, Orthopaedic surgery,   Montgomery, al, Usa; 5Community  health network, neurosurgery,   indianapolis, in, Usa Correspondence: stacey J ackerman   Covance Market access services inc,  10300 Campus Point Drive, suite 225,  san Diego, Ca 92121-1511, Usa   Tel +1 858 352 2498   Fax +1 858 200 1498   Email stacey.ackerman@covance.co mIntroduction:  Low back pain is common and originates in the sacroiliac (SI) joint in 15%–30%  of cases.",Non-OADS,/arxiv_data1/oa_pdf/4b/4a/ceor-6-063.PMC3930483.pdf
Available from: http://www.cdc.gov/nchs/data/icd/ icd9cm_guidelines_2011.pdf.,OADS,/arxiv_data1/oa_pdf/4b/4a/ceor-6-063.PMC3930483.pdf
Available from: http://data.bls.gov/timeseries/CUUR0000SAM?,OADS,/arxiv_data1/oa_pdf/4b/4a/ceor-6-063.PMC3930483.pdf
Available from: http://www.nber.org/papers/w14455.pdf?new_ window=1%20August%20200 8.,Non-OADS,/arxiv_data1/oa_pdf/4b/4a/ceor-6-063.PMC3930483.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/4b/4a/ceor-6-063.PMC3930483.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/4a/ceor-6-063.PMC3930483.pdf
Available from: http://www.rti.org/pubs/COI_Primer.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4b/4a/ceor-6-063.PMC3930483.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/88/ijn-9-823.PMC3930484.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 823–839International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  823OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5633 9cognitive  deficits and decreased locomotor   activity induced by single-walled carbon   nanotubes and neuroprotective effects   of ascorbic acid Xudong liu1,* Yuchao Zhang1,* Jinquan li1 Dong Wang1 Yang Wu1 Yan li2 Zhisong lu3 samuel cT Yu4 rui li1 Xu Yang1 1laboratory of environmental Biomedicine,   hubei Key laboratory of genetic  regulation and Integrative Biology, college  of life science, central china Normal  University, Wuhan, People’s republic  of china; 2chemical and Biomolecular  engineering Department, hong Kong  University of science and T echnology,   hong Kong special administrative region;   3Institute for clean energy and advanced  Materials, southwest University, chongqing,   People’s republic of china; 4Division of  environment, hong Kong University of  science and Technology, hong Kong special  administrative region *These authors contributed equally to   this work correspondence: Xu Yang   hubei Key laboratory of genetic regulation   and Integrative Biology, college of life science,   central china Normal University, Wuhan 430079,   People’s republic of china   Tel +86 138 7136 1954   Fax +86 27 6786  1936   email yangxu@mail.ccnu.edu.c n    rui li   hubei Key laboratory of genetic regulation   and Integrative Biology, college of life science,   central china Normal University, Wuhan 430079,   People’s republic of china   Tel +86 151 7238 5189   Fax +86 27 6786 1936   email ruili@mail.ccnu.edu.c nAbstract:  Single-walled carbon nanotubes (SWCNTs) have shown increasing promise in the  field of biomedicine, especially in applications related to the nervous system.",Non-OADS,/arxiv_data1/oa_pdf/78/88/ijn-9-823.PMC3930484.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/78/88/ijn-9-823.PMC3930484.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/88/ijn-9-823.PMC3930484.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/d4/ijn-9-865.PMC3930485.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 865–866International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  865Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJN.S5867 4MRI-based identification of undifferentiated cells:  looking at the two faces of Janus Ciprian tomuleasa1,2 Ioan Stefan Florian3 Cristian Berce4 Alexandru Irimie5,6 Ioana Berindan-Neagoe2,7,9 Andrei Cucuianu1,8 1Department of Hematology, Ion  Chiricuta Cancer Center, Cluj  Napoca, romania; 2research Center  for Functional Genomics and  translational Medicine, Iuliu Hatieganu  University of Medicine and Pharmacy,   Cluj Napoca, romania; 3Department  of Neurosurgery, 4Animal Facility, Iuliu  Hatieganu University of Medicine  and Pharmacy, Cluj Napoca, romania;   5Department of Surgery, Ion Chiricuta  Cancer Center, Cluj Napoca, romania;   6Department of Oncology, Iuliu  Hatieganu University of Medicine  and Pharmacy, Cluj Napoca, romania;   7Department of Functional Genomics,   the Oncology Institute Ion Chiricuta,   Cluj Napoca, romania; 8Department  of Hematology, 9Department  of Immunology, Iuliu Hatieganu  University of Medicine and Pharmacy,   Cluj Napoca, romaniaDear editor We have read with great interest the paper of Ketkar-Atre et al,1 in which they have  developed a new way of tracking stem cells after transplantation using a magnetic  resonance imaging (MRI)-based method.",Non-OADS,/arxiv_data1/oa_pdf/08/d4/ijn-9-865.PMC3930485.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/08/d4/ijn-9-865.PMC3930485.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/d4/ijn-9-865.PMC3930485.pdf
"Journal of  Preventive Medicine  & Public Health 1 Copyright © 2014  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:1-6   •  http://dx.doi.org/10.3961/jpmph.2014.47.1.1 Overview of the Development of the Korean Exposure  Factors Handbook Jae-Yeon Jang, Soo-Nam Jo, So-Yeon Kim, Hyung-Nam Myung Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon, KoreaSpecial Article A set of exposure factors that reflects the characteristics of individual behavior capable of influencing exposure is essential for risk and  exposure assessment.",Non-OADS,/arxiv_data1/oa_pdf/b4/6b/jpmph-47-1.PMC3930803.pdf
"Key words:  Risk assessment, Environmental exposure, Handbooks Received:  September 2, 2013; Accepted:  November 26, 2013 Corresponding author:  Jae-Yeon Jang, PhD 206 World cup-ro, Yeongtong-gu, Suwon 443-721, Korea Tel: +82-31-219-5293, Fax: +82-31-219-5084   E-mail : free5293@gmail.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Human exposure assessment of environmental contaminants  has been used as an important tool to establish environmen - tal standards and public health policies [1].",Non-OADS,/arxiv_data1/oa_pdf/b4/6b/jpmph-47-1.PMC3930803.pdf
Available from: http://unit.aist.go.jp/riss/crm/ exposurefactors/english_summary.html.,OADS,/arxiv_data1/oa_pdf/b4/6b/jpmph-47-1.PMC3930803.pdf
Available from: http://www.craes.cn/cn/index.html  (Chinese).,Non-OADS,/arxiv_data1/oa_pdf/b4/6b/jpmph-47-1.PMC3930803.pdf
Available from: http://www.kefh.,Non-OADS,/arxiv_data1/oa_pdf/b4/6b/jpmph-47-1.PMC3930803.pdf
"Journal of  Preventive Medicine  & Public Health 18 Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:18-26   •  http://dx.doi.org/10.3961/jpmph.2014.47.1.18 Food Ingestion Factors of the Korean Exposure Factors  Handbook Jae-Yeon Jang1, Soo-Nam Jo1, Sun-Ja Kim1, Hyung-Nam Myung1, Cho-Il Kim2 1Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon; 2Korea Health Industry Development Institute,  Cheongwon, KoreaSpecial Article The purpose of this study was to establish food ingestion factors needed to assess exposure to contaminants through food ingestion.",Non-OADS,/arxiv_data1/oa_pdf/8f/56/jpmph-47-18.PMC3930804.pdf
"Key words:  Risk assessment, Food, Exposure factors Received:  September 2, 2013; Accepted:  December 27, 2013 Corresponding author:  Jae-Yeon Jang, PhD 206 World cup-ro, Yeongtong-gu, Suwon 443-721, Korea Tel: +82-31-219-5293, Fax: +82-31-219-5084   E-mail : free5293@gmail.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION The intake of grain, meat, fish and shellfish, vegetables, fruits,  and dairy products is a major path of exposure to environmen - tal contaminants, which makes it an important factor for an pISSN 1975-8375 eISSN 2233-4521  exposure assessment [1].",Non-OADS,/arxiv_data1/oa_pdf/8f/56/jpmph-47-18.PMC3930804.pdf
Available from:  http://knhanes.cdc.go.kr/knhanes/index.do (Korean).,Non-OADS,/arxiv_data1/oa_pdf/8f/56/jpmph-47-18.PMC3930804.pdf
Available  from: http://www.cdc.gov/nchs/nhanes.htm.,OADS,/arxiv_data1/oa_pdf/8f/56/jpmph-47-18.PMC3930804.pdf
Available from: http://unit.aist.go.jp/riss/crm/ exposurefactors/english_summary.html.,OADS,/arxiv_data1/oa_pdf/8f/56/jpmph-47-18.PMC3930804.pdf
"Journal of  Preventive Medicine  & Public Health 27 Copyright © 2014  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:27-35   •  http://dx.doi.org/10.3961/jpmph.2014.47.1.27 Activity Factors of the Korean Exposure Factors   Handbook Jae-Yeon Jang1, Soo-Nam Jo1, So-Yeon Kim1, Kyung-Eun Lee1, Kyung-Ho Choi2, Young-Hee Kim2 1Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon, 2Graduate School of Public Health,   Seoul National University, Seoul, KoreaSpecial Article Exposure factors based on the Korean population are required for making appropriate risk assessment.",Non-OADS,/arxiv_data1/oa_pdf/52/a2/jpmph-47-27.PMC3930805.pdf
"Key words:  Risk assessment, Handbooks, Environmental exposure  Received:  September 2, 2013; Accepted:  December 17, 2013 Corresponding author:  Jae-Yeon Jang, PhD 206 World cup-ro, Yeongtong-gu, Suwon 443-721, Korea Tel: +82-31-219-5293, Fax: +82-31-219-5084   E-mail : free5293@gmail.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Exposure to contaminants varies according to the frequency  and time of exposure in addition to the concentration of the  contaminant.",Non-OADS,/arxiv_data1/oa_pdf/52/a2/jpmph-47-27.PMC3930805.pdf
Avail - able from: http://meta.narastat.kr/metasvc/svc/SvcMetaDcDta - Popup.do?confmNo =10152&inputYear =2004 (Korean).,OADS,/arxiv_data1/oa_pdf/52/a2/jpmph-47-27.PMC3930805.pdf
Available from: http://www.census.go.kr/hcen - sus/ui/html/data/data_060_010.jsp?q_menu =4&q_sub =5&  (Korean).,OADS,/arxiv_data1/oa_pdf/52/a2/jpmph-47-27.PMC3930805.pdf
Available from: http://unit.aist.go.jp/riss/crm/ exposurefactors/english_summary.html.,OADS,/arxiv_data1/oa_pdf/52/a2/jpmph-47-27.PMC3930805.pdf
"Journal of  Preventive Medicine  & Public Health 36 Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:36-46   •  http://dx.doi.org/10.3961/jpmph.2014.47.1.36 Levothyroxine Dose and Fracture Risk According to the  Osteoporosis Status in Elderly Women  Young-Jin Ko1, Ji Young Kim1, Joongyub Lee2, Hong-Ji Song3, Ju-Young Kim4, Nam-Kyong Choi2, Byung-Joo Park1,5 1Department of Preventive Medicine, Seoul National University College of Medicine, Seoul; 2Medical Research Collaborating Center, Seoul National   University Hospital, Seoul; 3Department of Family Medicine, Hallym University College of Medicine, Chuncheon; 4Department of Family Medicine,  Health Promotion Center, Seoul National University Bundang Hospital, Seongnam; 5Korea Institute of Drug Safety and Risk Management, Seoul, KoreaOriginal Article Objectives: To evaluate the association between fracture risk and levothyroxine use in elderly women with hypothyroidism, according  to previous osteoporosis history.",Non-OADS,/arxiv_data1/oa_pdf/30/e0/jpmph-47-36.PMC3930806.pdf
"Key words:  Thyroxine, Fractures, Cohort studies, Aged, Osteoporosis Received:  July 7, 2013; Accepted:  November 26, 2013 Corresponding author:  Byung-Joo Park, MD, PhD  103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea Tel: +82-2-740-8325, Fax: +82-2-747-4830   E-mail : bjpark@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Hypothyroidism is common in elderly women, with preva - lence rates of 3% to 10% in the general population and 11% to 15% in the elderly population [1].",Non-OADS,/arxiv_data1/oa_pdf/30/e0/jpmph-47-36.PMC3930806.pdf
"Journal of  Preventive Medicine  & Public Health 47 Copyright © 2014  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:47-56   •  http://dx.doi.org/10.3961/jpmph.2014.47.1.47 Implementation and Results of a Survey on Safe   Community Programs in Gangbuk-gu, Korea:   Focusing on Participants at a Local Public Health Center Hyun-Joong Kim1, Se-Min Hwang1,2, In-Young Lee2, Joon-Pil Cho3, Myoung-Ok Kwon4, Jae-Hun Jung1, Ju-Young Byun1 1Department of Preventive Medicine, Korea University College of Medicine, Seoul; 2Department of Health Promotion Team, Gangbuk Health Center,  Seoul; 3Department of Emergency Medicine, Ajou University School of Medicine, Suwon; 4Health Policy and Hospital Management Graduate School  of Public Health, Korea University, Seoul, KoreaOriginal Article Objectives: The purpose of this study was to investigate the current status of and problems with the Safe Community Programs in  Gangbuk-gu, one of the 25 districts of the capital city of Korea.",Non-OADS,/arxiv_data1/oa_pdf/38/d9/jpmph-47-47.PMC3930807.pdf
"Key words:  Safe Community, Mortality, Active participation Received:  August 9, 2013; Accepted:  November 19, 2013 Corresponding author:  Se-Min Hwang, MD, MPH 897 Hancheon-ro, Gangbuk-gu, Seoul 142-707, Korea Tel: +82-2-901-7685, Fax: +82-2-901-7669   E-mail : karlfreud@naver.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION As injury came to be perceived as a disease, John Gordon, a  researcher in public health in the 1940s, proposed that injury,  like other types of disease, had epidemic events, seasonal chang -pISSN 1975-8375 eISSN 2233-4521  es, long-term trends, and high-risk groups in its demographic  distribution.",Non-OADS,/arxiv_data1/oa_pdf/38/d9/jpmph-47-47.PMC3930807.pdf
Available from:  http://www.who.int/ageing/publications/Falls_prevention - 7March.pdf.,Non-OADS,/arxiv_data1/oa_pdf/38/d9/jpmph-47-47.PMC3930807.pdf
"Journal of  Preventive Medicine  & Public Health 57 Copyright © 2014  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:57-63   •  http://dx.doi.org/10.3961/jpmph.2014.47.1.57 IL-4 and IL-5 Secretions Predominate in the Airways of   Wistar Rats Exposed to Toluene Diisocyanate Vapor  Kouame Kouadio1,2, Kui-Cheng Zheng1,3, Abdoulaye Abba Toure2, Mireille Dosso2, Hidemi Todoriki1 1Department of Environmental and Preventive Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan; 2Eco-epidemiology Unit,  Department of Environmental Health, Institut Pasteur of Côte d’Ivoire, Côte d’Ivoire, West Africa; 3Fujian Provincial Center for Desease Control, Fu - zhou, ChinaOriginal Article Objectives: We established a Wistar rat model of asthma caused by toluene diisocyanate (TDI) exposure, and investigated the rela - tionship between TDI exposure concentrations and respiratory hypersensitivity, airway inflammation, and cytokine secretions in ani - mals, to better understand the mechanism of TDI induced occupational asthma.",Non-OADS,/arxiv_data1/oa_pdf/41/5a/jpmph-47-57.PMC3930808.pdf
"Key words:  Toluene 2,4-diisocyanate, Wistar rat, Bronchoalveolar lavage, Cytokines, Eosinophils, Airway  Received:  August 17, 2013; Accepted:  December 4, 2013 Corresponding author:  Kouame Kouadio, MD, PhD 01 BP 490 Abidjan 01, Côte d’Ivoire, West Africa Tel: +225-06-29-44-20, Fax: +225-22-48-53-05   E-mail : kouadiokouame@yahoo.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Asthma is a chronic respiratory disease characterized by the  presence of reversible airway constriction and airway hyperre - sponsiveness to various stimuli.",Non-OADS,/arxiv_data1/oa_pdf/41/5a/jpmph-47-57.PMC3930808.pdf
"Journal of  Preventive Medicine  & Public Health 64 Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:64-71   •  http://dx.doi.org/10.3961/jpmph.2014.47.1.64 Factors Predicting the Physical Activity Behavior of   Female Adolescents: A Test of the Health Promotion  Model  Hashem Mohamadian1, Mohammad Ghannaee Arani2  1Research Centre for Health-Related Social Determinates, Department of Public Health, School of Health, Kashan University of Medical Sciences,  Kashan; 2Trauma Research Centre, Kashan University of Medical Sciences, Kashan, IranOriginal Article Objectives: Physical activity behavior begins to decline during adolescence and continues to decrease throughout young adulthood.",Non-OADS,/arxiv_data1/oa_pdf/c2/05/jpmph-47-64.PMC3930809.pdf
"Key words:  Self efficacy, Social support, Adolescent, Health promotion Received:  August 8, 2013; Accepted:  December 31, 2013 Corresponding author:  Mohammad Ghannaee Arani, MSc Ghotb-e-Ravandi Blvd, Kashan, Iran Tel: +98-913-3622326, Fax: +98-361-5551112   E-mail : mohammadarani@yahoo.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Insufficient physical activity (IPA) is one of the leading risk  factors of mortality [1].",Non-OADS,/arxiv_data1/oa_pdf/c2/05/jpmph-47-64.PMC3930809.pdf
Available from:  http://www.cdc.gov/physicalactivity/everyone/getactive/bar - riers.html.,OADS,/arxiv_data1/oa_pdf/c2/05/jpmph-47-64.PMC3930809.pdf
"Journal of  Preventive Medicine  & Public Health 7 Copyright © 2014  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:7-17   •  http://dx.doi.org/10.3961/jpmph.2014.47.1.7 General Factors of the Korean Exposure Factors   Handbook Jae-Yeon Jang1, So-Yeon Kim1, Sun-Ja Kim1, Kyung-Eun Lee1, Hae-Kwan Cheong2, Eun-Hye Kim2, Kyung-Ho Choi3,   Young-Hee Kim3 1Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon; 2Department of Social and Preventive Medicine,  Sungkyunkwan University School of Medicine, Suwon; 3Graduate School of Public Health, Seoul National University, Seoul, KoreaSpecial Article Risk assessment considers the situations and characteristics of the exposure environment and host.",Non-OADS,/arxiv_data1/oa_pdf/89/d9/jpmph-47-7.PMC3930810.pdf
"Key words:  Risk assessment, Environmental exposure, Environmental health Received:  September 2, 2013; Accepted:  November 26, 2013 Corresponding author:  Jae-Yeon Jang, PhD 206 World cup-ro, Yeongtong-gu, Suwon 443-721, Korea Tel: +82-31-219-5293, Fax: +82-31-219-5084   E-mail : free5293@gmail.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Exposure to harmful elements poses unique situations and  characteristics for each nation and geographical area, which  increases the need to measure physiological variables that re - flect the characteristics of the population to make reliable ex - posure assessment [1,2].",Non-OADS,/arxiv_data1/oa_pdf/89/d9/jpmph-47-7.PMC3930810.pdf
Available from: http://www.who.int/foodsafety/pub - lications/micro/cac1999/en/.,Non-OADS,/arxiv_data1/oa_pdf/89/d9/jpmph-47-7.PMC3930810.pdf
Available from: http://kosis.kr/common/meta_onedepth.,OADS,/arxiv_data1/oa_pdf/89/d9/jpmph-47-7.PMC3930810.pdf
Available from: http://kostat.go.kr/survey/lifestyle/ls_ dl/1/2/index.board?bmode =read&bSeq =&aSeq=151449&p ageNo=1&rowNum =10&navCount =10&currPg =&sTarget = title&sTxt = (Korean).,Non-OADS,/arxiv_data1/oa_pdf/89/d9/jpmph-47-7.PMC3930810.pdf
Available from: http://unit.aist.go.jp/riss/crm/exposurefactors/ english_summary.html.,OADS,/arxiv_data1/oa_pdf/89/d9/jpmph-47-7.PMC3930810.pdf
http://dx.doi.org/10.1016/j.gynor.2013.12.004 Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/a8/80/main.PMC3930812.pdf
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.gynor.2014.01.001 Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/01/62/main.PMC3930814.pdf
http://dx.doi.org/10.1016/j.gynor.2013.12.002 Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/e5/23/main.PMC3930815.pdf
http://dx.doi.org/10.5580/1bac .,OADS,/arxiv_data1/oa_pdf/e5/23/main.PMC3930815.pdf
http://dx.doi.org/10.1016/j.gynor.2013.12.001 Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor,Non-OADS,/arxiv_data1/oa_pdf/42/bd/main.PMC3930816.pdf
"Centers for Disease Control and Prevention (2010) Flu-related hospitalizations and deaths in the United States from April 2009 – January 30, 2010. http://www.cdc.gov/h1n1flu/hosp_deaths_ ahdra.htm .",Non-OADS,/arxiv_data1/oa_pdf/5a/10/431_2013_Article_2023.PMC3930829.pdf
http://www.cdc.gov/flu/protect/ whoshouldvax.htm .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/431_2013_Article_2023.PMC3930829.pdf
https://www.wp.dh.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/431_2013_Article_2023.PMC3930829.pdf
"Reingold AL, on behalf of Miller L and the SAGE Influenza Working Group (2012) Proposed revisions to the 2005 WHO position paper on influenza vaccines, 2012. http://www.who.int/ immunization/sage /meetings/2012/apri l/4_A.Reingold_WHO- InflWorkGrpPosPaper.pdf .",Non-OADS,/arxiv_data1/oa_pdf/5a/10/431_2013_Article_2023.PMC3930829.pdf
Available at: http://www.who.int/csr/resour ces/publications/swineflu/h1n1_ guidelines_pharmaceutical_mngt.pdf 133.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/431_2013_Article_2023.PMC3930829.pdf
Department of Health and Human Services (2010) Healthy People 2020. http://www.cdc.gov/nchs /healthy_people/hp2020.htm .,Non-OADS,/arxiv_data1/oa_pdf/33/60/431_2013_Article_2158.PMC3930830.pdf
http://www.bhfactive.,Non-OADS,/arxiv_data1/oa_pdf/33/60/431_2013_Article_2158.PMC3930830.pdf
WHO Reference 2007. http://www.who.int/growthref/en/ .,OADS,/arxiv_data1/oa_pdf/33/60/431_2013_Article_2158.PMC3930830.pdf
http://www.who.int/dietphysicalactivity/ factsheet_recommendations/en/ .,Non-OADS,/arxiv_data1/oa_pdf/33/60/431_2013_Article_2158.PMC3930830.pdf
Available from: http://www.info4pi.org/aboutPI/index.cfm?section= aboutPI&content=warningsigns .,OADS,/arxiv_data1/oa_pdf/b0/ac/10875_2013_Article_9954.PMC3930833.pdf
Available from: http://www.esid.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/10875_2013_Article_9954.PMC3930833.pdf
Available from: http://www.usidnet.org/pub/Disease-Registry .,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/10875_2013_Article_9954.PMC3930833.pdf
Available from: http://primaryimmune.org/about-primary- immunodeficiency-diseases .,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/10875_2013_Article_9954.PMC3930833.pdf
Available from: http://www.idfnz.org.nz/pub/cms/ resources__medical/files/GPPRIM1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/10875_2013_Article_9954.PMC3930833.pdf
Available at: http://www.aao.org/ppp .,Non-OADS,/arxiv_data1/oa_pdf/83/e4/12325_2014_Article_95.PMC3930835.pdf
http://innovation.cms.gov/ initiatives/index.html#views=models .,Non-OADS,/arxiv_data1/oa_pdf/97/83/12325_2014_Article_98.PMC3930836.pdf
http://www.morepress.net .,Non-OADS,/arxiv_data1/oa_pdf/74/90/12325_2013_Article_90.PMC3930838.pdf
Clinical Trial Registration InformationNCT00863213 ( http://clinicaltrials.gov/ct2/show/NCT00863213 ).,OADS,/arxiv_data1/oa_pdf/ca/ea/eht457.PMC3930872.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/ea/eht457.PMC3930872.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/a0/eht491.PMC3930873.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/ef/eht504.PMC3930874.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/2e/ket278.PMC3930883.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/92/ket373.PMC3930885.pdf
"National Rheumatoid Arthritis Society Survey 2007: I Want to Work2007, http://www.nras.org.uk/includes/documents/cm_docs/2010/f/final_final_work_survey.pdf (28 October 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/8b/92/ket373.PMC3930885.pdf
"A National Picture 2010, http://www.nras.org.uk/includes/documents/cm_docs//2010/j/j4660_scottish_survey_doc_revised.pdf (28 October 2013, datelast accessed).",Non-OADS,/arxiv_data1/oa_pdf/8b/92/ket373.PMC3930885.pdf
"2012. http://www.nras.org.uk/includes/ documents/cm_docs/2010/j/j4203_revised_purple_bene-fits_booklet_final.pdf (28 October 2013, date lastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/8b/92/ket373.PMC3930885.pdf
"2013. https://www.gov.uk/browse/benefits (28 October 2013,date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/8b/92/ket373.PMC3930885.pdf
"http://apps.who.int/bmi/index.jsp?introPage=intro_3.html (28 October 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/8b/92/ket373.PMC3930885.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/28/ket378.PMC3930886.pdf
http://www.rheumatology.org/practice/clinical/classification/SLE/1997_update_of_the_1982_acr_revised_criteria_for_classification_of_sle.,Non-OADS,/arxiv_data1/oa_pdf/8a/28/ket378.PMC3930886.pdf
"Firstly, 12 SNPs which showed strong linkage disequilibrium (LD) with rs11879293 (r 2.0.8) were found within the promising LD block by utilizing the genotyping data from 1000 Genome Project data (http://browser.1000genomes.org/Homo_sapiens/Info/Index) using 1000GENOMES: phase_1_CHS among Southern Han Chinese.",OADS,/arxiv_data1/oa_pdf/72/5c/srep04147.PMC3930892.pdf
"Meanwhile, SMARCA4 has also been found under expressed in human hepatocellular carcinoma bysearching gene expression atlas (http://www.ebi.ac.uk/gxa/qrs) 36.I n the study, SMARCA4 rs11879293 A allele presented a significantly decreased risk of HCC compared with rs11879293 G allele in boththe detection and validation stages.",Non-OADS,/arxiv_data1/oa_pdf/72/5c/srep04147.PMC3930892.pdf
"In stage 1, TagSNPs were selected by SNPs genotype information downloaded from HapMap (http://www.hapmap.org/) using phase 2 and phase 3 Data Release 27 among Chinese population (Chinese Han from Beijing-CHB) for genes ARID2 ,ARID1A ,BRD7 , PBRM1 ,SMARCA4 , and SNF5 , using the criteria of r2.0.8 and minor allele frequency (MAF) .0.05 across the region of candidate genes.",Non-OADS,/arxiv_data1/oa_pdf/72/5c/srep04147.PMC3930892.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/72/5c/srep04147.PMC3930892.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4147 | DOI: 10.1038/srep04147 6",Non-OADS,/arxiv_data1/oa_pdf/72/5c/srep04147.PMC3930892.pdf
To date smallest commercially available SNOM tips achieve aperture diameters of 50 nm - 100 nm (Nanonics - Optometronic 4000TMat http://www.nanonics.co.il/products/nsom-spm-systems/optometronic-4000.html).,Non-OADS,/arxiv_data1/oa_pdf/a1/97/srep04096.PMC3930893.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4096 | DOI: 10.1038/srep04096 8",Non-OADS,/arxiv_data1/oa_pdf/a1/97/srep04096.PMC3930893.pdf
This is an open- access article distributed under the terms of the Creative C ommons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/82/44/jcav05p0143.PMC3930905.pdf
http://www.botanicasp.org.br/pau_brasil/resumos/29.htm.,Non-OADS,/arxiv_data1/oa_pdf/82/44/jcav05p0143.PMC3930905.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e3/dc/jcav05p0151.PMC3930906.pdf
"Since the incidences of breast and endometrial cancer  have been increasing (Figure 1), according to the  Taiwan  cancer  registration  system  (https://cris.bhp.",Non-OADS,/arxiv_data1/oa_pdf/e3/dc/jcav05p0151.PMC3930906.pdf
The above data were obtained  from  the National Health Insurance Research Database  (NHIRD)  (http://www.nhri.org.tw/nhird/en/index.,OADS,/arxiv_data1/oa_pdf/e3/dc/jcav05p0151.PMC3930906.pdf
This is an open- access article distributed  under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/fc/3e/jcav05p0156.PMC3930907.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.11.002☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/ea/e6/main.PMC3930956.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.12.002☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/45/98/main.PMC3930957.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.11.004☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/e2/c8/main.PMC3930958.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.11.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/70/3b/main.PMC3930959.pdf
"Published by Elsevier B.V. All rights reserved.http://dx.doi.org/10.1016/j.mmcr.2014.01.002☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium,provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/f6/4c/main.PMC3930961.pdf
"In the data given by the European Confederation of Medical Mycology (ECMM) Working Group of the Survey of Coccidioidomycosis in Europe, 36 cases were reported from nine countries but limited or no data were provided ( http://www.ecmm.eu/node/193 ).",Non-OADS,/arxiv_data1/oa_pdf/f6/4c/main.PMC3930961.pdf
"Published by Elsevier B.V. All rights reserved.http://dx.doi.org/10.1016/j.mmcr.2013.11.003☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c0/c7/main.PMC3930962.pdf
References [1] 〈http://www.usrds.org/default.aspx 〉.,OADS,/arxiv_data1/oa_pdf/c0/c7/main.PMC3930962.pdf
"http://dx.doi.org/10.1016/j.mmcr.2013.10.003☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permitsnon-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/24/ef/main.PMC3930963.pdf
"The paradigm version of this family is E. coli lacZ pro- duct, which is a large/soluble polypeptide of 1024 amino acids/residues ( ,120 kDa) (http://www.ecogene.org/old/geneinfo.php?",Non-OADS,/arxiv_data1/oa_pdf/b4/e2/srep04140.PMC3931136.pdf
"The multiple alignments were conducted using ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2/index.html), and the resultant output was processed by program ESPript 2.2 (http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.cgi) 46–48.",OADS,/arxiv_data1/oa_pdf/b4/e2/srep04140.PMC3931136.pdf
"The structure of S. suis BgaC homologue was modelled through CPHmodels 3.0 Server (http://www.cbs.dtu.dk/services/CPHmodels), and superimposed with the known structure of S. pneumonia e BgaC.",OADS,/arxiv_data1/oa_pdf/b4/e2/srep04140.PMC3931136.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4140 | DOI: 10.1038/srep04140 9",Non-OADS,/arxiv_data1/oa_pdf/b4/e2/srep04140.PMC3931136.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)High-density great tit linkage maps Kv a nO e r s et al 316 Heredity",Non-OADS,/arxiv_data1/oa_pdf/54/6a/hdy2013107a.PMC3931172.pdf
"http://www.R-project.orgVienna Rockman MV, Kruglyak L (2009).",Non-OADS,/arxiv_data1/oa_pdf/69/60/hdy2013100a.PMC3931175.pdf
org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Experimental evolution of inbreeding depression IM Chelo et al 254 Heredity,Non-OADS,/arxiv_data1/oa_pdf/69/60/hdy2013100a.PMC3931175.pdf
Available from: http://digicollection.org/hss/documents/ s18063en/s18063en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a4/fd/PRev-8-22.PMC3931198.pdf
"Available from: http://biodiversity.uno.edu/delta/,  14th December 2000.",Non-OADS,/arxiv_data1/oa_pdf/a4/fd/PRev-8-22.PMC3931198.pdf
Available  from: http://frlht.org.in/html/reports/meghalayaslpc.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a4/fd/PRev-8-22.PMC3931198.pdf
12. http://eng.hi138.com [homepage on the Internet].,Non-OADS,/arxiv_data1/oa_pdf/91/26/PRev-8-45.PMC3931200.pdf
"Research  paper centre, Yang M, Yang C, Bai S, Zhao M, Zhu M.  Tribulus terrestris Extraction of total flavonoids, Posted:  2011‑4‑27 16:01:00 Available from: http://eng.hi138.com/ medicine‑papers/pharmacypapers/201104/304632_ tribulus‑terrestris‑extraction‑of‑total‑flavonoids.asp#.UekwFtIwet8.",Non-OADS,/arxiv_data1/oa_pdf/91/26/PRev-8-45.PMC3931200.pdf
Available from: http://news.sciencemag.org/ sciencenow/2009/05/28‑01.html.,Non-OADS,/arxiv_data1/oa_pdf/5a/21/PRev-8-52.PMC3931201.pdf
Available from: http://www.essentialdayspa.com/Skin_ Anathomy_And_Physiology.htm.,Non-OADS,/arxiv_data1/oa_pdf/5a/21/PRev-8-52.PMC3931201.pdf
Available from: http://www.webmd.com/skin‑problems.,Non-OADS,/arxiv_data1/oa_pdf/5a/21/PRev-8-52.PMC3931201.pdf
Available from: http://www.zipcodezoo.com/Plants/C/Costus_ igneus/.,Non-OADS,/arxiv_data1/oa_pdf/75/71/PRev-8-67.PMC3931203.pdf
Available from: http://www.pharmacologyonline.,Non-OADS,/arxiv_data1/oa_pdf/75/71/PRev-8-67.PMC3931203.pdf
"Shetty AJ, HYPERLINK “http://www.ncbi.nlm.nih.gov/ pubmed/?term=Choudhury%20D%5Bauth%5D” Choudhury D,  Rejeesh VN, Nair V, Kuruvilla M, Kotian S. Effect of the insulin  plant ( Costus igneus ) leaves on dexamethasone‑induced  hyperglycemia.",Non-OADS,/arxiv_data1/oa_pdf/75/71/PRev-8-67.PMC3931203.pdf
Available  from:http://www.appliedradiology.com/uploadedfiles/Issues/2002/08/ Supplements/AR_SCVIR_August02_Abu_Judeh.pdf [last cited 2014 Jan  11].,Non-OADS,/arxiv_data1/oa_pdf/9b/91/IJABMR-4-1.PMC3931205.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/9b/91/IJABMR-4-1.PMC3931205.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/9b/91/IJABMR-4-1.PMC3931205.pdf
http://ratings2005.healthcarecommission.org.uk 11.,Non-OADS,/arxiv_data1/oa_pdf/a8/32/IJABMR-4-11.PMC3931206.pdf
"Available from: http://www.msdh.state.ms.us/msdhsite/43,10520,297,146.",Non-OADS,/arxiv_data1/oa_pdf/a8/32/IJABMR-4-11.PMC3931206.pdf
Available from: http://www.nvbdcp.gov.in/ Chikun‑main.html.,Non-OADS,/arxiv_data1/oa_pdf/65/09/IJABMR-4-47.PMC3931215.pdf
Clin Microbiol Rev  1997;10:781‑91.Letter to the Editor Instructions for Authors: Please see on http://www.ijabmr.org /contributors.asp,Non-OADS,/arxiv_data1/oa_pdf/70/74/IJABMR-4-59.PMC3931219.pdf
Available from: http://www.scipy.org.,Non-OADS,/arxiv_data1/oa_pdf/3b/15/IJABMR-4-7.PMC3931220.pdf
"1, 20143 Karam: Measurement Traceability Efforts in positioning NMI attention strategically to address  stakeholder needs [such as the International Committee for  Weights and Measures’ Consultative Committee on Ionizing  Radiation (CCRI), (http://www.bipm.org/utils/common/pdf/ CCRI22.pdf) and of the Committee on Ionizing Radiation  Measurements and Standards, CIRMS (www.cirms.org)]  have increased in recent years.",Non-OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
"With the collaborations  that continue to develop between NMIs and stakeholders  such as clinics, user groups (the Radiological Society of  North America, the Society of Nuclear Medicine, and the  American Association of Physicists in Medicine in the  Americas as examples), international organizations (such as  the International Organization of Medical Physics, IOMP ,  http://www.iomp.org/) and others, measurement traceability  will lead to confidence in the key results needed for drug  and device development and marketing, therapy planning  and efficacy, disease screening, patient safety, and industry  support for now and into the future.",Non-OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
"Available from: http://www.bipm.org/utils/common/documents/jcgm/JCGM_200_2012.pdf (or via the BIPM  homepage at www.bipm.org), 2012 [Last accessed on 2013 Dec 17].",Non-OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
"Available  from: https://www.ilac.org/documents/ILAC_P10_01_2013.pdf,  2013 [Last accessed on 2013 Dec 17].",Non-OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
"Available from: http://www.bipm.org/utils/ common/documents/jcgm/JCGM_100_2008_E.pdf, 2008 [Last  accessed on 2013 Dec 17].",OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
Available  from: http://www.gpo.gov/fdsys/pkg/CFR‑2011‑title21‑vol8/ pdf/CFR‑2011‑title21‑vol8‑sec900‑12.pdf [Last accessed on  2013 Dec 17].,Non-OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
Available from: http://www.fda.gov/Radiation‑EmittingProducts/ Mammography Quality Standards Actand Program/ FacilityCertificationandInspection/[Last accessed on 2013 Dec 17].,OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2807674/[Last accessed on 2013 Dec 17].,Non-OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
Available from: http://www.nist.gov/pml/div682/grp04/petct‑imaging.,OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
Available from: http://www.nist.gov/pml/div682/grp04/pet‑scanner.,OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
Available from http://www.nist.gov/pml/div682/grp02/index.,OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/d2/ac/JMP-39-1.PMC3931221.pdf
http://www.nist.gov/pml/data/ xcom/index.cfm.,OADS,/arxiv_data1/oa_pdf/72/97/JMP-39-24.PMC3931224.pdf
Available from:  http://www.irs.inms.nrc.ca/EGSnrc/pirs702.pdf [Last accessed on  2013 May 15.],OADS,/arxiv_data1/oa_pdf/6b/3c/JMP-39-4.PMC3931226.pdf
Available from: http://www.irs.,OADS,/arxiv_data1/oa_pdf/6b/3c/JMP-39-4.PMC3931226.pdf
Available from:  http://physics.nist.gov/PhysRefData/Xcom/html/xcom1.html [Last  accessed on 2013 Aug 01.],OADS,/arxiv_data1/oa_pdf/6b/3c/JMP-39-4.PMC3931226.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/6b/3c/JMP-39-4.PMC3931226.pdf
Available from: http://www.crcpd.org/PDF/NEXT2000 CTProl.,Non-OADS,/arxiv_data1/oa_pdf/88/51/JMP-39-50.PMC3931229.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/88/51/JMP-39-50.PMC3931229.pdf
Access this article online Quick Response Code: Website:   www.jmp.org.in DOI:   10.4103/0971-6203.125510 For instructions for authors please visit our website http://www.jmp.org.in/contributors.asp,Non-OADS,/arxiv_data1/oa_pdf/de/30/JMP-39-56.PMC3931230.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9a/9e/jcav05p0166.PMC3931264.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/83/25/jcav05p0173.PMC3931265.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f0/bb/jcav05p0182.PMC3931266.pdf
http://seer.cancer.gov/csr/1975_2009_pops09/.,Non-OADS,/arxiv_data1/oa_pdf/f0/bb/jcav05p0182.PMC3931266.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/98/95/jcav05p0192.PMC3931267.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/13/47/jcav05p0203.PMC3931268.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c7/89/jcav05p0214.PMC3931269.pdf
"We identified a cohort of men diagnosed with  prostate cancer between 1 January 2006 and 31 D e- cember 2011 from the New Zealand Cancer Registry (NZCR , http://www.health.govt.nz/nz -health -statist ics/n ational -collections -and-surveys/collections/ne w-zealand -cancer -registry -nzcr),  which collects data  on all new cases  of malignant cancers in NZ excluding  squamous cell carcinoma and basal cell carcinoma of the skin.",Non-OADS,/arxiv_data1/oa_pdf/c7/89/jcav05p0214.PMC3931269.pdf
"The information included chemical ID, indicating the primary active  chemical ingredient, and the therapeutic group level  1-3 (more  detail  on http://www.pharmac.hea lth.nz/   tools -resources/pharmaceutical -schedule ).",OADS,/arxiv_data1/oa_pdf/c7/89/jcav05p0214.PMC3931269.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.The RISE Consortium*780 Diabetes Care Volume 37, March 2014EMERGING TECHNOLOGIES AND THERAPEUTICS",Non-OADS,/arxiv_data1/oa_pdf/9b/09/780.PMC3931376.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0816/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/f1/43/625.PMC3931377.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Steven A. Safren,1Jeffrey S. Gonzalez,2,3 Deborah J. Wexler,4Christina Psaros,1 Linda M. Delahanty,4Aaron J. Blashill,1 Aleksandra I. Margolina,1and Enrico Cagliero4Diabetes Care Volume 37, March 2014 625CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL",Non-OADS,/arxiv_data1/oa_pdf/f1/43/625.PMC3931377.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Rosette J. Chakkalakal,1 Sunil Kripalani,1David G. Schlundt,2,3 Tom A. Elasy,1,3and Chandra Y. Osborn1,3,4Diabetes Care Volume 37, March 2014 e53eLETTERS –OBSERVATIONS",Non-OADS,/arxiv_data1/oa_pdf/b6/b7/e53.PMC3931378.pdf
Available from http://pewinternet.org/Reports/2012/Digital-differences.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b6/b7/e53.PMC3931378.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1755/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c4/ca/830.PMC3931379.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Rita Rastogi Kalyani,1Mariana Lazo,2 Pamela Ouyang,3Evrim Turkbey,4 Karinne Chevalier,2Frederick Brancati,2 Diane Becker,2and Dhananjay Vaidya2830 Diabetes Care Volume 37, March 2014CARDIOVASCULAR AND METABOLIC RISK",Non-OADS,/arxiv_data1/oa_pdf/c4/ca/830.PMC3931379.pdf
A full list of participating MESAinvestigators and institutions can be found athttp://www.mesa-nhlbi.org.,Non-OADS,/arxiv_data1/oa_pdf/c4/ca/830.PMC3931379.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Catherine Kim,1Patricia A. Cleary,2 Catherine C. Cowie,3Barbara H. Braffett,2 Rodney L. Dunn,4Mary E. Larkin,5 Patricia M. Gatcomb,6Hunter B. Wessells,7 David M. Nathan,5and Aruna V. Sarma,4 for the DCCT/EDIC Research Group*Diabetes Care Volume 37, March 2014 701EPIDEMIOLOGY/HEALTH SERVICES RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/60/48/701.PMC3931380.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1545/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/3e/22/634.PMC3931381.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Michael E. Miller,1Jeff D. Williamson,1 Hertzel C. Gerstein,2Robert P. Byington,1 William C. Cushman,3Henry N. Ginsberg,4 Walter T. Ambrosius,1Laura Lovato,1and William B. Applegate,1for the ACCORD Investigators*634 Diabetes Care Volume 37, March 2014CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL",Non-OADS,/arxiv_data1/oa_pdf/3e/22/634.PMC3931381.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Gayatri Sarkar,1May Alattar,1 Rebecca J. Brown,1Michael J. Quon,2 David M. Harlan,3and Kristina I. Rother1666 Diabetes Care Volume 37, March 2014CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL",Non-OADS,/arxiv_data1/oa_pdf/98/b2/666.PMC3931382.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Danielle Hessler,1Lawrence Fisher,1 Russell E. Glasgow,2Lisa A. Strycker,3 L. Miriam Dickinson,4Patricia A. Arean,1 and Umesh Masharani1Diabetes Care Volume 37, March 2014 617CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL",Non-OADS,/arxiv_data1/oa_pdf/07/e2/617.PMC3931383.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Vera Novak,1William Milberg,2 Ying Hao,1,3Medha Munshi,1,4 Peter Novak,5Andrew Galica,1 Bradley Manor,1Paula Roberson,6 Suzanne Craft,7and Amir Abduljalil8Diabetes Care Volume 37, March 2014 751EMERGING TECHNOLOGIES AND THERAPEUTICS",Non-OADS,/arxiv_data1/oa_pdf/67/e9/751.PMC3931384.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Babak Mokhlesi,1,2 Daniela Grimaldi,1,2and Eve Van Cauter1,3e60 Diabetes Care Volume 37, March 2014eLETTERS –COMMENTS AND RESPONSES",Non-OADS,/arxiv_data1/oa_pdf/5d/0a/e60.PMC3931385.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-1276/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b8/cf/876.PMC3931386.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Nisa M. Maruthur,1,2,3 Matthew O. Gribble,2,3 Wendy L. Bennett,1,2Shari Bolen,4,5,6 Lisa M. Wilson,7Poojitha Balakrishnan,3 Anita Sahu,8Eric Bass,1,7 W.H.",Non-OADS,/arxiv_data1/oa_pdf/b8/cf/876.PMC3931386.pdf
"‡By convention, for CYP2C9 , numerals (e.g., 1, 2, and 3) are used to identify haplotypes rather than base or amino acid changes, and the “1”allele is the wild-type or ancestral haplotype (technically, “1A”; The Human Cytochrome P450 Allele Nomenclature Committee; CYP2C9 allele nomenclature; http://www.cypalleles.ki.se/cyp2c9.htm, accessed 5 November 2013).",Non-OADS,/arxiv_data1/oa_pdf/b8/cf/876.PMC3931386.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Jennifer L. Sherr, Miladys Palau Collazo, Eda Cengiz, Camille Michaud, Lori Carria, Amy T. Steffen, Kate Weyman,Melinda Zgorski, Eileen Tichy,William V. Tamborlane, andStuart A. WeinzimerDiabetes Care Volume 37, March 2014 773EMERGING TECHNOLOGIES AND THERAPEUTICS",Non-OADS,/arxiv_data1/oa_pdf/55/df/773.PMC3931387.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Stacy A. Brethauer,1Ali Aminian,1 Raul J. Rosenthal,2John P. Kirwan,3 Sangeeta R. Kashyap,3 and Philip R. Schauer1Diabetes Care Volume 37, March 2014 e51eLETTERS –OBSERVATIONS",Non-OADS,/arxiv_data1/oa_pdf/f2/bd/e51.PMC3931388.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0790/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/53/4d/686.PMC3931389.pdf
"See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.Peter E. Linz,1Laura C. Lovato,2 Robert P. Byington,2Patrick J. O ’Connor,3 Lawrence A. Leiter,4Daniel Weiss,5 Rex W. Force,6John R. Crouse,2 Faramarz Ismail-Beigi,7Debra L. Simmons,8 Vasilios Papademetriou,9 Henry N. Ginsberg,10and Marshall B. Elam11686 Diabetes Care Volume 37, March 2014CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL",Non-OADS,/arxiv_data1/oa_pdf/53/4d/686.PMC3931389.pdf
The author thanks all of the participants in the Wolfram Syndrome International Registry (http://wolframsyndrome.dom.wustl.edu/) and the Washington University Wolfram Clinic for their time and effort.,Non-OADS,/arxiv_data1/oa_pdf/d7/3b/844.PMC3931391.pdf
"In particular, the Phenotype-Genotype Integrator(https://www.ncbi.nlm.nih.gov/gap/PheGenI),Pritchard ’s laboratory eQTL browser (http://eqtl.",Non-OADS,/arxiv_data1/oa_pdf/a1/6f/1154.PMC3931395.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 227–236Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  227Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S3408 9Clinical utility in the treatment of type 2 diabetes  with the saxagliptin/metformin fixed combination George S Panagoulias1 John Doupis2,3 11st Department of Propaedeutic and  internal Medicine, Athens University  Medical School, Laiko General  Hospital, Athens, Greece; 2Salamis  Naval Hospital, Athens, Greece;  3Diabetes Division, iatriko Paleou  Falirou Medical Center, Athens,  Greece Correspondence: John Doupis   iatriko Paleou Falirou Medical Center,   Diabetes Division, 36 Areosst,   175 62 Paleou Falirou, Athens, Greece   Tel/Fax +30 210 989 2300   email john.doupis@joslin.harvard.ed uAbstract:  Fixed-dose combination (FDC) products represent a widely accepted approach to  type 2 diabetes treatment, given that monotherapies sometimes fail to meet the treatment  targets –  obtaining a sustained reduction in micro- and macrovascular complications.",Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Available  from: http://www.cdc.gov/diabetes/pubs/factsheet11.htm .,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Available from: http://web.archive.org/ web/20070929152824/http://www.fda.gov/bbs/topics/ANSWERS/ ANS00627.html .,OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Available from: http://www.drugs.co m/symlin.html.,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Avail - able from http://www.gsk.com/media/press-releases/2013/regulatory- update--gsk-announces-regulatory-submission-for-albig.html.,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Available from http://google2.fda.gov/searchq=Albiglutide&client=   FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&output=   xml_no_dtd&getfields=*.,OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Available from: http://www.fda.gov/Safety/ MedWatch/ SafetyInformation/SafetyAlertsforHumanMedicalProducts/ ucm258826.htm .,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Availabe from http://clinicaltrials.gov/ct2/show/ NCT00690638?term=Dutogliptin&rank=9.,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Available from: http://www.bms.com/Documents/news/onglyza_  available.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Public_assessment_report/human/001039/ WC500044319.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Available from:  http://www.onglyza.com/about/faq.aspx .,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Available from: http://packageinserts.bms.,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Available from: http://clinicaltrials.gov/ct2/ results?ter m=saxagliptin&Search =Search.,OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Geneva: World Health Organization; 2013; Available from:  http://www.who.int/chp/knowledge/publications/adherence_report/en /.,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
"Available from: http://news.bms.com/ press-release/astrazeneca-and-bristol-myers-squibb-announce-top-line- results-savor-timi-53-cardiova s. Accessed July 29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
"Available  from: http://www.drugs.co m. Accessed July 21, 2013.",Non-OADS,/arxiv_data1/oa_pdf/b6/ff/ppa-8-227.PMC3931578.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/36/ppa-8-219.PMC3931579.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 219–226Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  219OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5863 1strategies for enhancing information, motivation,   and skills for self-management behavior changes:   a qualitative study of diabetes care for older   adults in Korea suyoung choi1 Misoon song2 sun Ju chang3 se-an Kim4 1college of nursing, Jeju national  University, Jeju, Korea; 2college of  nursing, and The research institute  of nursing science, seoul national  University, seoul, Korea; 3Department  of nursing science, chungbuk  national University, cheongju, Korea;   4college of nursing, seoul national  University, seoul, Korea correspondence: Misoon song   college of nursing, seoul national   University, 28 Yeongun-Dong,   chongno-gu, seoul 110-799, Korea   Tel +82 2 740 8826   Fax +82 2 764 8457   email msong@snu.ac.k rPurpose:  To describe strategies for enhancing information, motivation, and skills related to  changes in diabetes self-management behavior among community-dwelling older adults in  Korea.",Non-OADS,/arxiv_data1/oa_pdf/e0/36/ppa-8-219.PMC3931579.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/e0/36/ppa-8-219.PMC3931579.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/36/ppa-8-219.PMC3931579.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/62/prbm-7-053.PMC3931580.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPsychology Research and Behavior Management 2014:7 53–66Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  53Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PRBM.S4046 1Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/a5/62/prbm-7-053.PMC3931580.pdf
"Or use: http://dvpr.es/1apIXu gFamily structure and risk behaviors: the role   of the family meal in assessing likelihood   of adolescent risk behaviors Samantha Goldfarb will L Tarver Bisakha Sen Department of Health Care  Organization and Policy, School of  Public Health, University of Alabama  at Birmingham, Birmingham, AL, USA Correspondence: Bisakha Sen   Department of Health Care   Organization and Policy, School of   Public Health, University of Alabama   at Birmingham, Ryals Public Health   Building, 1665 University Boulevard,   Birmingham, AL 35294-0022, USA   Tel +1 205 975 8960   email bsen@uab.ed uBackground:  Previous literature has asserted that family meals are a key protective factor for  certain adolescent risk behaviors.",Non-OADS,/arxiv_data1/oa_pdf/a5/62/prbm-7-053.PMC3931580.pdf
"There  is a substantial literature that finds that eating with the  family more frequently is associated with better psycho - logical well-being4–8 and a lower risk of substance use and  delinquency.4,5,7,9–13 Such findings have inspired community-,  state-, and national-level programs that promote the concept  of regular family meals, eg, the Family Day program initiated  by the National Center on Addiction and Substance Abuse  (http://www.casafamilyday.org ).11 Numerous mechanisms  via which family meals can improve adolescent well-being  have been posited.",Non-OADS,/arxiv_data1/oa_pdf/a5/62/prbm-7-053.PMC3931580.pdf
Available  from: http://www.nytimes.com/2009/10/04/fashion/04dinner.html .,Non-OADS,/arxiv_data1/oa_pdf/a5/62/prbm-7-053.PMC3931580.pdf
Available from: http://clinton3.nara.gov/WH/EOP/ CEA/html/Teens_Paper_Final.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a5/62/prbm-7-053.PMC3931580.pdf
Available from: http://www.casacolumbia.org/upload /2012/2012924familydinnersVIII.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a5/62/prbm-7-053.PMC3931580.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/a5/62/prbm-7-053.PMC3931580.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a5/62/prbm-7-053.PMC3931580.pdf
Available from: http://www.npr.org/blogs/ health/2011/12/12/143521104/french-lessons-why-letting-kids-drink- at-home-isn-t-tres-bien .,Non-OADS,/arxiv_data1/oa_pdf/a5/62/prbm-7-053.PMC3931580.pdf
Available from:  http://www.cdc.gov/media/releases/2013/p0905-ecigarette-use.html .,OADS,/arxiv_data1/oa_pdf/a5/62/prbm-7-053.PMC3931580.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/46/ppa-8-237.PMC3931581.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 237–246Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  237OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S5756 7Barriers and facilitators to self-monitoring   of blood glucose in people with type 2 diabetes  using insulin: a qualitative study Woon May Ong1 siew siang chua1 chirk Jenn ng2 1Department of Pharmacy, 2University  of Malaya Primary care research  group (UMP crg ), Department of  Primary care Medicine, Faculty of  Medicine, University of Malaya, Kuala  lumpur, Malaysia correspondence: siew siang chua   Department of Pharmacy, Faculty   of Medicine, University of Malaya,   50603 Kuala lumpur, Malaysia   Tel +60 3 7967 6688   Fax +60 3 7967 4964   email chuass@um.edu.m yBackground:  Self-monitoring of blood glucose (SMBG) helps to improve glycemic control  and empowerment of people with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/8a/46/ppa-8-237.PMC3931581.pdf
Available from: http://www.sign.ac.uk/pdf/ sign116.pdf /.,Non-OADS,/arxiv_data1/oa_pdf/8a/46/ppa-8-237.PMC3931581.pdf
Available from:  http://www.treasury.gov.my/index.php?option =com_ conte nt&view=ar ticle&id=1041&Itemid =167&lang =my/.,Non-OADS,/arxiv_data1/oa_pdf/8a/46/ppa-8-237.PMC3931581.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/8a/46/ppa-8-237.PMC3931581.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/46/ppa-8-237.PMC3931581.pdf
"Analysis and presentation of T-cell subset distributions were performed using SPICE version 5.1, downloaded fromhttp://exon.niaid.nih.gov.",OADS,/arxiv_data1/oa_pdf/ae/38/mi201362a.PMC3931584.pdf
55 SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGEMENTS This work was funded by Cancer Research Wales and a University Award from the Wellcome Trust (Awen Gallimore).,Non-OADS,/arxiv_data1/oa_pdf/ae/38/mi201362a.PMC3931584.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLES Mucosal Immunology |VOLUME 7 NUMBER 2 |MARCH 2014 439",Non-OADS,/arxiv_data1/oa_pdf/ae/38/mi201362a.PMC3931584.pdf
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS The Research was supported by the National Institute for Health ResearchNewcastle Biomedical Research Centre based at Newcastle Hospitals Foundation Trust and Newcastle University.,Non-OADS,/arxiv_data1/oa_pdf/05/e1/mi201387a.PMC3931585.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLES Mucosal Immunology |VOLUME 7 NUMBER 3 |MAY 2014 693",Non-OADS,/arxiv_data1/oa_pdf/05/e1/mi201387a.PMC3931585.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/c9/ott-7-289.PMC3931632.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 289–295OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  289Case RepORTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OTT .S5808 9axitinib for preoperative downstaging of renal   cell carcinoma with sarcomatoid differentiation   and direct invasion of the duodenum and inferior   vena cava: a case report Hideo Yuki1,* Takao Kamai1,* Keiichi Kubota2 Hideyuki abe1 Daisaku Nishihara1 T omoya Mizuno1 akinori Masuda1 Hironori Betsunoh1 Masahiro Yashi1 Y oshitatsu Fukabori1 Ken-Ichiro Y oshida1 1Department of Urology,    2Department of Gastroenterological  surgery, Dokkyo Medical University,   Mibu, T ochigi, Japan *These authors contributed equally   to this manuscript Correspondence: Takao Kamai   Department of Urology,   Dokkyo Medical University,   880 Kitakobayashi Mibu,   Tochigi, 321-0293, Japan   Tel +81 282 87 2162   Fax +81 282 86 7533   email kamait@dokkyomed.ac.j pBackground:  Renal cell carcinoma (RCC) with sarcomatoid differentiation is invasive,  refractory to treatment, and has a higher mortality.",Non-OADS,/arxiv_data1/oa_pdf/00/c9/ott-7-289.PMC3931632.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/00/c9/ott-7-289.PMC3931632.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/c9/ott-7-289.PMC3931632.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/1a/tcrm-10-107.PMC3931636.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 107–112Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  107ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5625 5actual preoperative fasting time in Brazilian  hospitals: the BigF asT multicenter study José e de aguilar- nascimento1 ana l de almeida Dias2 Diana B Dock-n ascimento3 Maria isabel TD Correia4 antonio Cl Campos5 Pedro eder Portari-Filho6 sergio s Oliveira7 1Department of surgery, Julio Muller  University hospital, Cuiaba, Brazil;   2Federal University of Mato grosso,   Cuiaba, Brazil; 3Department of  sciences and Food, Federal University  of Mato grosso, Cuiaba, Brazil;   4Department of surgery, Federal  University of Minas gerais, Belo  horizonte, Brazil; 5Department of  surgery, Federal University of Parana,   Curitiba, Brazil; 6Department of  surgery, Federal University of Rio de  Janeiro state, Rio de Janeiro, Brazil;   7service of anesthesiology, Julio  Muller University hospital, Cuiaba,   Brazil On behalf of the BigF asT (Brazilian  group for the study of Preoperative  Fasting Time) group Correspondence: José eduardo de  aguilar-nascimento   Rodovia helder Cândia 2577,  Condomínio Country, Casa 15, 78048- 150, Cuiabá-MT, Brazil   Tel +55 653 623 7065   Fax +55 653 623 4020   email aguilar@terra.com.b rBackground:  Prolonged fasting increases organic response to trauma.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/tcrm-10-107.PMC3931636.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/tcrm-10-107.PMC3931636.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/1a/tcrm-10-107.PMC3931636.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/ott-7-263.PMC3931637.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 263–267OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  263Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S5690 9The relationship between intervention   in the CD40 signal pathway and choroidal   neovascularization Peipei Zhang1,2 Yan Su1,2 Fang Liu1,2 1Shanghai Tenth People’s Hospital of  Tongji University, Shanghai, People’s   Republic of China; 2wenzhou  Ophthalmology and Optometry  Hospital, wenzhou Medical College,  wenzhou, People’s Republic of China Correspondence: Fang Liu   Tenth People’s Hospital of Tongji   University, 301 YanChang Rd,   Shanghai 20072, People’s Republic   of China   email fangliu_2004@yahoo.co mAbstract:  Age-related macular degeneration, pathologic myopia, ocular trauma, and other  eye diseases can cause choroidal neovascularization (CNV).",Non-OADS,/arxiv_data1/oa_pdf/7d/40/ott-7-263.PMC3931637.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/40/ott-7-263.PMC3931637.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/40/ott-7-263.PMC3931637.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/d6/ppa-8-199.PMC3931638.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 199–209Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  199OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5058 3results of a human factors experiment of  the usability and patient acceptance of a new  autoinjector in patients with rheumatoid arthritis Florence schwarzenbach1 Michèle Dao Trong1 laurent grange2 Philippe e laurent3 herve Abry4 Joël cotten5 corinne granger1 1Medical Affairs, Becton Dickinson  Medical Pharmaceutical systems,   le-Pont-de-claix, France;   2rheumatology clinic, south  University hospital, echirolles, France;   3creabio-ra sAs, centre hospitalier,   givors, France; 4commercial  Development self Administration/ injec table systems, Becton  Dickinson Medical Pharmaceutical  systems, le-Pont-de-claix, France;   5Marketing, Becton Dickinson Medical  Pharmaceutical systems, le-Pont-de- claix, France correspondence: Florence schwarzenbach   Medical Affairs, Becton Dickinson Medical  Pharmaceutical systems, 11 rue A Berges,  F-38801 le-Pont-de-claix cedex, France   Tel +33 476 689 407   Fax +33 476 689 669   email florence_schwarzenbach@europe.",Non-OADS,/arxiv_data1/oa_pdf/e5/d6/ppa-8-199.PMC3931638.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/e5/d6/ppa-8-199.PMC3931638.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/d6/ppa-8-199.PMC3931638.pdf
"Available from: http://www.fda.gov/MedicalDevices/ Device Regulationand Guidance/GuidanceDocuments/ucm259748.ht m.  Accessed March 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/e5/d6/ppa-8-199.PMC3931638.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/65/ijn-9-975.PMC3931640.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 975–984International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  975OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4841 6In vivo and in vitro investigations   of a nanostructured coating material –   a preclinical study Martin adam1 cornelia ganz1 Weiguo Xu1 hamid-reza sarajian2 Werner götz3 Thomas gerber1 1Institute of Physics, rostock  University, rostock, germany;  2Department of Oral and Maxillofacial  Plastic surgery, rostock University,  rostock, germany; 3Department  of Orthodontics, center of Dento- Maxillo-Facial Medicine, Faculty of  Medicine, University of Bonn, Bonn,  germany correspondence: Thomas gerber   Universitätsplatz 3, Institute of Physics,  Faculty of Mathematics and Natural  sciences, rostock University,   18055 rostock, germany   Tel +49 381 498 6840   Fax +49 381 498 6862   email thomas.gerber@uni-rostock.d eAbstract:  Immediate loading of dental implants is only possible if a firm bone-implant  anchorage at early stages is developed.",Non-OADS,/arxiv_data1/oa_pdf/31/65/ijn-9-975.PMC3931640.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/31/65/ijn-9-975.PMC3931640.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/ijn-9-975.PMC3931640.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpSubstance Abuse and Rehabilitation 2013:4 75–82Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  75Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S3676 1Antitussives and substance abuse Jarrett M Burns edward w Boyer Division of Medical T oxicology,   Department of emergency Medicine,   University of Massachusetts Medical  School, worcester, MA, USA Correspondence: edward w Boyer   Division of Medical Toxicology,   Department of emergency Medicine,   University of Massachusetts Medical   School, 55 Lake Avenue North,   worcester, MA 01655, USA   Tel +1 508 421 1400   email edward.boyer@childrens.harvard.",Non-OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
To produce nominal effects from dextromethorphan – the  first plateau – online drug encyclopedias such as Erowid  (http://www.erowid.or g) describe a dose of between 100 and  200 mg.,Non-OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
Available from: https://aapcc.s3.amazonaws.,Non-OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
Available from: http://articles.latimes.com/2013/mar/18/entertainment/ la-et-ms-lil-wayne-hospital-nicki-minaj-drake-20130318.,Non-OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
"Available from: http://www.drugs.com/mtm/promethazine-with- codeine.htm l. Accessed June 19, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
"Available from:  http://www.rxlist.com/codeine-sulfate-drug/clinical-pharmacology.ht m.  Accessed June 19, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
Available at: http://www.erowid.org/ chemicals/dxm/faq/.,OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
Visit http://www.dovepress.com/testimonials.php   to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
Available from: http://www.erowid.,Non-OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
"Available from: http://www.fda.gov/Drugs/DrugSafety/ ucm236651.ht m. Accessed June 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a3/ec/sar-4-075.PMC3931656.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/dd/dddt-8-239.PMC3931658.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 239–243Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  239Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5254 5effect of vildagliptin add-on treatment  to metformin on plasma asymmetric  dimethylarginine in type 2 diabetes   mellitus patients Mustafa cakirca1 cumali Karatoprak1 Mehmet Zorlu1 Muharrem Kiskac1 Mustafa Kanat2 Mehmet ali cikrikcioglu1 Pinar soysal3 Mehmet hursitoglu4 ahmet adil camli1 reha erkoc1 Muhammad abdul-ghani5 1internal Medicine clinic, Faculty of  Medicine, Bezmialem Vakif University,   2Department of internal Medicine,   Medical Faculty, istanbul Medipol  University, 3Department of geriatric  Medicine, Medical Faculty, Dokuz  eylül University, 4Department of  internal Medicine, Kanuni sultan  suleyman Training and research  hospital, istanbul, T urkey; 5Division  of Medicin e – Diabetes, University of  Texas health science center at san  antonio, san antonio, TX, Usa correspondence: cumali Karatoprak   internal Medicine clinic, Faculty of   Medicine, Bezmialem Vakif University,   Adnan Menderes Bulvarı Vatan   caddesi, Fatih, istanbul 34093, Turkey   Tel +90 212 453 1700 ext 1074   Fax +90 212 533 2326   email ckaratoprak@hotmail.co mAims:  A close association has been demonstrated between increased cardiovascular risk and  high asymmetric dimethylarginine (ADMA) levels in type 2 diabetes mellitus (DM) patients.",Non-OADS,/arxiv_data1/oa_pdf/70/dd/dddt-8-239.PMC3931658.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/70/dd/dddt-8-239.PMC3931658.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/dd/dddt-8-239.PMC3931658.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/0c/ott-7-281.PMC3931660.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 281–288OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  281Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5659 6The value of radiotherapy in breast cancer patients  with isolated ipsilateral supraclavicular lymph node  metastasis without distant metastases at diagnosis:  a retrospective analysis of chinese patients san-gang Wu1,* Jia-Yuan sun2,* Juan Zhou3,* Feng-Yan li2 Qin lin1 huan-Xin lin2 Zhen-Yu he2 1Xiamen cancer center, Department  of radiation Oncology, the First  affiliated hospital of Xiamen  University, Xiamen, People’s republic  of china; 2sun Yat-sen University  cancer center, state Key laboratory  of Oncology in south china,   Department of radiation Oncology,   collaborative innovation center of  cancer Medicine, guangzhou, People’s  republic of china; 3Xiamen cancer  center, Department of Obstetrics  and gynecology, the First affiliated  hospital of Xiamen University,   Xiamen, People’s republic of china *These authors contributed equally  to this work correspondence: Zhen-Yu he   sun Yat-sen University cancer center,  state Key laboratory of Oncology in  south china, Department of radiation  Oncology, collaborative innovation  center of cancer Medicine,   651 Dongfeng road east, guangzhou  510060, People’s republic of china   Tel +86 20 8734 3543   Fax +86 20 8734 3392   email hezhy@sysucc.org.c nBackground:  The purpose of this study was to investigate the prognosis of ipsilateral  supraclavicular lymph node metastasis (ISLM) without evidence of distant metastases at  diagnosis in Chinese women with breast cancer and to elucidate the clinical value of adjuvant  radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/65/0c/ott-7-281.PMC3931660.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/65/0c/ott-7-281.PMC3931660.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/0c/ott-7-281.PMC3931660.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/sar-5-013.PMC3931661.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpSubstance Abuse and Rehabilitation 2014:5 13–23Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  13ORiginAl ReSeARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S5518 0Factors associated with reductions in alcohol   use between high school and college: an analysis  of data from the college Alcohol Study christopher A Swann1 Michelle Sheran1 Diana Phelps2 1Department of economics, University  of north carolina at greensboro,   greensboro, nc, USA; 2RTi  international, Research Triangle Park,   nc, USA correspondence: christopher A Swann   Department of economics, University   of north carolina at greensboro,   1400 Spring garden Street greensboro,  nc 27412, USA   email chris_swann@uncg.ed uBackground:  The consumption of alcohol by college students is a significant public health  concern, and a large amount of literature explores this issue.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/sar-5-013.PMC3931661.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/b7/98/sar-5-013.PMC3931661.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/98/sar-5-013.PMC3931661.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/2a/ott-7-269.PMC3931666.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 269–280OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  269Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5804 4nickel nanoparticle-induced dose-dependent  cyto-genotoxicity in human breast carcinoma  McF-7 cells Maqusood ahamed1 hisham a alhadlaq1,2 1King abdullah institute for  nanotechnology, King saud University,   2Department of Physics and  astronomy, college of science, King  saud University, riyadh, saudi arabia correspondence: Maqusood ahamed   King abdullah institute for nanotechnology,   King saud University, PO Box 2454,   riyadh 11451, saudi arabia   Tel +966 469 8781   Fax +966 467 0664   email mahamed@ksu.edu.s aAbstract:  Despite the widespread application of nickel nanoparticles (Ni NPs) in industrial,  commercial, and biomedical fields, their response to human cells has not been clearly elucidated.",Non-OADS,/arxiv_data1/oa_pdf/4e/2a/ott-7-269.PMC3931666.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4e/2a/ott-7-269.PMC3931666.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/2a/ott-7-269.PMC3931666.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/72/sar-4-083.PMC3931692.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpSubstance Abuse and Rehabilitation 2013:4 83–99Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  83Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S3725 83,4-methylenedioxymethamphetamine   (MDMA): current perspectives Jerrold S Meyer Department of Psychology,   Neuroscience and Behavior Program,   University of Massachusetts, Amherst,   MA, USA Correspondence: Jerrold S Meyer   Department of Psychology,   T obin Hall, 135 Hicks way, University of   Massachusetts, Amherst, MA 01003, USA   Tel +1 413 545 2168   Fax +1 413 545 0996   email jmeyer@psych.umass.ed uAbstract:  Ecstasy is a widely used recreational drug that usually consists primarily of 3,4-meth - ylenedioxymethamphetamine (MDMA).",Non-OADS,/arxiv_data1/oa_pdf/df/72/sar-4-083.PMC3931692.pdf
Available from: http://www.unodc.,Non-OADS,/arxiv_data1/oa_pdf/df/72/sar-4-083.PMC3931692.pdf
Available from: http://ndarc.med.,Non-OADS,/arxiv_data1/oa_pdf/df/72/sar-4-083.PMC3931692.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/df/72/sar-4-083.PMC3931692.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/72/sar-4-083.PMC3931692.pdf
"Available from: http://www.drugabuse.gov/publica - tions/research-reports/mdma-ecstasy-abus e. Accessed July 21, 2013.",OADS,/arxiv_data1/oa_pdf/df/72/sar-4-083.PMC3931692.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/36/ndt-10-289.PMC3931693.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 289–295Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  289OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S5550 7effect of the coadministration of citalopram   with mirtazapine or atipamezole on rat   contextual conditioned fear Takahiro Masuda1,2 Takeshi inoue1 Yan an1 Naoki Takamura1,3 shin Nakagawa1 Yuji Kitaichi1 Tsukasa Koyama1 ichiro Kusumi1 1Department of Psychiatry, hokkaido  University graduate school of  Medicine, sapporo Japan; 2Medical  affairs, Dainippon sumitomo Pharma,   co, ltd, T okyo, Japan; 3regenerative  and cellular Medicine Office,   Dainippon sumitomo Pharma, co, ltd,   Osaka, Japan correspondence: Takeshi inoue   Department of Psychiatry, hokkaido  University graduate school of Medicine,  North 15, West 7, sapporo 060-8638,  Japan   Tel +81 117 065 160   Fax +81 117 065 081   email tinoue@med.hokudai.ac.j pBackground:  Mirtazapine, a noradrenergic and specific serotonergic antidepressant , which  blocks the α2-adrenergic autoreceptors and heteroreceptors, has shown anxiolytic properties  in clinical trials and preclinical animal experiments.",Non-OADS,/arxiv_data1/oa_pdf/24/36/ndt-10-289.PMC3931693.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/24/36/ndt-10-289.PMC3931693.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/36/ndt-10-289.PMC3931693.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/5b/sccaa-7-019.PMC3931695.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpStem Cells and Cloning: Advances and Applications 2014:7 19–29Stem Cells and Cloning: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  19Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SCCAA.S3800 6Direct reprogramming of adult cells: avoiding   the pluripotent state Sophia Kelaini Amy Cochrane Andriana Margariti Centre for experimental Medicine,  School of Medicine, Dentistry  and Biomedical Sciences, Queen’s  University Belfast, institute of Clinical  Sciences, Belfast, UK Correspondence: Andriana Margariti   Centre for experimental Medicine,  School of Medicine, Dentistry and  Biomedical Sciences, Queen’s University  Belfast, institute of Clinical Sciences   Belfast, BT12 6BA, UK   Tel +44 28 9063 4306   email a.margariti@qub.ac.u kAbstract:  The procedure of using mature, fully differentiated cells and inducing them toward  other cell types while bypassing an intermediate pluripotent state is termed direct reprogramming.",Non-OADS,/arxiv_data1/oa_pdf/68/5b/sccaa-7-019.PMC3931695.pdf
"Stem Cells and Cloning: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/stem-cells-and-cloning-advances-and-applications-journa lStem Cells and Cloning: Advances and Applications is an international,  peer-reviewed, open access journal.",Non-OADS,/arxiv_data1/oa_pdf/68/5b/sccaa-7-019.PMC3931695.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/5b/sccaa-7-019.PMC3931695.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/be/ndt-10-283.PMC3931697.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 283–287Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  283Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S58714T wo cases of mild serotonin toxicity via  5-hydroxytryptamine 1a receptor stimulation Hiroto Nakayama1,* sumiyo Umeda2,* Masashi Nibuya3 Takeshi T erao4 Koichi Nisijima5 soichiro Nomura3 1Yamaguchi prefecture Mental  Health Medical Center, Yamaguchi,   Japan; 2Department of psychiatry,   NTT West osaka Hospital, osaka,   Japan; 3Department of psychiatry,   National Defense Medical College,   saitama, Japan; 4Department of  Neuropsychiatry, oita University  Faculty of Medicine, oita, Japan;   5Department of psychiatry, Jichi  University school of Medicine,    T ochigi, Japan *These authors contributed equally   to this work Correspondence: Masashi Nibuya   Department of psychiatry, National   Defense Medical College, Namiki 3-2,   Tokorozawa, saitama 359-8513, Japan   email nibrin@ndmc.ac.j pAbstract:  We propose the possibility of 5-hydroxytryptamine (5-HT)1A  receptor involvement  in mild serotonin toxicity.",Non-OADS,/arxiv_data1/oa_pdf/22/be/ndt-10-283.PMC3931697.pdf
"The receptor binding  profiles of perospirone (excluding 5-HT1A receptor bind - ing) and its pharmacological properties targeting the positive  and negative symptoms of schizophrenia resemble those of  risperidone .7 The Ki values of perospirone for the dopamine  receptor D2, as well as for the 5-HT2A and 5-HT1A recep - tors are 1.4 nM, 0 .6 nM, and 2.9 nM, respectively,7 whereas  those of risperidone are 3.3 nM, 0.16 nM, and 250 nM,  respectively.8 Data on the Ki values measured from various  tissue sources can be viewed in the National Institute of   Mental Health  Psychoactive Drug Screening Program Ki  database (http://pdsp.med.unc.edu/pdsp.ph p) by choosing a  psychotropic drug for the test ligand.",Non-OADS,/arxiv_data1/oa_pdf/22/be/ndt-10-283.PMC3931697.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/22/be/ndt-10-283.PMC3931697.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/be/ndt-10-283.PMC3931697.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/sar-5-001.PMC3931699.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpSubstance Abuse and Rehabilitation 2014:5 1–12Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S3790 7Alcohol use disorder: pathophysiology, effects,   and pharmacologic options for treatment Robin C wackernah1 Matthew J Minnick1 Peter Clapp2 1Department of Pharmacy Practice,   2Department of Pharmaceutical  Sciences, School of Pharmacy,   Rueckert-Hartman College for Health  Professions, Regis University,    Denver, CO, USA Correspondence: Peter Clapp   Regis University, Rueckert-Hartman  College for Health Professions, School  of Pharmacy, 3333 Regis Blvd, H-28,  Denver, CO 80221-1099, USA   Tel +1 303 625 1312   Fax +1 303 625 1305   email pclapp@regis.ed uAbstract:  Alcohol use disorders (AUD) continue to be a concerning health issue worldwide.",Non-OADS,/arxiv_data1/oa_pdf/b0/9c/sar-5-001.PMC3931699.pdf
Available from: http://www.cdc.gov/nchs/data/series/ sr_10/sr10_256.pdf.,OADS,/arxiv_data1/oa_pdf/b0/9c/sar-5-001.PMC3931699.pdf
Available from: http://www.samhsa.gov/data/2k9/2k9Resultsweb/ web/2k9results.pdf.,OADS,/arxiv_data1/oa_pdf/b0/9c/sar-5-001.PMC3931699.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/b0/9c/sar-5-001.PMC3931699.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/9c/sar-5-001.PMC3931699.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/67/ndt-10-277.PMC3931701.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 277–282Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  277OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5705 7screening for autism in preterm children   with extremely low and very low birth weight iva Dudova1 Martina Kasparova2 Daniela Markova3 Jana Zemankova4 stepanka Beranova1 T omas Urbanek5 Michal hrdlicka1 1Department of child Psychiatry,   charles University second Faculty  of Medicine and University hospital  Motol, Prague, czech republic;   2Department of Pediatrics, charles  University second Faculty of Medicine  and University hospital Motol, Prague,   czech republic; 3Department of  Pediatrics and adolescent Medicine,   charles University First Faculty of  Medicine and general University  hospital, Prague, czech republic;   4Department of Pediatrics, charles  University Faculty of Medicine  and University hospital, hradec  Kralove, czech republic; 5institute  of Psychology, academy of sciences,   Brno, czech republic correspondence: iva Dudova   Department of child Psychiatry, charles  University second Faculty of Medicine,  University hospital Motol, V Uvalu 84,  15006 Prague, czech republic   Tel +42 02 2443 3458   Fax +42 02 2443 3420   email iva.dudova@lfmotol.cuni.c zBackground:  Studies of children with very low birth weight (VLBW , 1,000–1,500 g) and  extremely low birth weight (ELBW , less than 1,000 g) indicate that this population seems to  be at increased risk of autism spectrum disorder (ASD).",Non-OADS,/arxiv_data1/oa_pdf/36/67/ndt-10-277.PMC3931701.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/36/67/ndt-10-277.PMC3931701.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/67/ndt-10-277.PMC3931701.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/5c/ijn-9-877.PMC3931713.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 877–890International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  877OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5567 8Novel targeting using nanoparticles: an approach  to the development of an effective anti-leishmanial  drug-delivery system  Tatiana g ribeiro1 Miguel a chávez-Fumagalli2 Diogo g Valadares3 Juçara r França1 lívia B rodrigues1 Mariana c Duarte2 Paula s lage2 Pedro h r andrade4 Daniela P lage4 leonardo V arruda5,6 Daniel r abánades5,6 lourena e costa2 Vivian T Martins3 carlos aP Tavares3 rachel O castilho1,7,* eduardo aF coelho2,4,* andré ag Faraco1,7,* 1Programa de Pós-graduação em ciências  Farmacêuticas, Faculdade de Farmácia,   Universidade Federal de Minas gerais, Belo  horizonte, Minas gerais, Brazil; 2Programa de  Pós-graduação em ciências da saúde: Infectologia  e Medicina Tropical, Faculdade de Medicina,   Universidade Federal de Minas gerais, Belo  horizonte, Minas gerais, Brazil; 3Departamento  de Bioquímica e Imunologia, Instituto de ciências  Biológicas, Universidade Federal de Minas  gerais, Belo horizonte, Minas gerais, Brazil;   4Departamento de Patologia clínica, cOlTec,   Universidade Federal de Minas gerais, Belo  horizonte, Minas gerais, Brazil; 5Programa de Pós- graduação em Patologia humana, Universidade  Federal da Bahia, salvador, Bahia, Brazil; 6centro  de Pesquisas gonçalo Moniz (cPqgM), Fundação  Oswaldo cruz (FIOcr UZ), salvador, Bahia, Brazil;   7Departamento de Produtos Farmacêuticos,   Faculdade de Farmácia, Universidade Federal de  Minas gerais, Belo horizonte, Minas gerais, Brazil *These authors contributed equally to   this workAbstract:  The study reported here aimed to develop an optimized nanoparticle delivery sys - tem for amphotericin B (AmpB) using a polyelectrolyte complexation technique.",Non-OADS,/arxiv_data1/oa_pdf/ca/5c/ijn-9-877.PMC3931713.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ca/5c/ijn-9-877.PMC3931713.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/5c/ijn-9-877.PMC3931713.pdf
Published  by  Elsevier  Ltd.   http://dx.doi.org/10.1016/j.dcn.2013.08.001Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"34  (2),  163–175, Retrieved  from  http://www.ncbi.nlm.nih.gov/pubmed/15162935 Baron-Cohen,  S.,  Wheelwright,  S.,  Jolliffe,  T.,  1997.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"10  (6),  258–264, http://dx.doi.org/10.1016/j.tics.2006.05.001.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neuroimage  35  (1),  430–440,  Retrieved  from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1862681/ Blake, R.,  Turner,  L.M.,  Smoski,  M.J.,  Pozdol,  S.L.,  Stone,  W.L.,  2003.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"14  (2),  151–157,  Retrieved  from http://www.ncbi.nlm.nih.gov/pubmed/15922565 Boynton,  G.M.,  Engel,  S.A.,  Glover,  G.H.,  Heeger,  D.J.,  1996.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"16  (13),  4207–4221,  Retrieved  from http://www.ncbi.nlm.nih.gov/pubmed/8753882 Bullmore,  E.,  Rabe-Hesketh,  S.,  Morris,  R.,  Williams,  S.,  Greg- ory,  L.,  Gray,  J.,  Brammer,  M.,  1996.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neuroimage 33 (4), 16–33,  Retrieved  from http://www.researchgate.net/publication/13882570 Functional magnetic resonance  image  analysis  of  a  large-scale  neurocognitive network/ﬁle/79e4150a8f8a76bf4c.pdf Chawarska, K., Shic, F., 2009.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Disord.,  1663–1672, http://dx.doi.org/10.1007/s10803-009-0803-7.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"33  (4),  427–433,  Retrieved  from http://www.ncbi.nlm.nih.gov/pubmed/12959421 Cook,  J.,  Saygin,  A.P.,  Swain,  R.,  Blakemore,  S.-J.,  2009.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neuropsychologia  47  (14),  3275–3278, http://dx.doi.org/10.1016/j.neuropsychologia.2009.07.010.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"38  (3),  464–473, http://dx.doi.org/10.1007/s10803-007-0486-x.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neu- roimage 15  (4),  870–878,  http://dx.doi.org/10.1006/nimg.2001.1037.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Psychiatry  63  (6),  577–586,  Retrieved  from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483789/ Gotham,  K.,  Risi,  S.,  Pickles,  A.,  Lord,  C.,  2007.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"37,  613–627, http://dx.doi.org/10.1007/s10803-006-0280-1.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neuroimage  49  (1),  1055–1065, http://dx.doi.org/10.1016/j.neuroimage.2009.07.057.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"1  (1),  18–25, http://dx.doi.org/10.1093/scan/nsl001.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Emotion  (Washington,  D.C.)  3  (4),  394–400, http://dx.doi.org/10.1037/1528-3542.3.4.394.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Gen.  Psychiatry  59  (9),  809–816,  Retrieved  from http://www.ncbi.nlm.nih.gov/pubmed/12215080 Klin,  A.,  Lin,  D.J.,  Gorrindo,  P.,  Ramsay,  G.,  Jones,  W.,  2009.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Nature  459  (7244),  257–261, http://dx.doi.org/10.1038/nature07868.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"5  (4),  238–342, http://dx.doi.org/10.1002/(SICI)1097-0193.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"10  (3),  120–131, Retrieved from  http://www.ncbi.nlm.nih.gov/pubmed/10912591 Lang, P.J., Bradley,  M.M.,  Cuthbert,  B.N.,  2008.  International  Affective Picture  System  (IAPS):  Affective  Ratings  of  Pictures  and  Instruction Manual  (Technical  Report  A-8,  Gainesville,  FL).",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"116  (1), 252–282,  http://dx.doi.org/10.1037/a0014172.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"133  (Pt  2),  611–624, http://dx.doi.org/10.1093/brain/awp306.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"30  (3),  205–223,  Retrieved  from http://www.ncbi.nlm.nih.gov/pubmed/11055457 Lord,  C.,  Rutter,  M.,  1994.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neuroimage  28  (4),  757–762, http://dx.doi.org/10.1016/j.neuroimage.2005.03.011.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"17  (8),  1306–1315, http://dx.doi.org/10.1162/0898929055002418.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neuron 50  (4),  655–663, http://dx.doi.org/10.1016/j.neuron.2006.03.040.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neuroimage  31  (1),  440–457, http://dx.doi.org/10.1016/j.neuroimage.2005.12.002.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Cognition Emotion  (March),  37–41, http://dx.doi.org/10.1080/02699931.2012.762900.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neuroimage  23  (2),  483–499, http://dx.doi.org/10.1016/j.neuroimage.2004.06.030.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neuroimage  28  (1),  249–255,  Retrieved  from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427145/ Pfeifer,  J.H.,  Merchant,  J.S.,  Colich,  N.L.,  Hernandez,  L.M.,  Rudie, J.D.,  Dapretto,  M.,  2013.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"43  (2),  272–285, http://dx.doi.org/10.1007/s10803-012-1563-3.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neuroimage  59  (3),  2142–2154, http://dx.doi.org/10.1016/j.neuroimage.2011.10.018.Rogers,  J.,  Viding,  E.,  Blair,  R.J.,  Frith,  U.,  Happé,  F.,  2006.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"36  (12),  1789–1798, http://dx.doi.org/10.1017/S0033291706008853.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Social  Neuroscience  6  (1),  1–21, http://dx.doi.org/10.1080/17470911003708032.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Neuroimage  50  (3),  1027–1035, http://dx.doi.org/10.1016/j.neuroimage.2009.12.119.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"Social  Neuroscience 3  (2),  97–112,  http://dx.doi.org/10.1080/17470910701577020.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"11  (4),  153–157, http://dx.doi.org/10.1016/j.tics.2007.01.001.",OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
"16  (3),  255–278, http://dx.doi.org/10.1080/09297041003601454.",Non-OADS,/arxiv_data1/oa_pdf/55/3a/main.PMC3931746.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004289).,Non-OADS,/arxiv_data1/oa_pdf/9a/30/bmjopen-2013-004289.PMC3931983.pdf
Two sources were used to determine the postmarket therapeutic value of the NAS: the annual reports of the Patented Medicine Prices Review Board (PMPRB) avail- able online from 2003 to 2011 at http://www.pmprb-cepmb.gc.ca/english/View.asp?x=91 and for previous years by directly contacting the PMPRB at pmprb@ pmprb-cepmb.gc.ca and the online reviews published byPrescrire International up to 14 February 2013 http:// english.prescrire.org/en/.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/bmjopen-2013-004289.PMC3931983.pdf
13 Safety warnings and drug withdrawals for the period 1 January 1997 to 31 December 2012 were identi ﬁed through advisories for health professionals on theMedEffect Canada website http://www.hc-sc.gc.ca/dhp- mps/medeff/advisories-avis/prof/index-eng.php.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/bmjopen-2013-004289.PMC3931983.pdf
"When necessary, notices on the MedEffect website weresupplemented by searching on the product name in the Drug Product Database (DPD) http://webprod3.hc-sc.",OADS,/arxiv_data1/oa_pdf/9a/30/bmjopen-2013-004289.PMC3931983.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi: 10.5061/dryad.fg679.,OADS,/arxiv_data1/oa_pdf/9a/30/bmjopen-2013-004289.PMC3931983.pdf
http://www.hc-sc.gc.ca/dhp-mps/prodpharma/notices-avis/noc-acc/term_noc_acc-eng.php 13.,OADS,/arxiv_data1/oa_pdf/9a/30/bmjopen-2013-004289.PMC3931983.pdf
http://www.hc-sc.gc.ca/dhp-mps/pubs/medeff/_fs-if/2012-hpvf-cvps/index-eng.php 18.,Non-OADS,/arxiv_data1/oa_pdf/9a/30/bmjopen-2013-004289.PMC3931983.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004425).,Non-OADS,/arxiv_data1/oa_pdf/b8/ee/bmjopen-2013-004425.PMC3931985.pdf
"Instead of converting model estimates to a pointsystem, and using intervals for continuous variables such as age, as in V .1.0, V .2.0 directly utilises model estimates them- selves to compute cumulative risk (see: http://www.outcomes-umassmed.org/grace/ ﬁles/GRACE_RiskModel_ Coefﬁcients.pdf).",Non-OADS,/arxiv_data1/oa_pdf/b8/ee/bmjopen-2013-004425.PMC3931985.pdf
"34For further information see http://www.gracescore.co.uk and http://www.outcomes.org/grace.Table 4 The simplified GRACE risk score, with substitutions for Killip and creatinine (n=3035), tested in FAST-MI 2005 From ACS presentationOverall population (death) N=3035STEMI (death) N=1596Non-STEMI (death) N=1439Overall death/ MI 1-year death 0.82 0.84 0.80 0.80 3-year death 0.82 0.83 0.82 0.78Hospital survivors N=2872 N=1504 N=1368 1-year death 0.80 0.83 0.78 0.743-year death 0.81 0.80 0.80 0.76 ACS, acute coronary syndrome; GRACE, Global Registry of Acute Coronary Events; FAST-MI, French registry of Acute ST-elevation and non-ST-elevation MI; STEMI, ST segment elevation myocardial infarction.",Non-OADS,/arxiv_data1/oa_pdf/b8/ee/bmjopen-2013-004425.PMC3931985.pdf
Data sharing statement The GRACE risk score has been made available to download without cost (http://www.gracescore.co.uk and http://www.outcomes.org/grace).,Non-OADS,/arxiv_data1/oa_pdf/b8/ee/bmjopen-2013-004425.PMC3931985.pdf
NICEguideline 94 March 2010. http://www.nice.co.uk/guidance/CG94 2.,Non-OADS,/arxiv_data1/oa_pdf/b8/ee/bmjopen-2013-004425.PMC3931985.pdf
"gracescore.co.uk and http://www.outcomes.org/grace 10 Fox KAA, FitzGerald G, Puymirat E, et al.BMJ Open 2014; 4:e004425.",Non-OADS,/arxiv_data1/oa_pdf/b8/ee/bmjopen-2013-004425.PMC3931985.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004226).,Non-OADS,/arxiv_data1/oa_pdf/88/a0/bmjopen-2013-004226.PMC3931986.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004418).,Non-OADS,/arxiv_data1/oa_pdf/9f/ef/bmjopen-2013-004418.PMC3931987.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9f/ef/bmjopen-2013-004418.PMC3931987.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004251).,Non-OADS,/arxiv_data1/oa_pdf/4c/03/bmjopen-2013-004251.PMC3931988.pdf
"CKD and the Swedish National Health Service Sweden had a population of 9.4 million on 31December 2010 (http://www.scb.se), and comprised 21 counties.",OADS,/arxiv_data1/oa_pdf/4c/03/bmjopen-2013-004251.PMC3931988.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003579).,Non-OADS,/arxiv_data1/oa_pdf/d4/19/bmjopen-2013-003579.PMC3931989.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d4/19/bmjopen-2013-003579.PMC3931989.pdf
"Australian Bureau of Statistics: Regional Population Growth, Australia, 2011. http://www.abs.gov.au/ausstats/abs@.nsf/mf/3218.0 26.",Non-OADS,/arxiv_data1/oa_pdf/d4/19/bmjopen-2013-003579.PMC3931989.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003642).,Non-OADS,/arxiv_data1/oa_pdf/f0/f9/bmjopen-2013-003642.PMC3931990.pdf
http://www.vancouverobserver.com/politics/investigations/2012/01/04/american-guns-canadian-deaths 54.,Non-OADS,/arxiv_data1/oa_pdf/f0/f9/bmjopen-2013-003642.PMC3931990.pdf
"Since 2009, PROMs have been used on a routine and mandated basis to assess outcomes in four elective surgical proce- dures in the NHS in England (http://www.ic.nhs.uk/proms, accessed 21 March 2013).",Non-OADS,/arxiv_data1/oa_pdf/fe/b9/bmjopen-2013-003968.PMC3931992.pdf
RESULTS Recruitment of participants The total number of patients extracted from each searchwas compared with 50% of the total QOF estimate (by LTC) based on the 2009/2010 QOF prevalence rates (http://www.qof.ic.nhs.uk/search/).,Non-OADS,/arxiv_data1/oa_pdf/fe/b9/bmjopen-2013-003968.PMC3931992.pdf
The full report of the study is available on the website of the Policy Research Unit on Quality and Outcomes of Person-centred care (http://www.qoru.ac.uk/).,Non-OADS,/arxiv_data1/oa_pdf/fe/b9/bmjopen-2013-003968.PMC3931992.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003512).,Non-OADS,/arxiv_data1/oa_pdf/92/f2/bmjopen-2013-003512.PMC3931993.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/92/f2/bmjopen-2013-003512.PMC3931993.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003991).,Non-OADS,/arxiv_data1/oa_pdf/7f/1f/bmjopen-2013-003991.PMC3931994.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ad/c1/bmjopen-2013-004247.PMC3931995.pdf
http://ec.europa.eu/europe2020/pdf/themes/25_ poverty_and_social_inclusion.pdf (accessed 17 Jan 2013) 9.,Non-OADS,/arxiv_data1/oa_pdf/ad/c1/bmjopen-2013-004247.PMC3931995.pdf
Statistics Netherlands; Statline database: http://statline.cbs.nl/ statweb/?LA=en (accessed 20 Jun 2013).,OADS,/arxiv_data1/oa_pdf/ad/c1/bmjopen-2013-004247.PMC3931995.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004258).,Non-OADS,/arxiv_data1/oa_pdf/e2/f5/bmjopen-2013-004258.PMC3931996.pdf
Trial registration: http://clincialtrials.gov (NCT00765453).,Non-OADS,/arxiv_data1/oa_pdf/e2/f5/bmjopen-2013-004258.PMC3931996.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1. WHO.,Non-OADS,/arxiv_data1/oa_pdf/e2/f5/bmjopen-2013-004258.PMC3931996.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004684).,Non-OADS,/arxiv_data1/oa_pdf/ac/e2/bmjopen-2013-004684.PMC3931997.pdf
http://www.bowelcanceruk.org.uk/media/75220/staying_healthy.pdf (accessed 20 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/ac/e2/bmjopen-2013-004684.PMC3931997.pdf
http://www.euroqol.org/eq-5d/what-is-eq-5d/eq-5d- nomenclature.html (accessed 16 May 2011).,OADS,/arxiv_data1/oa_pdf/ac/e2/bmjopen-2013-004684.PMC3931997.pdf
2005. http://guidance.nice.,Non-OADS,/arxiv_data1/oa_pdf/02/89/bmjopen-2013-004640.PMC3931998.pdf
http://www.rcpch.ac.uk/system/files/protected/page/FTF%20Full.pdf (accessed 2 Apr 2013).,OADS,/arxiv_data1/oa_pdf/02/89/bmjopen-2013-004640.PMC3931998.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004033).,Non-OADS,/arxiv_data1/oa_pdf/90/d9/bmjopen-2013-004033.PMC3931999.pdf
http://w3.nhri.org.tw/nhird//date_01.html(accessed 13 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/90/d9/bmjopen-2013-004033.PMC3931999.pdf
http://www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm095283.htm (accessed 20 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/90/d9/bmjopen-2013-004033.PMC3931999.pdf
http://www.nhi.gov.tw/query/query1.aspx?menu=21&menu_id=713&webdata_id=3510&WD_ID=851(accessed 16 Aug 2013).,OADS,/arxiv_data1/oa_pdf/90/d9/bmjopen-2013-004033.PMC3931999.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004429).,Non-OADS,/arxiv_data1/oa_pdf/63/35/bmjopen-2013-004429.PMC3932000.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1. WHO.,Non-OADS,/arxiv_data1/oa_pdf/63/35/bmjopen-2013-004429.PMC3932000.pdf
"World TB Day, 24 March 2013. http://www.who.int/campaigns/ tb-day/2013/event/en/ (accessed 1 Oct 2013).",Non-OADS,/arxiv_data1/oa_pdf/63/35/bmjopen-2013-004429.PMC3932000.pdf
"In addition, Internetsearches will also be carried out using specialist search gateways (such as OMNI: http://www.omni.ac.uk/), general search engines (such as Google: http://www.",Non-OADS,/arxiv_data1/oa_pdf/91/10/bmjopen-2013-004377.PMC3932001.pdf
google.co.uk/) and metasearch engines (such as Copernic: http://www.copernic.com/).,Non-OADS,/arxiv_data1/oa_pdf/91/10/bmjopen-2013-004377.PMC3932001.pdf
This involved a sys-tematically recruited group of international experts who have produced methodological guidance and publica- tion standards (http://www.ramesesproject.org).,Non-OADS,/arxiv_data1/oa_pdf/91/10/bmjopen-2013-004377.PMC3932001.pdf
http://www.dh.gov.uk/en/Healthcare/Longtermconditions/tenthingsyouneedtoknow/index.htm 19.,Non-OADS,/arxiv_data1/oa_pdf/91/10/bmjopen-2013-004377.PMC3932001.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004215).,Non-OADS,/arxiv_data1/oa_pdf/9a/a4/bmjopen-2013-004215.PMC3932002.pdf
Further ana-lyses and video and audio extracts from the interviews can be found at http://healthtalkonline.org/peoples- experiences/cancer/pancreatic-cancer/topics.,Non-OADS,/arxiv_data1/oa_pdf/9a/a4/bmjopen-2013-004215.PMC3932002.pdf
http://www.cancerresearchuk.org/cancer-help/ type/pancreatic-cancer/about/pancreatic-cancer-risks-and-causes(accessed 15 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/9a/a4/bmjopen-2013-004215.PMC3932002.pdf
http://info.cancerresearchuk.org/cancerstats/ types/pancreas/survival/ (accessed 2 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/9a/a4/bmjopen-2013-004215.PMC3932002.pdf
45. http://www.dh.gov.uk/en/Healthcare/Cancer/Earlydiagnosis/index.,Non-OADS,/arxiv_data1/oa_pdf/9a/a4/bmjopen-2013-004215.PMC3932002.pdf
46. http://info.cancerresearchuk.org/spotcancerearly/naedi/AboutNAEDI/ achieving-early-presentation/ (accessed 13 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/9a/a4/bmjopen-2013-004215.PMC3932002.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/6d/sbt044.PMC3932086.pdf
Image preprocessing was carried  out using SPM5 ( http://www.fil.ion.ucl.ac.uk/spm ) and  Resting-State fMRI Data Analysis Toolkit (REST) ( http:// www.restfmri.net ).,OADS,/arxiv_data1/oa_pdf/b8/6d/sbt044.PMC3932086.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/sbt149.PMC3932088.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/8b/sbt162.PMC3932089.pdf
"Network  metrics were all based on NOS-weighted networks and  computed using the MATLAB-based Brain Connectivity  Toolbox ( http://www.brain-connectivity-toolbox.net ).53 Rich Club Organization Rich club organization has been described in detail pre - viously.20,21,23,24,54 In short, rich club organization of a  network is characterized by an above-average level of  connectivity between the high-degree nodes of a network,  over what can be expected by chance.55 If a rich club is  present, the high-degree (‘rich’) nodes of the network are  tightly interconnected, forming a densely connected core  or ‘club’ of nodes: the rich club.Rich Club Definition.",OADS,/arxiv_data1/oa_pdf/1b/8b/sbt162.PMC3932089.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/08/sbt233.PMC3932101.pdf
"For Pluritest analysis, intensity data files were uploaded at http://www.pluritest.org and analysis performed according to Muller et al.",OADS,/arxiv_data1/oa_pdf/f5/99/213_2013_Article_3196.PMC3932164.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Expression Profile of Fas-Fas Ligand in Spiral  Ganglion Cells During Apoptosis Tae Woo Gu1·Woo Y ong Bae1·Hwan Tae Park2·Jae Hoon Lee1·Min Y oung Kang1·Sung Wook Jeong1  Y oon Kyung Shin2 Departments of 1Otorhinolaryngology-Head and Neck Surgery and 2Physiology, Medical Science Research Institute,   Dong-A University College of Medicine, Busan, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/4a/f4/ceo-7-1.PMC3932342.pdf
"1: 1- 6, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.1 Original Article INTRODUCTION Acoustic stimulation is converted to electric stimulation in audi - tory hair cells and transmitted to spiral ganglion cells (SGCs).",Non-OADS,/arxiv_data1/oa_pdf/4a/f4/ceo-7-1.PMC3932342.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Protective Effect of Hexane and Ethanol Extract of  Piper Longum  L. on Gentamicin-Induced Hair Cell  Loss in Neonatal Cultures Mukesh Kumar Y adav1·June Choi2·Jae-Jun Song1 1Department of Otorhinolaryngology-Head and Neck Surgery, Dongguk University Ilsan Hospital, Goyang;   2Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/2f/b4/ceo-7-13.PMC3932343.pdf
"1: 13- 18, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.13 Original Article INTRODUCTION Aminoglycoside antibiotics, including gentamicin (GM), display  ototoxicity resulting in sensorineural hearing loss and dizziness [1].",Non-OADS,/arxiv_data1/oa_pdf/2f/b4/ceo-7-13.PMC3932343.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Olfactory Identification Test Using Familiar  Distracters for Koreans  Jae-Myung Kim1·Mi Soon Jeong2·Dong-Hyuk Shin1·Jeong-Hun Seol1·Seok-Chan Hong1  Jae Hoon Cho1·Jin Kook Kim1 1Departments of Otorhinolaryngology-Head & Neck Surgery, Konkuk University School of Medicine, Seoul;   2Galimard Perfume & Flavor School, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/a1/43/ceo-7-19.PMC3932344.pdf
"1: 19- 23, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.19 Original Article INTRODUCTION With recent changes in Korea from the ancient agricultural life  to an urban culture, the effect on quality of life of smell is also  changing.",Non-OADS,/arxiv_data1/oa_pdf/a1/43/ceo-7-19.PMC3932344.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Development of the Korean Version of the Sleep  Apnea Quality of Life Index Hyun-Uk Jang1·Ki-Soo Park2·Sang-Myung Cheon3·Ho-Won Lee4·Sung-Wan Kim5·Seung-Hoon Lee6·Jung-Soo Kim1 1Department of Otorhinolaryngology-Head and Neck Surgery, Kyungpook National University School of Medicine, Daegu; 2Department of  Preventive Medicine, Gyeongsang National University School of Medicine, Jinju; 3Department of Neurology, Dong-A University College of  Medicine, Busan; 4Department of Neurology, Brain Science and Engineering Institute, Kyungpook National School of Medicine, Daegu;  5Department of Otolaryngology-Head and Neck Surgery, Kyung Hee University School of Medicine, Seoul; 6Department of Otolaryngology-Head  and Neck Surgery, Korea University College of Medicine, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/35/5e/ceo-7-24.PMC3932345.pdf
"1: 24- 29, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.24 Original Article INTRODUCTION Obstructive sleep apnea (OSA) is characterized by recurrent epi - sodes of partial or complete upper airway obstruction during  sleep.",Non-OADS,/arxiv_data1/oa_pdf/35/5e/ceo-7-24.PMC3932345.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A Randomized, Multi-Center, Single Blind, Active- Controlled, Matched Pairs Clinical Study to Evaluate  Prevention of Adhesion Formation and Safety of  HyFence in Patients After Endoscopic Sinus Surgery Chul Chang1,*·Sung-Moon Hong2,3,*·Jin-Hee Cho4·Sang Yul Shim1·Jung-Sun Cho3·Heung-Man Lee2,3  1Department of Otorhinolaryngology, Bundang CHA Hospital, Cha University College of Medicine, Seongnam; 2Department of  Otorhinolaryngology-Head and Neck Surgery, 3Medical Devices Clinical Trial Center, Korea University Guro Hospital, Seoul; 4Department of  Otolaryngology-Head and Neck Surgery, St. Mary’ s Hospital, The Catholic University of Korea College of Medicine, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/b4/16/ceo-7-30.PMC3932346.pdf
"1: 30- 35, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.30 Original Article INTRODUCTION Despite the established efficacy of endoscopic sinus surgery (ESS) for the treatment of chronic rhinosinusitis, recurrent symptoms  that lead to revision surgery develop in 8%-38% of patients [1].",Non-OADS,/arxiv_data1/oa_pdf/b4/16/ceo-7-30.PMC3932346.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Risk Factors and Survival Outcomes for Patients  With Anastomotic Leakage After Surgery for Head  and Neck Squamous Cell Carcinoma Do-Y oun Kim1*·Jong-Lyel Roh1*·Jong Woo Choi2·Seung-Ho Choi1·Soon Yuhl Nam1·Sang Y oon Kim1,3 Departments of 1Otolaryngology and 2Plastic and Reconstructive Surgery, Asan Meidcal Center, University of Ulsan College of Medicine, Seoul;  3Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/dc/f1/ceo-7-36.PMC3932347.pdf
"1: 36- 41, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.36 Original Article INTRODUCTION Anastomotic leakage (AL) from the upper aerodigestive tract is  a serious complication after surgery for head and neck cancer,  with a reported incidence of 5% to 65% [1-9].",Non-OADS,/arxiv_data1/oa_pdf/dc/f1/ceo-7-36.PMC3932347.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Association Study of FOS–Like Antigen-2 Promoter  Polymorphisms With Papillary Thyroid Cancer in  Korean Population Seung Woo Kim1·Choon Dong Kim1·Joo Ho Chung2·Kee Hwan Kwon3 1Department of Otorhinolaryngology Head & Neck Surgery, VHS Medical Center, Seoul; 2Kohwang Medical Research Institute,   Kyung Hee University School of Medicine, Seoul; 3Department of Otolaryngology-Head and Neck Surgery, Ilsong Memorial Institute of   Head and Neck Cancer, Hallym University College of Medicine, Seoul, Korea Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/e2/ad/ceo-7-42.PMC3932348.pdf
"1: 42- 46, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.42 Original Article INTRODUCTION Thyroid cancer is the most common neoplasm in Korea [1].",Non-OADS,/arxiv_data1/oa_pdf/e2/ad/ceo-7-42.PMC3932348.pdf
We calculated the sample power to  verify our data (http://www.stat.ubc.ca/~rollin/stats/ssiz e/b2.,OADS,/arxiv_data1/oa_pdf/e2/ad/ceo-7-42.PMC3932348.pdf
Available from: http://www.cancer.go.kr/cms/statics/incidence/in - dex.html#2.,Non-OADS,/arxiv_data1/oa_pdf/e2/ad/ceo-7-42.PMC3932348.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Favorable Vocal Fold Wound Healing Induced by  Platelet-Rich Plasma Injection Seung Hoon Woo1,2*·Han-Sin Jeong3*·Jin Pyeong Kim1·Eun-Ha Koh2,4·Seon Uk Lee5·Sung Min Jin5  Dong Hoon Kim6·Jin Hee Sohn6·Sang Hyuk Lee5 1Department of Otolaryngology, 2Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju; 3Department of  Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 4Department of Laboratory  Medicine, Gyeongsang National University School of Medicine, Jinju; Departments of 5Otorhinolaryngology-Head and Neck Surgery and 6Pathology,  Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/36/af/ceo-7-47.PMC3932349.pdf
"1: 47- 52, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.47 Original Article INTRODUCTION Vocal fold vibration is the source of voice production, which is  directly driven by the biomechanical properties of the layered  vocal fold lamina propria.",Non-OADS,/arxiv_data1/oa_pdf/36/af/ceo-7-47.PMC3932349.pdf
"Densitometry was performed using the Im - ageJ 1.38 (Windows version of NIH Image, http://rsb.info.nih.",OADS,/arxiv_data1/oa_pdf/36/af/ceo-7-47.PMC3932349.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Loss of Heterozygosities in Five Tumor Suppressor  Genes (FHIT Gene, p16, pRb, E-Cadherin and p53) in  Thyroid Tumors Jin Hwan Kim1·Kyu Y oung Choi1·Dong Jin Lee1·Y oung-Soo Rho1·Sung-Jin Jo2 Departments of 1Otorhinolaryngology-Head and Neck Surgery and 2Pathology, Hallym University College of Medicine, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/63/40/ceo-7-53.PMC3932350.pdf
"1: 53- 58, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.53 Original Article INTRODUCTION Thyroid cancer is one of major malignancies in young adult pa - tients and recently shows an increasing tendency in incidence in  Korea.",Non-OADS,/arxiv_data1/oa_pdf/63/40/ceo-7-53.PMC3932350.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Petrositis With Bilateral Abducens Nerve Palsies  complicated by Acute Otitis Media Kyu Y oung Choi ·Su-Kyoung Park Department of Otorhinolaryngology-Head and Neck Surgery, Kangnam Sacred Heart Hospital, Hallym University College of Medicine,   Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/aa/80/ceo-7-59.PMC3932351.pdf
"1: 59- 62, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.59 Case Report INTRODUCTION Petrous apicitis is an extension of infection from the mastoid air  cell tract into a pneumatized anterior or posterior petrous apex.",Non-OADS,/arxiv_data1/oa_pdf/aa/80/ceo-7-59.PMC3932351.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Aggravation of Relapsing Polychondritis due to the  Infection and Its Manifestation on a Nasal Tip Graft  Seung Beom Son1·Woo-Hee Han1·Jae Hong Park1·Hyun Pyo Hong1·Sung Won Y oon1·Soo-Chan Jung1  Mi Ra Kim1·Y oung-Jin Kim1·Hyun-Seok Lee1·Soo Bin Son2·Woo Sung Cho1 1Department of Otorhinolaryngology-Head and Neck Surgery, Bundang Jesaeng General Hospital, Daejin Medical Center, Seongnam;  2Department of Dermatology, Korea University College of Medicine, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/d5/c0/ceo-7-63.PMC3932352.pdf
"1: 63- 65, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.63 Case Report INTRODUCTION Relapsing polychondritis (RP) is an uncommon systemic disease  that is characterized by episodic and progressive inflammation  of the cartilaginous structures, including the elastic cartilage of  the ear and nose, the hyaline cartilage of the peripheral joints,  the fibrocartilage at axial sites and the cartilage of the tracheo - bronchial tree, which can be very debilitating and in some in - stances life-threatening [1].",Non-OADS,/arxiv_data1/oa_pdf/d5/c0/ceo-7-63.PMC3932352.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Palatal Implants for Persistent Snoring and Mild  Obstructive Sleep Apnea After Laser-Assisted  Uvulopalatoplasty Ji Ho Choi ·Eun Joong Kim ·Kang Woo Kim ·Y oung Ho Ju ·Euy Hyun Park ·Seung Hoon Lee Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/a7/52/ceo-7-66.PMC3932353.pdf
"1: 66- 68, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.66 Case Report INTRODUCTION Sleep-disordered breathing (SDB), such as snoring or obstruc - tive sleep apnea (OSA) is characterized by repeated narrowing  or collapse of the upper airway during sleep.",Non-OADS,/arxiv_data1/oa_pdf/a7/52/ceo-7-66.PMC3932353.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Coexistence of a Carotid Body Tumor and  Thyroglossal Duct Carcinoma With Cervical Lymph  Node Metastasis  Jae Wook Kim1·Seung Won Lee2·Hyun Suk Hong3·Eun Seok Koh4·Eun Chang Choi5·Y oon Woo Koh5 1Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Seoul;   Departments of 2Otorhinolaryngology-Head and Neck Surgery, 3Radiology, and 4Pathology, Soonchunhyang University College of Medicine,  Bucheon; 5Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea INTRODUCTION Thyroglossal duct remnants represent a common developmental  abnormality of the thyroid gland, and thyroglossal duct carcino - ma (TGDC) reportedly occurs in approximately 1% of all thyro - glossal duct remnants [1,2].",Non-OADS,/arxiv_data1/oa_pdf/af/67/ceo-7-69.PMC3932354.pdf
"1: 69- 72, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.69 Case ReportpISSN 1976-8710   eISSN 2005-0720",Non-OADS,/arxiv_data1/oa_pdf/af/67/ceo-7-69.PMC3932354.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Decreased Pattern-Recognition Receptor-Mediated  Cytokine mRNA Expression in Obese Children With  Otitis Media With Effusion Y oun Jung Kim1,*·Sung Ho Cha2·Ho Yun Lee3,*·Sun Kyu Lee3·Hee Y ong Chung3·Joon Hyung Y eo3  Y oung Il Kim4·Seung Geun Y eo3,4 1Kyung Hee University College of Nursing Science, Seoul; Departments of 2Pediatrics and 3Otolaryngology, Kyung Hee University School of  Medicine, Seoul; 4Medical Science Research Institute, Kyung Hee University Medical Center, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/fe/42/ceo-7-7.PMC3932355.pdf
"1: 7- 12, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.7 Original Article INTRODUCTION Otitis media with effusion (OME), a disease in which secreted  fluid accumulates in the middle ear cavity, is a major cause of  hearing loss in children [1].",Non-OADS,/arxiv_data1/oa_pdf/fe/42/ceo-7-7.PMC3932355.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Atypical Fibroxanthoma in Head and Neck Jin Pyeong Kim1,2·Gyung Hyuck Ko3·Jin Y oung Kim1·Seung Hoon Woo1,2 1Department of Otolaryngology, 2Institute of Health Sciences, 3Department of Pathology, Gyeongsang National University College of Medicine,  Jinju, Korea INTRODUCTION Atypical fibroxanthoma (AFX) is a malignancy developed typi - cally in the dermis of the head and neck of senior Caucasians,  however it is a very rare tumor in Asians [1-5].",Non-OADS,/arxiv_data1/oa_pdf/7e/cc/ceo-7-73.PMC3932356.pdf
"1: 73- 75, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.73 Case ReportpISSN 1976-8710   eISSN 2005-0720",Non-OADS,/arxiv_data1/oa_pdf/7e/cc/ceo-7-73.PMC3932356.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A Hypopharyngeal Ductal Cyst Masquerading as a  Laryngopharyngeal Reflux Disease Ji-Y oung Choi ·Jung-Hae Cho ·Y oung-Hoon Joo ·Dong-Il Sun Department of Otorhinolaryngology-Head and Neck Surgery, The Catholic University of Korea College of Medicine, Seoul, Korea INTRODUCTION Benign tumors of the hypopharynx are very rare, with the most  common two being the fibrolipoma and leiomyoma.",Non-OADS,/arxiv_data1/oa_pdf/d5/3d/ceo-7-76.PMC3932357.pdf
"1: 76- 78, March 2014 http://dx.doi.org/10.3342/ceo.2014.7.1.76 Case ReportpISSN 1976-8710   eISSN 2005-0720",Non-OADS,/arxiv_data1/oa_pdf/d5/3d/ceo-7-76.PMC3932357.pdf
"REVIEW Korean J Intern Med 2014;29:1-11 http://dx.doi.org/10.3904/kjim.2014.29.1.1 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgAntiangiogenesis therapy: an update after the first  decade Sandro De Falco Angiogenesis LAB, Institute of  Genetics and Biophysics ‘Adriano  Buzzati-Traverso’, Napoli, Italy  Received : October 8, 2013 Accepted: November 19, 2013 Correspondence to Sandro De Falco, M.D.",Non-OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.1and arteriogenesis requires the cooperation of several  growth factor families, their related receptors, multiple  cell types, and the presence of certain conditions, such  as hypoxia [9].",Non-OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
3 De Falco S. Recent advances on antiangiogenic therapy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.1ral cells.,OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.1The semaphorin (SEMA) family The SEMA family is composed of a large number of se - creted or Gpi-anchored proteins that are able to bind  plexin receptors or NRP coreceptors [41].",OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
5 De Falco S. Recent advances on antiangiogenic therapy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.1with intolerance to the drug [50].,Non-OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.12009 for f irst-line treatment of metastatic RCC [52].",Non-OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
Please  see http://www.cancer.gov/clinicaltrials or http://clini - caltrials.gov/ct2/home for more information.,Non-OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
"7 De Falco S. Recent advances on antiangiogenic therapy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.1agents, it is interesting to note drugs directed towards  specific targets that are not related to the mechanism of  action of currently approved drugs.",Non-OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.1plored in the future to improve anticancer immune  therapy and prevent metastatic spread.",Non-OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
9 De Falco S. Recent advances on antiangiogenic therapy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.1regulation of PlGF.,Non-OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.1cer.",Non-OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
11 De Falco S. Recent advances on antiangiogenic therapy www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.1dren’s Oncology Group.,Non-OADS,/arxiv_data1/oa_pdf/6f/3b/kjim-29-1.PMC3932378.pdf
"Korean J Intern Med 2014;29:101-105 http://dx.doi.org/10.3904/kjim.2014.29.1.101 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgCASE REPORTHepatoduodenal fistula formation following   transcatheter arterial chemoembolization and   radiotherapy for hepatocellular carcinoma:    treatment with endoscopic Histoacryl injection Jaryong Jeon, Joonseong Ahn, Hongseok Yoo, Taek Kyu Park, Dongmo Je , Hyemin Jeong, and  Kwang Hyuck Lee Department of Medicine,  Samsung Medical Center,  Sungkyunkwan University School  of Medicine, Seoul, Korea Received : May  31, 2012 Revised  : June 26, 2012 Accepted: June 29, 2012 Correspondence to  Kwang Hyuck Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/90/c8/kjim-29-101.PMC3932379.pdf
102 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.101The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/90/c8/kjim-29-101.PMC3932379.pdf
"103 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.101 Jeon J, et al.",OADS,/arxiv_data1/oa_pdf/90/c8/kjim-29-101.PMC3932379.pdf
104 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.101The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/90/c8/kjim-29-101.PMC3932379.pdf
"105 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.101 Jeon J, et al.",OADS,/arxiv_data1/oa_pdf/90/c8/kjim-29-101.PMC3932379.pdf
"Korean J Intern Med 2014;29:106-110 http://dx.doi.org/10.3904/kjim.2014.29.1.106 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org CASE REPORTSpontaneous coronary artery dissection by    intravascular ultrasound in a patient with    myocardial infarction Ji Hun Jang, Dae Hyeok Kim, Dong Hyuk Yang, Seong Il Woo, Jun Kwan, Keum Soo Park,     and Sung-Hee Shin Division of Cardiology,  Department of Internal Medicine,  Inha University School of   Medicine , Incheon, Korea Received : July 10, 2012 Revised  : August 23, 2012 Accepted: October 4, 2012 Correspondence to Sung-Hee Shin, M.D.",Non-OADS,/arxiv_data1/oa_pdf/0c/48/kjim-29-106.PMC3932380.pdf
"107 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.106 Jang JH, et al.",OADS,/arxiv_data1/oa_pdf/0c/48/kjim-29-106.PMC3932380.pdf
                             108 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.106The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/0c/48/kjim-29-106.PMC3932380.pdf
"109 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.106 Jang JH, et al.",OADS,/arxiv_data1/oa_pdf/0c/48/kjim-29-106.PMC3932380.pdf
110 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.106The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/0c/48/kjim-29-106.PMC3932380.pdf
"Korean J Intern Med 2014;29:111-115 http://dx.doi.org/10.3904/kjim.2014.29.1.111 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgCASE REPORTHypothermia-induced acute kidney injury in an  elderly patient Hyun Ju Yoon, Mun Chul Kim, Jae Woo Park, Min A Yang, Cheon Beom Lee, In O Sun, and    Kwang Young Lee Division of Nephrology,  Department of Internal Medicine,  Presbyterian Medical Center,  Jeonju, Korea  Received  : July 30, 2012 Revised   : August 29, 2012 Accepted : October 5, 2012 Correspondence to  Kwang Young Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/07/81/kjim-29-111.PMC3932381.pdf
112 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.111The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/07/81/kjim-29-111.PMC3932381.pdf
"113 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.111 Yoon HJ, et al.",OADS,/arxiv_data1/oa_pdf/07/81/kjim-29-111.PMC3932381.pdf
114 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.111The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/07/81/kjim-29-111.PMC3932381.pdf
"115 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.111 Yoon HJ, et al.",OADS,/arxiv_data1/oa_pdf/07/81/kjim-29-111.PMC3932381.pdf
"Korean J Intern Med 2014;29:116-119 http://dx.doi.org/10.3904/kjim.2014.29.1.116 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org LETTER TO THE EDITORDiabetic ketoacidosis as a presenting symptom of  complicated pancreatic cancer Kyung Ae Lee1, Kyung Taek Park2, Woong Ji Kim3, Tae Sun Park1, Hong Sun Baek1, and Heung Yong Jin1 1Division of Endocrinology and  Metabolism, Department of  Internal Medicine, Research  Institute of Clinical Medicine,  Chonbuk National University  Hospital, Jeonju; 2Yeolin Hospital,  Jeonju; 3Jeonju Hospital, Jeonju,  Korea Received : February 3, 2013 Revised : April 18, 2013 Accepted : July 5, 2013 Correspondence to  Heung Yong Jin, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ef/04/kjim-29-116.PMC3932382.pdf
"117 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.116 Lee KA, et al.",OADS,/arxiv_data1/oa_pdf/ef/04/kjim-29-116.PMC3932382.pdf
                             118 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.116The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/ef/04/kjim-29-116.PMC3932382.pdf
"119 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.116 Lee KA, et al.",OADS,/arxiv_data1/oa_pdf/ef/04/kjim-29-116.PMC3932382.pdf
"REVIEW Korean J Intern Med 2014;29:12-19 http://dx.doi.org/10.3904/kjim.2014.29.1.12 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgS100A8/A9 as a biomarker for synovial inflammation  and joint damage in patients with rheumatoid   arthritis  Kwi Young Kang1,2, Jung-Won Woo3,4, and Sung-Hwan Park1,3 1Division of Rheumatology,  Department of Internal Med - icine, The Catholic University  of Korea College of Medicine,  Seoul; 2Division of Rheuma - tology, Department of Internal  Medicine, Incheon St. Mary’s  Hospital, The Catholic Univer - sity of Korea College of Medi - cine, Incheon; 3Department of  Convergent Research Consortium  for Immunologic Disease,  Seoul  St. Mary’s Hospital, The Catholic  University of Korea College of  Medicine, Seoul; 4Business Devel - opment, Genexine Inc., Seong - nam, Korea Received : December 10, 2013 Accepted: December 14, 2013 Correspondence to  Sung-Hwan Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/aa/fa/kjim-29-12.PMC3932383.pdf
S100A8/A9 as a biomarker in RA www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.12vation of synovial macrophages or synovial fibroblasts  may trigger the activation of lymphocytes and subse - quent inf lammation in synovium since inactivating  these cells reduces arthritis in experimental models [3].,Non-OADS,/arxiv_data1/oa_pdf/aa/fa/kjim-29-12.PMC3932383.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.12an increase in S100A8 and S100A9 mRNA expression by  fibroblast-like synoviocytes (FLS) in a murine model of  RA has been reported and both S100A8 and S100A9 pro - teins were detected in synovial resident cells in the car - tilage-pannus junction of RA synovial membranes [34].",OADS,/arxiv_data1/oa_pdf/aa/fa/kjim-29-12.PMC3932383.pdf
S100A8/A9 as a biomarker in RA www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.12disease activity.,OADS,/arxiv_data1/oa_pdf/aa/fa/kjim-29-12.PMC3932383.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.12The MBDA score was calculated using the concentra - tion of 12 biomarkers (SAA, IL-6, TNF-RI, vascular en - dothelial growth factor A, matrix metalloproteinase 1  [MMP-1], cartilage glycoprotein 39 [YKL-40], MMP-3,  epidermal growth factor, vascular cell adhesion mole - cule 1, leptin, resistin and CRP).",OADS,/arxiv_data1/oa_pdf/aa/fa/kjim-29-12.PMC3932383.pdf
S100A8/A9 as a biomarker in RA www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.125.,OADS,/arxiv_data1/oa_pdf/aa/fa/kjim-29-12.PMC3932383.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.12to identify protein biomarkers of disease severity in the  synovial f luid and serum of patients with rheumatoid  arthritis.",Non-OADS,/arxiv_data1/oa_pdf/aa/fa/kjim-29-12.PMC3932383.pdf
S100A8/A9 as a biomarker in RA www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.12Res Clin Rheumatol 2007;21:663-675.,Non-OADS,/arxiv_data1/oa_pdf/aa/fa/kjim-29-12.PMC3932383.pdf
"Korean J Intern Med 2014;29:120-122 http://dx.doi.org/10.3904/kjim.2014.29.1.120 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org LETTER TO THE EDITORNeuropathic truncal pain in patients with type 2  diabetes mellitus relieved by topical cream and  nerve block Sun Hee Kim, Cho-Ok Baek , Kyung Ae Lee, Heung Yong Jin, Hong Sun Baek, and Tae Sun Park Division of Endocrinology and  Metabolism, Department of  Internal Medicine, Research  Institute of Clinical Medicine,  Chonbuk National University  Hospital, Jeonju, Korea Received : July 4, 2013 Revised : October 28, 2013 Accepted : November 11, 2013 Correspondence to  Tae Sun Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/88/13/kjim-29-120.PMC3932384.pdf
"121 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.120 Kim SH, et al.",OADS,/arxiv_data1/oa_pdf/88/13/kjim-29-120.PMC3932384.pdf
                             122 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.120The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/88/13/kjim-29-120.PMC3932384.pdf
"Korean J Intern Med 2014;29:123-125 http://dx.doi.org/10.3904/kjim.2014.29.1.123 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgLETTER TO THE EDITORSuccessful treatment of myelodysplastic    syndrome and Behcet colitis after allogeneic   hematopoietic stem cell transplantation Min-Ha Kook1, Ho-Young Yhim1, Na-Ri Lee1,2, Eun-Kee Song1,2, Hee Sun Kim3, Chang-Yeol Yim1,2,    and Jae-Yong Kwak1,2 1Division of Hematology and  Oncology, Department of Internal  Medicine and 2Advanced Research  Cancer Center, Chonbuk National  University Medical School, Jeonju;  3Department of Nursing, Woosuk  University, Wanju, Korea Received : April 26, 2013 Revised : July 22, 2013 Accepted : October 4, 2013 Correspondence to Jae-Yong Kwak, M.D.",Non-OADS,/arxiv_data1/oa_pdf/93/64/kjim-29-123.PMC3932385.pdf
124 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.123The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/93/64/kjim-29-123.PMC3932385.pdf
"125 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.123 Kook MH, et al.",OADS,/arxiv_data1/oa_pdf/93/64/kjim-29-123.PMC3932385.pdf
"Korean J Intern Med 2014;29:126-129 http://dx.doi.org/10.3904/kjim.2014.29.1.126 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org LETTER TO THE EDITOREosinophilic organ infiltration without     eosinophilia or direct parasite infection Il Young Jang1, Young-Joo Yang1, Hyung Jin Cho1, Yunsik Choi1, Eun-Hye Shin1, Dong-Uk Kang1,    and Tae-Bum Kim1,2 1Department of Internal Medicine  and 2Division of Allergy and  Clinical Immunology, Department  of Internal Medicine, Asan  Medical Center, University of  Ulsan College of Medicine, Seoul,  Korea Received : May 9, 2013 Revised : June 11, 2013 Accepted : July 22, 2013 Correspondence to  Tae-Bum Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/1f/28/kjim-29-126.PMC3932386.pdf
"127 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.126 Jang IY, et al.",OADS,/arxiv_data1/oa_pdf/1f/28/kjim-29-126.PMC3932386.pdf
                             128 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.126The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/28/kjim-29-126.PMC3932386.pdf
"129 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.126 Jang IY, et al.",OADS,/arxiv_data1/oa_pdf/1f/28/kjim-29-126.PMC3932386.pdf
"Korean J Intern Med 2014;29:130 http://dx.doi.org/10.3904/kjim.2014.29.1.130  Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org IMAGE OF INTERESTAcupuncture needle: an obscure cause of anal pain Tae Hee Lee and Joon Seong Lee Institute for Digestive Research,  Digestive Disease Center,  Soonchunhyang University  Hospital, Seoul, Korea Received : November 22, 2012 Revised : November 23, 2012 Accepted : November 23, 2012 Correspondence to  Joon Seong Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/54/60/kjim-29-130.PMC3932387.pdf
"Korean J Intern Med 2014;29:131 http://dx.doi.org/10.3904/kjim.2014.29.1.131  Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgIMAGE OF INTERESTCervical spine fracture in advanced ankylosing  spondylitis Jennifer Lee, Sung-Hwan Park, and Kyung-Su Park Division of Rheumatology,  Department of Internal Medicine,  Seoul St. Mary’s Hospital, The  Catholic University of Korea  College of Medicine, Seoul, Korea Received : September 26, 2013 Revised : October 2, 2013 Accepted : October 28, 2013 Correspondence to Kyung-Su Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/7d/1f/kjim-29-131.PMC3932388.pdf
"GUIDELINE Korean J Intern Med 2014;29:132-147 http://dx.doi.org/10.3904/kjim.2014.29.1.132 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgSevere influenza treatment guideline Won Suk Choi1, Ji Hyeon Baek2, Yu Bin Seo3, Sae Yoon Kee4, Hye Won Jeong5, Hee Young Lee6,    Byung Wook Eun7, Eun Ju Choo8, Jacob Lee3, Young Keun Kim9, Joon Young Song1, Seong-Heon Wie10,    Jin Soo Lee2, Hee Jin Cheong1, Woo Joo Kim1, and Transgovernmental Enterprise for Pandemic Influenza in Korea 1Department of Internal Medicine,  Korea University College of  Medicine, Seoul; 2Department of  Internal Medicine, Inha University  School of Medicine, Incheon;  3Department of Internal Medicine,  Hallym University College of  Medicine, Seoul; 4Department  of Internal Medicine, Konkuk  University School of Medicine,  Chungju; 5Department of Internal  Medicine, Chungbuk National  University College of Medicine,  Cheongju; 6Gachon University Gil  Hospital Cancer Center, Gachon  University Gil Medical Center,  Incheon; 7Department of Pediatrics,  Eulji University School of Medicine,  Daejeon; 8Department of Internal  Medicine, Soonchunhyang  University College of Medicine,  Bucheon; 9Department of Internal  Medicine, Yonsei University Wonju  College of Medicine, Wonju;  10Department of Internal Medicine,  The Catholic University of Korea  College of Medicine, Seoul, Korea Received : December 12, 2013 Accepted: December 17, 2013 Correspondence to  Seong-Heon Wie, M.D.",Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
"Severe influenza treatment guideline  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132- Dyspnea, tachypnea, or hypoxia - Radiological signs of lower respiratory tract disease -   Central nervous system involvement (e.g., encephalopathy, en cephalitis) - Severe dehydration - Acute renal failure - Septic shock -   Exacerbation of underlying chronic disease, including asthma,  chronic obstructive pulmonary disease (COPD), chronic hepatic  or renal insufficiency, diabetes mellitus, or other cardiovascular  conditions -   Any other influenza-related condition or clinical presentation  requiring hospital admission Users of this guideline are all general practitioners and  medical specialists who treat severe influenza patients.",Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132questions (Appendix 2).",Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
Severe influenza treatment guideline  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132Many studies have been conducted to compare and  evaluate the effects of treatment using a standard- and  high-dose of antiviral agent with mild influenza infec - tion patients without any complications.,Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132guideline also stated that a longer use of an antiviral  agent may be considered if a severe state continues even  after using an antiviral agent for 5 days [13].",Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
"Severe influenza treatment guideline  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132quinolones that show an antibacterial activity to  Staphylococcus  aureus, Streptococcus pneumonia, Streptococcus pyogenes, and  Moraxella catarrhalis  are recommended (BII).",Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132conventional therapy [29-31].",Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
Severe influenza treatment guideline  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132tered.,Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132A statin, which is an inhibitor of 3-hydroxy-3-methyl - glutaryl-CoA reductase, blocks intracellular signal  transduction via isoprenoid showing an anti-inflam ma- tory effect, regulating immune response, and inhibit - ing cell growth.",Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
Severe influenza treatment guideline  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132This guideline provides the basic treatment princi - ples appropriate to the circumstances in Korea as of  November 2013 for the treatment of severe seasonal in - f luenza.,Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
Available from: http://www.who.int/csr/resources/ publications/swineflu/h1n1_use_antivirals_20090820/ en/.,OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.13216.",Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
Severe influenza treatment guideline  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132ry support during the influenza A (H1N1) pandemic flu  in Sweden.,Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132interstitial pneumonia due to the negative results of  a rapid-antigen test.",Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
Severe influenza treatment guideline  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.13282.,Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132Appendix 1.",Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
Severe influenza treatment guideline  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.132Appendix 2.,Non-OADS,/arxiv_data1/oa_pdf/e5/d8/kjim-29-132.PMC3932389.pdf
"EDITORIAL Korean J Intern Med 2014;29:20-22 http://dx.doi.org/10.3904/kjim.2014.29.1.20 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgOxidative stress, point-of-care test, and metabolic  syndrome Ji Sun Nam1 and Chul Woo Ahn2 1Department of Internal Medicine,  Yongin Severance Hospital, Yonsei  University College of Medicine ,  Yongin ; 2Department of Internal  Medicine, Gangnam Severance  Hospital , Yonsei University  College of Medicine , Seoul, Korea Received: December 17, 2013 Accepted: December 18, 2013 Correspondence to  Chul Woo Ahn, M.D.",Non-OADS,/arxiv_data1/oa_pdf/16/7b/kjim-29-20.PMC3932390.pdf
21 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.20Nam JS and Ahn CW.,OADS,/arxiv_data1/oa_pdf/16/7b/kjim-29-20.PMC3932390.pdf
22 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.20The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/16/7b/kjim-29-20.PMC3932390.pdf
"EDITORIAL Korean J Intern Med 2014;29:23-26 http://dx.doi.org/10.3904/kjim.2014.29.1.23 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgRisks associated with sunitinib use and monitoring  to improve patient outcomes Bum Soon Choi Division of Nephrology,  Department of Internal Medicine,  The Catholic University of Korea  College of Medicine, Seoul, Korea Received: December 12, 2013 Accepted: December 16, 2013 Correspondence to  Bum Soon Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/9f/0a/kjim-29-23.PMC3932391.pdf
24 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.23The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/9f/0a/kjim-29-23.PMC3932391.pdf
25 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.23Choi BS.,Non-OADS,/arxiv_data1/oa_pdf/9f/0a/kjim-29-23.PMC3932391.pdf
26 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.23The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/9f/0a/kjim-29-23.PMC3932391.pdf
"EDITORIAL Korean J Intern Med 2014;29:27-30 http://dx.doi.org/10.3904/kjim.2014.29.1.27 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgThird-generation cephalosporin resistance in  gram-negative bacteria in the community: a  growing public health concern Sun Hee Park Division of Infectious Diseases,  Department of Internal Medicine,  Daejeon St. Mary’s Hospital,  The Catholic University of Korea  College of Medicine, Daejeon,  Korea Received: December 26, 2013 Accepted: December 28, 2013 Correspondence to  Sun Hee Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/f1/02/kjim-29-27.PMC3932392.pdf
28 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.27The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/f1/02/kjim-29-27.PMC3932392.pdf
29 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.27Park SH.,Non-OADS,/arxiv_data1/oa_pdf/f1/02/kjim-29-27.PMC3932392.pdf
30 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.27The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/f1/02/kjim-29-27.PMC3932392.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:31-39 http://dx.doi.org/10.3904/kjim.2014.29.1.31  Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine,  Bundang Jesaeng Hospital,  Seongnam; 2Department of  Family Medicine, Inje University  Ilsan Paik Hospital, Goyang;  3Seoul National University  Graduate School of Public Health,  Seoul, Korea Received : August 10, 2012 Revised : November 7, 2012 Accepted : November 29, 2012 Correspondence to  Hyun Wook Baik, M.D.",Non-OADS,/arxiv_data1/oa_pdf/8b/17/kjim-29-31.PMC3932393.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.31to data from the Korean National Health and Nutri - tion Survey [2].",OADS,/arxiv_data1/oa_pdf/8b/17/kjim-29-31.PMC3932393.pdf
Antioxidant capacity and MetS www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.31lated by dividing the body weight (kg) by the square of  the height (m).,Non-OADS,/arxiv_data1/oa_pdf/8b/17/kjim-29-31.PMC3932393.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.31was 1,937.3 μmol/L, significantly lower than that of the  non-MetS group.",OADS,/arxiv_data1/oa_pdf/8b/17/kjim-29-31.PMC3932393.pdf
Antioxidant capacity and MetS www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.31a16 141210 86420Insulin (µU/mL)  Normal Antioxidant capacityReduceda4.5 4 3.5 3 2.5 2 1.5 1 0.5 0HOMA-IR Normal Antioxidant capacityReduced a10 9 8 765 4 321 0Adiponectim (µg/mL)  Normal Antioxidant capacityReduced1.8 1.6 1.4 1.2 1 0.8 0.60.40.2 0IL-6 (Pg/mL) Normal Antioxidant capacityReduced 4.5 4 3.5 3 2.5 2 1.5 1 0.5 0TNF-α (pg/mL)  Normal Antioxidant capacityReduceda 0.25 0.2 0.15 0.1 0.05 0hs-CRP (mg/dL) Normal Antioxidant capacityReduced Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/8b/17/kjim-29-31.PMC3932393.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.31linear regression analysis was performed to evaluate  the association between reduced antioxidant capacity  and inflammatory markers and adipocytokines (Table  2).",OADS,/arxiv_data1/oa_pdf/8b/17/kjim-29-31.PMC3932393.pdf
"Antioxidant capacity and MetS www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.31DISCUSSION In this study, we found that subjects with MetS showed  a reduced antioxidant capacity that was significantly  correlated with lower adiponectin and higher HO - MA-IR and hs-CRP levels.",Non-OADS,/arxiv_data1/oa_pdf/8b/17/kjim-29-31.PMC3932393.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.31ods to prevent the onset of diseases via controlling  them before the overt onset stage by predicting MetS  in healthy adults.",Non-OADS,/arxiv_data1/oa_pdf/8b/17/kjim-29-31.PMC3932393.pdf
Antioxidant capacity and MetS www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.31mation in obese adults with metabolic syndrome.,Non-OADS,/arxiv_data1/oa_pdf/8b/17/kjim-29-31.PMC3932393.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:40-48 http://dx.doi.org/10.3904/kjim.2014.29.1.40 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartment of Internal Medicine,  Seoul National University  Hospital, Seoul, Korea Received : August 14, 2012 Revised : August 28, 2012 Accepted : October 15, 2012 Correspondence to   Kwon-Wook Joo, M.D.",Non-OADS,/arxiv_data1/oa_pdf/85/77/kjim-29-40.PMC3932394.pdf
Renal adverse effects of sunitinib www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.40line treatment of advanced and/or metastatic renal cell  carcinoma (mRCC) and is effective in the treatment of  advanced gastrointestinal stromal tumor (GIST) after  failure of imatinib treatment [6-8].,Non-OADS,/arxiv_data1/oa_pdf/85/77/kjim-29-40.PMC3932394.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.40as an increase ≥ 50% or ≥ 0.5 mg/dL in sCr levels; RI  with identifiable causes was not included.",Non-OADS,/arxiv_data1/oa_pdf/85/77/kjim-29-40.PMC3932394.pdf
Renal adverse effects of sunitinib www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.40one patient.,Non-OADS,/arxiv_data1/oa_pdf/85/77/kjim-29-40.PMC3932394.pdf
"aAccording to the National Cancer Institute proteinuria grading, available at: http://evs.nci.nih.gov/ftp1/CTCAE/About.html",Non-OADS,/arxiv_data1/oa_pdf/85/77/kjim-29-40.PMC3932394.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.40Relationship between PU and PFS Because few patients suffered from non-mRCC, in - cluding GIST and thyroid cancer, and those with  mRCC were more homogeneous, the relationship  between PFS and PU was analyzed only in patients  with mRCC.",Non-OADS,/arxiv_data1/oa_pdf/85/77/kjim-29-40.PMC3932394.pdf
Renal adverse effects of sunitinib www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.40adverse effects.,Non-OADS,/arxiv_data1/oa_pdf/85/77/kjim-29-40.PMC3932394.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.40depletion and use of nephrotoxic drugs to be causes of  renal dysfunction, which were reversible, and so not  categorized as RI.",Non-OADS,/arxiv_data1/oa_pdf/85/77/kjim-29-40.PMC3932394.pdf
Renal adverse effects of sunitinib www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.40which might affect PU and/or RI.,Non-OADS,/arxiv_data1/oa_pdf/85/77/kjim-29-40.PMC3932394.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.40with renal insufficiency.",Non-OADS,/arxiv_data1/oa_pdf/85/77/kjim-29-40.PMC3932394.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:49-56 http://dx.doi.org/10.3904/kjim.2014.29.1.49 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartments of 1Internal  Medicine and 2Laboratory  Medicine, Daegu Fatima Hospital,  Daegu, Korea Received : November 22, 2012 Revised : January 11, 2013 Accepted : March 8, 2013 Correspondence to  Ki Tae Kwon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/11/f9/kjim-29-49.PMC3932395.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.49[4-6].",Non-OADS,/arxiv_data1/oa_pdf/11/f9/kjim-29-49.PMC3932395.pdf
"E. coli, K. pneumoniae  bacteremia in ED www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.49pneumoniae , respectively, at the Daegu Fatima Hospital  ED during the study period.",Non-OADS,/arxiv_data1/oa_pdf/11/f9/kjim-29-49.PMC3932395.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.49community-onset E. coli  bacteremia was caused by ES - BL-producers [10].",Non-OADS,/arxiv_data1/oa_pdf/11/f9/kjim-29-49.PMC3932395.pdf
"E. coli, K. pneumoniae  bacteremia in ED www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.49abilities of ESBL types [15].",Non-OADS,/arxiv_data1/oa_pdf/11/f9/kjim-29-49.PMC3932395.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.49are likely similar to those in other primary or second - ary care hospitals in Korea.",Non-OADS,/arxiv_data1/oa_pdf/11/f9/kjim-29-49.PMC3932395.pdf
"E. coli, K. pneumoniae  bacteremia in ED www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.49was ~45%, its empirical use for treating infections  caused by gram-negative organisms could be inappro - priate.",Non-OADS,/arxiv_data1/oa_pdf/11/f9/kjim-29-49.PMC3932395.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.49ulation-based laboratory surveillance for AmpC beta- lactamase-producing Escherichia coli, Calgary.",Non-OADS,/arxiv_data1/oa_pdf/11/f9/kjim-29-49.PMC3932395.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:57-65 http://dx.doi.org/10.3904/kjim.2014.29.1.57  Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Division of Gastroenterology  and Hepatology, Department  of Internal Medicine, Korea  University Ansan Hospital,  Ansan; 2Division of Hepatology,  Department of Internal  Medicine, Korea University Guro  Hospital, Seoul; 3Division of  Gastroenterology and Hepatology,  Department of Internal Medicine,  Korea University Anam Hospital,  Seoul, Korea Received : May 5, 2013 Revised : June 18, 2013 Accepted : July 18, 2013 Correspondence to Hyung Joon Yim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/09/ca/kjim-29-57.PMC3932396.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.57acting on the central nervous system (CNS), hypoten - sion, and hypoxemia [6].",Non-OADS,/arxiv_data1/oa_pdf/09/ca/kjim-29-57.PMC3932396.pdf
"Propofol in cirrhotic patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.57A visual analogue scale (VAS), for which patients grade  their level of pain during the endoscopy from point 0  (no discomfort) to 10 (severe pain), was conducted after  the endoscopy to assess the efficacy of sedation.",Non-OADS,/arxiv_data1/oa_pdf/09/ca/kjim-29-57.PMC3932396.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.57and postprocedural level measured 2 days after the  procedure.",Non-OADS,/arxiv_data1/oa_pdf/09/ca/kjim-29-57.PMC3932396.pdf
Propofol in cirrhotic patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.57after the procedure showed no significant difference ( p  = 0.456 in the cirrhotic group and p = 0.172 in the con - trol group) (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/09/ca/kjim-29-57.PMC3932396.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.57sus 9.9 in alcoholic and nonalcoholic cirrhosis pa - tients, respectively ( p > 0.05 between the groups at all  time points).",Non-OADS,/arxiv_data1/oa_pdf/09/ca/kjim-29-57.PMC3932396.pdf
"Propofol in cirrhotic patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.57for propofol dose adjustment in cases of hepatic im - pairment, and it seems more useful in sedation of cir - rhotic patients than any other drug [9,18].",Non-OADS,/arxiv_data1/oa_pdf/09/ca/kjim-29-57.PMC3932396.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.57wide range of hepatic function in cirrhotic patients.",Non-OADS,/arxiv_data1/oa_pdf/09/ca/kjim-29-57.PMC3932396.pdf
"Propofol in cirrhotic patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.57Propofol sedation for upper gastrointestinal endosco - py in patients with liver cirrhosis as an alternative to  midazolam to avoid acute deterioration of minimal en - cephalopathy: a randomized, controlled study.",Non-OADS,/arxiv_data1/oa_pdf/09/ca/kjim-29-57.PMC3932396.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:66-75 http://dx.doi.org/10.3904/kjim.2014.29.1.66  Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartments of 1Internal Medicine  and 2Cardiothoracic Surgery,  Keimyung University School of  Medicine, Daegu, Korea Received : February 11, 2013 Revised : March 15, 2013 Accepted : June 28, 2013 Correspondence to  Seung-Ho Hur, M .D.",Non-OADS,/arxiv_data1/oa_pdf/86/b1/kjim-29-66.PMC3932397.pdf
IVUS- guided PPCI in STEMI www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.66in patients with stable coronary artery disease undergo - ing elective PCI [1-4].,Non-OADS,/arxiv_data1/oa_pdf/86/b1/kjim-29-66.PMC3932397.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.66using chi-square  and Fisher exact tests.",Non-OADS,/arxiv_data1/oa_pdf/86/b1/kjim-29-66.PMC3932397.pdf
"IVUS- guided PPCI in STEMI www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.66the groups (1.7% vs. 1.5%, p = 1.0 at 1 and 2 years ; 2.3%  vs. 1.5%, p = 1.0 at 3 years, respectively).",OADS,/arxiv_data1/oa_pdf/86/b1/kjim-29-66.PMC3932397.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.66with DES versus BMS, driven mainly by reduced TVR  or target lesion revascularization (TLR), without safety  issues, in AMI patients during 3  to 5 years of follow-up  [18-22].",Non-OADS,/arxiv_data1/oa_pdf/86/b1/kjim-29-66.PMC3932397.pdf
"IVUS- guided PPCI in STEMI www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.66of very late ST and late infarction were significantly  higher in patients treated with DES (HR, 2.81; 95% CI,  1.28 to 6.19; p = 0.04 and HR, 2.06; 95% CI, 1.22  to 3.49; p  = 0.03, respectively) [15].",Non-OADS,/arxiv_data1/oa_pdf/86/b1/kjim-29-66.PMC3932397.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.66[26,27].",Non-OADS,/arxiv_data1/oa_pdf/86/b1/kjim-29-66.PMC3932397.pdf
"IVUS- guided PPCI in STEMI www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.66sions and stent implantation were both higher and pro - cedural time was prolonged in the IVUS-guided group,  1-year clinical outcomes did not dif fer between IVUS -  guided PCI and angiography-guided PCI [5,6].",Non-OADS,/arxiv_data1/oa_pdf/86/b1/kjim-29-66.PMC3932397.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.66REFERENCES   1.",Non-OADS,/arxiv_data1/oa_pdf/86/b1/kjim-29-66.PMC3932397.pdf
IVUS- guided PPCI in STEMI www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.66tional Stent in Myocardial Infarction with ST-Segment  Elevation) trial.,Non-OADS,/arxiv_data1/oa_pdf/86/b1/kjim-29-66.PMC3932397.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:76-84 http://dx.doi.org/10.3904/kjim.2014.29.1.76 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal  Medicine, Inje University  Ilsan Paik Hospital, Goyang;  2Department of Preventive  Medicine, Inje University College  of Medicine, Busan; 3Department  of Rheumatology, Ajou University  School of Medicine, Suwon;  4Withus Medical Clinic, Goyang,  Korea Received : February 6, 2013 Revised : March 6, 2013 Accepted : April 15, 2013 Correspondence to  Bo Young Yoon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/41/03/kjim-29-76.PMC3932398.pdf
"Poor agreement between latent TB tests www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.76In the detection and prophylactic treatment of LTBI,  diagnostic tools for LTBI are used to decide whether  antitumor necrosis factor- α (anti-TNF- α) agents  should be administered [1].",Non-OADS,/arxiv_data1/oa_pdf/41/03/kjim-29-76.PMC3932398.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.76Korea.",OADS,/arxiv_data1/oa_pdf/41/03/kjim-29-76.PMC3932398.pdf
Poor agreement between latent TB tests www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.76Table 1.,Non-OADS,/arxiv_data1/oa_pdf/41/03/kjim-29-76.PMC3932398.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.76cutoff value, the agreement between the two test results  was 28/53 (52.8%) and κ = 0.05 in patients with RA and  45/79 (60.0%) and  κ = 0.05 in healthy controls (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/41/03/kjim-29-76.PMC3932398.pdf
Poor agreement between latent TB tests www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.76the TST in LTBI diagnosis among individuals infected  with the human immunodeficiency virus [14].,Non-OADS,/arxiv_data1/oa_pdf/41/03/kjim-29-76.PMC3932398.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.76significantly associated with elderly and immunocom - promised patients.",Non-OADS,/arxiv_data1/oa_pdf/41/03/kjim-29-76.PMC3932398.pdf
Poor agreement between latent TB tests www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.76REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/41/03/kjim-29-76.PMC3932398.pdf
Available from: http://www.who.int/ tb/en/.,Non-OADS,/arxiv_data1/oa_pdf/41/03/kjim-29-76.PMC3932398.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.76in patient in patients treated with TNF blockers [Inter - net].",Non-OADS,/arxiv_data1/oa_pdf/41/03/kjim-29-76.PMC3932398.pdf
Available from: http://www.mfds.,Non-OADS,/arxiv_data1/oa_pdf/41/03/kjim-29-76.PMC3932398.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:85-95 http://dx.doi.org/10.3904/kjim.2014.29.1.85  Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine,  Inje University Busan Paik  Hospital, Busan; 2Department of  Internal Medicine, Seoul National  University Hospital, Seoul;  3Institute of Allergy and Clinical  Immunology, Seoul National  University Medical Research  Center, Seoul, Korea Received : January 22, 2013 Revised : March 20, 2013 Accepted : July 10, 2013 Correspondence to  Hye-Ryun Kang , M.D.",Non-OADS,/arxiv_data1/oa_pdf/b2/95/kjim-29-85.PMC3932399.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.85vasculitides [2].",Non-OADS,/arxiv_data1/oa_pdf/b2/95/kjim-29-85.PMC3932399.pdf
"Churg-Strauss syndrome in Koreans www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.85Statistical analyses were conducted using the Mann-   Whitney U test and Fisher exact test for comparisons  between groups: ANCA(+) versus ANCA(-) patients, and  good versus poor responders.",OADS,/arxiv_data1/oa_pdf/b2/95/kjim-29-85.PMC3932399.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.85Organ involvement in Churg-Strauss syndrome The frequencies of organ involvement in CSS patients  are listed in Table 2.",Non-OADS,/arxiv_data1/oa_pdf/b2/95/kjim-29-85.PMC3932399.pdf
Churg-Strauss syndrome in Koreans www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.85with the most common presentation being nonpalpa - ble purpura (seven patients).,Non-OADS,/arxiv_data1/oa_pdf/b2/95/kjim-29-85.PMC3932399.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.85significantly less frequent in ANCA(-) than in ANCA(+)  patients (8.6% vs. 42.9%; p = 0.048).",Non-OADS,/arxiv_data1/oa_pdf/b2/95/kjim-29-85.PMC3932399.pdf
Churg-Strauss syndrome in Koreans www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.85= 0.004).,Non-OADS,/arxiv_data1/oa_pdf/b2/95/kjim-29-85.PMC3932399.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.85patients, the asthma prevalence in our study would in - crease to 86.5%.",Non-OADS,/arxiv_data1/oa_pdf/b2/95/kjim-29-85.PMC3932399.pdf
"Churg-Strauss syndrome in Koreans www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.85munosuppressants in 2005, it was reported that the  5-year survival rate was up to 98% [27,28].",Non-OADS,/arxiv_data1/oa_pdf/b2/95/kjim-29-85.PMC3932399.pdf
"1, January 2014 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.85diagnosis with those before diagnosis in most pa - tients.",Non-OADS,/arxiv_data1/oa_pdf/b2/95/kjim-29-85.PMC3932399.pdf
Churg-Strauss syndrome in Koreans www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.85Clin Immunol 2010;30:314-319.,Non-OADS,/arxiv_data1/oa_pdf/b2/95/kjim-29-85.PMC3932399.pdf
"Korean J Intern Med 2014;29:96-100 http://dx.doi.org/10.3904/kjim.2014.29.1.96 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org CASE REPORTDuodenal adenocarcinoma following a     neuroendocrine tumor in the duodenum Bun Kim1, Ji Hye Huh1, Youngsook Kim1, Moon Jae Chung1, Jeong Youp Park1, Si Young Song1,2,3,    and Seung Woo Park1 1Division of Gastroenterology,  Department of Internal Medicine,  2Brain Korea 21 Project for  Medical Science, and 3Severance  Biomedical Science Institute,  Yonsei University College of  Medicine, Seoul, Korea Received : June  8, 2012 Revised  : September 26, 2012 Accepted: December 3, 2012 Correspondence to  Seung Woo Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/bc/7d/kjim-29-96.PMC3932400.pdf
"97 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.96 Kim B, et al.",OADS,/arxiv_data1/oa_pdf/bc/7d/kjim-29-96.PMC3932400.pdf
                             98 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.96The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/bc/7d/kjim-29-96.PMC3932400.pdf
"99 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.96 Kim B, et al.",OADS,/arxiv_data1/oa_pdf/bc/7d/kjim-29-96.PMC3932400.pdf
100 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.1.96The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/bc/7d/kjim-29-96.PMC3932400.pdf
"In addition to nearly 700 000 genotyped SNPs, more thanone million other SNPs were imputed using IMPUTE v.2 software (https://mathgen.stats.ox.ac.uk/impute/impute.html).",OADS,/arxiv_data1/oa_pdf/96/92/mp2012191a.PMC3932402.pdf
"2011, Available from http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/96/92/mp2012191a.PMC3932402.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Genetic stability but increasing heritability M Trzaskowski et al 384 Molecular Psychiatry (2014), 380 – 384 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/96/92/mp2012191a.PMC3932402.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Journal of Human Hypertension website (http://www.nature.com/jhh)Blood pressure after renal denervation A Persu et al 156 Journal of Human Hypertension (2014) 150 – 156 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/82/31/jhh201388a.PMC3932403.pdf
"37The measurements were dichotomized at 0.2 optical density units, yielding a prevalence consistent with those measured in European populations.38 Statistical analysis All analyses were performed using the software PLINK (http://pngu.mgh.harvard.edu/ Bpurcell/plink/)39unless otherwise stated.",OADS,/arxiv_data1/oa_pdf/0c/13/mp20132a.PMC3932405.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp) APPENDIX Genetic Risk and Outcome in Psychosis (GROUP Investigators): Rene´S Kahn1, Don H Linszen2, Jim van Os3, DurkbWiersma4, Richard Bruggeman4, Wiepke Cahn1, Lieuwe de Haan2, Lydia Krabbendam3, Inez Myin-Germeys3.",Non-OADS,/arxiv_data1/oa_pdf/0c/13/mp20132a.PMC3932405.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/15/3c/srep04160.PMC3932448.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4160 | DOI: 10.1038/srep04160 10",Non-OADS,/arxiv_data1/oa_pdf/15/3c/srep04160.PMC3932448.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7c/2a/srep04159.PMC3932449.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4159 | DOI: 10.1038/srep04159 6",Non-OADS,/arxiv_data1/oa_pdf/7c/2a/srep04159.PMC3932449.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/amiajnl-2013-001825).,Non-OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
"All resources, including the OpenMRS demonstration, can befound at http://harvest.research.chop.edu INTRODUCTION Biomedical researchers are often challenged with navigating the large volumes of data available frommedical and research information systems.",Non-OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
"The demon-stration application, system documentation tutorials, and ETLpackage may be found at http://harvest.research.chop.edu.",OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Fox P, Hendler J.",Non-OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
Secondary Python Programming Language —Ofﬁcial Website 2013. http://www.python.org 11 Django Secondary Django 2013. http://www.djangoproject.com/12 Avocado —Metadata APIs for Django.,OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
Secondary Avocado —Metadata APIs for Django 2013. http://cbmi.github.com/avocado/ 13 Django documentation —Models and databases.,OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
Secondary Django documentation —Models and databases 2013. http://docs.djangoproject.com/en/dev/topics/db 14 Django Guardian.,OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
Secondary Django Guardian 2013. http://pythonhosted.org/ django-guardian/ 15 Serrano —Hypermedia API for Avocado.,OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
2013. http://github.com/cbmi/serrano 16 PostgreSQL.,Non-OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
Secondary PostgreSQL 2013. http://www.postgresql.org/17 SQLite.,OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
Secondary SQLite 2013. http://www.sqlite.org/18 NGINX Web Server.,OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
Secondary NGINX Web Server 2013. http://wiki.nginx.org/Main 19 Apache HTTP Server Project.,Non-OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
Secondary Harvest Vocab Browser 2013. https://github.com/ cbmi/harvest-vocab 21 OpenMRS Demo Data.,OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
Secondary OpenMRS Demo Data 2013. https://wiki.openmrs.,OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
"Secondary Harvest Website 2013. http://harvest.research.chop.edu Pennington JW, et al.J Am Med Inform Assoc 2014; 21:379–383.",OADS,/arxiv_data1/oa_pdf/08/cd/amiajnl-2013-001825.PMC3932456.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Williams T, VanStaa T, Padmanabhan S, et al.",Non-OADS,/arxiv_data1/oa_pdf/5f/26/amiajnl-2013-001847.PMC3932457.pdf
"Read Codes Version 2 (5-byte); 2007. http://www.nottm-vts.org.uk/ReferenceMaterial/ 4 Dave S, Petersen I.",Non-OADS,/arxiv_data1/oa_pdf/5f/26/amiajnl-2013-001847.PMC3932457.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/amiajnl-2013-001935).,Non-OADS,/arxiv_data1/oa_pdf/6f/fc/amiajnl-2013-001935.PMC3932460.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Mathias JS, Gossett D, Baker DW.",Non-OADS,/arxiv_data1/oa_pdf/6f/fc/amiajnl-2013-001935.PMC3932460.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Clark DE.,Non-OADS,/arxiv_data1/oa_pdf/68/9b/amiajnl-2013-002034.PMC3932463.pdf
http://www.iplantcollaborative.org/ for additional information.,Non-OADS,/arxiv_data1/oa_pdf/f0/a3/amiajnl-2013-002059.PMC3932465.pdf
Researchers considering NCGAS resources can visithttp://ncgas.org for allocation information.,OADS,/arxiv_data1/oa_pdf/f0/a3/amiajnl-2013-002059.PMC3932465.pdf
"T o determine if your insti-tution has an XSEDE campus champion, visit https://www.xsede.org/campus-champions; otherwise researchers can requestXSEDE allocations at https://www.xsede.org.",Non-OADS,/arxiv_data1/oa_pdf/f0/a3/amiajnl-2013-002059.PMC3932465.pdf
12Researchers interested in the OSG can visit https://www.opensciencegrid.org/.,Non-OADS,/arxiv_data1/oa_pdf/f0/a3/amiajnl-2013-002059.PMC3932465.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Stewart CA, Simms S, Plale B, et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/a3/amiajnl-2013-002059.PMC3932465.pdf
2 https://www.xsede.org/web/guest/overview (accessed May 2013).3 https://opensciencegrid.org/bin/view (accessed May 2013).,OADS,/arxiv_data1/oa_pdf/f0/a3/amiajnl-2013-002059.PMC3932465.pdf
12 http://display.grid.iu.edu/ (accessed May 2013).13 http://irnclinks.net/ (accessed May 2013).14 http://www.skatelescope.org/uploaded/21705_130_Memo_Dewdney.pdf (accessed May 2013).,Non-OADS,/arxiv_data1/oa_pdf/f0/a3/amiajnl-2013-002059.PMC3932465.pdf
"Efforts to this end are demonstrated by a spateof new data sharing and aggregation initiatives by aca-demics, private –public partnerships, and publishers, for example Sage Bionetworks, 14the Pistoia Alliance (http://www.pistoiaalliance.org) and DRYAD,15among others.16–18At the national level in the USA, the data sharing trend is re ﬂected in programs such as the National Institutes of Health ’s( N I H )r e c e n t l y announced ‘Big Data to Knowledge ’(BD2K) initia- tive,19and the White House of ﬁce of science and technology policy ’s recent directive that the results of government-funded research be made publicly avail- able.20The Innovative Medicines Initiative (http:// www.imi.europa.eu/) is Europe ’sl a r g e s tp u b l i c –private initiative that supports collaborative research projectsand builds networks of industrial and academicexperts in order to boost pharmaceutical innovation inEurope.",Non-OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
"Internationally, the Research Data Alliance(https://rd-alliance.org/) has been established by aninternational steering group from funding agencies inthe USA, EU and Australia; and recently the globalalliance for genomic and clinical data sharing hasbrought together over 70 leading healthcare, research,and disease advocacy organizations, involving research-ers from more than 40 countries, to enable securesharing of genomic and clinical data.",OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
"However, for an individual investigator who wants to bestandards-compliant and does not know where to begin, expert advice can save significant time in researching options Quality assurance tools Similar to syntax validators such as for RDF, tools to gauge or validate standards compliance are useful for data submitters a s well as reviewers NCBO, National Center for Biomedical Ontology (http://www.bioontology.org/); RDF, Resource Description Framework.",Non-OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Request for Information (RFI ): input into the Deliberations of the Advisory Committee to the NIH Director Working Group on Data and Informatics.,Non-OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
2012. http://grants.nih.gov/ grants/guide/notice- ﬁles/NOT-OD-12-032.html (accessed 30 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
2013. http://www.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
2012. http://grants.nih.gov/grants/guide/notice- ﬁles/ NOT-OD-12-160.html (accessed 16 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
2011. https://www.federalregister.gov/ articles/2011/11/04/2011-28621/request-for-information-public-access-to-digital- data-resulting-from-federally-funded-scienti ﬁc (accessed 30 May 2013).,OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
http://datadryad.org/ (accessed 31 May 2013).16 One Mind.,Non-OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
http://1mind4research.org/17 Eastman P. ASCO ’s continuous learning prototype passes proof-of-principle test.,Non-OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
2013. http://www.nlm.nih.gov/cde/ (accessed 23 May 2013).,OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
http://www.iso.org/iso/ home/standards.htm (accessed 1 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
2013. http://www.nature.com/scienti ﬁcdata/ (accessed 8 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/d7/ce/amiajnl-2013-002066.PMC3932466.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/amiajnl-2013-002147).,Non-OADS,/arxiv_data1/oa_pdf/5e/c9/amiajnl-2013-002147.PMC3932469.pdf
The software is freely available at https://sourceforge.net/projects/hierachicaldnac/with a General Public License(GPL) license.Limitation Our method requires having different reference genomes and prolongs the execution time foradditional alignments.Conclusions The proposed multi-reference-based compression algorithm for aligned reads outperformsexisting single-reference based algorithms.,Non-OADS,/arxiv_data1/oa_pdf/5e/c9/amiajnl-2013-002147.PMC3932469.pdf
"Additionally, we used the HCC1954 genome from the University of California,Santa Cruz mixed spike-in low coverage sample for the CancerGenome Atlas Benchmark 4, found at https://cghub.ucsc.edu/datasets/benchmark_download.html.",OADS,/arxiv_data1/oa_pdf/5e/c9/amiajnl-2013-002147.PMC3932469.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Ng SB, Turner EH, Robertson PD, et al.",Non-OADS,/arxiv_data1/oa_pdf/5e/c9/amiajnl-2013-002147.PMC3932469.pdf
http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?,Non-OADS,/arxiv_data1/oa_pdf/5e/c9/amiajnl-2013-002147.PMC3932469.pdf
ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/pilot2_high_cov_ GRCh37_bams/data/NA12878/alignment/NA12878.chrom20.ILLUMINA.bwa.CEU.,OADS,/arxiv_data1/oa_pdf/5e/c9/amiajnl-2013-002147.PMC3932469.pdf
"Experimental setup and public repository Both the ﬂat SVM and the hierarchy-based SVM were imple- mented with SVMlightwith default parameters.31T raining and testing sets, scripts for all evaluation metrics, and source codefor the classi ﬁers are available as part of a PhysioNet project “ICD9 coding of discharge summaries ”at https://physionet.org/ works/ICD9CodingofDischargeSummaries.",OADS,/arxiv_data1/oa_pdf/f9/0f/amiajnl-2013-002159.PMC3932472.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Cimino JJ.,Non-OADS,/arxiv_data1/oa_pdf/f9/0f/amiajnl-2013-002159.PMC3932472.pdf
http://www.who.int/classi ﬁcations/icd/ en/ (accessed 29 Apr 2013).,OADS,/arxiv_data1/oa_pdf/f9/0f/amiajnl-2013-002159.PMC3932472.pdf
"2007. http://www.computationalmedicine.org/challenge/previous 28 Saeed M, Villarroel M, Reisner AT, et al.",OADS,/arxiv_data1/oa_pdf/f9/0f/amiajnl-2013-002159.PMC3932472.pdf
"http://svmlight.joachims.org Perotte A, et al.J Am Med Inform Assoc 2014; 21:231–237.",Non-OADS,/arxiv_data1/oa_pdf/f9/0f/amiajnl-2013-002159.PMC3932472.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4155 | DOI: 10.1038/srep04155 7",Non-OADS,/arxiv_data1/oa_pdf/28/34/srep04155.PMC3932477.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b1/ca/srep04162.PMC3932478.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4162 | DOI: 10.1038/srep04162 8",Non-OADS,/arxiv_data1/oa_pdf/b1/ca/srep04162.PMC3932478.pdf
"2008, http://oncodb.hcc.ibms.sinica.edu.tw/index.htm), HCC.net (Update time: Apr 18, 2010, http://www.megabionet.org/hcc/index.php), dbHCCvar (Lastmodified on Sep 4, 2012, http://genetmed.fudan.edu.cn/dbHCCvar/), EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online, Last modified on Sep, 2012, http://ehco.iis.sinica.edu.tw), and Liverome (Last modified on Apr 14, 2011, http://liverome.kobic.re.kr/).",OADS,/arxiv_data1/oa_pdf/55/c9/srep04154.PMC3932480.pdf
"Screening of similar drugs and prediction of putative targets for GSBXT .As our previous study 20, we used Drug Similarity Search tool in Therapeutic Targets Database37(TTD, http://xin.cz3.nus.edu.sg/group/cjttd/ ttd.asp, Version 4.3.02 release on Aug 25th 2011) to screen similar drugs of GSBXT through the structural similarity comparison.",OADS,/arxiv_data1/oa_pdf/55/c9/srep04154.PMC3932480.pdf
"Gene Ontology (GO) and pathway enrichment analysis for HCC significant proteins and putative targets of GSBXT .We used Database for Annotation, Visualization and Integrated Discovery38(DAVID, http://david.abcc.ncifcrf.gov/home.jsp,version 6.7) for GO enrichment analysis.",OADS,/arxiv_data1/oa_pdf/55/c9/srep04154.PMC3932480.pdf
"We also performed pathway enrichment analysis using pathway data obtained from the FTP service of KEGG39(Kyoto Encyclopedia of Genes and Genomes, http://www.genome.jp/kegg/, Last updated: Oct 16, 2012).",OADS,/arxiv_data1/oa_pdf/55/c9/srep04154.PMC3932480.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/55/c9/srep04154.PMC3932480.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4154 | DOI: 10.1038/srep04154 10",Non-OADS,/arxiv_data1/oa_pdf/55/c9/srep04154.PMC3932480.pdf
"L.I.J., C.V. and R.A. wrote the manuscript with input from all otherco-authors.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/63/c9/srep04157.PMC3932481.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4157 | DOI: 10.1038/srep04157 5",Non-OADS,/arxiv_data1/oa_pdf/63/c9/srep04157.PMC3932481.pdf
"Developmental Cognitive Neuroscience 7 (2014) 43–52 Contents lists available at ScienceDirect Developmental Cognitive Neuroscience journal homepage: http://www.elsevier.com/locate/dcn Caudate responses to reward anticipation associated with delay discounting behavior in healthy youth Margaret M. Benningﬁelda,b,∗, Jennifer U. Blackforda,c, Melissa E. Ellswortha, Gregory R. Samanez-Larkind, Peter R. Martina,e, Ronald L. Cowana,c,f, David H. Zalda,c aDepartment of Psychiatry, Vanderbilt University School of Medicine, 1601 23rd Avenue South, Nashville, TN 37212, United States bDepartment of Pediatrics, Vanderbilt University School of Medicine, 2200 Children’s Way, Nashville, TN, 37232, United States cDepartment of Psychology, Vanderbilt University, 2301 Vanderbilt Place, PMB 407817, Nashville, TN 37240, United States dDepartment of Psychology, Yale University, Box 208205, New Haven, CT 06520, United States eDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 215 Light Hall, Nashville, TN 37232, United States fDepartment of Radiology and Radiological Sciences, Vanderbilt University School of Medicine, 1161 Medical Center Drive, Medical Center North, Suite CCC-1100, Nashville, TN 37232, United States article info Article history: Received 6 March 2013 Received in revised form 29 October 2013 Accepted 30 October 2013 Keywords:AdolescentRewardfMRIDelay discountingIntertemporal choiceDelayed gratiﬁcationabstract Background: Choices requiring delay of gratiﬁcation made during adolescence can have sig- niﬁcant impact on life trajectory.",Non-OADS,/arxiv_data1/oa_pdf/f5/73/main.PMC3932556.pdf
http://dx.doi.org/10.1016/j.dcn.2013.10.009Open access under CC BY-NC-ND license.,OADS,/arxiv_data1/oa_pdf/f5/73/main.PMC3932556.pdf
"To control fortype 1 error, we used Monte Carlo simulation executedin AlphaSim (http://afni.nimh.nih.gov/afni/) to determine acluster threshold for family wise error correction to p< .05.",Non-OADS,/arxiv_data1/oa_pdf/f5/73/main.PMC3932556.pdf
Available from: http://www.NCCN.org.,Non-OADS,/arxiv_data1/oa_pdf/49/40/IJMPO-34-234.PMC3932587.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/d4/92/IJMPO-34-247.PMC3932590.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/66/a1/IJMPO-34-264.PMC3932593.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/1e/f5/IJMPO-34-309.PMC3932601.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/1e/f5/IJMPO-34-309.PMC3932601.pdf
To view please visit thejournal online (http://dx.doi.org/10.1136/gutjnl-2013- 304472).,Non-OADS,/arxiv_data1/oa_pdf/c8/85/gutjnl-2013-304472.PMC3932740.pdf
"1Institute of Infection & Immunity, Cardiff University,Cardiff, UK 2Department of Histopathology, University Hospital of Wales, Cardiff, UK 3Haematology Trials Unit, Institute of Translation, Innovation, Methodology and Engagement, Cardiff University,University Hospital of Wales,Cardiff, UK Correspondence to Dr Andrew Godkin, Instituteof Infection and Immunity,Cardiff University, Henry Wellcome Building, Heath Park, Cardiff CF14 4XN, UK;godkinaj@cardiff.ac.uk Received 7 January 2013 Revised 9 April 2013 Accepted 11 April 2013Published Online First11 May 2013 ▸http://dx.doi.org/10.1136/ gutjnl-2013-305087 To cite: Pembroke T, Christian A, Jones E, et al.",Non-OADS,/arxiv_data1/oa_pdf/c8/85/gutjnl-2013-304472.PMC3932740.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Day C, Lauer G, Robbins G, et al.",Non-OADS,/arxiv_data1/oa_pdf/c8/85/gutjnl-2013-304472.PMC3932740.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 T rinh KV , Graham N, Gross AR, et al.",Non-OADS,/arxiv_data1/oa_pdf/b2/2a/acupmed-2013-010410.PMC3932742.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ sextrans-2013-051147).,Non-OADS,/arxiv_data1/oa_pdf/55/7f/sextrans-2013-051147.PMC3932743.pdf
"1School of Social & Community Medicine, University of Bristol,Bristol, UK 2University College London, London, UK 3Centre for Clinical Infection & Diagnostics Research, Guy ’s & St. Thomas ’NHS Foundation Trust and King ’s College, London, UK 4Aquarius Population Health, Bristol, UK Correspondence to Dr Elisabeth Adams, AquariusPopulation Health, Engine Shed, Temple Meads, Bristol BS1 6QH, UK, elisabeth.adams@aquariusph.com Received 28 March 2013 Revised 3 October 2013 Accepted 27 October 2013 Published Online First22 November 2013 ▸http://dx.doi.org/10.1136/ sextrans-2013-051428 To cite: Turner KME, Round J, Horner P, et al.Sex Transm Infect2014; 90:104–111.ABSTRACT Objectives To estimate the costs and bene ﬁts of clinical pathways incorporating a point of care (POC)nucleic acid ampli ﬁcation test (NAAT) for chlamydia and gonorrhoea in genitourinary medicine (GUM) clinicscompared with standard off-site laboratory testing.Method We simulated 1.2 million GUM clinic attendees in England.",Non-OADS,/arxiv_data1/oa_pdf/55/7f/sextrans-2013-051147.PMC3932743.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Health Protection Agency.,Non-OADS,/arxiv_data1/oa_pdf/55/7f/sextrans-2013-051147.PMC3932743.pdf
"2012. http://www.hpa.org.uk 2 Horner PJ, Boag FC.",Non-OADS,/arxiv_data1/oa_pdf/55/7f/sextrans-2013-051147.PMC3932743.pdf
"BMC Public Health 2006;6:106. http://www.biomedcentral.com/1471 –2458/ 6/106 25 Adams EJ, Turner KME, Edmunds WJ.",Non-OADS,/arxiv_data1/oa_pdf/55/7f/sextrans-2013-051147.PMC3932743.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Guyatt GH, Akl EA, Crowther M, et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/6f/bmjqs-2012-001782.PMC3932749.pdf
2008. http://www.surgeongeneral.gov/topics/deepvein/ (accessed 30 Aug 2011).,Non-OADS,/arxiv_data1/oa_pdf/8b/6f/bmjqs-2012-001782.PMC3932749.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Yu DT , Jones AY .",Non-OADS,/arxiv_data1/oa_pdf/3a/82/acupmed-2013-010407.PMC3932756.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Bourdieu P. The Forms of Capital.,Non-OADS,/arxiv_data1/oa_pdf/d2/03/jech-2013-202996.PMC3932759.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Aiken LH, Cimiotti JP , Sloane DM, et al.",Non-OADS,/arxiv_data1/oa_pdf/66/f3/bmjqs-2012-001734.PMC3932760.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/jmedgenet-2013-102066).,Non-OADS,/arxiv_data1/oa_pdf/b0/76/jmedgenet-2013-102066.PMC3932761.pdf
"See: http://creativecommons.org/licenses/by/3.0/ REFERENCES 1 Sandal T, Laborie LB, Brusgaard K, Eide S, Christesen HBT, Søvik O, Njølstad PR, Molven A.",Non-OADS,/arxiv_data1/oa_pdf/b0/76/jmedgenet-2013-102066.PMC3932761.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ heartjnl-2013-304262).,Non-OADS,/arxiv_data1/oa_pdf/f1/e2/heartjnl-2013-304262.PMC3932762.pdf
"International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London,London, UK Correspondence to Dr Sonia Bouri, International Centre for Circulatory Health, National Heart and LungInstitute, Imperial CollegeLondon, St Mary ’s Hospital, 59-61 North Wharf Road, London W2 1LA, UK;soniabouri@nhs.net Received 11 May 2013 Revised 11 July 2013 Accepted 12 July 2013Published Online First31 July 2013 ▸http://dx.doi.org/10.1136/ heartjnl-2013-305384 To cite: Bouri S, Shun- Shin MJ, Cole GD, et al.",Non-OADS,/arxiv_data1/oa_pdf/f1/e2/heartjnl-2013-304262.PMC3932762.pdf
"W e searched Medline (1966 to 1 April 2013),the Cochrane Central Register of RandomisedControlled T rials, the WHO International ClinicalT rials Registry Platform Search Portal (http://apps.who.int/trialsearch/), Excerpta Medica Database(EMBASE) and the Cumulative Index to Nursingand Allied Health Literature (CINAHL) using thesearch terms available in the online supplement on23 March 2013 (see online supplementary appendix1).",OADS,/arxiv_data1/oa_pdf/f1/e2/heartjnl-2013-304262.PMC3932762.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery, European Society of Cardiology (ESC);Poldermans D, Bax JJ, Boersma E, et al.",Non-OADS,/arxiv_data1/oa_pdf/f1/e2/heartjnl-2013-304262.PMC3932762.pdf
http://www.escardio.org/about/press/press-releases/pr-11/Pages/Dismissal-Don-Poldermans.aspx (accessed 10 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/f1/e2/heartjnl-2013-304262.PMC3932762.pdf
31 http://www.hscic.gov.uk/article/2677/Linked-HES-ONS-mortality-data.,Non-OADS,/arxiv_data1/oa_pdf/f1/e2/heartjnl-2013-304262.PMC3932762.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 FDA Science and Mission at Risk: Report of the Subcommittee on Science and Technology.,Non-OADS,/arxiv_data1/oa_pdf/e9/58/tobaccocontrol-2012-050746.PMC3932763.pdf
"FDA Science Board, Nov 2007. http://www.fda.gov/ohrms/dockets/ac/ 07/brie ﬁng/2007-329b_02_01_FDA%20Report%20on%20Science%20and% 20Technology.pdf (accessed 24 aug 2012).",OADS,/arxiv_data1/oa_pdf/e9/58/tobaccocontrol-2012-050746.PMC3932763.pdf
http://www.who.int/tobacco/training/success_stories/en/ best_practices_brazil_labelling.pdf (accessed 22 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/e9/58/tobaccocontrol-2012-050746.PMC3932763.pdf
"Department of Marketing, Massey University, November, 2006. http://www.sfc.org.nz/resources/rrevaluationjanethoek.pdf (accessed 31 Jul 2011).",Non-OADS,/arxiv_data1/oa_pdf/e9/58/tobaccocontrol-2012-050746.PMC3932763.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/f3/agt174.PMC3932831.pdf
facebook.com/fostershttp://www.facebook.,Non-OADS,/arxiv_data1/oa_pdf/04/f3/agt174.PMC3932831.pdf
com/Carlinghttp://www.facebook.,Non-OADS,/arxiv_data1/oa_pdf/04/f3/agt174.PMC3932831.pdf
com/tiamariadrinkhttp://www.facebook.com/ stellaartoisukhttp://www.facebook.,Non-OADS,/arxiv_data1/oa_pdf/04/f3/agt174.PMC3932831.pdf
"http://www.comscore.com/ (28 June 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/04/f3/agt174.PMC3932831.pdf
"http://www.insidefacebook.com/2012/ 01/10/people-talking-about-this-defined/ (18 March 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/04/f3/agt174.PMC3932831.pdf
"APGAR scores were 8 and 9 at 1 and 5 min,  *Correspondence to: Wendy K Chung; Email: wkc15@columbia.edu Submitted: 05/22/2013; Revised: 08/26/2013; Accepted: 08/29/2013; Published Online: 09/05/2013http://dx.doi.org/10.4161/rdis.26314Mutation in SNAP25  as a novel genetic cause   of epilepsy and intellectual disability Luis r ohena1, Julie Neidich2, Megan Truitt c ho1, Kelly DF Gonzalez2, sha Tang2, Orrin Devinsky3, and Wendy K c hung4,* 1children’s h ospital of New y ork; New y ork c ity, N y Usa; 2ambry Genetics; a liso Viejo, ca U sa; 3New y ork University; New y ork c ity, N y Usa;   4columbia University Medical c enter; New y ork c ity, N y Usa Keywords:  SNAP25, intellectual disability, epilepsy, whole exome sequencing, novel mutation Abbreviations:  ADHD, attention deficit hyperactivity disorder; DICIPHER, Database of Chromosomal Imbalance and Phenotype  in Humans Using Ensembl Resources; EEG, electroencephalogram; FISH, fluorescent in Situ hybridization; MERRF, myoclonic  epilepsy ragged red fibers; SNAP25, synaptosomal associated protein-25kDa; SNARE, soluble N-ethylmaleimide-sensitive factor  attachment protein receptor; SNP, single nucleotide polymorphisms Whole exome sequencing using a parent-child trio design to identify de novo mutations provides an efficient method  to identify novel genes for rare diseases with low reproductive fitness that are difficult to study by more classical genetic  methods of linkage analysis.",Non-OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
J Vis Exp 2011; PMID:21712793 ; http://dx.doi.org/10.3791/2534 2.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Genome Biol  2011 ; 12:228;  PMID:21920049 ; http://dx.doi.org/10.1186/ gb-2011-12-9-228 3.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Nat Genet 2010 ; 42:1109 -12;  PMID:21076407 ; http://dx.doi.org/10.1038/ng.712 4.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Neurol Res Int 2012 ;  2012 :876234 ; PMID:22645681 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Front Psychiatry  2012 ;  3:19; PMID:22457654 ; http://dx.doi.org/10.3389/ fpsyt.2012.00019 7.,Non-OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Am J Hum Genet 2008 ; 83:89-93;  PMID:18571142 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Am J Hum Genet 2004 ; 75:1149 -54;  PMID:15499549 ; http://dx.doi.org/10.1086/4264609.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Annu  Rev Neurosci  2003 ; 26:599-625; PMID:14527270 ;  http://dx.doi.org/10.1146/annurev.neuro.26.010302.081210 10.,Non-OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Am  J Hum Genet 2008 ; 83:572-81; PMID:18976727 ;  http://dx.doi.org/10.1016/j.ajhg.2008.10.003 11.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Nat Biotechnol  2009 ; 27:182- 9; PMID:19182786 ; http://dx.doi.org/10.1038/ nbt.1523 12.,Non-OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Genome Med  2009 ; 1:13; PMID:19348700 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Nucleic Acids Res  2001 ; 29:308-11; PMID:11125122 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Nature  2003 ;  426:789-96; PMID:14685227 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Nat Methods  2010 ; 7:248- 9; PMID:20354512 ; http://dx.doi.org/10.1038/ nmeth0410-24817.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Nat Protoc  2009 ; 4:1073 - 81; PMID :19561590 ; http://dx.doi.org/10.1038/ nprot.2009.86 18.,Non-OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Nat Biotechnol   2011 ; 29:24-6; PMID:21221095 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Cold Spring Harb Perspect Biol 2011 ; 3:1-14;  PMID:22026965 ; http://dx.doi.org/10.1101/ cshperspect.a005637 20.,Non-OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Int J Biochem Cell Biol 1998 ;  30:1069 -73; PMID:9785471 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Proc Natl Acad Sci U S A 2007 ; 104:2431 - 6; PMID:17283335 ; http://dx.doi.org/10.1073/ pnas.0610222104 23.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
PLoS One  2011 ; 6:e25158 ;  PMID:21949876 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Cereb Cortex  2012 ;  PMID:23064108 ; http://dx.doi.org/10.1093/cercor/ bhs316,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
PLoS Genet  2008 ;  4:e1000278 ; PMID:19043548 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Nature  1995 ;  375:488-93; PMID:7777057 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
J Med Genet  2004 ; 41:183-6; PMID:14985377 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Ann Neurol   2009 ; 65:748-53; PMID:19557857 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Nat Genet 2008 ; 40:782-8;  PMID:18469812 ; http://dx.doi.org/10.1038/ng.150 30.,Non-OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Epilepsia  2010 ;  51:2449 -52; PMID:21204804 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Eur J Hum Genet 2011 ; 19:1238 - 45; PMID:21694734 ; http://dx.doi.org/10.1038/ ejhg.2011.121 32.,OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
Available from: http://decipher.sanger.ac.uk,Non-OADS,/arxiv_data1/oa_pdf/82/98/rdis-1-e26314.PMC3932847.pdf
"Proc Natl Acad Sci U S A 2013; 110:2157-62; PMID:23355676; http://dx.doi.org/10.1073/pnas.1201993110.Keywords:  ectodermal dysplasia  syndrome, p63, skin, cornea, APR246/ PRIMA-1MET Submitted: 02/19/13 Revised: 03/06/13Accepted: 03/08/13Published Online: 03/18/13http://dx.doi.org/10.4161/rdis.24247 Citation: Zhou H, Aberdam D. A step closer toward  therapies for p63-related disorders.",Non-OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Oncogene 2010; 29:4245-52; PMID:20498645;  http://dx.doi.org/10.1038/onc.2010.188.,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Science 1994; 265:346-55; PMID:8023157; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Oncogene 2010; 29:6442-51; PMID:20818419;  http://dx.doi.org/10.1038/onc.2010.382.,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Cell Death Differ 2008; 15:718- 29; PMID:18202704; http://dx.doi.org/10.1038/sj.cdd.4402301.,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Cell Death Differ 2011; 18:887- 96; PMID:21127502; http://dx.doi.org/10.1038/ cdd.2010.159.,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Stem Cells 2012; 30:898-909; PMID:22367714; http://dx.doi.org/10.1002/ stem.1068.8.,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Stem Cells 2011; 29:1672-83; PMID:21898690; http://dx.doi.org/10.1002/ stem.723.,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Nature 1999; 398:714-8;  PMID:10227294; http://dx.doi.org/10.1038/19539.,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Nature  1999; 398:708-13; PMID:10227293; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Development  2008; 135:1377-88; PMID:18326838; http://dx.doi.org/10.1242/dev.011759.,OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Am J Med Genet A 2006; 140:1396-406; PMID:16691622; http://dx.doi.org/10.1002/ ajmg.a.31271.,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Proc Natl Acad Sci U S A 2005; 102:9523-8; PMID:15983386; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Proc Natl Acad Sci U S A 2013; 110:2152- 6; PMID:23355677; http://dx.doi.org/10.1073/ pnas.1201753109.,OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Oncogene 2007; 26:2145- 56; PMID:17401423; http://dx.doi.org/10.1038/ sj.onc.1210280.,OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Cell Cycle 2007; 6:262- 8; PMID:17224651; http://dx.doi.org/10.4161/ cc.6.3.3796.,OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
Ophthalmology 2012; 119:74-83; PMID:21959367;  http://dx.doi.org/10.1016/j.ophtha.2011.06.044.,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
J Clin Oncol 2012; 30:3633- 9; PMID:22965953; http://dx.doi.org/10.1200/JCO.2011.40.7783.,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/rdis-1-e24247.PMC3932939.pdf
" Review www.landesbioscience.com Rare Diseases e23579-1Rare Diseases 1, e23579; 2013; © 2013 Landes BioscienceReview Introduction Pediatric rare diseases have received increased attention in recent  years due to greater public awareness, significantly improved understanding and treatment of the relatively more common  *Correspondence to: Shahram Yazdani; Email: syazdani@mednet.ucla.edu Submitted: 08/27/12; Revised: 11/13/12; Accepted: 11/13/12;  Published Online: 02/11/13http://dx.doi.org/10.4161/rdis.23579Citation: Bavisetty S, Grody WW, Yazdani S. Emergence of pediatric rare diseases: Review of present policies and opportunities for improvement.",Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
"16  Also in the US, over 1,000 individual patient- and parent-run support groups for rare genetic disorders are networked together under the umbrella of the Genetic Alliance ( http://www.geneti - calliance.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
J Intern Med 2006; 260:1-10; PMID:16789973;  http://dx.doi.org/10.1111/j.1365-2796.2006.01666.x.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from: http://www.eurordis.org/IMG/pdf/ princeps_document-EN.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from: http://www.fda.gov/orphan/oda.htm9.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from: http://rarediseases.info.nih.gov/asp/ html/reports/fy2005/Annual_Report_FY_05_Final.,OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from: http://www.orpha.net/testor/ doc/French_National_Plan.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from:  http://ec.europa.eu/health/ph_threats/non_com/docs/ rare_com_en.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from: http://www.medicalhomeinfo.org/ 17.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available  from: http://www.eurordis.org/IMG/pdf/draft-leaflet_ rapsody08-1.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from: http://archive.eurordis.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from:  http://www.dhcs.ca.gov/services/ccs/scc/Pages/default.,OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from: http://www.orpha.net/testor/doc/rdtf/wg/ECRFinalReport.pdf,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from: http://archive.eurordis.org/article.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from: http://archive.eurordis.org/article.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from:  http://www.eurordis.org/IMG/pdf/ECRD2007- LeCam.pdf 36.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available  from: http://www.rare-diseases.eu/2007/IMG/File/ ECRD%202007%20report.pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Pediatrics 2003; 112:997- 9; PMID:14523202; http://dx.doi.org/10.1542/peds.112.4.997.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Drug  Discov Today 2009; 14:1166-73; PMID:19818412;  http://dx.doi.org/10.1016/j.drudis.2009.09.008.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Int J Technol Assess Health Care  2007; 23:36-42; PMID:17234015; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
N Engl J Med 2006; 354:445- 7; PMID:16452556; http://dx.doi.org/10.1056/ NEJMp058317.,OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available  from: http://rarediseases.info.nih.gov/Resources.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Arch Pediatr  Adolesc Med 2004; 158:884-90; PMID:15351754;  http://dx.doi.org/10.1001/archpedi.158.9.884.21.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from:  http://ec.europa.eu/health/ph_threats/non_com/docs/ impact_assessment_en.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from:  http://report.nih.gov/biennialreport/ViewSection.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
J Dev Behav Pediatr 2010; 31:622-31; PMID:20814260;  http://dx.doi.org/10.1097/DBP .0b013e3181eedf01.,OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Genet Med 2008; 10:343- 8; PMID:18496033; http://dx.doi.org/10.1097/ GIM.0b013e318172837c.,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
Available from: http://www.govtrack.us/congress/bill- text.xpd?bill=h107-4013,Non-OADS,/arxiv_data1/oa_pdf/87/31/rdis-1-e23579.PMC3932940.pdf
"Nature 2013; 495:467-73; PMID:23455423; http://dx.doi.org/10.1038/nature11922Keywords:  prion, prion-like domain,  hnRNPA1, hnRNPA2/B1,   amyotrophic lateral sclerosis,  multisystem proteinopathy Submitted: 04/23/13Revised: 05/14/13Accepted: 05/28/13Published Online: 07/03/13 Citation: Shorter J, Taylor JP.",Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Rare Diseases 2013; 1:e25200; http://dx.doi.org/10.4161/rdis.25200Correspondence to: James Shorter and  J. Paul Taylor; Email: jshorter@mail.med.upenn.edu   and JPaul.Taylor@stjude.orgApproximately 1% of human proteins  harbor a prion-like domain (PrLD)  of similar low complexity sequence and amino acid composition to domains that drive prionogenesis of yeast proteins like Sup35.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Mol Biosyst 2010; 6:1115- 30; PMID:20422111; http://dx.doi.org/10.1039/ c004550k 2.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nat Rev Microbiol 2011; 9:771-7;  PMID:21947062; http://dx.doi.org/10.1038/nrmi - cro2650 3.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Science 2007;  318:930-6; PMID:17991853; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Neuron  2009; 64:783-90; PMID:20064386; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
J Cell Sci  2010; 123:1191-201; PMID:20356930; http://dx.doi.org/10.1242/jcs.051672 6.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nat Rev Genet 2005; 6:435-50; PMID:15931169; http://dx.doi.org/10.1038/nrg1616 7.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Cell 2013; 153:153-65; PMID:23540696; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nature 2012; 482:363-8; PMID:22337056; http://dx.doi.org/10.1038/nature10875 9.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Science 2010; 330:629-32;  PMID:21030648; http://dx.doi.org/10.1126/sci - ence.1191081 10.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Cell 2009; 137:146-58; PMID:19345193; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Science  2012; 336:355-9; PMID:22517861; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Brain Res  2012; 1462:61-80; PMID:22445064; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nat Chem Biol 2009; 5:936- 46; PMID:19915541; http://dx.doi.org/10.1038/ nchembio.246 17.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Chem Biol 2012; 19:1400-10; PMID:23177195; http://dx.doi.org/10.1016/j.chem - biol.2012.09.013 19.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Science 2000; 287:661-4; PMID:10650001; http://dx.doi.org/10.1126/sci - ence.287.5453.661 20.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Proc Natl Acad Sci U S A 2005; 102:12825-30; PMID:16123127; http://dx.doi.org/10.1073/ pnas.0506136102,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Muscle Nerve 2009; 40:19-31; PMID:19533646;  http://dx.doi.org/10.1002/mus.21386 51.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Eur J Neurol 2013; 20:251-8;  PMID:22900631; http://dx.doi.org/10.1111/j.1468- 1331.2012.03831.x 52.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Neuron  2010; 68:857-64; PMID:21145000; http://dx.doi.org/10.1016/j.neuron.2010.11.036 53.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nat Genet 2004; 36:377-81; PMID:15034582; http://dx.doi.org/10.1038/ng1332 54.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nat Cell Biol 2012; 14:117-23; PMID:22298039;  http://dx.doi.org/10.1038/ncb2407 55.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Neurobiol Aging 2012; 33:e7-13;  PMID:22078486; http://dx.doi.org/10.1016/j.neu - robiolaging.2011.10.006 56.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Eur J Neurol  2012; 19:501-9; PMID:22040362; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Mol Genet Metab 2011; 103:287-92; PMID:21501964;  http://dx.doi.org/10.1016/j.ymgme.2011.03.021 58.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Exp Cell Res  1999; 246:399-411; PMID:9925756; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Traffic 2010; 11:886-98;  PMID:20406423; http://dx.doi.org/10.1111/j.1600- 0854.2010.01072.x 60.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Proc Natl Acad Sci U S A 1989; 86:9788-92; PMID:2557628; http://dx.doi.org/10.1073/ pnas.86.24.9788 61.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
J Neurol Sci 2010; 291:79-85; PMID:20116073;  http://dx.doi.org/10.1016/j.jns.2009.12.008 62.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
J Neurosci 2010; 30:7729- 39; PMID:20519548; http://dx.doi.org/10.1523/ JNEUROSCI.5894-09.201036.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nature 1992; 359:162-5; PMID:1522903; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Oncogene 1999; 18:7599-601; PMID:10602520; http://dx.doi.org/10.1038/sj.onc.1203156 38.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Am J Med  Genet B Neuropsychiatr Genet 2011; 156B:285- 90; PMID:21438137; http://dx.doi.org/10.1002/ ajmg.b.31158 39.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
J Biol Chem 2005;  280:37572-84; PMID:16157593; http://dx.doi.org/10.1074/jbc.M505557200 41.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
J Proteome Res 2010; 9:1104- 20; PMID:20020773; http://dx.doi.org/10.1021/ pr901076y 42.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Mol Biol Cell 2004; 15:5383-98; PMID:15371533;  http://dx.doi.org/10.1091/mbc.E04-08-0715 43.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Cell 2012; 149:1188-91;  PMID:22682242; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Science 2012;  337:1047-9; PMID:22936764; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Science 2009; 324:1729-32; PMID:19460965; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Biochim Biophys Acta  2013; 1834:918-31; PMID:23328411; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nature 2012; 483:336-40; PMID:22398450; http://dx.doi.org/10.1038/nature10879 48.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Neuromuscul Disord 2009; 19:308- 15; PMID:19380227; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Neurology 2013; 80:1874-80; PMID:23635965;  http://dx.doi.org/10.1212/WNL.0b013e3182929fc321.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nature 2013;  495:467-73; PMID:23455423; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
J Cell Biol  2013; 201:361-72; PMID:23629963; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Prion  2011; 5:179-87; PMID:21847013; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nat Rev Neurol 2010; 6:211-20; PMID:20234357; http://dx.doi.org/10.1038/nrneu - rol.2010.18 25.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Brain Res 2012; 1462:40-3; PMID:22261247;  http://dx.doi.org/10.1016/j.brainres.2011.12.010 26.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nat Rev Neurosci  2013; 14:248-64; PMID:23463272; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Curr  Opin Neurobiol 2011; 21:904-19; PMID:21813273;  http://dx.doi.org/10.1016/j.conb.2011.05.029 28.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Cell 2012; 149:768- 79; PMID:22579282; http://dx.doi.org/10.1016/j.cell.2012.04.016 29.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
J  Biol Chem 2009; 284:20329-39; PMID:19465477;  http://dx.doi.org/10.1074/jbc.M109.010264 30.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Cell 2012; 149:753-67; PMID:22579281;  http://dx.doi.org/10.1016/j.cell.2012.04.017 31.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
PLoS Biol 2011; 9:e1000614;  PMID:21541367; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Hum Mol Genet 2012; 21:2899-911; PMID:22454397; http://dx.doi.org/10.1093/hmg/dds116 33.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Proc Natl Acad Sci U S A 2011; 108:20881- 90; PMID:22065782; http://dx.doi.org/10.1073/ pnas.1109434108 34.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
J Mol Cell Biol  2009; 1:82-92; PMID:19783543; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nature 1993;  363:640-4; PMID:8510758; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Neurology 2009; 73:805-11; PMID:19738176; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Proc Natl Acad Sci U S A 2013; 110:5951-6; PMID:23509289; http://dx.doi.org/10.1073/ pnas.1217321110 77.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
PLoS Genet 2013; 9:e1003351;  PMID:23555277; http://dx.doi.org/10.1371/journal.pgen.1003351 78.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Acta  Neuropathol 2013; 125:413-23; PMID:23381195;  http://dx.doi.org/10.1007/s00401-013-1088-7 80.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Cell 2013: 153:1461- 74; PMID:23791177; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Hum Mol Genet 2013; 22:1193-205;  PMID:23257289; http://dx.doi.org/10.1093/hmg/ dds526 70.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Nature 2010; 466:1069-75; PMID:20740007; http://dx.doi.org/10.1038/ nature09320 71.,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
PLoS One  2010; 5:e12247; PMID:20806063; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Cell Rep 2012; 1:167-78; PMID:22574288; http://dx.doi.org/10.1016/j.cel - rep.2012.02.001 74.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Mol Cell 2013; 49:972-82; PMID:23394998; http://dx.doi.org/10.1016/j.molcel.2012.12.02563.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
J Cell Biol 2009; 187:875- 88; PMID:20008565; http://dx.doi.org/10.1083/ jcb.200908115 64.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Proc Natl Acad Sci U S A 2010; 107:3487-92; PMID:20133726; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
Protein Eng Des Sel 2009; 22:531-6; PMID:19602569; http://dx.doi.org/10.1093/pro - tein/gzp037 66.,OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
J Neurochem 2009; 111:1051-61; PMID:19765185;  http://dx.doi.org/10.1111/j.1471-4159.2009.06383.x,Non-OADS,/arxiv_data1/oa_pdf/e0/63/rdis-1-e25200.PMC3932941.pdf
"Rare Diseases 2013; 1:e25001; http://dx.doi.org/10.4161/rdis.25001*Correspondence to: Ole Winther;  Email: owi@imm.dtu.dkIn our recent paper, we study web  search as an aid in the process of  diagnosing rare diseases.",Non-OADS,/arxiv_data1/oa_pdf/a4/84/rdis-1-e25001.PMC3932942.pdf
Int J Med Inform 2013; 82:528-38; PMID:23462700; http://dx.doi.org/10.1016/j.ijmedinf.2013.01.005,OADS,/arxiv_data1/oa_pdf/a4/84/rdis-1-e25001.PMC3932942.pdf
"Overview of the rare disease resources used by FindZebra Resource Entries Online m endelian i nheritance in m an (O mim ) http://www.ncbi.nlm.nih.gov/omim20,369 Genetic and r are d iseases i nformation c enter (GA rd) http://rarediseases.info.nih.gov/GA rd4,578 Orphanet http://www.orpha.net2,967 Wikipedia http://www.wikipedia.org/2,239 national Organization for rare d isorders ( nOrd) http://rarediseases.org1,230 Genetics Home r eference http://ghr.nlm.nih.gov626 madisons Foundation r are Pedriatic d isease d atabase http://www.madisonsfoundation.org522 About.com r are disease d atabase http://rarediseases.about.com316 Health on the n et Foundation r are d isease d atabase http://www.hon.ch183 Swedish n ational Board of Health and Welfare www.socialstyrelsen.se/rarediseases114",Non-OADS,/arxiv_data1/oa_pdf/a4/84/rdis-1-e25001.PMC3932942.pdf
Available from: http://www.uptodate.com/ home/ellen-uses-uptodate-find-diagnosis 9.,Non-OADS,/arxiv_data1/oa_pdf/a4/84/rdis-1-e25001.PMC3932942.pdf
Available from: http://archive.eurordis.org/article.,Non-OADS,/arxiv_data1/oa_pdf/a4/84/rdis-1-e25001.PMC3932942.pdf
Available from: http://themedicalfuturist.com 11.,Non-OADS,/arxiv_data1/oa_pdf/a4/84/rdis-1-e25001.PMC3932942.pdf
Available from:  https://www.crowdmed.com4.,Non-OADS,/arxiv_data1/oa_pdf/a4/84/rdis-1-e25001.PMC3932942.pdf
BMJ  2006; 333:1143-5; PMID:17098763; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/84/rdis-1-e25001.PMC3932942.pdf
Available from: http://raredr.com/medicine/articles/ interview-developers-findzebra-search-engine-rare- diseasesReferences 1.,Non-OADS,/arxiv_data1/oa_pdf/a4/84/rdis-1-e25001.PMC3932942.pdf
Int J Med Inform 2013; 82:528- 38; PMID:23462700; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a4/84/rdis-1-e25001.PMC3932942.pdf
Available from: http://www.orpha.net/orphacom/ cahiers/docs/GB/List_of_rare_diseases_in_alpha - betical_order.pdf contains a list of around 7.000 rare diseases.,Non-OADS,/arxiv_data1/oa_pdf/a4/84/rdis-1-e25001.PMC3932942.pdf
Rare Diseases 2013; 1:e24995; http://dx.doi.org/10.4161/rdis.24995*Correspondence to: Hannele Ruohola-Baker; Email: hannele@u.washington.eduProgress into developing therapeutics  for rare diseases can be accelerated  for those diseases that can be modeled in genetically tractable organisms.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
Development 2013; 140:136-46; PMID:23154413; http://dx.doi.org/10.1242/dev.087791,OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
Dev Biol 2008; 313:519- 32; PMID:18093579; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
PLoS One 2008; 3:e2418;  PMID:18545683; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
Nat Rev Drug Discov 2013; 12:287- 305; PMID:23493083; http://dx.doi.org/10.1038/ nrd3831 2.,OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
EMBO J 2007; 26:481-93; PMID:17215867; http://dx.doi.org/10.1038/sj.emboj.7601503or suppressive in normal age-dependent  muscle degeneration—the dramatic loss of muscle strength that takes place in all of us above 20 years of age—would increase lifespan and be significantly beneficial to modern society.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
J Med Chem 2010; 53:8650-62; PMID:21090716; http://dx.doi.org/10.1021/ jm101183p 13.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
Pharmacol Rev  2011; 63:411-36; PMID:21415126; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
Cell Mol Life Sci 2008;  65:3725-36; PMID:18668202; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
Mol Cell Biochem 2008; 314:193-9; PMID:18454302;  http://dx.doi.org/10.1007/s11010-008-9780-y 10.,Non-OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
Dev Biol 2011; 352:228-42; PMID:21256839; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
Development 2013; 140:136-46; PMID:23154413; http://dx.doi.org/10.1242/dev.087791 7.,OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
J Neurol Sci 1989; 93:147-56; PMID:2592979; http://dx.doi.org/10.1016/0022- 510X(89)90185-8,OADS,/arxiv_data1/oa_pdf/0b/e7/rdis-1-e24995.PMC3932943.pdf
"5 The final  process that untethers NOTCH receptors from the cell membrane is mediated by the enzymatic action of γ-secretase and  can be blocked with pharmacological NOTCH signaling in immune-mediated bone marrow failure   of aplastic anemia Lisa M Minter Department of Veterinary and Animal Sciences; University of Massachusetts Amherst; Amherst, MA USA Keywords:  aplastic anemia, NOTCH,  autoimmunity, bone marrow failure,  gamma secretase inhibitor, T helper cell, Th1 Abbreviations: T-BET, T-box protein  expressed in T cells; Th1, T helper type-1; Th17, T helper type 17; IFN γ,  interferon gamma; TNF, tumor necrosis factor; ER +, estrogen receptor positive;  CD4, Cluster designation 4; CD8, cluster designation 8; IL-17, interleukin 17 Correspondence to: Lisa M Minter;   Email: lminter@vasci.umass.edu Submitted: 07/27/2013; Revised: 10/03/2013;   Accepted: 10/09/2013;  Published Online: 12/02/2013 http://dx.doi.org/10.4161/rdis.26764Citation: Minter LM.",Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
J Exp Med 2013; 210:1311-29; PMID:23733784; http://dx.doi.org/10.1084/jem.20112615,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Curr Opin Hematol 2008; 15:162-8;  PMID:18391779 ; http://dx.doi.org/10.1097/ MOH.0b013e3282fa7470 2.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Expert Rev Hematol 2011 ; 4:221- 30; PMID:21495931 ; http://dx.doi.org/10.1586/ ehm.11.11 4.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Nat  Rev Immunol  2007 ; 7:64-75; PMID:17170755 ;  http://dx.doi.org/10.1038/nri1998 5.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Curr Top Microbiol Immunol 2012 ;  360:99-114; PMID:22695917 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Nature   1999 ; 398:518-22; PMID:10206645 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Cancer Res  2007 ; 67:1879 -82; PMID:17332312 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Nat Immunol  2005 ;  7:680-8; http://dx.doi.org/10.1038/ni1209 9.,OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Mol Cancer Ther 2010 ; 9:1618 -28;  PMID:20530712 ; http://dx.doi.org/10.1158/1535- 7163.MCT-10-0034 10.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Blood  2009 ; 113:1689 - 98; PMID:19001083 ; http://dx.doi.org/10.1182/ blood-2008-03-147967 13.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Immunity   2003 ; 19:549-59; PMID:14563319 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Blood  2011 ; 117:299-308; PMID:20870902 ;  http://dx.doi.org/10.1182/blood-2010-03-271940 16.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Cell 2000 ;  100:655-69; PMID:10761931 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Blood   2010 ; 115:541-8; PMID:19903901 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Blood  2006 ; 107:3983 - 91; PMID:16434488 ; http://dx.doi.org/10.1182/ blood-2005-10-4201 19.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
"J  Exp Med 2013 ; 210:1311-29; PMID:23733784 ;  http://dx.doi.org/10.1084/jem.20112615 20. de Latour RP, Visconte  V, Takaku  T, Wu C, Erie AJ,  Sarcon  AK, Desierto  MJ, Scheinberg  P, Keyvanfar  K,  Nunez  O, et al.",OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Blood   2010 ; 116:4175 -84; PMID:20733158 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Clin  Exp Immunol  2011 ; 164:66-71; PMID:21235539 ;  http://dx.doi.org/10.1111/j.1365-2249.2010.04310.x22.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Immunol Rev  2013 ;  252:89-103; PMID:23405897 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Rheumatol Int   2013 ; 33:2093 -9; PMID:23412693 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
J  Neuroimmunol  2012 ; 246:18-26; PMID:22445739 ;  http://dx.doi.org/10.1016/j.jneuroim.2012.02.011 26.,OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
JAMA   1999 ; 282:271-8; PMID:10422997 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
Cell 2004 ; 117:515-26; PMID :15137944 ;  http://dx.doi.org/10.1016/S0092-8674(04)00451-9 28.,OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
J Biol Chem 2003 ;  278:7751 -4; PMID:12551931 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
J Biol Chem 2003 ; 278:34427 - 37; PMID:12826675 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/39/31/rdis-1-e26764.PMC3932944.pdf
"3 Cilia  are finger-like organelles at the cell surface Common skeletal features in rare diseases New links between ciliopathies and FGF-related syndromes Basil Z  Yannakoudakis  and Karen J  Liu* Department of Craniofacial Development and Stem Cell Biology; King’s College London; London, UK Keywords:  ciliopathy, FGF, skeletal  dysplasia Abbreviations: C, cleft; CF, cervical  fusion; CS, coronal synostosis; HA, high arch; PD, polydactyly; SD, syndactyly; SL, short limbs; SS, sagittal synostosis *Correspondence to: Karen J Liu;   Email: karen.liu@kcl.ac.uk Submitted: 08/18/2013; Revised: 10/24/2013;   Accepted: 11/06/2013;  Published Online: 12/03/2013 http://dx.doi.org/10.4161/rdis.27109Citation: Yannakoudakis BZ, Liu KJ.",Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Dev Cell 2013; 25:623-35; PMID:23806618; http://dx.doi.org/10.1016/j.devcel.2013.05.021,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Genes Dev  2002; 16:1446-65;  PMID:12080084 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Cytokine Growth Factor Rev 2005 ; 16:107-37;  PMID:15863029 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Nephron Physiol  2009 ; 111:39-53; PMID:19276629 ;  http://dx.doi.org/10.1159/000208212 4.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Chest  1980 ; 78:580- 2; PMID:6448132 ; http://dx.doi.org/10.1378/ chest.78.4.580 5.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Annu Rev Cell Dev Biol  2007 ; 23:345-73; PMID:17506691 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Curr Top Dev Biol  2008 ; 85:303-32; PMID:19147010 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
J Med Genet  2013 ; 50:91-8; PMID:23339108 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Am J Med Genet A 2010 ; 152A :2995 - 3006 ; PMID:21108387 ; http://dx.doi.org/10.1002/ ajmg.a.33727 11.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Am J Med Genet C Semin  Med Genet 2009 ; 151C :318-25; PMID:19876934 ;  http://dx.doi.org/10.1002/ajmg.c.30224 12.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
J Pediatr  1977 ; 90:55-61; PMID:830894 ;  http://dx.doi.org/10.1016/S0022-3476(77)80764-6 14.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Hum  Mol Genet  2011 ; 20:4324 -33; PMID:21840926 ;  http://dx.doi.org/10.1093/hmg/ddr35915.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Nat Genet 2006 ; 38:303-11;  PMID:16493421 ; http://dx.doi.org/10.1038/ng1753 16.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Nat Cell Biol 2009 ; 11:1225 -32;  PMID:19767740 ; http://dx.doi.org/10.1038/ ncb1966 18.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Dev Cell  2013 ; 25:623- 35; PMID:23806618 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Am J Med Genet 1993 ; 47:624- 32; PMID:8266987 ; http://dx.doi.org/10.1002/ ajmg.1320470509 20.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Cleft Palate Craniofac  J 1995 ; 32:62-70; PMID:7727489 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Cleft Palate Craniofac J  1995 ; 32:251-4; PMID:7605793 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Cleft Palate Craniofac  J 1997 ; 34:79-82; PMID:9003917 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Am J Med Genet  2001 ; 99:63-6; PMID:11170096 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Cell 2012 ; 149:295-306; PMID:22484060 ;  http://dx.doi.org/10.1016/j.cell.2012.02.054 27.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Development   2004 ; 131:325-35; PMID:14668415 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Acta  Neuropathol  2012 ; 123:695-709; PMID:22331178 ;  http://dx.doi.org/10.1007/s00401-012-0951-229.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Development  2005 ; 132:3537 -48; PMID:15975938 ;  http://dx.doi.org/10.1242/dev.01914 31.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Dis  Model Mech  2011 ; 4:43-56; PMID:21045211 ;  http://dx.doi.org/10.1242/dmm.006262 36.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Am J Med Genet 2000 ; 90:310- 4; PMID:10710229 ; http://dx.doi.org/10.1002/ (SICI)1096-8628(20000214)90:4<310::AID- AJMG9>3.0.CO;2-N 39.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Am J Hum Genet  2011 ; 89:634-43; PMID:22019273 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
J Med Genet  1989 ; 26:393-6; PMID:2661822 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Hum Mol Genet 2009 ; 18:4565 -75;  PMID:19776033 ; http://dx.doi.org/10.1093/hmg/ ddp422 44.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Bone   2012 ; 50:28-41; PMID:21911092 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Development  2007 ; 134:2903 - 12; PMID:17660199 ; http://dx.doi.org/10.1242/ dev.007542 46.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Dev Biol   2011 ; 349:179-91; PMID:20920500 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Spine (Phila Pa 1976)  1997 ; 22:402-5; PMID:9055367 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Proc Natl Acad Sci U S A  2006 ; 103:18603 -8; PMID:17132737; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Cleft Palate  Craniofac J 2006 ; 43:740-8; PMID:17105336 ;  http://dx.doi.org/10.1597/05-21253.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Nat Genet 1995 ; 10:357- 9; PMID:7670477 ; http://dx.doi.org/10.1038/ ng0795-357 54.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Am J Med Genet 1985 ; 22:669-83; PMID:4073120 ;  http://dx.doi.org/10.1002/ajmg.1320220404 55.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Am J Med Genet A 2011 ; 155A :1969 - 71; PMID:21739570 ; http://dx.doi.org/10.1002/ ajmg.a.33744 56.,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
Genes Dev 2004 ;  18:290-305; PMID:14871928 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
J Clin Invest 1999 ; 104:1517-25; PMID :10587515 ;  http://dx.doi.org/10.1172/JCI6690,Non-OADS,/arxiv_data1/oa_pdf/9c/99/rdis-1-e27109.PMC3932950.pdf
To view these ﬁles please visit the journal online (http://dx.doi.org/10.1136/ tobaccocontrol-2012-050849).,Non-OADS,/arxiv_data1/oa_pdf/4c/34/tobaccocontrol-2012-050849.PMC3932951.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030.",Non-OADS,/arxiv_data1/oa_pdf/4c/34/tobaccocontrol-2012-050849.PMC3932951.pdf
2012. http://www.who.int/fctc/signatories_parties/en/index.html (accessed 23 Oct 2012).16 WHO.,OADS,/arxiv_data1/oa_pdf/4c/34/tobaccocontrol-2012-050849.PMC3932951.pdf
2012. http://www.who.int/fctc/cop/sessions/en/ (accessed 23 Oct 2012).,OADS,/arxiv_data1/oa_pdf/4c/34/tobaccocontrol-2012-050849.PMC3932951.pdf
http://www.fctc.org/index.php?option=com_content&view=article&id=809: governments-participation-in-global-tobacco-control-efforts-threatened&catid=275: fctc-action-now-fctc-processes&Itemid=503 (accessed 23 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/4c/34/tobaccocontrol-2012-050849.PMC3932951.pdf
2012. http://data.worldbank.org/about/ country-classi ﬁcations (accessed 23 Oct 2012).,OADS,/arxiv_data1/oa_pdf/4c/34/tobaccocontrol-2012-050849.PMC3932951.pdf
"Author af ﬁliations 1Cancer Epidemiology and Population Health, King ’s Health Partners Cancer Centre, London, UK 2Public Health England, Knowledge & Intelligence Team, London, UK 3The Academic Division of Thoracic Surgery, The Royal Brompton Hospital, London, UK 4Department of Thoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK 5Respiratory Medicine Unit, Nottingham University Hospitals and University of Nottingham, David Evans Centre, Nottingham City Hospital Campus, Nottingham, UK 6Department of Thoracic Surgery, The Danish Lung Cancer Registry, Odense University Hospital, Odense, Denmark 7Department of Public Health and Research Centre for Cancer Diagnosis in Primary Care, Aarhus University, Aarhus, Denmark 8Queens Centre for Oncology and Haematology, Hull and East Yorkshire NHS Trust, Hull, UK 9Department of Respiratory Medicine, Glen ﬁeld Hospital, Leicester, UK 10Department of Oncology, Herlev University Hospital, Copenhagen, Denmark 11Department of Research Oncology, Division of Cancer Studies, King ’s College London, London, UK 12Department of Thoracic Surgery, Guy ’s and St Thomas ’NHS Foundation Trust, and Division of Cancer Studies, King ’s College London, London, UK Acknowledgements This paper is a contribution from the National Cancer Intelligence Network and is based on the information collected and quality assured by the national cancer registration service in England (http://www.ukacr.org; http://www.ncin.org.uk).",Non-OADS,/arxiv_data1/oa_pdf/4b/b9/thoraxjnl-2013-203884.PMC3932952.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Sobin LH, Wittekind C. International Union Against Cancer (UICC) TNM classi ﬁcation of malignant tumors.",Non-OADS,/arxiv_data1/oa_pdf/4b/b9/thoraxjnl-2013-203884.PMC3932952.pdf
"The MUFI group had a signi ﬁcant decrease in waist circumference compared to the SIFI group.The trial is registered at http://www.clinicaltrials.gov (NCT00872807) INTRODUCTION Being obese may have negative effects on physical and psychosocial health.1Therefore, the worldwide increase in childhood overweight and obesity is ofgreat concern.",Non-OADS,/arxiv_data1/oa_pdf/96/bb/archdischild-2012-303571.PMC3932955.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Reilly JJ.,Non-OADS,/arxiv_data1/oa_pdf/96/bb/archdischild-2012-303571.PMC3932955.pdf
"Secondary Child obesity calculator using British 1990 growth reference data.http://www.phsim.man.ac.uk 17 Cole TJ, Freeman JV, Preece MA.",Non-OADS,/arxiv_data1/oa_pdf/96/bb/archdischild-2012-303571.PMC3932955.pdf
"To view please visit the journal online (http://dx.doi.org/10.1136/bjophthalmol-2013-303953) Open Access This is an Open Access article distributed in accordance with the Creative CommonsAttribution Non Commercial (CC BY-NC 3.0) license,which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided theoriginal work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/f3/d0/bjophthalmol-2013-303953.PMC3932960.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/ To cite Kawashima M, Uchino M, Yokoi N, et al.Br J Ophthalmol 2014; 98:418–420.",Non-OADS,/arxiv_data1/oa_pdf/f3/d0/bjophthalmol-2013-303953.PMC3932960.pdf
Speci ﬁed Medical Checkup and Health Education for Metabolic syndrome ( ﬁnal edition) 2007. http://www.mhlw.go.jp/ bunya/kenkou/seikatsu in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/f3/d0/bjophthalmol-2013-303953.PMC3932960.pdf
"ORIGINAL ARTICLE Contribution of health status and prevalent chronic disease to individual risk for workplace injury in themanufacturing environment Jessica Kubo,1Benjamin A Goldstein,1Linda F Cantley,2Baylah Tessier-Sherman,2 Deron Galusha,2Martin D Slade,2Isabella M Chu,3Mark R Cullen3 1Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California,USA 2Yale Occupational & Environmental Medicine, Yale School of Medicine, NewHaven, Connecticut, USA 3General Medical Disciplines, Stanford University School of Medicine, Stanford, California,USA Correspondence to Dr Mark Cullen, General Medical Disciplines, StanfordUniversity School of Medicine,1265 Welch Road, MSOB X- 338, Stanford, CA 94305- 5411, USA; mrcullen@stanford.edu Received 7 June 2013 Revised 6 September 2013 Accepted 13 September 2013 Published Online First16 October 2013 ▸http://dx.doi.org/10.1136/ oemed-2013-101875 To cite: Kubo J, Goldstein BA, Cantley LF, et al.Occup Environ Med 2014; 71:159–166.ABSTRACT Objectives An‘information gap ’has been identi ﬁed regarding the effects of chronic disease on occupationalinjury risk.",Non-OADS,/arxiv_data1/oa_pdf/a2/77/oemed-2013-101653.PMC3932962.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Committee on the Health and Safety Needs of Older Workers —National Research Council.,Non-OADS,/arxiv_data1/oa_pdf/a2/77/oemed-2013-101653.PMC3932962.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2013-204588).,OADS,/arxiv_data1/oa_pdf/19/b7/annrheumdis-2013-204588.PMC3932966.pdf
"Correspondence to Dr Cécile Gaujoux-Viala, Service de Rhumatologie, CHU de Nîmes Carémeau, Place duProfesseur Robert Debré,30029 Nîmes cedex 9, France; cecilegaujouxviala@yahoo.fr Received 9 September 2013 Revised 2 November 2013Accepted 11 December 2013Published Online First 6 January 2014 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-204573▸http://dx.doi.org/10.1136/ annrheumdis-2013-204575 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-204577 To cite: Gaujoux-Viala C, Nam J, Ramiro S, et al .Ann Rheum Dis 2014; 73: 510–515.ABSTRACT Objectives To update a previous systematic review assessing the ef ﬁcacy of conventional synthetic disease- modifying antirheumatic drugs (csDMARDs) inrheumatoid arthritis (RA).Methods Two systematic reviews of the literature using PubMed, Embase and the Cochrane library were performed from 2009 until January 2013 to assess theefﬁcacy of csDMARDs (as monotherapy or combination therapy) in adults with RA, and the ef ﬁcacy of glucocorticoids in early RA.",Non-OADS,/arxiv_data1/oa_pdf/19/b7/annrheumdis-2013-204588.PMC3932966.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Smolen JS, Landewé R, Breedveld FC, et al .",Non-OADS,/arxiv_data1/oa_pdf/19/b7/annrheumdis-2013-204588.PMC3932966.pdf
"First published online December 12, 2013.Brazilian Journal of Medical and Biological Research (2014) 47(1): 1-10, http://dx.doi.org/10.1590/1414-431X20133177 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 47(1) 2014",Non-OADS,/arxiv_data1/oa_pdf/a9/7d/1414-431X-bjmbr-47-01-00001.PMC3932967.pdf
"First published online January 9, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(1): 11-18, http://dx.doi.org/10.1590/1414-431X20133308 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 47(1) 2014",Non-OADS,/arxiv_data1/oa_pdf/f4/ca/1414-431X-bjmbr-47-01-00011.PMC3932968.pdf
"First published online December 12, 2013.Brazilian Journal of Medical and Biological Research (2014) 47(1): 19-23, http://dx.doi.org/10.1590/1414-431X20133365 ISSN 1414-431X Concepts and Comments www.bjournal.com.br Braz J Med Biol Res 47(1) 2014",Non-OADS,/arxiv_data1/oa_pdf/b9/2a/1414-431X-bjmbr-47-01-00019.PMC3932969.pdf
"More recently, in July 2012, the National Network of Alternative Methods (RENAMA; http://www.mct.gov.br/ index.php/content/view/340586.html) was established for the development and implementation of alternative methods for the use of animals in Brazil and in the world, in a clear demonstration of the commitment of the Brazilian scientific society to contribute to a full ethical posture toward laboratory animals.",Non-OADS,/arxiv_data1/oa_pdf/b9/2a/1414-431X-bjmbr-47-01-00019.PMC3932969.pdf
http://ec.europa.eu/environment/chemicals/ lab_animals/pdf/sec_2010_1107.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/2a/1414-431X-bjmbr-47-01-00019.PMC3932969.pdf
"Ottawa, 2010. http://www.ccac.ca/Documents/ Publications/Statistics/Survey_2009.pdf.",OADS,/arxiv_data1/oa_pdf/b9/2a/1414-431X-bjmbr-47-01-00019.PMC3932969.pdf
http://www.aphis.,Non-OADS,/arxiv_data1/oa_pdf/b9/2a/1414-431X-bjmbr-47-01-00019.PMC3932969.pdf
http://cceb.uncisal.,Non-OADS,/arxiv_data1/oa_pdf/b9/2a/1414-431X-bjmbr-47-01-00019.PMC3932969.pdf
"First published online December 12, 2013.Brazilian Journal of Medical and Biological Research (2014) 47(1): 24-34, http://dx.doi.org/10.1590/1414-431X20132938 ISSN 1414-431X Braz J Med Biol Res 47(1) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/7a/fa/1414-431X-bjmbr-47-01-00024.PMC3932970.pdf
"First published online November 29, 2013.Brazilian Journal of Medical and Biological Research (2014) 47(1): 35-41, http://dx.doi.org/10.1590/1414-431X20133046 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(1) 2014",Non-OADS,/arxiv_data1/oa_pdf/f8/17/1414-431X-bjmbr-47-01-00035.PMC3932971.pdf
http://globocan.iarc.fr/factsheet.asp.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/1414-431X-bjmbr-47-01-00035.PMC3932971.pdf
"First published online December 12, 2013.Brazilian Journal of Medical and Biological Research (2014) 47(1): 42-49, http://dx.doi.org/10.1590/1414-431X20132809 ISSN 1414-431X Braz J Med Biol Res 47(1) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/fe/d9/1414-431X-bjmbr-47-01-00042.PMC3932972.pdf
Peaks were displayed through the UCSC Genome Browser (http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/fe/d9/1414-431X-bjmbr-47-01-00042.PMC3932972.pdf
AmiGO is accessible online at the Gene Ontology (GO) website (http://www.geneontology.org/) for users to obtain the data provided by the GO Consortium (16).,OADS,/arxiv_data1/oa_pdf/fe/d9/1414-431X-bjmbr-47-01-00042.PMC3932972.pdf
"First published online November 11, 2013.Brazilian Journal of Medical and Biological Research (2014) 47(1): 50-59, http://dx.doi.org/10.1590/1414-431X20133028 ISSN 1414-431X Braz J Med Biol Res 47(1) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/b2/a9/1414-431X-bjmbr-47-01-00050.PMC3932973.pdf
"First published online January 9, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(1): 60-69, http://dx.doi.org/10.1590/1414-431X20133324 ISSN 1414-431X Braz J Med Biol Res 47(1) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/26/d4/1414-431X-bjmbr-47-01-00060.PMC3932974.pdf
"First published online.Brazilian Journal of Medical and Biological Research (2013) 00: 1-10, http://dx.doi.org/10.1590/1414-431X20133097 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 00(00) 2013",Non-OADS,/arxiv_data1/oa_pdf/8e/75/1414-431X-bjmbr-47-01-00070.PMC3932975.pdf
"First published online December 12, 2013.Brazilian Journal of Medical and Biological Research (2014) 47(1): 80-89, http://dx.doi.org/10.1590/1414-431X20132932 ISSN 1414-431X Braz J Med Biol Res 47(1) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/fa/e3/1414-431X-bjmbr-47-01-00080.PMC3932976.pdf
"Specifically, physicians spoke about the requirement outlined by The Royal College ofPhysicians and Surgeons of Canada in the CanMEDs framework (http://www.royalcollege.ca/portal/page/ portal/rc/canmeds/framework), while pharmacistsspoke about the need to integrate patient safety into new curriculum to achieve the educational outcomes defined by the Association of Faculties of Pharmacy ofCanada.",Non-OADS,/arxiv_data1/oa_pdf/90/ae/bmjqs-2013-001900.PMC3932978.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Cronenwett L, Sherwood G, Barnsteiner J, et al.",Non-OADS,/arxiv_data1/oa_pdf/90/ae/bmjqs-2013-001900.PMC3932978.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2012-303883).,OADS,/arxiv_data1/oa_pdf/cd/40/gutjnl-2012-303883.PMC3932979.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Davies EJ, Marsh V, Clarke AR.",Non-OADS,/arxiv_data1/oa_pdf/cd/40/gutjnl-2012-303883.PMC3932979.pdf
"Competing interests All authors have completed the Uni ﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from thecorresponding author) and declare that (1) none has company support for thesubmitted work; (2) the authors have no relationships with companies that might have an interest in the submitted work in the previous 3 years; (3) their spouse,partners, or children have no ﬁnancial relationships that may be relevant to the submitted work; and (4) the authors have no non- ﬁnancial interests that may be relevant to the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/68/19/emermed-2012-202058.PMC3932981.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Bracken MB, Shepard MJ, Collins WF, et al.",Non-OADS,/arxiv_data1/oa_pdf/68/19/emermed-2012-202058.PMC3932981.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ jmedgenet-2013-101818).,OADS,/arxiv_data1/oa_pdf/3e/bb/jmedgenet-2013-101818.PMC3932983.pdf
23The published data on http://www.mtdb.igp.uu.se/ were used to determine the allelicfrequency of the identi ﬁed variants.,OADS,/arxiv_data1/oa_pdf/3e/bb/jmedgenet-2013-101818.PMC3932983.pdf
These variants in RNAs and polypeptides were further analysed by allelic frequency in control individualsaccording to the data published on http://www.mtdb.igp.uu.se/and according to phylogenetic analysis encompassing 17 verte-brate species.,OADS,/arxiv_data1/oa_pdf/3e/bb/jmedgenet-2013-101818.PMC3932983.pdf
Allelic frequency analysis showed that the 2336T>C mutation was absent in the 2704controls (http://www.genpat.uu.se/mtDB).,Non-OADS,/arxiv_data1/oa_pdf/3e/bb/jmedgenet-2013-101818.PMC3932983.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB.",Non-OADS,/arxiv_data1/oa_pdf/3e/bb/jmedgenet-2013-101818.PMC3932983.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Leape LL, Bates DW , Cullen DJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/b4/50/bmjqs-2013-001812.PMC3932984.pdf
http://www.iea.cc/ergonomics/ (accessed 22 Aug 2004).,OADS,/arxiv_data1/oa_pdf/b4/50/bmjqs-2013-001812.PMC3932984.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/68/lra-7-001.PMC3933023.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpLocal and Regional Anesthesia 2014:7 1–4Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  1CAse Repo Rtopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/LRA.S5766 0posterior reversible encephalopathy syndrome   following an inadvertent dural puncture during   an emergency laparotomy for ischemic colitis –   a case report Reena shah Agnieszka Kubisz-p udelko Jeremy Reid Yeovil District Hospital, Yeovil, UK Correspondence: Dr Reena shah   Yeovil District Hospital   Higher Kingston, Yeovil,   somerset BA21 4A t, UK  tel +44 1935 475 122   email reena.shah@doctors.org.u kAbstract:  Posterior reversible encephalopathy syndrome (PRES) is a clinico-neuroradiological  syndrome characterized by various symptoms of neurological disease.",Non-OADS,/arxiv_data1/oa_pdf/46/68/lra-7-001.PMC3933023.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/46/68/lra-7-001.PMC3933023.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/68/lra-7-001.PMC3933023.pdf
Available from: http://www.uptodate.com/contents/ reversible-posterior-leukoencephalopathy-syndrome#H 1.,Non-OADS,/arxiv_data1/oa_pdf/46/68/lra-7-001.PMC3933023.pdf
"Available from:  http://emedicine.medscape.com/article/166129-overvie w. Accessed   December 11, 2013.",Non-OADS,/arxiv_data1/oa_pdf/46/68/lra-7-001.PMC3933023.pdf
"This is an Open Access article distrib uted under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is prope rly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/e9/pit058.PMC3933042.pdf
Available at:http://www.phac-aspc.gc.ca/im/ptimprog-progimpt/table-1-eng.,Non-OADS,/arxiv_data1/oa_pdf/95/e9/pit058.PMC3933042.pdf
"Nat Genet 2012; 44:1302-9; PMID:23104007; http://dx.doi.org/10.1038/ng.2434.Keywords:  ALS, TDP-43, yeast, Dbr1,  neurodegeneration Submitted: 02/22/13Revised: 03/12/13Accepted: 03/22/13Published Online: 04/10/13http://dx.doi.org/10.4161/rdis.24420 Citation: Figley MD, Gitler AD.",OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Nat Rev Neurol 2011; 7:603-15; PMID:21989245;  http://dx.doi.org/10.1038/nrneurol.2011.150.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Nature  1993; 362:59-62; PMID:8446170; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Amyotroph Lateral Scler  2008; 9:4-15; PMID:18273714; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Nat Rev Neurol 2011; 7:639-49;  PMID:21989247; http://dx.doi.org/10.1038/nrneu - rol.2011.153.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Science 2006; 314:130- 3; PMID:17023659; http://dx.doi.org/10.1126/sci - ence.1134108.6.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Cell 2009; 136:1001- 4; PMID:19303844; http://dx.doi.org/10.1016/j.cell.2009.03.006.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Nat Rev Neurol 2010; 6:211-20;  PMID:20234357; http://dx.doi.org/10.1038/nrneu - rol.2010.18.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Arch Neurol 2009; 66:180-9;  PMID:19204154; http://dx.doi.org/10.1001/arch - neurol.2008.558.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Neurology 2011; 76:2066-72; PMID:21562247; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Hum Mol Genet 2011; 20:3207-12; PMID:21610160; http://dx.doi.org/10.1093/hmg/ ddr227.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Neurology  2011; 76:2050-1; PMID:21562249; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Nat Genet 2012; 44:1302- 9; PMID:23104007; http://dx.doi.org/10.1038/ ng.2434.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Cell 1991; 65:483-92; PMID:1850323;  http://dx.doi.org/10.1016/0092-8674(91)90466-C. 40.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Nucleic Acids Res 2005; 33:6349-60; PMID:16275784; http://dx.doi.org/10.1093/nar/ gki934.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Nat Protoc 2009; 4:1274-84; PMID:19680241;  http://dx.doi.org/10.1038/nprot.2009.115.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Proc Natl Acad Sci U S A 2011; 108:20881- 90; PMID:22065782; http://dx.doi.org/10.1073/ pnas.1109434108.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Hum Mol Genet 2012; 21:2899-911;  PMID:22454397; http://dx.doi.org/10.1093/hmg/ dds116.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Nature 2013;  495:467-73; PMID:23455423; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Brain Res  2012; 1462:61-80; PMID:22445064; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Science 2011; 334:1241-5; PMID:22033521; http://dx.doi.org/10.1126/sci - ence.1213210.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Dis Model Mech  2010; 3:194-208; PMID:20038714; http://dx.doi.org/10.1242/dmm.004267.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
PLoS Biol 2011; 9:e1001052; PMID:21541368; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
J Biol Chem 2009; 284:20329-39; PMID:19465477;  http://dx.doi.org/10.1074/jbc.M109.010264.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
J Neurosci 2010; 30:639-49; PMID:20071528; http://dx.doi.org/10.1523/JNEUROSCI.4988-09.2010.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Science 2008; 319:1668-72; PMID:18309045; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
J Neurosci 2010; 30:7729- 39; PMID:20519548; http://dx.doi.org/10.1523/ JNEUROSCI.5894-09.2010.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Hum Mol Genet  2010; 19:671-83; PMID:19959528; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
J Neurosci 2010; 30:16208-19; PMID:21123567; http://dx.doi.org/10.1523/ JNEUROSCI.2911-10.2010.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Proc Natl Acad Sci U S A 2010; 107:3169- 74; PMID:20133767; http://dx.doi.org/10.1073/ pnas.0913602107.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Neurology 2011; 76:2062-5; PMID:21562248; http://dx.doi.org/10.1212/WNL.0b013e31821f4447.9.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Nature 2010; 466:1069- 75; PMID:20740007; http://dx.doi.org/10.1038/ nature09320.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Neuron 2011; 72:245-56;  PMID:21944778; http://dx.doi.org/10.1016/j.neu - ron.2011.09.011.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Neuron 2011; 72:257-68;  PMID:21944779; http://dx.doi.org/10.1016/j.neu - ron.2011.09.010.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Curr  Opin Neurobiol 2011; 21:904-19; PMID:21813273;  http://dx.doi.org/10.1016/j.conb.2011.05.029.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
PLoS Biol 2011; 9:e1000614;  PMID:21541367; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Science 2003; 302:1769-72; PMID:14657499;  http://dx.doi.org/10.1126/science.1090389.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Science 2006; 313:324-8; PMID:16794039;  http://dx.doi.org/10.1126/science.1129462.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Proc Natl Acad Sci U S A 2000; 97:1589- 94; PMID:10677504; http://dx.doi.org/10.1073/ pnas.97.4.1589.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
Nat Genet 2005; 37:526- 31; PMID:15806102; http://dx.doi.org/10.1038/ng1542.,OADS,/arxiv_data1/oa_pdf/dc/e2/rdis-1-e24420.PMC3933050.pdf
"6,7 Using antisense oligonucleotide tech - nology, we silenced the expression of the Wnk1/Hsn2 isoform in embryos to mimic WNK1/HSN2 isoform and the regulation of KCC2 activity Valérie Bercier Institut Curie; Centre de Recherche; CNRS UMR 3215/INSERM U934; Paris, France Keywords:  zebrafish, Danio rerio,  WNK1, HSN2, HSAN type 2, KCC2, lateral line, neuromast Correspondence to: Valérie Bercier;  Email: bercier.valerie@gmail.com Submitted: 07/27/2013Revised: 09/08/2013Accepted: 09/18/2013Published Online: 10/15/2013http://dx.doi.org/10.4161/rdis.26537Citation: Bercier V. WNK1/HSN2 isoform and the  regulation of KCC2 activity.",Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
PLoS Genet 2013; 9:e1003124; PMID:23300475; http://dx.doi.org/10.1371/journal.pgen.1003124,Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
Brain  1973; 96:387-94;  PMID:4123669 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
Orphanet J Rare Dis 2007; 2:39; PMID :17915006 ;  http://dx.doi.org/10.1186/1750-1172-2-39 3.,Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
PLoS One 2012; 7:e37751; http://dx.doi.org/10.1371/journal.pone.0037751 ;  PMID:22701532 5.,Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
Cell 2009; 138:525-36;  PMID:19665974 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
"Ghysen A, Dambly-Chaudière C. Le développement du système nerveux: de la mouche au poisson, du  poisson à l’homme..... Med Sci (Paris) 2003; 19:575- 81; PMID:12836391 ; http://dx.doi.org/10.1051/ medsci/2003195575 7.",Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
Genes Dev 2007; 21:2118- 30; PMID:17785522 ; http://dx.doi.org/10.1101/ gad.1568407 8.,OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
J Biol Chem 2011; 286:30171-80; PMID:21733846 ;  http://dx.doi.org/10.1074/jbc.M111.2228939.,OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
J Neurosci 2008; 28:1588-97;  PMID:18272680 ; http://dx.doi.org/10.1523/ JNEUROSCI.3791-07.2008 11.,Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
J Neurosci 2007; 27:1642-50; PMID:17301172 ; http://dx.doi.org/10.1523/ JNEUROSCI.3104-06.2007 12.,Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
J Neurosci 2004; 24:4683-91; PMID:15140939 ; http://dx.doi.org/10.1523/ JNEUROSCI.5265-03.2004 13.,Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
Brain Struct Funct 2013;  PMID:23420348 ; http://dx.doi.org/10.1007/ s00429-013-0515-9 14.,Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
Eur J Neurosci  2010; 31:2142-55;  PMID:20529123 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
J Neurosci 2005;  25:10607-16;  PMID:16291933 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
Biochim Biophys Acta 2010; 1802:1150-8; PMID:20637866 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
J Neurol 2011; 258:1890-2; PMID:21625937 ;  http://dx.doi.org/10.1007/s00415-011-6025-x 18.,Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
PLoS One 2013; 8:e57807; http://dx.doi.org/10.1371/journal.pone.0057807 ;  PMID:23451271 19.,Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
Am J Hum Genet 2011; 89:219-30; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
Nat Neurosci 2006; 9:907-16;  PMID:16751763 ; http://dx.doi.org/10.1038/nn1717,Non-OADS,/arxiv_data1/oa_pdf/82/05/rdis-1-e26537.PMC3933052.pdf
[cited 2012]; Available  from: URL:   http://godsonx.blog.163.com/blog/static/109609057  201211180155507/  16.,Non-OADS,/arxiv_data1/oa_pdf/bc/02/ARYA-09-350.PMC3933060.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/thoraxjnl-2013-203867).,Non-OADS,/arxiv_data1/oa_pdf/ce/31/thoraxjnl-2013-203867.PMC3933066.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Snider GL, Kleinerman J, Thurlbeck WM, et al.",Non-OADS,/arxiv_data1/oa_pdf/ce/31/thoraxjnl-2013-203867.PMC3933066.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2012-303424).,OADS,/arxiv_data1/oa_pdf/09/bb/gutjnl-2012-303424.PMC3933070.pdf
"METHODS Study design and patient population This was an 8-week, phase II, double-blind, placebo-controlled, randomised, multicentre study of BMS-936557 (trial identi ﬁer: NCT00656890; URL: http://clinicaltrials.gov/ct2/show/NCT00656890), conducted at 54 medical centres in eight countries(Ukraine, Hungary, Latvia, USA, Czech Republic, Romania,Canada and Russia) between 26 March 2008 and 14 September2009.",Non-OADS,/arxiv_data1/oa_pdf/09/bb/gutjnl-2012-303424.PMC3933070.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Ordas I, Eckmann L, Talimini M, et al.",Non-OADS,/arxiv_data1/oa_pdf/09/bb/gutjnl-2012-303424.PMC3933070.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Wright AF, Chakarova CF, Abd El-Aziz MM, et al.",Non-OADS,/arxiv_data1/oa_pdf/4f/6e/bjophthalmol-2013-303958.PMC3933073.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-204573) For numbered af ﬁliations see end of article.,Non-OADS,/arxiv_data1/oa_pdf/e9/21/annrheumdis-2013-204573.PMC3933074.pdf
"Correspondence to Professor Josef S Smolen, Division of Rheumatology,Department of Medicine 3,Medical University of Vienna, Waehringer Guertel 18-20, Vienna A-1090, Austria;josef.smolen@wienkav.at JSS and RL serve as joint ﬁrst authors Received 7 September 2013 Revised 5 October 2013Accepted 11 October 2013Published Online First 25 October 2013 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-204577 ▸http://dx.doi.org/10.1136/ annrheumdis-2013-204588 To cite: Smolen JS, Landewé R, Breedveld FC, et al.Ann Rheum Dis 2014; 73:492–509.ABSTRACT In this article, the 2010 European League againstRheumatism (EULAR) recommendations for themanagement of rheumatoid arthritis (RA) with syntheticand biological disease-modifying antirheumatic drugs(sDMARDs and bDMARDs, respectively) have beenupdated.",Non-OADS,/arxiv_data1/oa_pdf/e9/21/annrheumdis-2013-204573.PMC3933074.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Smolen JS, Aletaha D, Koeller M, et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/21/annrheumdis-2013-204573.PMC3933074.pdf
2008. http://www.jruorthopguse/ (accessed 23 Aug 2008).,Non-OADS,/arxiv_data1/oa_pdf/e9/21/annrheumdis-2013-204573.PMC3933074.pdf
2012. http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/e9/21/annrheumdis-2013-204573.PMC3933074.pdf
Risk of cancer recurrence or new tumors in RA patients with prior malignancies treated with various biologic agents.Arhritis Rheum 2013; (ACR 2013 Abstract online (https://ww2.rheumatology.org/ apps/MyAnnualMeeting/Abstract/36584).,Non-OADS,/arxiv_data1/oa_pdf/e9/21/annrheumdis-2013-204573.PMC3933074.pdf
2013. http://www.kompendium.ch/prod/pnr/ 1234138/de.,Non-OADS,/arxiv_data1/oa_pdf/e9/21/annrheumdis-2013-204573.PMC3933074.pdf
2013. http://www.ema.europa.eu/docs/en_GB/ document_library/Press_release/2013/ 06/WC500144941.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/21/annrheumdis-2013-204573.PMC3933074.pdf
"2013. http://www.ema.europa.eu/ema/ indexjsp?curl=pages/medicines/human/medicines/002542/smops/Negative/human_ smop_000501jsp&mid=WC0b01ac058001d127 (accessed 25 May, 2014).",Non-OADS,/arxiv_data1/oa_pdf/e9/21/annrheumdis-2013-204573.PMC3933074.pdf
22 –25 July 2013. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/ news/2013/07/news_detail_001851.jsp&mid=WC0b01ac058004d5c1.,Non-OADS,/arxiv_data1/oa_pdf/e9/21/annrheumdis-2013-204573.PMC3933074.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Aylin P , Yunus A, Bottle A, et al.",Non-OADS,/arxiv_data1/oa_pdf/04/c8/bmjqs-2013-002218.PMC3933164.pdf
"A similar pattern was observed with occupation, andFigure 2 Cigarette products of Chinese Tobacco Industry, 1952 –2011 (data source: Network of Industry in China, http://www.chinair.org/data/ D08/201007/01-46830.htm/).",Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 National Cancer Institute.,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
"Civil Action Number 99-2496 (GK), 2006. http://www.tobaccolawcenter.org/documents/FinalOpinion.pdf(accessed 31 Jan 2013).",Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://www.echinatobacco.com/101588/ 102220/102333/102336/32117.html (accessed 31 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://www.tobacco.gov.cn/history_ ﬁlesystem/ 07zzcx/ltbj-1.htm (accessed 20 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
State tobacco (2006) 412. http://www.tobaccoinfo.com.cn/zhxx/szgdgg/2006/06/25477.shtml (accessed 31 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://www.tobaccochina.com/news/ China/highlight/20101/20101206213_392774.shtml (accessed 20 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://www.tobaccoinfo.com.cn/ztxw/2010/04/33312.shtml (accessed 31 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
13 January 2009. http://www.tobacco.gov.cn/history_ ﬁlesystem/2009gzh/news1.html (accessed 31 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://cdmd.cnki.com.cn/Article/CDMD-84501-2009203572.htm (accessed 20 Mar 2012).,OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
"Chinese Tobacco Academic Annual Meeting, 2002. http://wenku.baidu.com/view/c65f5124bcd126fff7050bd3.html (accessed 31 Jan 2013).",Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
Tob Sci Technol 2009;2. http://www.cnki.com.cn/Article/CJFDTotal-YCKJ200902001.,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://mall.cnki.net/magazine/Article/ZGYV200202009.htm (accessed 31 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://baike.baidu.com/view/2908328.,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
"Geneva: WHO, 2003. http://www.who.int/ tobacco/sactob/recommendations/en/iso_ftc_en.pdf (accessed 20 Mar 2012).",Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://www.echinatobacco.com/zhongguoyancao/2011-02/01/content_250361.htm(accessed 31 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://www.most.gov.cn/cxfw/kjjlcx/kjjl2003/200802/t20080214_59048.htm (accessed 20 Mar 2012).,OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://www.most.gov.cn/cxfw/kjjlcx/kjjl2004/200802/t20080214_59054 .htm (accessed 20 Mar 2012).,OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://www.most.gov.cn/ztzl/gjkxjsjldh/ jldh2010/jldh10jlgg/201101/t20110115_84315.htm (accessed 20 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://china.nfdaily.cn/ content/2011-12/09/content_34672668.htm (accessed 20 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
April 2012 http://www.moh.gov.cn/public ﬁles/ business/html ﬁles/mohbgt/s3582/201204/54488.htm (accessed 31 Jan 2013).,OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://news.163.com/12/0530/02/82NHNTV000014 AED.html (accessed 31 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
South Metropolis Daily 2012. http://gcontent.oeeee.com/1/49/14919153f8aaf3af/Blog/f04/5269ac.html (accessed31 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://www.hudong.com/wiki/%E4%BA% 94%E5%8F%B6%E7%A5%9E#7 (accessed 20 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
New Tobacco 2011;21. http://www.echinatobacco.com/xinyancao/2011-11/01/ content_292532.htm (accessed 31 Jan 2013).33 Chinese Center for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://www.gov.cn/fwxx/content_1780112.htm (accessed20 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
http://www.gov.cn/gzdt/2008-04/10/content_941504.,Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
"Low-tar cigarettes as deadly as regular cigarettes, WHO Says, 2008. http://www.ecplaza.net/news/11/9341/lowtar_cigarettes_as.html (accessed20 Mar 2012).",Non-OADS,/arxiv_data1/oa_pdf/c0/16/tobaccocontrol-2012-050691.PMC3933165.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Weber ED, Colyer MH, Lesser RL, et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/78/bjophthalmol-2013-303536.PMC3933168.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Wagner CL, Greer FR.",Non-OADS,/arxiv_data1/oa_pdf/1e/6f/fetalneonatal-2013-303999.PMC3933171.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ gutjnl-2012-304110).,OADS,/arxiv_data1/oa_pdf/e8/dc/gutjnl-2012-304110.PMC3933173.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Ludvigsson JF, Lef ﬂer DA, Bai JC, et al.",Non-OADS,/arxiv_data1/oa_pdf/e8/dc/gutjnl-2012-304110.PMC3933173.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Campbell AJ, Borrie MJ, Spears GF.",Non-OADS,/arxiv_data1/oa_pdf/01/5c/bjophthalmol-2013-304179.PMC3933174.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Danese S, Fiocchi C. Ulcerative colitis.",Non-OADS,/arxiv_data1/oa_pdf/46/61/gutjnl-2012-304258.PMC3933176.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2012-303013).,Non-OADS,/arxiv_data1/oa_pdf/37/cf/gutjnl-2012-303013.PMC3933177.pdf
"These sequences(or reads) were subsequently ﬁltered using V .1.3 of the QIIME pipeline (http://qiime.sourceforge.net/), following the recom-mendations of Huse et al.",OADS,/arxiv_data1/oa_pdf/37/cf/gutjnl-2012-303013.PMC3933177.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Azpiroz F, Levitt M. Intestinal gas.",Non-OADS,/arxiv_data1/oa_pdf/37/cf/gutjnl-2012-303013.PMC3933177.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Sacco RL, Kargman DE, Gu Q, et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/1d/neurintsurg-2012-010608.PMC3933179.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Park MS, Stiefel MF, Fiorella D, et al.",Non-OADS,/arxiv_data1/oa_pdf/43/8d/neurintsurg-2013-010655.PMC3933180.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/4c/btt-8-041.PMC3933241.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2014:8 41–55Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  41Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S5578 3A critical evaluation of the role of subcutaneous  abatacept in the treatment of rheumatoid  arthritis: patient considerations Alvin F wells1,2 Nicole Jodat1 Michael Schiff3 1Rheumatology and immunotherapy  Center, Franklin, wi, USA; 2Duke  University Medical Center, Durham,   NC, USA; 3University of Colorado,   School of Medicine, Denver, CO, USA Correspondence: Alvin F wells   Rheumatology and immunotherapy  Center, 4225 west Oakwood Park  Court, Franklin, wi 53154, USA   Tel +1 414 435 0025   Fax +1 414 435 0026   email a.f.wells@att.ne tAbstract:  There are now more therapeutic options for the treatment of rheumatoid arthritis  (RA) than ever before, involving a range of mechanisms of action and different routes of  administration.",Non-OADS,/arxiv_data1/oa_pdf/5c/4c/btt-8-041.PMC3933241.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/5c/4c/btt-8-041.PMC3933241.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5c/4c/btt-8-041.PMC3933241.pdf
Available from: http://www.medicines.org.uk/emc/medicine/27216/ SPC/.,Non-OADS,/arxiv_data1/oa_pdf/5c/4c/btt-8-041.PMC3933241.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/05/cia-9-323.PMC3933242.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 323–331Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  323OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5464 4Adherence of older women with strength   training and aerobic exercise Alexandra Miranda  Assumpção Picorelli Daniele sirineu Pereira Diogo Carvalho Felício Daniela Maria Dos Anjos Danielle Aparecida gomes  Pereira rosângela Corrêa Dias Marcella guimarães Assis leani souza Máximo  Pereira graduate Program in rehabilitation  sciences, Department of Physical  Therapy, Universidade Federal de  Minas gerais, Belo horizonte, Minas  gerais, Brazil Correspondence: Alexandra Miranda  Assumpção Picorelli   Departamento de Fisioterapia da  Universidade Federal de Minas gerais,   Av Antônio Carlos, 6627, C eP 31270-901,   Belo horizonte, Minas gerais, Brazil   Tel +55 31 3499 4783   Fax +55 31 3499 4781   email alexandram.fisio@gmail.co mBackground:  Participation of older people in a program of regular exercise is an effective  strategy to minimize the physical decline associated with age.",Non-OADS,/arxiv_data1/oa_pdf/d0/05/cia-9-323.PMC3933242.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d0/05/cia-9-323.PMC3933242.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/05/cia-9-323.PMC3933242.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/92/btt-8-067.PMC3933243.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2014:8 67–81Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  67Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S4147 7Update on the use of systemic biologic agents   in the treatment of noninfectious uveitis Sirichai Pasadhika1 James T Rosenbaum2 1Department of Ophthalmology,   Southern Arizona veterans  Administration Health Care System,    T ucson, AZ, USA; 2Legacy Devers   eye institute, Portland, OR, USA Correspondence: James T Rosenbaum   Legacy Devers eye institute,   1040 Nw 22nd Ave; Suite 200,   Portland, OR 97210, USA   Tel +1 503 413 8203   Fax +1 503 413 6937   email jtrosenb@lhs.or gAbstract:  Uveitis is one of the leading causes of blindness worldwide.",Non-OADS,/arxiv_data1/oa_pdf/91/92/btt-8-067.PMC3933243.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/91/92/btt-8-067.PMC3933243.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/91/92/btt-8-067.PMC3933243.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/3f/cia-9-333.PMC3933245.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 333–339Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  333OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4445 3Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/9f/3f/cia-9-333.PMC3933245.pdf
"Or use: http://dvpr.es/1exyZb eneuroautonomic evaluation of patients with  unexplained syncope: incidence of complex  neurally mediated diagnoses in the elderly Martina rafanelli Alessandro Morrione Annalisa landi emilia ruffolo Valentina M Chisciotti Maria A Brunetti niccolò Marchionni Andrea Ungar syncope Unit, Cardiology and  geriatric Medicine, University of  Florence and Azienda Ospedaliero- Universitaria Careggi, Florence, Italy Correspondence: Andrea Ungar   syncope Unit, Cardiology and geriatric  Medicine, University of Florence and  Azienda Ospedaliero-Universitaria  Careggi, Viale Pieraccini 6,   Florence 50139, Italy   Tel +39 05 5427 1467   Fax +39 05 5427 1469   email aungar@unifi.i tBackground:  The incidence of syncope increases in individuals over the age of 70 years,  but data about this condition in the elderly are limited.",Non-OADS,/arxiv_data1/oa_pdf/9f/3f/cia-9-333.PMC3933245.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/9f/3f/cia-9-333.PMC3933245.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/3f/cia-9-333.PMC3933245.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/aa/ccid-7-073.PMC3933246.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 73–88Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  73OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S5358 0an integral topical gel for cellulite reduction:  results from a double-blind, randomized,   placebo-controlled evaluation of efficacy eric Dupont1 Michel Journet2 Marie-laure Oula3 Juan gomez1 Claude léveillé4 estelle loing5 Diane Bilodeau6 1Immanence IDC Inc, Québec, QC,   Canada; 2Clinique de Dermatologie  st-Joseph, Montréal, QC, Canada;   3evalulab Inc, Mont-royal, QC,   Canada; 4Clinique de Chirurgie  esthétique du Québec Métropolitain,   lévis, QC, Canada; 5lucas Meyer  Cosmetics, Québec, QC, Canada;   6CosmeConsult, Québec, QC, Canada Correspondence: Diane Bilodeau   CosmeConsult, 174, 9e rue,   Québec, QC g1l 2n1, Canada   Tel +1 418 353 1106   Fax +1 418 658 4622   email diane.bilodeau@cosmeconsult.co mBackground:  Cellulite is a serious cosmetic concern for most of the 90% of women affected  by it.",Non-OADS,/arxiv_data1/oa_pdf/35/aa/ccid-7-073.PMC3933246.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/35/aa/ccid-7-073.PMC3933246.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/aa/ccid-7-073.PMC3933246.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/80/cia-9-309.PMC3933247.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 309–321Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  309OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S54383Beneficial effects of multisensory and cognitive  stimulation on age-related cognitive decline   in long-term-care institutions Thaís Cristina galdino De  Oliveira1 Fernanda Cabral soares1 liliane Dias e Dias De  Macedo1 Domingos Luiz Wanderley  Picanço Diniz1 natáli Valim Oliver Bento- T orres1,2 Cristovam Wanderley  Picanço-Diniz1 1Laboratory of Investigations in  Neurodgeneration and Infection,   Biological sciences Institute,   University Hospital João de Barros  Barreto, 2College of Physical Therapy  and Occupational Therapy, Federal  University of Pará, Belém, Brazil Correspondence: Cristovam Wanderley  Picanço-Diniz   laboratório de Investigações em  Neurodegeneração e Infecção,   Hospital Universitário João de Barros  Barreto, 4487 rua Dos Mundurucus,  Belém, Pará 66073005, Brazil   Tel/fax +55 91 3201 6756   email cwpdiniz@gmail.co mAbstract:  The aim of the present report was to evaluate the effectiveness and impact of   multisensory and cognitive stimulation on improving cognition in elderly persons living  in long-term-care institutions (institutionalized [I]) or in communities with their families   (noninstitutionalized [NI]).",Non-OADS,/arxiv_data1/oa_pdf/da/80/cia-9-309.PMC3933247.pdf
BioEstat version 5.0 ( http://www.mamiraua.,Non-OADS,/arxiv_data1/oa_pdf/da/80/cia-9-309.PMC3933247.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/da/80/cia-9-309.PMC3933247.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/80/cia-9-309.PMC3933247.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/7a/mdu003.PMC3933250.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/50/cia-9-301.PMC3933252.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 301–308Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  301OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S55972Different types of atrial fibrillation, renal   function, and mortality in elderly Chinese   patients with coronary artery disease Shihui Fu1,* Tao liu2,* leiming luo1 Ping Ye1 1Department of geriatric Cardiology;   2Nanlou Ultrasound Department,   Chinese People’s Liberation Army  General Hospital, Beijing, People’s  Republic of China *These authors are joint first authors Correspondence: leiming luo   Department of Geriatric Cardiology,  Chinese People’s Liberation Army  General Hospital, 28 Fuxing Road,   Beijing 100853, People’s Republic   of China   Tel +86 10 8862 6362   Fax +86 10 6687 6349   email lleim@sina.co mBackground:  Atrial fibrillation (AF) is the most common arrhythmia in patients with chronic  kidney disease (CKD), and the combined prevalence of these two disorders increases as the  population ages.",Non-OADS,/arxiv_data1/oa_pdf/69/50/cia-9-301.PMC3933252.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/69/50/cia-9-301.PMC3933252.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/50/cia-9-301.PMC3933252.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/d9/ccid-7-065.PMC3933343.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 65–72Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  65RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S4605 1Improving adherence to acne treatment:   the emerging role of application software Chanhyun Park1 Gilwan Kim1 Isha Patel2 Jongwha Chang3 Xi Tan2 1College of Pharmacy, University   of Texas at Austin, Austin, TX, USA;  2College of Pharmacy, University  of Michigan, Ann Arbor, MI, USA;  3Mcwhorter School of Pharmacy,  Samford University, Birmingham,   AL, USA Correspondence : Xi Tan   College of Pharmacy, University of  Michigan, 428 Church Street, CC Little   Building, Office 3568, Ann Arbor,   MI 48109, USA   Tel +1 734 936 1505   email tanxi@umich.ed u    Jongwha Chang   Mcwhorter School of Pharmacy,   Samford University, 800 Lakeshore   Drive, Birmingham, AL 35229, USA   Tel +1 205 726 4079   email jchang1@samford.ed uObjective:  To examine recent studies on the effect of mobile and electronic (ME)-health  technology on adherence to acne treatment.",Non-OADS,/arxiv_data1/oa_pdf/43/d9/ccid-7-065.PMC3933343.pdf
Available from:  http://www.ncbi.nlm.nih.gov/books/NBK11955/.,Non-OADS,/arxiv_data1/oa_pdf/43/d9/ccid-7-065.PMC3933343.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/43/d9/ccid-7-065.PMC3933343.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/d9/ccid-7-065.PMC3933343.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/ee/amep-5-027.PMC3933344.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 27–37Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  27REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S5847 6Evaluating medical residents as managers of care:  a critical appraisal of assessment methods Jamiu O Busari1,2 Lorette A Stammen2 Lokke M Gennissen2 Rob M Moonen1 1Department of Pediatrics, Atrium  Medical Center, Henri Dunantstraat 5,   6401 CX Heerlen, the Netherlands;   2Faculty of Health, Medicine and Life  Sciences, University of Maastricht,    the Netherlands Correspondence: Jamiu O Busari   Department of Pediatrics, Atrium   Medical Center, Henri Dunantstraat 5,  6401 CX Heerlen, the Netherlands   Tel +31 45 576 7222   Fax +31 45 574 1383   Email j.busari@atriummc.n lIntroduction:  The increasing demands for effective and efficient health care delivery systems  worldwide have resulted in an expansion of the desired competencies that physicians need to  possess upon graduation.",Non-OADS,/arxiv_data1/oa_pdf/6f/ee/amep-5-027.PMC3933344.pdf
"ACGME Out - come project 1999. http://www.mc.vanderbilt.edu/medschool/otlm/ ratl/references_pdf/Module_4/ACGMEOutcomeProject.pd f. Accessed  January 21, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6f/ee/amep-5-027.PMC3933344.pdf
Canada: Available from: http://www.royalcollege.ca/portal/page/portal/ rc/common/documents/canmeds/framework/the_7_canmeds_roles_e.,Non-OADS,/arxiv_data1/oa_pdf/6f/ee/amep-5-027.PMC3933344.pdf
Available  from: http://knmg.artsennet.nl/ Opleiding-en-herregistratie/Algemene- informatie/Nieuws/O-R-Nieuwsartikel/Modernisering-medische- vervolgopleidingen-nieuw-kaderbesluit-CCMS.htm .,Non-OADS,/arxiv_data1/oa_pdf/6f/ee/amep-5-027.PMC3933344.pdf
Available from: http://www.acgme.org/acgmeweb/ Portals/0/PFAssets/ProgramResources/430_ CompetencyDefinitions_RO_ ED_10182007.pdf .,OADS,/arxiv_data1/oa_pdf/6f/ee/amep-5-027.PMC3933344.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/6f/ee/amep-5-027.PMC3933344.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/ee/amep-5-027.PMC3933344.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/72/copd-9-187.PMC3933347.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 187–201International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  187RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S3893 4Pathogenesis of hyperinflation in chronic  obstructive pulmonary disease Philippe Gagnon1,2 Jordan A Guenette3,4 Daniel Langer5 Louis Laviolette2 vincent Mainguy1 François Maltais1,2 Fernanda Ribeiro1,2 Didier Saey1,2 1Faculté de Médecine, Université  Laval, 2Centre de Recherche, Institut  Universitaire de Cardiologie et de  Pneumologie de Québec, Université  Laval, Québec, QC, 3Centre for  Heart Lung Innovation, University of  British Columbia, St Paul’s Hospital,   4Department of Physical Therapy,   University of British Columbia,   vancouver, BC, Canada; 5Department  of Kinesiology and Rehabilitation  Sciences, KU Leuven, Leuven, Belgium Correspondence: Didier Saey   Institut Universitaire de   Cardiologie et de Pneumologie de   Québec, 2725 Chemin Ste-Foy   Québec, QC, Canada, G1v 4G5   Tel +1 418 656 8711 ext 2614   email didier.saey@rea.ulaval.c aAbstract:  Chronic obstructive pulmonary disease (COPD) is a preven table  and trea table  lung  disease characterized by airflow limitation that is not fully reversible.",Non-OADS,/arxiv_data1/oa_pdf/a1/72/copd-9-187.PMC3933347.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a1/72/copd-9-187.PMC3933347.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/72/copd-9-187.PMC3933347.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/78/bctt-6-029.PMC3933348.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBreast Cancer: Targets and Therapy 2014:6 29–36Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  29Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/BCTT .S4376 3Tamoxifen for women at high risk   of breast cancer Safia A Nazarali Steven A Narod women’s College Research institute,   women’s College Hospital, and  The University of T oronto, T oronto,   Ontario, Canada Correspondence: Steven Narod   women’s College Research institute,   790 Bay Street, Toronto, Ontario,   Canada M5G1N8   email steven.narod@wchospital.c aAbstract:  Tamoxifen has been used as a treatment for women who have been diagnosed with  breast cancer for roughly four decades and has been approved as chemoprevention for over  ten years.",Non-OADS,/arxiv_data1/oa_pdf/17/78/bctt-6-029.PMC3933348.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/17/78/bctt-6-029.PMC3933348.pdf
"Available from: http://www.nice.org.uk/newsroom/ pressreleases/NICERecommendsBreastCancerdrugs.js p. Accessed  November 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/17/78/bctt-6-029.PMC3933348.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/e4/clep-6-081.PMC3933349.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2014:6 81–87Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  81Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/CLEP .S5370 6self-reported knowledge and awareness   about blood pressure and hypertension:   a cross-sectional study of a random sample   of men and women aged 60–74 years ina Qvist1 Marie D Thomsen2 Jes s lindholt2,3 hans ibsen4 Jeroen M l hendriks5 lars Frost1 1Department of Medicine, Diagnostic  Centre, University research Clinic  for innovative Patient Pathways,   silkeborg regional hospital, silkeborg,   Denmark; 2Department of Vascular  surgery, Viborg regional hospital  and institute of Clinical Medicine,   aarhus University hospital, aarhus,   Denmark; 3Centre of individualized  Medicine in arterial Diseases,   Department of Cardiothoracic and  Vascular Department T, Odense  University hospital, Odense,   Denmark; 4Department of Medicine,   holbæk hospital, holbæk, Denmark;   5Department of Cardiology,   Maastricht University Medical Centre,   Maastricht, the netherlands Correspondence: ina Qvist   Department of Medicine M1,   Diagnostic Centre, silkeborg hospital,  Falkevej 1-3, 8600 silkeborg, Denmark   Email inaqvist@rm.d kBackground:  In general, it is assumed that patient education, by increasing knowledge, may  change behavior and lifestyle and promote health.",Non-OADS,/arxiv_data1/oa_pdf/ef/e4/clep-6-081.PMC3933349.pdf
Available from: http://www.apo-danmark.,Non-OADS,/arxiv_data1/oa_pdf/ef/e4/clep-6-081.PMC3933349.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/ef/e4/clep-6-081.PMC3933349.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/d9/copd-9-203.PMC3933352.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 203–213International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  203OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/COPD.S5250 0sex discrepancies in COPD patients and burden  of the disease in females: a nationwide study   in greece (greek Obstructive lung Disease  epidemiology and health economics:  gOlDen  study) andriana I Papaioannou1,2 eleni Bania2 evangelos C alexopoulos3 eirini Mitsiki4 Foteini Malli2 Konstantinos I  gourgoulianis2 13rd respiratory Medicine  Department, sismanoglio  general  hospital, Marousi, athens, greece;   2respiratory Medicine Department,   University of Thessaly Medical  school University hospital of larissa,   larissa, greece; 3Occupational health  Department, Onassis Cardiac surgery  Center, athens, greece; 4Medical  Department, novartis hellas, athens,   greece Correspondence: andriana I Papaioannou   3rd respiratory Medicine Department,  sismanoglio  general hospital,   sismanogleiou 1 str, 15126 Marousi,  athens, greece   Tel +30 213 205 8422   email papaioannouandriana@gmail.co mBackground : The prevalence of chronic obstructive pulmonary disease (COPD) in females  appears to be increasing.",Non-OADS,/arxiv_data1/oa_pdf/61/d9/copd-9-203.PMC3933352.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/61/d9/copd-9-203.PMC3933352.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/d9/copd-9-203.PMC3933352.pdf
Available from: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/61/d9/copd-9-203.PMC3933352.pdf
Available from:  http://www.statistics.gr/portal/page/portal/ESYE/PAGE-da tabase.,OADS,/arxiv_data1/oa_pdf/61/d9/copd-9-203.PMC3933352.pdf
Available from:  http://www.hts.org.gr /.,Non-OADS,/arxiv_data1/oa_pdf/61/d9/copd-9-203.PMC3933352.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/2b/cia-9-341.PMC3933353.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 341–350Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  341OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5611 6Peripheral nerve blocks versus general anesthesia  for total knee replacement in elderly patients   on the postoperative quality of recovery Junle liu1,* WeiXiu Yuan1,* Xiaolin Wang1,* Colin F royse2,3 MaoWei gong1 Ying Zhao1 hong Zhang1 1Anesthesia and Operation Center,   Chinese People’s liberation Army  general hospital and Medical school  of Chinese People’s liberation Army,   Beijing, People’s republic of China;   2Anesthesia and Pain Management  Unit, Department of surgery,   University of Melbourne, Melbourne,   Victoria, Australia; 3Department of  Anesthesia and Pain Management, The  royal Melbourne hospital, Melbourne,   Victoria, Australia *These authors contributed equally  to this work Correspondence: hong Zhang   Anesthesia and Operation Center,   Chinese People’s liberation Army   general hospital, 28 Fuxing road, Beijing,   100853, People’s republic of China   Tel +86 10 6693 8051   Fax +86 10 8827 1427   email mazuimao301 @163.comBackground:  Both peripheral nerve blocks with sedation or general anesthesia can be used  for total knee replacement surgery.",Non-OADS,/arxiv_data1/oa_pdf/2b/2b/cia-9-341.PMC3933353.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/2b/2b/cia-9-341.PMC3933353.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/2b/cia-9-341.PMC3933353.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/7e/ceor-6-093.PMC3933358.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2014:6 93–100ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  93ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/CEOR.S5479 7Predictors of biologic treatment of psoriasis:   a non-interventional study luis Puig1 Tao Fan2 Qian Ding2 nancy E smith2 1Department of Dermatology,   hospital de la santa Creu i sant Pau,   Universitat autònoma de Barcelona,   Barcelona, spain; 2global health  Outcomes, Merck and Co., inc., Usa Correspondence: Qian Ding   Merck and Co., inc., PO Box 100, One  Merck Drive, Ws2E-76, Whitehouse  station, nJ 08889, Usa   Tel +1 908 423 4987   Fax +1 908 735 1688   Email qian.ding@merck.co mBackground:  Biologic therapies represent a significant advance in the treatment of psoriasis.",Non-OADS,/arxiv_data1/oa_pdf/9d/7e/ceor-6-093.PMC3933358.pdf
Available from:  http://www.ema.europa.eu/ema/index.jsp?curl =pages/medicines/human/ medicines/000958/human_med_001065.jsp&murl =menus/medicines/ medicines.jsp&jsenabled =true.,Non-OADS,/arxiv_data1/oa_pdf/9d/7e/ceor-6-093.PMC3933358.pdf
Available  from: http://www.ema.europa.eu/ema/index.jsp?curl =pages/ medicines/human/medicines/000481/smops/Positive/human_ smop_000184.jsp&murl =menus/medicines/medicines.jsp&mid =  WC0b01ac058001d12 7.,Non-OADS,/arxiv_data1/oa_pdf/9d/7e/ceor-6-093.PMC3933358.pdf
Available from:  http://www.ema.europa.eu/ema/index.jsp?curl =pages/medicines/ human/medicines/000240/human_med_001023.jsp&murl =menus/ medicines/medicines.jsp&mid =WC0b01ac058001d124&jsenabled =t rue.,Non-OADS,/arxiv_data1/oa_pdf/9d/7e/ceor-6-093.PMC3933358.pdf
"Available from: http://www.nice.org.uk/nicemedia/pdf/ ta134guidance.pd f. Accessed December 5, 2013.",Non-OADS,/arxiv_data1/oa_pdf/9d/7e/ceor-6-093.PMC3933358.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/9d/7e/ceor-6-093.PMC3933358.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/7e/ceor-6-093.PMC3933358.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/8c/cia-9-351.PMC3933423.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 351–356Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  351OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5626 8effectiveness of a heel cup with an arch support  insole on the standing balance of the elderly Tzu-hsuan Chen1,* li-Wei Chou2,3,* Mei-Wun Tsai4 Ming-Jor lo5 Mu-Jung Kao4,5 1Department of rehabilitation,   Mackay Memorial hospital, hsinchu,   Taiwan; 2Department of Physical  Medicine and rehabilitation, China  Medical University hospital, Taichung,   Taiwan; 3school of Chinese Medicine,   College of Chinese Medicine, China  Medical University, Taichung, Taiwan;   4Department of Physical Therapy  and Assistive Technology, national  Yang-Ming University, Taipei, Taiwan;   5Department of rehabilitation,   Yangming Branch, Taipei City hospital,   Taipei, Taiwan *These authors contributed equally to  this paper Correspondence: Mu-Jung Kao   Department of rehabilitation,   Taipei City hospital, Yangming Branch,  no 105, Yu sheng road, shilin District,  Taipei 111, Taiwan   Tel +886 2 2835 3456 ext 6606   Fax +886 2 2837 8121   email woodkao35@yahoo.co m.twBackground:  The use of insoles may enhance postural s tability and prevent falls.",Non-OADS,/arxiv_data1/oa_pdf/cb/8c/cia-9-351.PMC3933423.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/cb/8c/cia-9-351.PMC3933423.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/8c/cia-9-351.PMC3933423.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/cmar-6-077.PMC3933425.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 77–92Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  77Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S5049 7DNA repair in cancer: emerging targets   for personalized therapy Rachel Abbotts Nicola Thompson Srinivasan Madhusudan University of Nottingham, Academic  Unit of Oncology, Division of  Oncology, School of Medicine,   Nottingham University Hospitals, City  Hospital Campus, Nottingham, UK Correspondence: Srinivasan Madhusudan   University of Nottingham, Academic   Unit of Oncology, Division of Oncology,   School of Medicine, Nottingham   University Hospitals, City Hospital   Campus, Hucknall Road, Nottingham   NG5 1PB, UK   Tel +44 115 823 1850   Fax +44 115 823 1849   email srinivasan.madhusudan@ nottingham.ac.u kAbstract:  Genomic deoxyribonucleic acid (DNA) is under constant threat from endogenous  and exogenous DNA damaging agents.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/cmar-6-077.PMC3933425.pdf
"Available  from: http://en.sanofi.com/Images/13666_20110127_BSI_en.pd f.  Accessed August 26, 2013.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/cmar-6-077.PMC3933425.pdf
"Available from: http://en.sanofi.com/ Images/33127_20130603_rdupdate_en.pd f. Accessed August 26,  2013.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/cmar-6-077.PMC3933425.pdf
Available from: http://www.clinicaltrials.gov/ct2/ show/NCT0184498 6.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/cmar-6-077.PMC3933425.pdf
Available from: http://www.clinicaltrials.gov/ct2/ show/NCT0187435 3.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/cmar-6-077.PMC3933425.pdf
"Available from: http://www.astrazeneca.com/ Media/Press-releases/Article/20111220-az-updates-olaparib-TC5214- developmen t. Accessed August 29, 2012.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/cmar-6-077.PMC3933425.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/2e/5f/cmar-6-077.PMC3933425.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/5f/cmar-6-077.PMC3933425.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c8/6d/dddt-8-245.PMC3933431.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 245–253Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  245Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S5659 7Efficacy and safety of febuxostat in the treatment  of hyperuricemia in s table kidney transplant  recipients Tadashi sofue1 Masashi inui2 Taiga hara1 Y oko nishijima1 Kumiko Moriwaki1 Yushi hayashida3 Nobufumi Ueda3 akira nishiyama4 Y oshiyuki Kakehi3 Masakazu Kohno1 1Division of nephrology and Dialysis,   Department of cardiorenal and  Cerebrovascular Medicine, Kagawa  University, Kagawa, 2Department of  Urology, Tokyo Women’s Medical  University, T okyo, 3Department  of Urology, 4Department of  Pharmacology, Kagawa University,   Kagawa, Japan correspondence: Tadashi sofue   Department of cardiorenal and  Cerebrovascular Medicine, Faculty   of Medicine, Kagawa University,   1750-1 Ikenobe, Miki-cho, Kita-gun,   Kagawa 761-0793, Japan   Tel +81 8 7891 2149 ext 2623   Fax +81 8 7891 2149   email sofue@med.kagawa-u.ac.j pBackground:  Post-transplant hyperuricemia (PTHU), defined as serum uric acid   concentration $7.0 mg/dL or need for treatment with allopurinol or benzbromarone,  reduces long-term allograft survival in kidney transplant recipients.",Non-OADS,/arxiv_data1/oa_pdf/c8/6d/dddt-8-245.PMC3933431.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c8/6d/dddt-8-245.PMC3933431.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/6d/dddt-8-245.PMC3933431.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/f3/clep-6-089.PMC3933432.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2014:6 89–97Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  89REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CLEP .S4084 1The epidemiology of eating disorders: genetic,  environmental, and societal factors Deborah Mitchison1 Phillipa J Hay2,3 1School of Medicine, University  of western Sydney, Sydney, NSw ,   Australia; 2Centre for Health  Research, School of Medicine,   University of western Sydney, Sydney,   NSw , Australia; 3School of Medicine,   James Cook University, T ownsville  City, QLD, Australia Correspondence: Phillipa J Hay   University of western Sydney,   Locked Bag 1797, Penrith,   NSw 2751, Australia   Tel +61 2 4620 3838   Fax +61 2 4620 3891   Email p.hay@uws.edu.a uBackground:  The aim of this review was to summarize the literature to date regarding the  sociodemographic, environmental, and genetic correlates of eating disorders (EDs) in adults.",Non-OADS,/arxiv_data1/oa_pdf/a4/f3/clep-6-089.PMC3933432.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/a4/f3/clep-6-089.PMC3933432.pdf
Available from: http://www.abs.gov.au/ausstats/abs@.nsf/ mf/4326.,Non-OADS,/arxiv_data1/oa_pdf/a4/f3/clep-6-089.PMC3933432.pdf
"Geneva: World Health Organization; 2011 [cited March 19,  2011]; Available from: http://www.who.int/classifications/icd/en/ bluebook.pd f. Accessed December 6, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a4/f3/clep-6-089.PMC3933432.pdf
Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/anie.201304922.,Non-OADS,/arxiv_data1/oa_pdf/e9/77/anie0052-10766.PMC3933447.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/35/ppa-8-263.PMC3933457.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 263–270Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  263OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5646 7Adherence to preventive medications   in asthmatic children at a tertiary care   teaching hospital in Malaysia Adyani Md redzuan Meng soon lee noraida Mohamed shah Faculty of Pharmacy, Universiti  Kebangsaan Malaysia, Kuala lumpur,   Malaysia correspondence: noraida Mohamed shah   Faculty of Pharmacy, Universiti  Kebangsaan Malaysia, Jalan raja Muda  Abdul Aziz, 50300 Kuala lumpur, Malaysia   Tel +60 3 92 89 7199   Fax +60 3 92 89 7090   email noraida_mohamedshah@yahoo.co mPurpose:  Asthma affects an estimated 300 million people worldwide.",Non-OADS,/arxiv_data1/oa_pdf/a8/35/ppa-8-263.PMC3933457.pdf
"Available from:  http://www.thestar.com.my/Lifestyle/Health/2011/05/29/Improving- asthma-control.asp x. Accessed December 15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a8/35/ppa-8-263.PMC3933457.pdf
"Available from: http://www.emro.who.int/ncd/Publications/ adherence_ report.pd f. Accessed October 23, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a8/35/ppa-8-263.PMC3933457.pdf
"Available from: http://www.nice.org.uk/nicemedia/ pdf/CG76FullGuideline.pd f. Accessed November 20, 2011.",Non-OADS,/arxiv_data1/oa_pdf/a8/35/ppa-8-263.PMC3933457.pdf
"Available at: http://www.consultantlive.com/ articles/medication-persistence-and-health-care-expenditures-managed- medicaid-population-asthm a. Accessed January 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a8/35/ppa-8-263.PMC3933457.pdf
Available from: http://www.statistics.gov.,OADS,/arxiv_data1/oa_pdf/a8/35/ppa-8-263.PMC3933457.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a8/35/ppa-8-263.PMC3933457.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/35/ppa-8-263.PMC3933457.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/52/ppa-8-257.PMC3933465.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:8 257–262Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  257OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5777 6Factors associated with the use of percutaneous   coronary intervention in elderly chinese   patients with a first sT elevated acute   myocardial infarction shan Zhou1 Jie chen2 ru-Yi Xu1 hai-Yun Wu2 1chinese navy general hospital,   Fucheng, Beijing, People’s republic  of china; 2institute of geriatric  cardiology, chinese P lA general  hospital, Beijing, People’s republic   of china correspondence: hai-Yun Wu   institute of geriatric cardiology, chinese   PlA general hospital, 28 Fuxing road,   Beijing, People’s republic of china, 100853   email why46301@163.co mIntroduction:  Rapid reperfusion therapies (RT), particularly percutaneous coronary inter - vention (PCI), improve short- and long-term outcomes in patients with ST segment elevation  myocardial infarction (STEMI).",Non-OADS,/arxiv_data1/oa_pdf/9b/52/ppa-8-257.PMC3933465.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9b/52/ppa-8-257.PMC3933465.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/52/ppa-8-257.PMC3933465.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/c4/tcrm-10-113.PMC3933466.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 113–120Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  113ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/TCRM.S5818 6Postural pattern recognition in children   with unilateral cerebral palsy Małgorzata Domagalska- Szopa Andrzej Szopa school of health sciences, Medical  University of silesia, Katowice, Poland Correspondence: Małgorzata  Domagalska-Szopa   school of health sciences, Medical   University of silesia, Medyków 12,   40-752 Katowice, Poland   Tel +48 32 208 87 12   Fax +48 32 208 87 12   email mdomagalska@sum.edu.p lBackground:  Several different strategies for maintaining upright standing posture in children  with cerebral palsy (CP) were observed .",Non-OADS,/arxiv_data1/oa_pdf/a1/c4/tcrm-10-113.PMC3933466.pdf
Available from http://citeseerx.ist.psu.,Non-OADS,/arxiv_data1/oa_pdf/a1/c4/tcrm-10-113.PMC3933466.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/a1/c4/tcrm-10-113.PMC3933466.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/c4/tcrm-10-113.PMC3933466.pdf
"Correspondence to: Barbara P Rattner; Email: barbara@landesbioscience.com Submitted: 11/14/2013; Accepted: 11/14/2013http://dx.doi.org/10.4161/epi.27247In this issue of Epigenetics Barbara P r attner Landes Bioscience; s an d iego, CA U sA",Non-OADS,/arxiv_data1/oa_pdf/0b/f5/epi-8-1247.PMC3933484.pdf
"4-9 Somatic  *Correspondence to: Adam Andreasson; Email: Adam.Andreasson@ki.se Submitted: 07/29/2013; Revised: 09/16/2013; Accepted: 10/02/2013http://dx.doi.org/10.4161/epi.26686The VHL  gene is epigenetically inactivated  in pheochromocytomas and abdominal  paragangliomas adam andreasson1,*, Nimrod B Kiss1, stefano c aramuta1, Luqman s ulaiman1, Fredrika s vahn1, Martin Bäckdahl2,3,   anders h öög1,4, c c hristofer Juhlin1,4, and c atharina Larsson1 1Department of Oncology-Pathology; Karolinska Institutet; Karolinska University h ospital; s tockholm, s weden; 2Department of Molecular Medicine and s urgery;   Karolinska Institutet; s tockholm, s weden; 3Department of Breast and e ndocrine s urgery; Karolinska University h ospital; s tockholm, s weden;   4Department of c linical Pathology and c ytology; Karolinska University h ospital; s tockholm, s weden Keywords:  Pheochromocytoma, paraganglioma, VHL,  DNA promoter methylation, gene expression, pyrosequencing, qRT-PCR Abbreviations: AFIP, armed forces institute of pathology; bp, base pair; CIMP, CpG island methylator phenotype; EGLN1  (PDH2) , egl nine homolog 1 gene; EPAS (HIF2A),  endothelial PAS domain 1 gene; KIF1B β, kinesin family member 1B beta  gene; MAX,  myc associated factor X gene; MEN 2A, multiple endocrine neoplasia type 2A; MetI, methylation index; NF1,  neurofibromatosis type 1 syndrome; NF1 , neurofibromin 1 gene; PCC, pheochromocytoma; PGL, abdominal paraganglioma;  RET,  rearranged during transfection proto-oncogene; SDHA,  succinate dehydrogenase complex, subunit A gene; SDHAF2  (SDH5),  succinate dehydrogenase complex assembly factor 2 gene; SDHB  succinate dehydrogenase complex, subunit B gene;  SDHC  succinate dehydrogenase complex, subunit C gene; SDHD  succinate dehydrogenase complex, subunit D gene; TMEM127 ,  transmembrane protein 127 gene; VHL, von Hippel-Lindau syndrome; VHL , von Hippel-Lindau tumor suppressor gene;   WHO, world health organization Pheochromocytoma (P cc) and abdominal paraganglioma (PGL) are neuroendocrine tumors that present with clinical  symptoms related to increased catecholamine levels.",Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
N Engl J Med 1984; 311:1298- 303; PMID:6149463 ; http://dx.doi.org/10.1056/ NEJM198411153112007 3.,OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
N Engl J Med 2002; 346:1459-66; PMID:12000816 ;  http://dx.doi.org/10.1056/NEJMoa020152 5.,OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Eur J Endocrinol 2012; 166:151-8; PMID:21896620 ;  http://dx.doi.org/10.1530/EJE-11-0497 6.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Hum Genet 2008; 124:279- 85; PMID:18726616 ; http://dx.doi.org/10.1007/ s00439-008-0553-1 7.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Lancet Oncol  2010; 11:366-72;  PMID:20071235 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Endocr Relat Cancer  2011; 18:73-83;  PMID:20959442 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Hum Mol Genet  2013; 22:2169-76;  PMID:23418310 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Hum Mol Genet 2012; 21:5397-405;  PMID:22962301 ; http://dx.doi.org/10.1093/hmg/ dds37411.,OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Hum Mol Genet  2012; 21:5406-16;  PMID:23010473 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Clin Cancer Res 2008; 14:2551-9; PMID:18451216 ;  http://dx.doi.org/10.1158/1078-0432.CCR-07-1867 13.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Endocr Relat Cancer 2013; 20:65-78; PMID:23154831 ; http://dx.doi.org/10.1530/ ERC-12-0267 14.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Cancer Cell 2013; 23:739-52; PMID:23707781 ;  http://dx.doi.org/10.1016/j.ccr.2013.04.018 15.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Exp Clin Endocrinol Diabetes  2005; 113:1-7;  PMID :15662588 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Nature 1983;  301:89-92;  PMID:6185846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
PLoS Genet 2011; 7:e1002312; PMID:22022277 ;  http://dx.doi.org/10.1371/journal.pgen.1002312 20.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Ann N Y Acad Sci 2006; 1073:290- 9; PMID:17102098 ; http://dx.doi.org/10.1196/ annals.1353.03321.,OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Endocr Relat Cancer 2010; 17:743-56;  PMID:20562231 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Endocr  Relat Cancer 2004; 11:897-911; PMID:15613462 ;  http://dx.doi.org/10.1677/erc.1.00838 23.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
PLoS Genet 2005; 1:72-80;  PMID:16103922 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
J Clin Endocrinol Metab 2007; 92:4865-72;  PMID:17878247 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
Epigenetics 2013; 8:646-55; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
PLoS  One 2010; 5:e9472; PMID:20208994 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
"Clin Chem 2009; 55:611- 22; PMID:19246619 ; http://dx.doi.org/10.1373/ clinchem.2008.112797Acknowledgments The authors wish to thank Ms Susanne Bergström for valu - able Think-Cell guidance and Ms Lisa Ånfalk at the Department  of Oncology-Pathology, Karolinska University Hospital Solna, for excellent sample collection and handling.Supplemental Materials Supplemental materials may be found here: www.landesbioscience.com/journals/epigenetics/article/26686",Non-OADS,/arxiv_data1/oa_pdf/d8/9d/epi-8-1347.PMC3933494.pdf
"Epigenetics 8:12, 1384–1384; December 2013; © 2013 Landes Bioscience CorrEC tion 1384 Epigenetics Volume 8 issue 12*Correspondence to: Elisabetta Rovida; Email: elisabetta.rovida@unifi.it; Persio Dello Sbarba; Email: persio@unifi.it Submitted: 9/10/2013; Accepted: 9/10/2013http://dx.doi.org/10.4161/epi.26983Correction to Barbetti V, et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/02/epi-8-1384.PMC3933497.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/a1/rmhp-7-029.PMC3933538.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpRisk Management and Healthcare Policy 2014:7 29–34Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  29ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RMHP .S5697 4Validation of a clinical risk-scoring algorithm   for severe scrub typhus Pamornsri sriwongpan1,2 Jayanton Patumanond3 Pornsuda Krittigamas4 Hutsaya Tantipong5 chamaiporn Tawichasri6 sirianong namwongprom1,7 1clinical epidemiology Program,   Faculty of Medicine, chiang Mai  University, chiang Mai, 2Department  of social Medicine, chiangrai  Prachanukroh Hospital, chiang Rai,   3clinical epidemiology Program,   Faculty of Medicine, Thammasat  University, Bangkok, 4Department  of general Pediatrics, nakornping  Hospital, chiang Mai, 5Department  of Medicine, chonburi Hospital,   chonburi, 6clinical epidemiology  society at chiang Mai, chiang Mai,   7Department of Radiology, Faculty  of Medicine, chiang Mai University,   chiang Mai, Thailand correspondence: sirianong  namwongprom   Department of Radiology, Faculty   of Medicine, chiang Mai University,   chiang Mai 50200, Thailand   Tel +66 53 945 458   Fax +66 53 945 476   email snamwong@med.cmu.ac.t hObjective:  The aim of the study reported here was to validate the risk-scoring algorithm for  prognostication of scrub typhus severity.",Non-OADS,/arxiv_data1/oa_pdf/08/a1/rmhp-7-029.PMC3933538.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/08/a1/rmhp-7-029.PMC3933538.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/a1/rmhp-7-029.PMC3933538.pdf
"Available from: http://www.who.int/csr/resources/publications/  surveillance/whocdscsrisr992.pd f. Accessed October 5, 2011.",OADS,/arxiv_data1/oa_pdf/08/a1/rmhp-7-029.PMC3933538.pdf
"Secondary structure prediction of DNAJB6 and sequence alignment The sequences of human DNAJB6 (isoform B, sp|O75190- 2) and DNAJB8 (sp|Q8NHS0), three ortogues to each of them, and human DNAJB1 (sp|P25685) were subjected to secondary structure prediction using several different pro-grams (JPRED, APSSP, NetSurfP, PROF, SCRATCH, JUFO, PSIPRED, YASPIN, PORTER, and PROTPRED) at ExPASy website ( http://www.expasy.org ) and compared to the secondary structure determined for human DNAJB1, the N-terminal domain (PDB 1HDJ; Qian et al.",OADS,/arxiv_data1/oa_pdf/02/cf/12192_2013_Article_448.PMC3933622.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bd/0b/hiv-6-009.PMC3933664.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHIV/AIDS – Research and Palliative Care 2014:6 9–18HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  9ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S5406 2Addressing vulnerabilities of female sex workers  in an HIV prevention intervention in Mumbai and  Thane: experiences from the Aastha project Virupax Ranebennur1 Sanjeevsingh gaikwad1 Sowmya Ramesh2 Amrita Bhende1 1FHI 360, Maharashtra, Mumbai, India;   2HIV/AIDS Programs, Population  Council , new Delhi, India Correspondence: Virupax Ranebennur   FHI 360, Maharashtra, 704-705 Balarama  Building, Bandra-Kurla Complex, Bandra  east, Mumbai 400051, India   Tel +91 22 6675 0457   Fax +91 22 2659 2344   email vranebennur@fhi360.or gBackground:  It is important for targeted interventions to consider vulnerabilities of female  sex workers (FSWs) such as poverty, work-related mobility, and literacy, for effective human  immunodeficiency virus (HIV) prevention.",Non-OADS,/arxiv_data1/oa_pdf/bd/0b/hiv-6-009.PMC3933664.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/bd/0b/hiv-6-009.PMC3933664.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/0b/hiv-6-009.PMC3933664.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/67/dddt-8-219.PMC3933665.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 219–226Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  219Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5325 3Difference in the effects of switching from  candesartan to Olmesartan or T elmisartan to  Olmesartan in hypertensive patients with type 2  diabetes: the cOTO study hiroyuki Daikuhara Kensaku Fukunaga T omie Ohshima Department of internal Medicine,   sakaide city hospital, Kagawa, Japan correspondence: hiroyuki Daikuhara   Department of internal Medicine,   sakaide city hospital, 1-6-43 Bunkyo-   cho, sakaide, Kagawa 762-0031, Japan   Tel +81 877 465 131   Fax +81 877 462 377   email daikusan@r5.dion.ne.j pPurpose:  This open-label controlled study compared the therapeutic efficacy of three  representative angiotensin II receptor blockers (ARBs) in hypertensive patients with type 2  diabetes attending a hospital outpatient clinic.",Non-OADS,/arxiv_data1/oa_pdf/e7/67/dddt-8-219.PMC3933665.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e7/67/dddt-8-219.PMC3933665.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/67/dddt-8-219.PMC3933665.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/f0/dddt-8-255.PMC3933667.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 255–262Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  255Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5356 8insulin induces drug resistance in melanoma  through activation of the Pi3K/akt pathway Mengna chi1 Yan Ye1 Xu Dong Zhang1 Jiezhong chen2,3 1school of Medicine and Public  health, The University of newcastle,  newcastle, nsW, australia; 2school of  Biomedical sciences, The University of  Queensland, Brisbane, Q lD, australia;  3Faculty of science, Medicine and  health, The University of Wollongong,  Wollongong, nsW, australia correspondence: Jiezhong chen   school of Biomedical sciences,  The University of Queensland, st lucia,  Brisbane, QlD 4072, australia   Tel +61 2 4921 8906   Fax +61 2 4913 8184   email j.chen4@uq.edu.a uIntroduction:  There is currently no curative treatment for melanoma once the disease spreads  beyond the original site.",Non-OADS,/arxiv_data1/oa_pdf/88/f0/dddt-8-255.PMC3933667.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/88/f0/dddt-8-255.PMC3933667.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/f0/dddt-8-255.PMC3933667.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/7f/ndt-10-339.PMC3933703.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 339–348Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  339OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S5752 2Neural basis of three dimensions of agitated   behaviors in patients with alzheimer disease Koichi Banno1 shutaro Nakaaki2 Junko sato1 Katsuyoshi T orii1 Jin Narumoto3 Jun Miyata4 Nobutsugu hirono5 T oshi a Furukawa6 Masaru Mimura2 Tatsuo akechi1 1Department of Psychiatry and  cognitive-Behavioral Medicine,   Nagoya city University graduate  school of Medical sciences,   Nagoya, Japan; 2Department of  Neuropsychiatry, Keio University  school of Medicine, T okyo, Japan;   3Department of Psychiatry, graduate  school of Medical science, Kyoto  Prefectural University of Medicine,   4Department of Neuropsychiatry,   graduate school of Medicine,   Kyoto University, Kyoto, Japan;   5Department of Psychology, Kobe  gakuin University; hyogo, Japan;   6Departments of health Promotion  and human Behavior and of clinical  epidemiology, graduate school of  Medicine/ school of Public health,   Kyoto University, Kyoto, Japan correspondence: shutaro Nakaaki   Department of Neuropsychiatry,   Keio University school of Medicine,   35 shinanomachi, shinjuku-ku,   Tokyo 160-8582, Japan   Tel +81 3 5363 3829   Fax +81 3 5379 0187   email hzi05510@nifty.co mBackground:  Agitated behaviors are frequently observed in patients with Alzheimer disease  (AD).",Non-OADS,/arxiv_data1/oa_pdf/b4/7f/ndt-10-339.PMC3933703.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b4/7f/ndt-10-339.PMC3933703.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/7f/ndt-10-339.PMC3933703.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/ndt-10-355.PMC3933704.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 355–359Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  355Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S3905 5Clinical utility of orally disintegrating olanzapine   in Chinese patients with schizophrenia: a review   of effectiveness, patient preference, adherence,   and other properties Jingping Zhao1 Jianjun Ou1 Haibo Xue2 Li Liu2 william Montgomery3 Tamas Treuer4 1Mental Health institute of The  Second Xiangya Hospital, Hunan  Province Technology institute  of Psychiatry, Key Laboratory of  Psychiatry and Mental Health of  Hunan Province, Central South  University, Changsha, Hunan,    2Lilly Suzhou Pharmaceutical Co, Ltd,    Jiangsu, People’s Republic of China;   3Global Health Outcomes, eli Lilly  and Company, Sydney, Australia;   4emerging Markets Business Unit  (Neuroscience), eli Lilly and Company,   Budapest, Hungary Correspondence: Jingping Zhao   Mental Health institute of The Second  Xiangya Hospital, Hunan Province  Technology institute of Psychiatry,   Key Laboratory of Psychiatry and Mental  Health of Hunan Province, Central South  University, 139 Middle Renmin Road,  Changsha, Hunan 410011, People’s  Republic of China   Tel +86 731 8555 4052   Fax +86 731 8555 4052   email zhaojingpingcsu@163.co mAbstract:  The primary objective of this systematic review was to examine the evidence for the  efficacy, effectiveness, and safety of orally disintegrating olanzapine in Chinese populations.",Non-OADS,/arxiv_data1/oa_pdf/b5/09/ndt-10-355.PMC3933704.pdf
"Currently in the People’ s Republic of  China, three antipsychotics are available as ODTs, ie, olan - zapine (Zyprexa® Zydis®, where Zydis refers to the patented  freeze-dried orodispersible technology of Catalent Pharma  Solutions, Somerset, NJ, USA), risperidone, and aripiprazole  (China Food and Drug Administration, http://www.sda.gov.",Non-OADS,/arxiv_data1/oa_pdf/b5/09/ndt-10-355.PMC3933704.pdf
US prescribing information is available  from http://pi.lilly.com/us/zyprexa-pi.pd f. ODO table ts dissolve in human saliva in seconds.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/ndt-10-355.PMC3933704.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b5/09/ndt-10-355.PMC3933704.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/09/ndt-10-355.PMC3933704.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/62/mder-7-017.PMC3933705.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 17–21Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  17Sho Rt REpo Rtopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/MDER.S5671 6Application of dynamic indocyanine green  perfusion imaging for evaluation of vasoactive  effect of acupuncture: a preliminary follow-up  study on normal healthy volunteers Yuri An1 Jong Wook Jeon2 Kihwan Kwon3 Chulhee Choi1 1Department of Bio and Brain  Engineering, KAIS t, Daejeon, South  Korea; 2Acupuncture, Moxibustion  and Meridian Research Centre,   Korea Institute of oriental Medicine,   Daejeon, South Korea; 3Department  of Cardiology, College of Medicine,   Ewha Womans University, Seoul,   Korea Correspondence: Chulhee Choi   Department of Bio and Brain Engineering,   KAISt, 291 Daehak-ro, Yuseong-gu,   Daejeon 305-701, South Korea   tel 82 42 869 4321   Fax 82 42-869 4380   Email cchoi@kaist.ac.k rBackground : Even though acupuncture has long been used for alleviating symptoms related to  vascular insufficiency, the clinical effect of acupuncture on peripheral circulation has not been  fully confirmed.",Non-OADS,/arxiv_data1/oa_pdf/af/62/mder-7-017.PMC3933705.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2014:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 21Indocyanine green perfusion imaging of acupuncture vasodilation,Non-OADS,/arxiv_data1/oa_pdf/af/62/mder-7-017.PMC3933705.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/59/ijnrd-7-089.PMC3933706.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 89–99International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  89RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S3563 3Revascularization as a treatment to improve   renal function Helen v Alderson James P Ritchie Philip A Kalra The University of Manchester,  Manchester Academic Health Sciences  Centre, vascular Research Group,  Department of Renal Medicine,  Salford Royal NHS Foundation   Trust, Salford, UK Correspondence: Philip A Kalra   Department of Renal Medicine,   Salford Royal Hospital, Salford,   Greater Manchester, M8 8HD, UK   email philip.kalra@srft.nhs.u kAbstract:  An aging atherosclerosis-prone population has led to an increase in the prevalence  of atherosclerotic renovascular disease (ARVD).",Non-OADS,/arxiv_data1/oa_pdf/01/59/ijnrd-7-089.PMC3933706.pdf
"Available from:  http://www.hscic.gov.uk/he s. Accessed September 22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/01/59/ijnrd-7-089.PMC3933706.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/01/59/ijnrd-7-089.PMC3933706.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/59/ijnrd-7-089.PMC3933706.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1005–1023International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1005RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5535 9Nanotherapeutics in the eU: an overview   on current state and future directions Anita Hafner1,* Jasmina Lovrić1,* Gorana Perina Lakoš2 Ivan Pepić1,3 1Department of Pharmaceutical  Technology, University of   Zagreb, Faculty of Pharmacy and  Biochemistry, Zagreb, Croatia;  2Medicines Authorisation Division,  Agency for Medicinal Products and  Medical Devices, Zagreb, Croatia;  3Centre for Applied Pharmacy,  University of Zagreb, Faculty   of Pharmacy and Biochemistry,  Zagreb, Croatia *These authors contributed equally  to this work Correspondence: Ivan Pepić   Department of Pharmaceutical  Technology, University of Zagreb,   Faculty of Pharmacy and Biochemistry,   A Kovačića 1, 10 000 Zagreb, Croatia   Tel +385 1 6394 766   Fax +385 1 46 12 691   email ipepic@pharma.h rAbstract:  The application of nanotechnology in areas of drug delivery and therapy  (ie, nanotherapeutics) is envisioned to have a great impact on public health.",Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
"Available  from: http://www.etp-nanomedicine.eu/public/press-documents/  publications/etpn-publications/091022_ETPN_Report_2009.pd f.  Accessed December 17, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
Cynviloq™  Available from: http://sorrentotherapeutics.com/cynviloq /.,OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2013/03/WC500140351.pd f.  Accessed December 17, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/Regulatory_and_procedural_guideline/2010/01/WC500069728.,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
"Available from: http://www.fda.gov/ ScienceResearch/ SpecialTopics/Nanotechnology/ucm301114.ht m. Accessed November  17, 2013.",OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
Available from: http://www.fda.gov/RegulatoryInformation/ Guidances/ucm257698.htm .,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
Available from: http://ec.europa.eu/health/ files/eudralex/vol-2/a/chap4rev200604_e n.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
Available from: http://www.fda.gov/ Drugs/ResourcesForY ou/SpecialFeatures/ucm279676.htm .,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
Available from: http://www.bccresearch.com/market-research/ healthcare/nanotechnology-medical-applications-hlc069a.html .,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
Available  from: http://www.etp-nanomedicine.eu/public/press-documents/ publications /etpn-publications/etpn-white-paper-H2020 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
82. http://www.etp-nanomedicine.e u.,OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-9-1005.PMC3933707.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d2/40/ijnrd-7-075.PMC3933708.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 75–88International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  75RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S3973 9Obesity, hypertension, and chronic   kidney disease Michael e Hall1,2 Jussara M do Carmo2 Alexandre A da Silva2 Luis A Juncos1,2 Zhen wang2 John e Hall2 1Department of Medicine,   2Department of Physiology and  Biophysics, Mississippi Center for  Obesity Research, University of  Mississippi Medical Center, Jackson,   MS, USA Correspondence: Michael e Hall   Department of Medicine, University of  Mississippi Medical Center, 2500 N State  St, Jackson, MS 39216-4505, USA   Tel +1 601 984 1801   Fax +1 601 984 1817   email mehall@umc.ed uAbstract:  Obesity is a major risk factor for essential hypertension, diabetes, and other  comorbid conditions that contribute to development of chronic kidney disease.",Non-OADS,/arxiv_data1/oa_pdf/d2/40/ijnrd-7-075.PMC3933708.pdf
"Available from: http://www.who.int/mediacentre/ factsheets/fs311/en/index.htm l. Accessed October 18, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d2/40/ijnrd-7-075.PMC3933708.pdf
"Available  from: http://www.cdc.gov/nccdphp/dnpa/obesity/trend/index.ht m.  Accessed on September 14, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d2/40/ijnrd-7-075.PMC3933708.pdf
Available from: http://kidney.niddk.nih.gov/kudiseases/pubs/kustats /.,Non-OADS,/arxiv_data1/oa_pdf/d2/40/ijnrd-7-075.PMC3933708.pdf
Available from:  http://www.usrds.org/atlas12.asp x.,OADS,/arxiv_data1/oa_pdf/d2/40/ijnrd-7-075.PMC3933708.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/d2/40/ijnrd-7-075.PMC3933708.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/40/ijnrd-7-075.PMC3933708.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/d8/ijn-9-985.PMC3933709.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 985–993International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  985OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5581 2The therapeutic effect of monocyte  chemoattractant protein-1 delivered by   an electrospun scaffold for hyperglycemia   and nephrotic disorders cai Y ong2,* Zhengxin Wang1,* Xing Zhang3 Xiaomin shi1 Zhijia Ni1 hong Fu1 guoshan Ding1 Zhiren Fu1 hao Yin1,3 1Department of surgery, Organ  Transplant center, shanghai  changzheng hospital, second Military  Medical University, shanghai, People’s  republic of china; 2Department  of Transplantation, First affiliated  hospital of Wenzhou Medical college,   Wenzhou, People’s republic of china;   3Department of surgery, University of  chicago, chicago, Il, Usa *These authors contributed equally to  this article correspondence: hao Yin   Department of surgery, shanghai  changzheng hospital, second   Military Medical University,   415 Fengyang road, shanghai 200003,  People’s republic of china   Tel +86 21 8188 5745   email haoyin.sh@gmail.co mAbstract:  Here, we investigated in diabetic mice the therapeutic effect of monocyte  chemoattractant protein-1 (MCP-1), locally delivered by an electrospun scaffold, on transplanted  islets.",Non-OADS,/arxiv_data1/oa_pdf/b0/d8/ijn-9-985.PMC3933709.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b0/d8/ijn-9-985.PMC3933709.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/d8/ijn-9-985.PMC3933709.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/4c/opth-8-405.PMC3933712.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 405–413Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  405Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S4605 7Self-adjus table glasses in the developing world venkata S Murthy  Gudlavalleti1 Komal Preet Allagh1 Aashrai Sv Gudlavalleti2 1indian institute of Public Health,   Public Health Foundation of india,   Hyderabad, 2Centre for Chronic  Disease Control, Public Health  Foundation of india, New Delhi, india Correspondence: venkata S Murthy  Gudlavalleti   Director, indian institute of Public Health,  Public Health Foundation of india, ANv  Arcade, 1 Amar Cooperative Society,  Kavuri Hills, Madhapur, Hyderabad,   india 500033   email gvsmurthy1956@gmail.co mAbstract:  Uncorrected refractive errors are the single largest cause of visual impairment  globally.",Non-OADS,/arxiv_data1/oa_pdf/f3/4c/opth-8-405.PMC3933712.pdf
Available  from: http://www.unesco.org/new/en/education/themes/leading-the- international-agenda/education-for-all / Millennium Development  Goals.,Non-OADS,/arxiv_data1/oa_pdf/f3/4c/opth-8-405.PMC3933712.pdf
Available from: http://www.un.org/millenniumgoals /.,Non-OADS,/arxiv_data1/oa_pdf/f3/4c/opth-8-405.PMC3933712.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f3/4c/opth-8-405.PMC3933712.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/4c/opth-8-405.PMC3933712.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/ff/ndt-10-325.PMC3933713.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 325–328Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  325Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S5948 1olanzapine use in a manic patient during second  and third trimester pregnancy Lynn Choi soo-Hyun Joo Jong-Hyun Jeong Department of psychiatry, st Vincent’s  Hospital, College of Medicine,    The Catholic University of Korea,   suwon, Korea Correspondence: Jong-Hyun Jeong   Department of psychiatry, st Vincent’s  Hospital, College of Medicine, The  Catholic University of Korea, 93 Ji-dong,  paldal-gu, suwon, 442-723, Korea   Tel +82 31 249 7150   Fax +82 31 248 6758   email anton3@catholic.ac.k rAbstract:  Women with bipolar disorder have a high risk for symptom exacerbation during  pregnancy and the risk is elevated further when mood stabilizers are discontinued.",Non-OADS,/arxiv_data1/oa_pdf/89/ff/ndt-10-325.PMC3933713.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/89/ff/ndt-10-325.PMC3933713.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/ff/ndt-10-325.PMC3933713.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/59/bc/mder-7-023.PMC3933714.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 23–28Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  23ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S6005 6cutting a mediolateral episiotomy   at the correct angle: evaluation of a new   device, the Episcissors-60 RM Freeman1,2 hJ hollands1 lF Barron3 Ds Kapoor4 1Directorate of Obstetrics and  gynaecology, Plymouth hospitals  nhs Trust, Derriford hospital,   2Plymouth University Peninsula  schools of Medicine and Dentistry,   3Directorate of healthcare science  and Technology at Plymouth hospitals  nhs Trust, Derriford hospital,   Plymouth, 4Urogynaecology Unit,   Royal Bournemouth hospital,   Bournemouth, UK correspondence: RM Freeman   Directorate of Obstetrics and  gynaecology, Derriford hospital,  Plymouth Pl6 8Dh, UK   Email robert.freeman@nhs.ne tBackground:  Anal incontinence is nine times more prevalent in women than in men due to  obstetric anal sphincter injury (OASI).",Non-OADS,/arxiv_data1/oa_pdf/59/bc/mder-7-023.PMC3933714.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/59/bc/mder-7-023.PMC3933714.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/9c/ndt-10-317.PMC3933715.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 317–323Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  317OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S5466 3altered baseline brain activity in children   with bipolar disorder during mania state:   a resting-state study Dali lu1 Qing Jiao2 Yuan Zhong3,4 Weijia gao1 Qian Xiao1 Xiaoqun liu1 Xiaoling lin5 Wentao cheng6 lanzhu luo6 chuanjian Xu3 guangming lu2 linyan su1 1Mental health institute of the second  Xiangya hospital, Key laboratory  of Psychiatry and Mental health  of hunan Province, central south  University, changsha, People’s  republic of china; 2Department of  radiology, Taishan Medical University,  Taian, People’s republic of china;  3Department of Medical imaging, Jinling  hospital, Nanjing University school of  Medicine, Nanjing, People’s republic  of china; 4school of Psychology,  Nanjing Normal University, Nanjing,  People’s republic of china; 5school of  Nursing of central south University,  changsha, People’s republic of china;  6Department of Pediatric and geriatric  Psychiatry, Fuzhou Neuropsychiatric  hospital, Fuzhou, People’s republic  of china correspondence: linyan su   Mental health institute of the second  Xiangya hospital, Key laboratory   of Psychiatry and Mental health of   hunan Province, central south University,  139 renmin Middle road, changsha,  410011, People’s republic of china   Tel/Fax +86 731 8529 2474   email childpsy2012@163.co mBackground:  Previous functional magnetic resonance imaging (fMRI) studies have shown  abnormal functional connectivity in regions involved in emotion processing and regulation in  pediatric bipolar disorder (PBD).",Non-OADS,/arxiv_data1/oa_pdf/49/9c/ndt-10-317.PMC3933715.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/49/9c/ndt-10-317.PMC3933715.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/9c/ndt-10-317.PMC3933715.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/04/idr-7-025.PMC3933716.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 25–35Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  25RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/IDR.S3777 3Long-term catheterization: current approaches   in the diagnosis and treatment of port-related  infections  Cesar Bustos1 Aitziber Aguinaga1 Francisco Carmona-T orre2 Jose Luis Del Pozo1,3 1Department of Clinical Microbiology,   2Department of Internal Medicine,   3Division of Infectious Diseases,   Clinica Universidad de Navarra,   Pamplona, Spain Correspondence: Jose Luis Del Pozo   Clinica Universidad de Navarra, Av de Pío  XII, 36, 31008, Pamplona, Navarra, Spain   email jdelpozo@unav.e sAbstract:  Since the first description in 1982, totally implanted venous access ports have   progressively improved patients’ quality of life and medical assistance when a medical condition  requires the use of long-term venous access.",Non-OADS,/arxiv_data1/oa_pdf/10/04/idr-7-025.PMC3933716.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/10/04/idr-7-025.PMC3933716.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/04/idr-7-025.PMC3933716.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/3d/ott-7-297.PMC3933717.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 297–304OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  297Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OTT .S5735 5Prognostic significance of the combined   expression of neutral endopeptidase and dipeptidyl   peptidase iV in intrahepatic cholangiocarcinoma   patients after surgery resection Jianyong Zhu1,* XiaoDong guo2,* Baoan Qiu1 Zhiyan li2 nianxin Xia1 Yingxiang Yang1 Peng liu1 1Department of Hepatobiliary   surgery, navy general hospital,    PLA, Beijing, People’s Republic of  china; 2302 Hospital of PLA, Beijing,   People’s Republic of China *These authors contributed equally   to this work correspondence: Baoan Qiu; Zhiyan li   Fucheng road 6, haidian District,   Department of Hepatobiliary Surgery,   navy general hospital, Pla, Beijing,   100048, People’s Republic of China   Tel +86 106 695 1296   Fax +86 106 695 1296   email qiubaoan2013@163.co mAim:  The aim of this study was to investigate the relationship between the expression of neutral  endopeptidase (NEP) and dipeptidyl peptidase IV (DPP IV) proteins, and the clinical significance  of the two proteins in patients with intrahepatic cholangiocarcinomas (IHCC).",Non-OADS,/arxiv_data1/oa_pdf/cd/3d/ott-7-297.PMC3933717.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets­and­therapy­journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/cd/3d/ott-7-297.PMC3933717.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/3d/ott-7-297.PMC3933717.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/6b/ijn-9-995.PMC3933718.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 995–1003International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  995OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5572 0enrichment of breast cancer stem-like cells   by growth on electrospun polycaprolactone- chitosan nanofiber scaffolds Jennifer sims-Mourtada1 rohina a Niamat2 shani samuel2 chris eskridge2 eric B Kmiec1,2 1center for Translational cancer  research, helen F graham cancer  center and research Institute,   christiana care health services, Inc,   Newark, 2Department of chemistry,   Delaware state University, Dover,    De, Usa correspondence: Jennifer sims-Mourtada   center for Translational cancer  research, helen F graham cancer  center and research Institute,   christiana care health services,   Inc, 4701 Ogletown stanton rd   suite 4300, Newark, De 19713, Usa   Tel +1 302 623 4648   Fax +1 302 623 4314   email jsimsmourtada@christianacare.or gAbstract:  A small population of highly tumorigenic breast cancer cells has recently been  identified.",Non-OADS,/arxiv_data1/oa_pdf/0a/6b/ijn-9-995.PMC3933718.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0a/6b/ijn-9-995.PMC3933718.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/6b/ijn-9-995.PMC3933718.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/17/ott-7-305.PMC3933719.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 305–314OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  305Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5712 6synergism from the combination of ulinastatin  and curcumin offers greater inhibition against  colorectal cancer liver metastases via modulating  matrix metalloproteinase-9 and e-cadherin  expression Fei shen1 Wen-song cai1 Jiang-lin li1 Zhe Feng1 Qi-cai liu2 huan-qing Xiao1 Jie cao1 Bo Xu1 1Department of general surgery,   guangzhou First People’s hospital,   guangzhou Medical University,   guangzhou, People’s republic  of china; 2experimental Medical  research center, guangzhou Medical  University, guangzhou, People’s  republic of china correspondence: Jie cao; Bo Xu   Department of general surgery,  guangzhou First People’s hospital,  guangzhou Medical University,   1 Panfu road, Yuexiu District,   guangzhou 510180, People’s   republic of china   Tel:  +86 159 1576 2586/   +86 139 2273 9975 Fax: +86 020 8104 8888/       +86 020 8104 8000   email aabb97@163.co m;   xubo_cancer@163.co mAbstract:  Liver metastasis is a major cause of mortality in colorectal cancer (CRC).",Non-OADS,/arxiv_data1/oa_pdf/e4/17/ott-7-305.PMC3933719.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e4/17/ott-7-305.PMC3933719.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/17/ott-7-305.PMC3933719.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/70/ijnrd-7-101.PMC3933720.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 101–105International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  101ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S5944 3higher diastolic blood pressure at admission   and antiedema therapy is associated with acute   kidney injury in acute ischemic stroke patients hasan Micozkadioglu Department of Nephrology, Faculty   of Medicine hospital of adana, Baskent  University school of Medicine , adana,  T urkey  correspondence : hasan Micozkadioglu   Department of Nephrology, Baskent  University school of Medicine, Dadaloglu  Mah.",Non-OADS,/arxiv_data1/oa_pdf/6e/70/ijnrd-7-101.PMC3933720.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/6e/70/ijnrd-7-101.PMC3933720.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/70/ijnrd-7-101.PMC3933720.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/44/ndt-10-349.PMC3933721.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 349–354Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  349Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S3954 4New generation multi-modal   antidepressants: focus on vortioxetine   for major depressive disorder Cornelius L Katona1 Cara P Katona2 1Division of Psychiatry, University  College London, 2North Central  London Psychiatry Training  Programme, London, UK Correspondence: Cornelius L Katona   UCL Division of Psychiatry, Charles  Bell House, 67-73 Riding House Street,  London w1w 7eJ, UK   Fax +44 1304 812514   email c.katona@ucl.ac.u kAbstract:  V ortioxetine is a novel antidepressant with effects on multiple 5-HT receptors and  on the serotonin transporter.",Non-OADS,/arxiv_data1/oa_pdf/16/44/ndt-10-349.PMC3933721.pdf
"The US  datasheet ( http://www.accessdata.fda.gov/drugsatfda_docs/ label/2013/204447s000lbl.pd f) recommends reducing the  dose of vortioxetine when giving it in combination with  powerful CYP2D6 inhibitors such as bupropion, fluoxetine,",Non-OADS,/arxiv_data1/oa_pdf/16/44/ndt-10-349.PMC3933721.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/16/44/ndt-10-349.PMC3933721.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/44/ndt-10-349.PMC3933721.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/7c/ndt-10-329.PMC3933722.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 329–338Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  329OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5753 1Psychological morbidity, quality of life,   and self-rated health in the military personnel han-Wei chou1–3 Wen-chii Tzeng4,5 Yu-ching chou6 hui-Wen Yeh4,7 hsin-an chang1,5 Yu-cheng Kao1,8 Nian-sheng Tzeng1,5 1Department of Psychiatry, Tri- service general hospital, school of  Medicine, 2Department of Psychiatry,   Tri-service general hospital, Beitou  Branch, National Defense Medical  center, Taipei, Taiwan; 3Department of  Psychiatry, Tao-Yuan general hospital,   Tao-Yuan, Taiwan; 4Department  of Nursing, Tri- service general  hospital, school of Nursing, 5student  counseling center, 6school of Public  health, National Defense Medical  center, Taipei, Taiwan; 7Department  of Nursing, school of Nursing, Kang- Ning health care and Management  college, Taipei, Taiwan; 8Department  of Psychiatry, Tri- service general  hospital, song-shan Branch, National  Defense Medical center, Taipei, Taiwan correspondence: Nian-sheng Tzeng   Division of community Psychiatry,  Department of Psychiatry, Tri-service  general hospital, 325, sec 2,   chenggong road, Neihu District,   Taipei city 114, Taiwan   Tel +886 287 927 299   Fax +886 287 927 221   email pierrens@mail.ndmctsgh.edu.t wObjective:  The mental health of military personnel varies as a result of different cultural,  political, and administrative factors.",Non-OADS,/arxiv_data1/oa_pdf/c5/7c/ndt-10-329.PMC3933722.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c5/7c/ndt-10-329.PMC3933722.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/7c/ndt-10-329.PMC3933722.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ijwh-6-221.PMC3933723.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 221–234International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  221RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S4681 1New and emerging contraceptives:   a state-of-the-art review Luis Bahamondes M valeria Bahamondes Human Reproduction Unit,   Department of Obstetrics and  Gynaecology, Faculty of Medical  Sciences, University of Campinas and  National Institute of Hormones and  Women’s Health, Campinas, SP , Brazil Correspondence: Luis Bahamondes   Caixa Postal 6181, 13084-971,   Campinas, SP, Brazil   Tel +55 19 3289 2856   Fax +55 19 3289 2440   email bahamond@caism.unicamp.b rBackground:  The first hormonal contraceptive was introduced onto the market in several  countries 50 years ago; however, the portfolio of contraceptive methods remains restricted with  regards to their steroid composition, their cost, and their ability to satisfy the requirements of  millions of women/couples in accordance with their different reproductive intentions, behaviors,  cultures, and settings.",Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ijwh-6-221.PMC3933723.pdf
Available from: http://www.un.org/millenniumgoals /.,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ijwh-6-221.PMC3933723.pdf
Available from: http://clinicaltrials.gov/show/NCT0114021 7.,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ijwh-6-221.PMC3933723.pdf
Available from:  http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid =3133.,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ijwh-6-221.PMC3933723.pdf
Available from: http://clinicaltrials.gov/show/ NCT0158600 0.,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ijwh-6-221.PMC3933723.pdf
"Available from: http://www.conceptfoundation.org/ hormonal-contraception.ph p. Accessed January 9, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ijwh-6-221.PMC3933723.pdf
Available from: http://www.cecinfo.org /.,Non-OADS,/arxiv_data1/oa_pdf/a6/c8/ijwh-6-221.PMC3933723.pdf
